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APOLIPOPROTEIN Ε4 AND ATTENTIONAL CONTROL: UNDERSTANDING THE 
TRAJECTORY OF COGNITIVE AGEING FROM MID-LIFE. 
  
The greatest genetic factor in how well we age cognitively is Apolipoprotein E (APOE), a single 
nucleotide polymorphism with three allelic variants: epsilon-2, epsilon-3 and epsilon-4 
(hereafter ε2, ε3, ε4). The ε4 allele is associated with an increased risk of cognitive 
disadvantage in later life, however, the effects of this variant are not isolated to old-age, with 
some studies reporting cognitive advantages in youth. This thesis investigates the influence of 
APOE ε4 on cognition from mid-adulthood, a point in the lifespan when the detrimental effects 
of this allele may be emerging.   
  
This thesis begins with a systematic review and meta-analysis of the literature to-date, and 
suggests attention may be sensitive to ε4 differences in mid-adulthood, however, effects of the 
allele are not consistently shown, perhaps due to methodological limitations including the use of 
insensitive neuropsychological batteries (Chapter 1). Next, behavioural paradigms providing a 
sensitive index of both selective (Chapter 2) and executive attention (Chapter 3), suggest many 
attentional processes are intact in mid-age (45-55 years) ε4 carriers. Subtle deficits, however, 
are apparent on prospective memory (PM) and Stroop-switch paradigms, indicating a goal 
maintenance disadvantage. In addition, a proxy of cognitive reserve was found to moderate the 
effects of ε4 on executive attention in mid-adulthood (Chapter 4).  Follow-up research used 
paradigms that target the distinct processes supporting focal and non-focal PM to interrogate the 
profile of change observed in mid-age ε4 carriers, identifying a profile of disadvantage 
consistent with that observed in pathological ageing (Chapter 5). PM, however, was not found 
to differentiate ε4 carriers in older individuals at heightened risk of converting to dementia 
(Chapter 6). Collectively, this research provides evidence for a profile of accelerated ageing in 
ε4 carriers, with subtle disadvantages apparent in executive attention by the end of the 5th 
decade.   
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1. General Introduction 
 
Ageing is inevitably associated with some degree of cognitive decline; however, there are 
considerable individual differences, both in the extent and rate of cognitive ageing. The 
consequences of cognitive ageing, including reduced occupational performance and 
impairment in the ability to live independently, motivate investigation into factors influencing 
the trajectory of age-related change (Salthouse, 2012).  Furthermore, with a rising proportion 
of elderly in the population (Office for National Statistics, 2012), the societal impact of 
cognitive ageing is increasing. This thesis focuses on understanding the role of the 
Apolipoprotein-E (APOE) epsilon-4 genetic variant, an established risk factor for poor 
cognitive ageing, on cognitive performance in mid-adulthood.   
 
This general introduction first provides a brief overview of the profile of cognitive change 
characteristic of both healthy and pathological ageing, before introducing the APOE gene and 
the domain-specific effects associated with the ε4 variant in older-adulthood. Specifically, 
attentional control differences are reported in APOE ε4 carriers on sensitive, nuanced 
measures of cognition; therefore how differences within individual attentional processes 
integrate with existing theoretical models of controlled cognition is discussed. The 
introduction then reviews evidence for APOE ε4 genotype effects in youth, and the impact 
these have on theoretical accounts of the association between ε4 and cognitive decline. A 
rationale for studying the emergence of ε4 effects from mid-adulthood is provided, followed 
by the key research aims and article outlines. 
 
1.1 Cognitive ageing: adopting a lifespan approach 
 
Age-related decline is not consistent across cognitive domains; however, the profile of change 
characteristic of ‘healthy’ ageing is well established in the literature. Whilst ‘crystallised’ or 
accumulated cognition (e.g. semantic memory, vocabulary) is relatively resistant to age-
related decline, more ‘fluid’ abilities (e.g. executive function (EF), memory, attention, speed 
of processing) are vulnerable to decline (Kievit et al., 2014; Salthouse, 2009; Salthouse, 
Atkinson, & Berish, 2003; Schaie, 2005). Corresponding changes within the brain, both 
structural (atrophy, loss of white matter integrity) (e.g. Bartzokis, 2004; Lockhart & DeCarli, 
2014; Raz & Rodrigue, 2006) and functional (e.g. Davis, Dennis, Daselaar, Fleck, & Cabeza, 
2007; Motes, Biswal, & Rypma, 2011), offer a biological basis for observed cognitive 
decline. Importantly, the region of these brain changes associate with the differential profile 
of decline across cognitive domains; medial temporal and frontal lobe structures are sensitive 
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to change early in the ageing trajectory, in accordance with the vulnerability of memory and 
EF to age-related decline (Fjell, McEvoy, Holland, Dale, & Walhovd, 2014; Raz et al., 2005).  
 
There is some overlap between healthy cognitive ageing and the profile of change associated 
with late-onset sporadic Alzheimer’s disease (LOAD), the most prevalent form of dementia 
(Kalaria et al., 2008; Rizzi, Rosset, & Roriz-cruz, 2014). While impairment in learning and 
memory is the most salient feature of this disease, EF, attention, language, and perceptual-
motor skills all demonstrate significant decline as the disease progresses (American 
Psychiatric Association, 2013). In addition to neurodegeneration, LOAD is associated with 
the accumulation of Braak pathology in the neocortex (amyloidosis, phosphorylated tau), with 
substantial build up in frontal and medial temporal lobe regions (Braak & Braak, 1991; 
Okamura et al., 2014; Thal, Attems, & Ewers, 2014). The accumulation of amyloid and 
phosphorylated tau however, is not limited to individuals diagnosed with AD, but also present 
in healthy older adults (e.g. Bennett et al., 2006; Fornicola et al., 2014; Jack et al., 2010). 
Furthermore, the greatest risk factor for AD is age (Kawas, Gray, Brookmeyer, Fozard, & 
Zonderman, 2000), supporting the need to consider both healthy and pathological ageing 
along a continuum to further understanding of individual differences in cognitive decline 
(Walhovd, Fjell, & Espeseth, 2014).  
 
Adopting a lifespan approach is necessary for establishing factors influencing how well we 
age cognitively (Walhovd et al., 2014). Although there is some inconsistency in the trajectory 
suggested by longitudinal and cross-sectional research, a continuous process of age-related 
cognitive decline is reported from early adulthood (Salthouse, 2009; Singh-Manoux et al., 
2012; Zimprich & Mascherek, 2010). Brain changes associated with cognitive ageing also 
emerge in early adulthood (Bartzokis et al., 2007; Raz et al., 2005). Hence, interventions 
targeting the initial trajectory of age-associated decline may be the most effective in slowing 
ageing (Salthouse, 2009), as opposed to trying to reverse the symptoms once decline is 
evident.  
 
1.2 Apolipoprotein Ε4  
Apolipoprotein E (APOE), a single nucleotide polymorphism found on chromosome 19, is the 
strongest genetic factor influencing LOAD, and also impacts age-associated cognitive decline 
in the absence of neurodegenerative disease (Corder et al., 1993; Farrer et al., 1997). Of the 
three allelic variants coded by APOE, epsilon-2, epsilon-3, epsilon-4 (henceforth ε2, ε3, ε4), 
the ε4 allele is focused on here due to its disadvantageous effects on later-life cognition. In 
contrast, the less frequently studied ε2 allele is premised to exert protective effects on 
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cognition and neurological function in later life (Corder, Saunders, Risch, Strittmatterl, & 
Schmechel, 1994; Suri, Heise, Trachtenberg, & Mackay, 2013). 
Carrying a copy of the APOE ε4 variant increases risk of AD in a gene dose dependent 
manner; risk of diagnosis increases 2-3 fold in heterogeneous ε4 carriers and 12-fold in 
homozygous ε4 carriers (Corder et al., 1993). Additionally, possession of ε4 allele is 
associated with an earlier age of symptom onset (Corder et al, 1993; Sweet et al., 2012), and a 
more rapid rate of cognitive decline in clinical groups (e.g. Cosentino et al., 2008; Craft et al., 
1998; Hirono, Hashimoto, Yasuda, Kazui, & Mori, 2003). Crucially, disadvantageous effects 
of the ε4 allele are also observed in healthy cognitive ageing (for reviews see Rusted & 
Carare, 2015; Small, Rosnick, Fratiglioni, & Bäckman, 2004; Wisdom, Callahan, & Hawkins, 
2011), hence the relationship between APOE and age more generally should be explored. 
APOE is implicated in multiple physiological functions, including in the metabolism and 
transport of cholesterol, and neuronal repair (Bu, 2009; Mahley, Weisgraber, & Huang, 
2006). Both pathological and non-pathological mechanisms underpin the association between 
APOE ε4 and cognitive ageing, further supporting the need to consider age-related change 
across a continuum. ApoE ε4 is associated with increased accumulation and reduced 
clearance of amyloid in the brain (Mahley et al., 2006)), a key determinant in the cascade of 
change associated with AD. In addition, the ε4 variant is associated with a general loss of 
neurological function, including reduced neuronal repair, reduced synaptic plasticity, 
mitochondrial dysfunction, neuroinflammation and altered neurovascular functions (Liu, 
Kanekiyo, Xu, & Bu, 2013).  
 
1.3 APOE ε4 and Late-life Cognition: Neuropsychological Assessment Measures  
 
The bulk of existing research has utilised neuropsychological assessment tools, designed for 
use in clinical settings, to explore APOE ε4 effects on late-life cognition. These measures 
provide a quick-to-administer assessment of performance on select domains, making them 
suitable for profiling cognition in larger groups. Next, we present an overview of the 
differential profile of APOE ε4 effects across cognitive domains, assessed using 
neuropsychological measures, for LOAD and healthy cognitive ageing.    
 
1.3.1 Pathological Ageing 
 
In LOAD, detrimental effects of APOE ε4 are predominantly reported for episodic memory, 
although not consistently (for a review see Haj et al, 2016). Small sample sizes, and hence 
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low statistical power, are suggested to account for variation in the reporting of ε4 effects in 
episodic memory (Haj et al., 2016). In addition, carrying an ε4 allele is associated with 
longitudinal increases in episodic memory decline (Hirono et al., 2003; Wilson, Bienias, 
Berry-Kravis, Evans, & Bennett, 2002; Wolk & Dickerson, 2010). The same trajectory of 
accelerated decline was not reported for working memory (WM), semantic memory, 
language, processing speed or visuospatial ability (Wilson et al., 2002). Interestingly, EF 
measures do not appear sensitive to APOE ε4 effects in LOAD (van der Vlies et al., 2007; 
Wolk & Dickerson, 2010). Furthermore, increased atrophy of medial temporal lobe regions in 
ε4 carriers is associated with episodic memory disadvantages in this group. A differential 
profile of LOAD-related degradation is reported in non-ε4 carriers, predominantly affecting 
frontal-parietal networks, consistent with the behavioural profile observed (Geroldi et al., 
1999; Wolk & Dickerson, 2010).  
 
Mild cognitive impairment (MCI) represents the transitional stage between healthy cognitive 
ageing and dementia, characterised by objective impairment in at least one cognitive domain 
alongside normal day-to-day functioning (Albert et al., 2011a; Mariani, Monastero, & 
Mecocci, 2007b; R. C. Petersen, 2004). On neuropsychological assessment measures, ε4 
status in individuals diagnosed with MCI is associated with increased impairment in episodic 
memory, fluency and processing speed, and EF measures (Risacher et al., 2013; Whitehair et 
al., 2010). Furthermore, ε4 status is associated with an accelerated trajectory of decline on 
measures of global cognition, WM, memory, fluency and language (Whitehair et al., 2010). 
APOE differences on neuropsychological measures in MCI patients has been linked to 
structural changes in the brain (Farlow et al., 2004), and differences in the deposition of 
amyloid (Risacher et al., 2013).  
 
1.3.2 Healthy ageing  
 
Systematic reviews of APOE ε4 genotype effects in healthy older adulthood report an 
association between ε4 status and cognitive disadvantages (Small et al., 2004; Wisdom et al., 
2011), however, detrimental effects of the variant are not consistently found in the literature 
(Bunce et al., 2014; Bunce, Kivipelto, & Wahlin, 2004; Caselli et al., 2014). Importantly, 
meta-analytic reviews confirm the profile of ε4 effects is not uniform across cognitive 
domains, with the greatest disadvantages seen for episodic memory, global cognition, EF and 
processing speed, while effects appear non-significant for attention, verbal abilities and 
visuospatial abilities (Wisdom et al., 2011). Several studies report effects of ε4 on episodic 
memory (e.g. Caselli et al., 1999; O’Hara et al., 1998; Packard et al., 2007; Staehelin, Perrig-
Chiello, Mitrache, Miserez, & Perrig, 1999). Effects outside of this domain are also reported 
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including on spatial processing (Berteau-Pavy, Park, & Raber, 2007) and WM (Reinvang, 
Winjevoll, Rootwelt, & Espeseth, 2010). Age appears an important determinant in the 
emergence of APOE ε4 effects (Wisdom et al., 2011), with the detrimental effect of ε4 on 
memory (Jochemsen, Muller, van der Graaf, & Geerlings, 2012; Laukka et al., 2013; 
Schiepers et al., 2012), as well as processing speed and global cognition measures increasing 
with age (Laukka et al., 2013). 
1.4 APOE ε4 and Late-life Cognition: Behavioural paradigms 
1.4.1 Sensitivity of cognitive assessment 
One issue with the reliance on neuropsychological assessment measures for detecting 
genotype differences in healthy cognitive ageing is the sensitivity of these tools for detecting 
differences within the bounds of normal cognitive performance. These tools also provide 
assessment at the level of a cognitive domain. Hence, to detect APOE ε4 differences in 
healthy ageing, paradigms capable of sensitively isolating individual cognitive processes may 
be needed to provide a more nuanced understanding. Several studies have used process-
specific paradigms to explore APOE differences in attentional control. These will now be 
reviewed, prefaced by a brief outline of attentional control and associated theoretical models.  
1.4.2 Attentional control 
 
‘Attentional control’ or the ‘executive control of attention’ describes goal directed attention, 
for which ‘top-down’ control mechanisms must be exerted (Petersen & Posner, 2012; 
Treisman & Gelade, 1980). This cognitive ability, importantly, incorporates several distinct 
but interactive sub-processes, for example selective attention, attentional updating, set 
shifting, and response inhibition. Of note, selective attention, WM capacity and goal 
maintenance are viewed as interdependent constructs, involving heightened processing of 
task-relevant information (Kane, Bleckley, Conway & Engle, 2001; Awh, Vogel, & Oh, 
2006; Chun, 2011; Cowan, 1999; Gazzaley & Nobre, 2012). The neural basis of these 
attentional control mechanisms includes prefrontal, cingulate and parietal regions (e.g. Fan, 
McCandliss, Fossella, Flombaum, & Posner, 2005; Hampshire & Owen, 2006; Hopfinger, 
Buonocore, & Mangun, 2000; Osaka et al., 2004; for review see Kane, 2002; Yuan & Raz, 
2014). These regions are vulnerable to age-related change in neural structure and functional 
activity (George Bartzokis et al., 2007; Grady, Springer, Hongwanishkul, McIntosh, & 
Winocur, 2006; Raz, 2000; Rowe et al., 2007; Villemagne et al., 2011).   
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In understanding how attentional control is impacted by age, whilst some theories suggest 
decline is observed as a result of a general slowing of processing ability (Salthouse, 1996), 
others emphasise an additional need to consider age-related change within individual sub-
processes (Verhaeghen & Cerella, 2002). There are several theoretical models of the 
interdependence of attentional control processes. Kane and Engle’s model of executive 
attention comprises two hierarchical processes.  The first actively maintains information as 
short-term memory representations (Simple WM span). The second process combines the 
concepts of executive processing with complex WM span, entailing the controlled processing 
of information in an active state, often in the context of additional task demands.  It includes 
inhibition and attentional set-shifting (Engle & Kane, 2002; Kane, 2002). Similarly, Faust & 
Balota (2007) propose an attentional control framework driven by central attentional set 
maintenance, upon which attentional control acts to enhance or inhibit response pathways. 
The widely cited ‘Unity/Diversity framework’ (Friedman & Miyake, 2015) suggests that 
there is a common executive ability relating to the active maintenance of information within 
attention, which supports additional elements of executive attention including response 
inhibition, updating and attentional-set shifting. A hierarchical account of executive attention 
has recently been proposed (Tiego, Testa, Bellgrove, Pantelis, & Whittle, 2017). This model 
suggests selective attention and inhibition are independent processes dependent on a higher-
order WM construct, with functions analogous to the central executive (reduced interference, 
divided attention, set-shifting and links to long-term memory) (Baddeley, 2012). 
 
1.4.3 Selective attention 
 
Selective or focused attention is often analogized to a ‘spotlight’ mechanism, with a gradient 
of heightened attentional processing surrounding a point of fixation (Posner, 1980). This 
‘spotlight’ of focused attention is needed to maximize the processing of goal relevant 
information whilst minimising interference from the processing of irrelevant information. 
Previous research has found LOAD and healthy cognitive ageing to be associated with 
declines in this attentional process (Cansino, Guzzon, Martinelli, Barollo, & Casco, 2011; 
Gazzaley, Cooney, Rissman, & D’Esposito, 2005; Hasher & Zacks, 1988; S. Kim, Hasher, & 
Zacks, 2007; Perry & Hodges, 1999). In healthy ageing, this manifests as a deficit in 
exclusively processing goal-relevant information in the presence of distractors.  
 
In older adulthood, carriers of an APOE ε4 variant demonstrate performance differences on 
visual search and spatial WM tasks consistent with accelerated or premature age-related 
impairment. During visual search, the use of spatial cues to actively adjust the breadth of 
selective attention, and hence minimise the processing of irrelevant information, is referred to 
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as attentional scaling (Greenwood & Parasuraman, 2004). Independent of genotype, ageing is 
associated first with an increase in dependence on top-down information to guide attentional 
scaling, followed by a decrease in the ability to use top-down information to more efficiently 
search (Parasuraman, Greenwood, & Alexander, 2000). APOE ε4 carriers in late-mid 
adulthood (aged 50 years and older) demonstrate reduced utilisation of attentional scaling 
consistent with a profile of premature ageing (Greenwood, P M, Sunderland, T., Friz, J., & 
Parasuraman, 2000). In addition, homozygous ε4 carriers showed a longitudinal reduction in 
attentional scaling across three years, which was absent in heterozygous ε4 carriers and non-
ε4 carriers (Greenwood, Sunderland, Putnam, Levy, & Parasuraman, 2005).  
 
On a simple spatial WM task requiring no active manipulation of stored information, older ε4 
carriers demonstrate poorer retrieval accuracy on trials with the highest discrimination 
difficulty (Greenwood, Espeseth, Lin, Reinvang, & Parasuraman, 2014). A smaller sample 
was followed longitudinally over 3 years; ε4 carriers demonstrated significant decline in 
performance, relative to non-ε4 carriers, consistent with a profile of accelerated ageing 
(Greenwood et al., 2014). Furthermore, Espeseth and colleagues (2008) report APOE 
genotype differences in older adults on a visual discrimination task (Parasuraman, 
Greenwood, Haxby, & Grady, 1992). The task required participants to search for a target 
stimulus amid an array of distractors, with a neutral, valid, invalid or no cue presented to aid 
performance. APOE ε4 status was associated with longer RTs for invalid cues, associated 
with reduced white matter volume. Follow-up research using a selective attention ‘odd-ball’ 
task reported lower accuracy in ε4 carriers (Thomas Espeseth et al., 2012).  
 
1.4.4. Attentional maintenance, shifting and inhibition 
 
The behavioural phenotype of LOAD is characterised by deficits in more complex attentional 
processes including the division of attention between multiple task goals and set shifting 
(Baddeley, Baddeley, Bucks, & Wilcock, 2001; Perry & Hodges, 1999; Sebastian, Menor, & 
Elosua, 2006). In addition, these processes are vulnerable to age-related change (e.g. Milham 
et al., 2002; Rodríguez-Aranda & Sundet, 2006; Wasylyshyn & Sliwinski, 2011). 
Performance on a Stroop-switch paradigm targeting goal maintenance, shifting and inhibition 
was found to be a reliable marker of LOAD diagnosis (Hutchison, Balota, & Ducheck, 2010), 
and had predictive utility for the subsequent development of the disease (Balota et al., 2010).  
 
Wetter et al., (2005) reported an effect of APOE ε4 on Stroop-switch performance in older 
adulthood.  Participants completed a computerised Stroop paradigm including distinct 
inhibition (incongruent trials) and inhibition plus switching (incongruent trials plus rule 
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switch) conditions. Relative to their ε3 peers, ε4 carriers selectively demonstrated greater 
errors for the condition with combined inhibition and switching demands, indicative of 
deficits in attentional set shifting. Furthermore, on a speeded category decision task assumed 
to load on attentional control processes, amyloid deposition was reported to mediate the 
relationship between APOE ε4 and errors (Aschenbrenner et al., 2015). Ε4 carriers (aged 50-
79 years) demonstrate poorer performance on an Operation Span task (Turner & Engle, 
1989), a measure of WM requiring divided attention, and hence executive control.  
 
1.4.4.1 Prospective memory 
 
Prospective memory (PM), pervasive in day-to-day life, is the timely retrieval of an earlier-
formed intention whilst engaged in ongoing cognitive activity. Non-focal PM, when retrieval 
of the intention involves processing distinct from ongoing cognitive activity, is a 
demonstration of attentional control in an everyday context. Executive processes are required 
to maintain multiple goals at the forefront of attention and actively monitor for the PM cue 
(Einstein et al., 2005; McDaniel, Umanath, Einstein, & Waldum, 2015; Scullin, McDaniel, 
Shelton, & Lee, 2010). Non-focal retrieval is mediated by the available executive resource, 
and supported by frontal, parietal and cingulate regions of the brain (Cona, Bisiacchi, Sartori, 
& Scarpazza, 2016; Cona, Scarpazza, Sartori, Moscovitch, & Bisiacchi, 2015; McDaniel, 
LaMontagne, Beck, Scullin, & Braver, 2013). Focal PM, or retrieval of a PM intention 
processed as an integral part of the ongoing cognitive activity, relies on ‘bottom-up’ attention 
and associative memory processes, mediated by mediated by occipital, parietal (Cona et al., 
2016) and temporal lobe regions (McDaniel et al., 2013).  
 
Healthy ageing is associated with select impairment in non-focal PM (for reviews see Henry, 
MacLeod, Phillips, & Crawford, 2004; Kliegel, Jäger, & Phillips, 2008), whereas individuals 
with MCI or in the early stages of LOAD demonstrate an additional impairment in focal PM 
(Blanco-Campal, Coen, Lawlor, Walsh, & Burke, 2009; Costa, Caltagirone, & Carlesimo, 
2011; Duchek, Balota, & Cortese, 2006; McDaniel, Shelton, & Breneiser, 2012). Thus far, 
research exploring APOE genotype effects on PM across the lifespan are mixed. In mild 
LOAD ε4 carriers demonstrate significant impairment on a focal PM task consistent with this 
variant exaggerating the impairment seen in LOAD (Duchek et al., 2006), however null 
effects of genotype were reported in a sample of healthy older adults (McDaniel et al., 2012).  
 
1.5 APOE ε4 earlier in the lifespan 
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The effects of APOE on cognition are not restricted to later life. Indeed, there is some support 
for ε4 carriers showing cognitive advantages in youth, supported by naturalistic studies 
reporting higher IQ and greater educational achievement in this group (Hubacek et al., 2001; 
Yu, Lin, Chen, Hong, & Tsai, 2000). Reports of beneficial effects in youth are inconsistent 
with the negative effects of APOE ε4 in later life, suggesting a change in the expression of 
this gene across the lifespan. This emphasizes the need to consider the cumulative impact of 
the ε4 allele across the lifespan (Rusted & Carare, 2015).  
 
Reviewing laboratory studies of APOE genotype effects on cognition in youth provides mixed 
evidence in favor of ε4 advantages. Several studies report equivalent performance across 
APOE genotype groups in children on measures of IQ and academic ability (Acevedo, Piper, 
Craytor, Benice, & Raber, 2010; Bloss, Delis, Salmon, & Bondi, 2010; Ruiz et al., 2010; 
Turic, Fisher, Plomin, & Owen, 2001). An Age x APOE interaction, however, was reported 
on a neuropsychological test battery; specifically homozygous ε4 carriers aged 8 years and 
younger were disadvantaged on EF and WM measures, whilst performance was equivalent or 
better in this group over the age of 8 years (Chang et al., 2016). This highlights the need for 
longitudinal assessment of how APOE effects change developmentally.  
 
In young adults, ε4 advantages are consistently reported on verbal fluency measures 
(Alexander et al., 2007; Han et al., 2007; Marchant, King, Tabet, & Rusted, 2010a; Puttonen, 
Elovainio, Kivimäki, Lehtimäki, & Keltikangas-Järvinen, 2003). Several other studies report 
null effects of the variant across a wider range of measures (Bunce et al., 2014; Dennis et al., 
2010; Jorm et al., 2007; Reiman et al., 2004; Taylor et al., 2011). Indeed, an earlier meta-
analytic review of the literature reported limited evidence for ε4 advantages prior to 35 years 
of age (Ihle, Bunce, & Kliegel, 2012), with the null effect size consistent across tasks 
categorized as both low and high executive demand.  
 
One issue consistently arising across the APOE literature is the validity of using 
neuropsychological assessment tools to detect subtle differences in healthy individuals. 
Behavioural paradigms designed to provide a nuanced measure of individual cognitive 
processes, as opposed to domains, in healthy adults are sensitive to ε4 advantages in youth. 
For example, ε4 carriers (mean age 23 years) demonstrate subtle advantages on a delayed 
episodic memory task probing face-profession associations, however, no differences were 
seen on a measure of WM (Mondadori et al., 2007). Further research, however, provides no 
support for APOE ε4 differences on episodic memory paradigms in youth (Filippini et al., 
2009; Suri et al., 2015). Support for ε4 advantages in spatial processing, reliant on 
hippocampal functioning, is also mixed. While no ε4 differences were recorded on word-list 
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learning (an index of episodic memory), ε4 carriers demonstrated spatial memory advantages 
on tasks including a virtual water maze, mental rotation task and object location task in adults 
aged 19-35 years (Stening et al., 2016). On an object location virtual arena memory task, 
young ε4 carriers demonstrated altered navigational strategies in association with disrupted 
functioning of grid-cell representations in the entorhinal cortex (Kunz et al., 2015). 
 
1.5.1 Young ε4 carriers and attentional control 
 
Focusing on attentional control, there has been some evidence for ε4 advantages in youth 
when probed with more nuanced behavioural measures. A rapid visual information processing 
task (RVIP), loading on attentional updating, demonstrated an ε4 advantage in target 
detection (Rusted et al., 2013). In addition, young ε4 carriers showed reduced cost of invalid 
spatial cues on a measure of covert attention (Rusted et al., 2013). Hence, it seems ε4 
advantages are present when using more nuanced measures of cognitive performance, with 
differences demonstrated in both memory and attention (executive and perceptual). In a 
slightly older sample (aged 20-40 years), ε4 status was associated with select disadvantages in 
episodic memory and attentional shifting (indexed using a More-Odd shifting task) (Nao et 
al., 2017). Genotype differences in WM and inhibition were non-significant.  
 
APOE ε4 genotype differences in PM in youth have been explored in association with the 
cholinergic agonist nicotine; a neurotransmitter system affected by the gene (Poirier et al., 
1995).  On a card-sort measure of non-focal PM, demanding of attentional control, ε4 carriers 
demonstrated greater retrieval accuracy following nicotine administration (Marchant et al., 
2010a). Follow up research, again probing the effect of nicotine on PM performance, did not 
find overall ε4 advantages on the task. Selectively for PM retrieval trials, however, nicotine 
advantaged ε4 response times (RTs), associated with increased extrastriate blood-oxygen-
level-dependent (BOLD) activations suggestive of increased bottom-up processing (Evans et 
al., 2013). Performance on a focal measure of PM, distinguished by a reliance on automatic, 
associative memory processes, was insensitive to genotype difference in youth (Duchek et al., 
2006).  
 
1.6 Theoretical accounts for the role of APOE ε4 in cognitive ageing  
 
Multiple theories have been proposed to account for the influence of APOE on cognition in 
the absence of LOAD. One option is that APOE ε4 represents a LOAD prodrome, with this 
genetic factor predisposing carriers to develop the disease (Smith et al., 1998). Hence, 
individuals with preclinical LOAD pathology and neurodegeneration may skew the effects of 
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APOE ε4 observed in older adulthood. The prodrome of LOAD typically begins 6-7 years 
prior to clinical symptoms, with the mean age of LOAD diagnosis currently 77.4 years old 
(Wilson et al., 2011), and so this explanation struggles to deal with cognitive differences in ε4 
carriers earlier in the lifespan, as well as effects reported in the absence of LOAD pathology. 
Furthermore, although evidence for ε4 advantages in youth is inconsistent, these do not align 
with the prodrome account.  
 
An alternative explanation is that APOE ε4 is linked to a cognitive phenotype (Greenwood, 
Lambert, Sunderland, Parasuraman, 2005; Negash et al., 2009), defined by a profile of 
behavioural symptoms independent of LOAD pathology. A general mechanism for APOE 
effects across the lifespan is required, hypothesised to stem from the physiological role of 
apoE in cholesterol and neuronal repair (Mahley et al., 2006). Carrying an ε4 variant is 
associated with an accelerated trajectory of de-myelination from the 5th decade (Bartzokis, 
2007), leaving individuals vulnerable to cognitive insult, and hence this would explain effects 
of ε4 from mid-adulthood. Advantages in youth may be explained by some form of early 
compensatory strategy that cannot be maintained across the lifespan (Greenwood et al., 
2014). Furthermore, not necessarily exclusive of the cognitive phenotype account, APOE ε4 
carriers may undergo premature or accelerated ageing. In support, BOLD activations reported 
in youth and mid-adulthood are consistent with an early compensatory shift similar to those 
seen in older-adulthood (Evans et al., 2014; Rusted et al., 2013). In addition, the differential 
effects of ε4 status on selective attention in mid-adulthood are comparable to those seen in 
older adults (Greenwood, Sunderland, Putnam, Levy, & Parasuraman, 2005). Whilst ε4 
carriers are reported to show greater decline in structural and cognitive measures (e.g. Cohen, 
Small, Lalonde, Friz, & Sunderland, 2001; Espeseth et al., 2008; Moffat, Szekely, 
Zonderman, Kabani, & Resnick, 2000), longitudinal research is needed to establish a profile 
of accelerated ageing across the lifespan.   
 
The changes associated with advantaged performance in youth may also be important for 
establishing a mechanism for emergent disadvantageous effects. For example, although 
Mondadori et al. (2007) reported decreased hippocampal activation across learning runs in ε4 
carriers, consistent with increased neural efficiency, several studies have reported greater 
activations in the absence of behavioural effects (Dennis et al., 2010; Filippini et al., 2009; 
Rusted et al. 2013). Although difficult to interpret in the absence of a cognitive difference, it 
may be that ε4 carriers are over-activating from youth. In addition, ε4 carriers have 
demonstrated medial temporal lobe recruitment, unrelated to task demands, indicative of 
unspecialized compensatory recruitment (Rusted et al., 2013). Hence, the functional 
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activation differences reported in young ε4 carriers are not inconsistent with carriers 
demonstrating premature ageing.  
 
An additional account of APOE ε4 in cognitive ageing is that this gene represents an example 
of antagonistic pleiotropy, according to which the effects of ε4 transition from advantageous 
to disadvantageous across the lifespan (Han & Bondi, 2008). Longitudinal lifespan research is 
needed to firmly establish this theory. In addition, cognitive advantages in youth are not yet 
well established.  
 
1.7 Mid-adulthood: a critical window for APOE effects? 
 
Mid-adulthood is a critical window for understanding cognitive ageing, as individual 
differences in early cognitive decline may first be detectable at this point.  In the adult 
lifespan, vulnerability triggered by the influence of genetic factors, the environment and 
vascular ageing may alter the pathway of both neurological and cognitive decline (Finch, 
2009; Herrup, 2010).To date, the influence of APOE at this stage of the lifespan is not clearly 
established. This thesis investigates how APOE genotype influences early cognitive ageing, to 
establish if cognition is sensitive to APOE ε4 genotype in mid-adulthood. In relation to the 
cognitive advantages reported in attention and memory in youth, ε4 differences may manifest 
as advantages in select cognitive processes only. By mid-adulthood, however, subtle 
disadvantages in ε4 carriers may emerge, supporting a profile of premature and/or accelerated 
cognitive ageing. Additional risk factors for cognitive decline, including vascular ageing, 
begin to impact cognitive from the 5th decade (Waldstein et al. 2008; Pace et al, 2010; Debette 
et al, 2011; Mitchell et al, 2011), which may further moderate the presence of ε4 effects in 
mid-adulthood.  
 
1.8 Research questions and article outline 
 
The present thesis explores two key questions: 1) Does APOE genotype differentially impact 
cognitive ageing from mid-adulthood? Included articles predominantly focus on the ε4 
differences apparent by mid-adulthood, a crucial window of the lifespan when impairment 
may first be detectable. In addition, there will be some consideration of the protective ε2 
allele to further understanding of how APOE variants independently contribute to behavioural 
change. 2) Does the APOE ε4 variant selectively impact specific cognitive processes? Focus 
will be on attentional control processes, and to the impact of change on everyday functioning 
in individuals experiencing mild cognitive deficits. The thesis also explores how additional 
factors mitigating cognitive ageing might moderate APOE effects early in the lifespan.  
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Article 1 provides a systematic and meta-analytic review of the literature to date, 
investigating the effects of APOE ε4 on cognition in mid-adulthood. The review collectively 
considers ε4 performance differences on both established neuropsychological assessment 
measures and computerised cognitive paradigms, as well as the influence of this variant on 
longitudinal cognitive change. The principle aims of this review are to establish: a) Is 
cognition sensitive to APOE ε4 effects in mid-life, b) Is there a differential profile of 
sensitivity across cognitive domains? In addition, this article highlights methodological 
shortcomings in the existing literature, important in shaping the subsequent empirical work of 
this thesis. 
 
Previous research using sensitive behavioural paradigms identified attentional control as 
sensitive to APOE ε4 effects in youth and middle age. Articles 2 and 3 report the use of six 
behavioural paradigms exploring APOE genotype differences in selective attention and more 
executive attention respectively. In light of the methodological limitations identified in 
Article 1, these articles independently compare all three variants of the APOE gene (ε2, ε3, 
and ε4) in volunteers, aged 45-55 years. Importantly, whilst ε2 genotype differences were 
reported in measures of visual search and sustained attention, performance of ε4 carriers was 
equivalent aside from on two tasks: a non-focal PM task and a Stroop-switch task. Together, 
this was interpreted as ε4 carriers showing a subtle disadvantage on the ability to maintain 
multiple goals at the forefront of attention. Following this, the thesis directly pursues APOE 
differences in tasks loading on this element of executive attention. 
 
One of the challenging issues in ageing research is the complexity of additional factors 
impacting cognitive decline. Article 4 presents an exploratory analysis of how lifestyle factors 
such as occupational complexity and leisure activities, physical activity and vascular health 
moderate the emergence of APOE genotype effects on executive attention in mid-adulthood. 
In line with predictions, cognitive reserve proxies are reported to benefit ε4 carriers goal 
maintenance abilities to a greater extent than their ε3 peers in mid-adulthood, demonstrating 
the importance of this factor in individual differences from early in the ageing trajectory. 
Non-significant effects of physical activity and physiological health are reported.  
 
Article 5 uses the distinction between non-focal and focal PM to explore age-related cognitive 
change in APOE ε4 carriers. PM paradigms provide an interesting framework for exploring 
genotype effects in mid-adulthood due to the distinct profile of impairment associated with 
healthy and pathological ageing. Specifically, Article 5 asks is ε4 associated with a cognitive 
phenotype of premature ageing or vulnerability consistent with the preclinical stages of 
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LOAD. The study includes a cross-sectional comparison of young and mid-age adults to infer 
the extent of age-related change. In addition, the study includes a manipulation of WM load 
to examine if increasing the burden on attentional control exaggerates ε4 differences in mid-
adulthood. Results indicate equivalent performance on PM retrieval accuracy between groups, 
however, the interference costs of carrying both a focal and non-focal PM intention were 
greater in mid-age ε4 carriers, consistent with the profile seen in pathological cognitive 
ageing. This suggests early vulnerability in ε4 carriers to change in processes that are also 
vulnerable to LOAD.  
 
Through several studies in this thesis, non-focal PM consistently demonstrated sensitivity to 
the effects of APOE ε4 in mid-adulthood. The final article (Article 6) explores whether 
performance differences on a non-focal PM paradigm are also seen in an ‘at-risk’ group of 
individuals, defined as those visiting a memory assessment clinician to report symptoms of 
mild cognitive decline, and the impact of APOE genotype differences in this group. There are 
numerous examples of PM in everyday functioning, and so as an additional goal, this research 
explores how non-focal performance correlates with subjective reports of cognitive failings in 
daily activity. There were no significant performance differences on a non-focal PM measure 
in this ‘at-risk’ group, however, in line with predictions, PM retrieval accuracy correlated 
with reports of attentional control in daily life.  APOE genotype did not moderate 
performance differences at this later stage of the lifespan. 
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2. Article 1  
 
The elusive nature of APOE ε4 in mid-adulthood: 
understanding the cognitive profile 
 
Article 1 is published in the Journal of the International Neuropsychological Society as: 
 
Lancaster, C., Tabet, N., & Rusted, J. (2017). The elusive nature of APOE ε4 in mid-
adulthood: understanding the cognitive profile. Journal of the International 
Neuropsychological Society, 23(3), 239-253. 
.  
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2. 1 Abstract 
 
Objective: The APOE ε4 allele is an established risk factor for dementia, yet this genetic 
variant is associated with a mixed cognitive profile across the lifespan. This paper undertakes 
both a systematic and meta-analytic review of research investigating APOE-related differences 
in cognition in mid-adulthood, when detrimental effects of the allele may first be detectable. 
Method: 36 papers investigating the behavioural effects of APOE ε4 at mid-age (defined as a 
mean sample age between 35-60 years) were reviewed. In addition, the effect of carrying an ε4 
allele on individual cognitive domains was assessed in separate meta-analyses.  
Results: The average effect size of APOE ε4 status was non-significant across cognitive 
domains. Further consideration of genotype effects indicates preclinical effects of APOE ε4 may 
be observable in memory and executive functioning. 
Conclusions: The cognitive profile of APOE ε4 carriers at mid-age remains elusive. Whilst 
there is support for maintained ε4 performance until the 5th decade, studies administering 
sensitive cognitive paradigms indicate a more nuanced profile of cognitive differences. 
Methodological issues in this field preclude strong conclusions, which future research must 
address, as well as considering the influence of further vulnerability factors on genotype effects.  
 
Keywords: Cognitive Ageing, Middle-aged, Neuroimageing, Alzheimer Disease, Memory, 
Executive Function 
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2.2 Introduction 
Pathological cognitive ageing is an increasing problem worldwide, with 850,000 cases 
of Alzheimer’s disease (AD) at present in the UK alone. With prevalence expected to double 
within the next 20 years (Alzheimer’s society, 2016), understanding the risk factors associated 
with dementia is crucial. The Apolipoprotein E (APOE) epsilon 4 (ε4) allele is the leading 
genetic risk factor for late-onset Alzheimer’s disease (Corder et al., 1993; Farrer et al., 1997). 
This variant of the APOE gene constitutes one of the three APOE alleles (ε2, ε3 and ε4), present 
in approximately 25% of the population (Mahley, 1988).  
 
Systematic reviews of studies including healthy older adults support an association 
between possession of an ε4 allele and cognitive impairment in ageing more generally (Small et 
al., 2004; Wisdom et al., 2011), although not all studies are consistent in reporting this effect 
(Bunce et al., 2014; Bunce, Kivipelto, & Wahlin, 2004; Caselli et al., 2014).  The association 
between ε4 and healthy cognitive ageing suggests the effects of this variant are not solely linked 
to neuropathology, and so a dimensional approach is needed to consider the overlap between 
healthy and pathological ageing (Walhovd et al., 2014). Potentially accounting for inconsistency 
within the older-adult literature, meta-analyses of study effect sizes suggest APOE-related 
differences are small and limited to certain classes of cognitive task, including global cognition, 
episodic memory, perceptual speed and executive function (EF) (Small et al., 2004; Wisdom et 
al., 2011). Age and gene-dose are also implicated as important moderators of ε4 effects (Small 
et al., 2004). These factors are important for how we approach understanding APOE genotype 
differences.  
 
Curiously, the detrimental effects of APOE ε4 are not consistent across the lifespan, 
muddying attempts to explain the causality of this risk factor for decline. In naturalistic 
research, ε4 carriers (henceforth ε4+) were reported to have higher IQ and greater educational 
achievement than ε4 non-carriers (henceforth ε4-) (Hubacek et al., 2001; Yu, Lin, Chen, Hong, 
& Tsai, 2000). This led to the hypothesis that ε4+ may show cognitive advantages earlier in life, 
with performance advantages similarly being demonstrated in some (Alexander et al., 2007; 
Han et al., 2007; Schultz et al., 2008), although not all (Bunce et al., 2014a; Bunce, Anstey, 
Burns, Christensen, & Easteal, 2011; Jorm et al., 2007) studies assessing genotype differences 
with neuropsychological batteries. Importantly, no steps have been taken to explore the 
potential moderating effects of early-life IQ and education on the trajectory of cognitive ageing 
in ε4+ through longitudinal research.   
 
A meta-analytic review found no conclusive support for an ε4 advantage in younger 
years (Ihle, Bunce, & Kliegel, 2012); however, the authors acknowledge conclusions may stem 
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from the predominant inclusion of studies using quick to administer behavioural assessments. 
Such assessments are typically used for detecting clinically relevant cognitive differences rather 
than the subtle changes expected in young healthy adults. When considering evidence from 
research paradigms designed to sensitively index select cognitive processes, ε4+ advantages 
have been reported. Young ε4+ showed behavioural advantages compared to ε4- on a delayed 
episodic memory measure (Mondadori et al., 2007). Furthermore, Marchant, King, Tabet, & 
Rusted (2010) demonstrated an ε4 advantage in 18-30 year olds across a number of domains 
including prospective memory, decision-making and sustained attention. Advantages in 
sustained attention were replicated in a further study (Rusted et al., 2013), which also reported 
ε4 advantages in covert attention (Rusted et al., 2013). In addition, ε4+ show EF advantages up 
until age 50 (Taylor et al., 2016). While carrying an ε4 allele might promote cognitive 
advantages in youth, it is important to understand how early differences cumulatively impact on 
the ageing trajectory of ε4+.   
 
This review attempts to unravel the development of APOE ε4 cognitive effects by 
considering studies recruiting healthy mid-age volunteers. Mid-adulthood, as well as being 
influenced by the cumulative impact of APOE ε4 in younger years, may represent a stage when 
the detrimental effects of carrying this gene are first appearing. Additionally, mid-adulthood 
represents a period of emergence for further risk factors for dementia (e.g. vascular health), 
which may modulate the trajectory of cognitive ageing. By studying the impact of risk factors 
for cognitive decline during mid-adulthood, there is the potential to facilitate the early 
identification and prevention of cognitive decline. In combination, these motivations emphasise 
the theoretical interest of studying the effects of APOE ε4 at mid-age.  
 
Here, we present a systematic review of research investigating APOE differences in 
mid-adulthood, including studies administering neuropsychological assessment measures, 
process-specific paradigms, and those assessing change in cognition over time. In addition, ε4 
differences in individual cognitive domains are subject to a meta-analytic review. 
 
2.3 Methods 
 
2.3.1 Selection of studies 
 
This review was conducted in accordance with the Helsinki declaration.  A literature 
search of 3 databases (PsychInfo, Web of Science and Scopus) was conducted, using search 
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terms including ‘APOE’, ‘Apolipoprotein’, ‘cognitive’, ‘cognition’, and ‘performance’ 1.  The 
search was limited to articles published post-1993 as this was when the link between APOE and 
detrimental cognitive ageing was first identified (Corder et al., 1993). Articles referenced by 
included papers were also considered if they aligned with the search criteria of this review. The 
last update for the search was conducted in July 2016.  An overview of the search procedure is 
given in Figure 2.1. 
 
 
2.3.2 Eligibility criteria 
 
Studies were included in the review if they met the following criteria: (1) The study 
included volunteers grouped by APOE genotype, enabling the comparison of ε4+ to an ε4- 
group. (2) The mean age of volunteers in the study falls between 35-60 years. If no mean was 
available, the entire age range included must fall within 35-60 years. (3) The study included 
cognitively healthy adult volunteers. Studies including clinical groups, for example diagnosed 
with dementia, neural trauma or a psychiatric condition were excluded. (4) At least one 
objective measure of cognition must be included. (5) The study was published in English. In 
some cases, studies overlapped in reporting cognitive performance of the same sample, and so 
some papers were omitted from the review (e.g. Caselli, Chen, Lee, Alexander, & Reiman, 
2008; Zuelsdorff et al., 2013).  
 
Papers were included in the meta-analytic review if sufficient statistical data was 
provided for calculating the standardised effect size of carrying an ε4 allele on cognitive 
performance (mean, standard deviation (sd)) compared to an ε4- group. Study outcomes were 
included if task performance could be summarised by a measure of accuracy. Authors were 
contacted where insufficient data was provided.  
 
																																																								1 The exact search terms were as follows: (Apolipoprotein E OR apoe OR Apoliopoprotein-E) AND 
(Cognition OR Behaviour OR Memory OR Performance OR Executive OR Attention OR Mid-age OR 
Adult OR Mid-adulthood). These key words must be found in the title or abstract of identified papers. 	
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Figure 2.1. Flow chart of study selection process for review of APOE effects in mid-adulthood.  
 
2.3.3 Organisation of studies 
 
36 studies met criteria for being included in this review, 23 of which were included in 
the meta-analysis. Separate meta-analyses were completed for performance in 7 cognitive 
domains (global cognition, memory, executive abilities, verbal fluency, language, visuospatial 
processing and processing speed). For the narrative review, studies were considered more 
broadly as those using neuropsychological assessment measures, those that administered more 
detailed research paradigms and longitudinal assessments. 
 
2.3.4 Statistical analysis 
For the outcome of each task included in the meta-analytic review, Hedge’s g was 
calculated as the difference in mean performance between ε4+ and ε4-, divided by the pooled 
sd. The unbiased estimate (Hedge’s d) was used in the analysis, with a positive effect size 
indicating stronger performance by the ε4+ group. In studies reporting multiple performance 
outcomes per cognitive domain, effect sizes were averaged across tasks (Borenstein, Hedges, 
Higgins, & Rothstein, 2009; De Costa, 2009) to prevent the average effect size being over-
biased by one sample. Multiple effect sizes were included when studies included more than one 
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sample of ε4 + and non-ε4 + grouped by another variable such as ethnicity or age (e.g (Blair et 
al., 2005; Shin et al., 2014). For each domain, a random-effects meta-analysis was completed. 
Tests of homogeneity were completed for each domain (QT, and I2) to check the validity of the 
model. A significant Q statistic indicates a non-homogenous distribution of effect sizes. The I2 
was used to further validate this statistic, as it is not dependent on the number of studies 
included. Where heterogeneity was detected, data was screened for outliers based on the 
standardised weight of residuals and the difference excluding a study made to heterogeneity.  
 
Results 
 
Table 2.1 presents a summary of cross-sectional studies included in this review, 
including details of the sample demographics and cognitive tasks administered. A further 
summary of the studies included in each meta-analysis and the associated effect sizes are shown 
in Table 2.2  
 
2.4.1 Meta-analyses 
 
A summary of the results from each meta-analytic model is provided in Table 2.3.  
Forest plots demonstrating the distribution of effect sizes per domain are shown in Figure 2.2. 
 
2.4.1.1 Global 
 
A meta-analysis of effect sizes from 9 studies assessing global cognition found carrying 
an ε4 allele had a non-significant effect on performance, d=.03, p>.05. Tests for homogeneity 
indicated moderate heterogeneity in the individual studies’ effect sizes, Q(8)=15.88, p=.044, 
I2=48.36%. Data was screened for outliers, with a sample aged 55-64 years (Shin et al., 2014) 
identified as substantially increasing heterogeneity. With this effect size removed, carrying an 
ε4 allele had a positive effect on global cognitive performance in mid-adulthood, with the effect 
size approaching significance, d=.09, p=.066 (Q(7)=5.20, p>.05, I2=0%). 
 
2.4.1.2 Memory 
 
Effect sizes from 20 studies were included in a meta-analysis of APOE ε4 effects on 
memory; ε4 status had a non-significant effect on performance (d=-.01, p>.05). Again, there 
was moderate heterogeneity in the sample of effect sizes, Q(19)=48.38, p<.001, I2=10%. After 
screening for outliers the effect size from Levy et al., (2004) was removed, but the average 
effect size remained non-significant (d=-.01, p>.05)(Q(18)=17.40, p>.05, I2=0%).  
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2.4.1.3 Executive abilities 
 
Effect sizes from 12 studies were included in a meta-analysis of APOE ε4 effects on 
executive skills. ε4 status did not significantly influence performance (d=-.03, p>.05). There 
was no significant heterogeneity in this collection of effect sizes, Q(11)=8.60, p>.05, I2=0%. 
 
2.4.1.4 Verbal fluency 
 
10 studies contributed effect sizes to a meta-analysis of ε4 effects on fluency 
performance. The average effect of APOE genotype was non-significant (d=.02, p>.05). There 
was no significant heterogeneity in this sample of effect sizes, Q(9)=8.17, p>.05, I2=21.25%. 
 
2.4.1.5 Language 
 
Effect sizes from 8 studies were included in a meta-analysis which found no significant 
effect of carrying an ε4 allele on language performance (d=.00, p>.05). There was no significant 
heterogeneity in this sample of effect sizes, Q(7)=6.81, p>.05, I2=26.65%. 
 
2.4.1.6 Visuospatial 
 
Effect sizes from 5 studies were included in the meta-analysis. There was no significant 
effect of carrying an ε4 allele on visuospatial performance (d=-.01, p>.05), with non-significant 
heterogeneity reported in the sample of effect sizes, Q(4)=2.78, p>.05, I2=11.96%. 
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Table 2.1. Overview of cross-sectional studies investigating APOE genotype differences in mid-adulthood.  
 
First Author 
(year) 
n 
Age: 
mean 
(range) 
Gender 
(% M) Ethnicity 
Cognitive 
domains Neuropsychological tasks Zygosity 
Bender (2012) 72 50  (19-77) - 
74% Caucasion, 
26% other. 
G, EM, EA, 
PS 
MMSE, Word recognition task (individual, 
paired association), Size judgement span, 
Spatial recall, Listening span, n-back; Letter 
same-different (PS), Pattern same-different 
(PS) 
ε4- vs. ε4+ (ε3/ε3, vs. ε3/ε4, ε4/ε4) 
Blair (2005) 6810 56  (45-64) 
51 6202 Caucasian EM, EA, 
VF DWR, DSS, VF 
1.  ε2+ vs. ε3 vs. ε4 He vs. ε4 Ho 
(ε2/ε2; ε2/ε3 vs. ε3/ε3 vs. ε2/ε4, 
ε3/ε4 vs. ε4/ε4) 2. ε4- vs. ε4+ 38 1693 African-American 
Caselli (1999) 100 56  (49-69) 28 - 
EM, EA, 
VF, L, VS 
AVLT, WAIS DS, WAIS Mental arithmetic, 
COWAT, WAIS Similarities, BNT, CFT, 
WAIS Block design 
ε4- vs. ε4+ (ε3/ε3, vs. ε3/ε4, ε4/ε4) 
Caselli (2011) 621 59 (21+) 30 - EM, EA, VF, PS AVLT, COWAT, DSS, PASAT, WCST ε4- vs. ε4+ (ε3/ε3, vs. ε3/ε4, ε4/ε4) 
Chen (2013) 18 42 (-) 44 - G, EA MMSE, n-back ε4- vs. ε4 He (ε2/ε2, ε2/ε3, ε3/ε3 vs. ε3/ε4) 
Deeny (2008) 54 60  (50-70) 56 - EA Sternberg WM task 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε3/ε4, ε4/ε4) 
Donix (2010) 28 55.3  (38-63) ~23 - 
G, EM, 
EA,VF, L, 
VS 
MMSE, WMS (logical memory-delayed, verbal 
paired associates), Buschke selective reminding 
test, DS (forward, backward), Stroop 
interference, WCST, TMT-B, VF, BNT, CFT  
ε4- vs. ε4+ (ε2/ε3, ε3/ε3, vs. ε3/ε4, 
ε4/ε4) 
Evans (2013; 
2014) 40 
50  
(43-58) 42 - EM, EA 
Immediate recall, PM hits, Covert attention 
task, RVIP ε3 vs. ε4 (ε3/ε3 vs. ε3/ε4, ε4/ε4) 
Flory  (2000) 220 47  (24-60) 51 - EM, EA 
Verbal learning, Verbal delayed recall, Figure 
delayed recall, DS (forward, backward), 
Recurring word test 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
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Goveas  
(2013) 46 
54  
(44-65) 33 - EM, EA, PS AVLT, TMT-A & B, DS 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Greenwood 
(2000) 97 59 (50+) 39 - EM, EA 
WMS General, WMS Delayed, Buschke 
selective reminding test, Cued letter 
discrimination task, Vigilance task, Dynamic 
scaling 
ε2+ vs. ε3 vs. ε4+ (ε2/ε2; ε2/ε3 vs. 
ε3/ε3 vs. ε2/ε4, ε3/ε4, ε4/ε4) 
Greenwood 
(2005a) 177 
59  
(41-85) 41 - EA 
Cued letter discrimination task, Spatial WM 
task, Attention/WM task 
ε4- vs. ε4 He vs. ε4 Ho (ε2/ε2, 
ε2/ε3, ε3/ε3 vs. ε2/ε4, ε3/ε4 vs. 
ε4/ε4 
Greenwood 
(2014) 591 
50  
(40-59) - 92% Caucasian EA 
MMSE, WAIS logical memory, WAIS letter-
number sequencing, Delayed match-sample 
task 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Jorm (2007) 2176 - (40-44) 47 - EM, EA, L, PS CVLT, DS (backward), Spot-the-word, DSS 
ε4- vs. ε4 He vs. ε4 Ho (ε2/ε2, 
ε2/ε3, ε3/ε3 vs. ε2/ε4, ε3/ε4 vs. 
ε4/ε4 
Langbaum 
(2010) 27 
55  
(47-68) 19 Latino 
G, EM, EA, 
VF, L, VS MMSE, WAIS, AVLT, COWAT, BNT, CFT 
ε4- vs. ε4+ (ε2/ε3, ε3/ε3, vs. ε2/ε4, 
ε3/ε4, ε4/ε4) 
Levy (2004) 176 59  (42-86) 36 - 
EM, VF, 
VS, L, PS 
WMS Logical Memory I & II, Buschke 
Selective Reminding Test, WMS Verbal Paired 
Associations I & II, WMS Visual Reproduction 
I & II, Verbal fluency (letter, category), BNT, 
CFT, Block design, DSS 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Marioni (2016) 12 472 
42  
(19-59) 41 - 
EM, VF, L, 
PS 
WAIS Logical memory, VF, Mill Hill 
Vocabulary scale, DSS 
ε2/ε2 vs. ε2/ε3 vs. ε2/ε4 vs. ε3/ε3 
vs. ε3/ε4 vs. ε4/ε4 
Nichols (2012) 133 36  (19-77) 44 Caucasian G, EM WAIS, Recognition memory task ε2/ε3 vs. ε3/ε3 vs. ε3/ε4 
Oberlin (2015) 975 45  (30-54) 49 Caucasian EM, EA 
WMS Logical memory, WMS Visual 
reproduction, TMT-A & B 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Panizzon 
(2014) 717 
56  
(51-60) 100 89.7% Caucasian EM CVLT, WMS Story recall, WMS Figure recall 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Patel (2013) 36 45  (-) 42 
72% Caucasian, 
19% Afro-
American, 9% 
Other 
G, EM, EA, 
VF, PS 
IQ, WRAT, BVMT (delayed recall, 
recognition), DS, VF, Groove-pegboard task, 
Letter-number sequencing, Symbol search, 
TMT A & B 
ε4- vs. ε4+ (ε2/ε3, ε3/ε3, vs. ε3/ε4, 
ε4/ε4) 
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Protas (2013) 149 56  (47-68) 36 - 
G, EM, VF, 
VS, L MMSE, WAIS, AVLT, CFT, COWAT, BNT 
ε4- vs. ε4 He vs. ε4 Ho (ε2/ε2, 
ε2/ε3, ε3/ε3 vs. ε2/ε4, ε3/ε4 vs. 
ε4/ε4 
Ready (2011) 23 56  (46-66) 39 - 
EM, EA, 
VF 
Memory composite (WMS Logical, CVLT, 
WMS Visual Reproduction), Trail-making 
composite, Colour-word composite, VF 
composite (letter, category) 
ε4- vs. ε4+ (ε2/ε3, ε3/ε3 vs. ε3/ε4) 
Sager (2005) 452 53  (40-65) 29 - 
EM, EA, 
VF, L, VS 
AVLT, Faces I and II, Stroop-colour, TMT-B, 
WCST, WAIS WM index, VF, WAIS 
Vocabulary, Similarities, Word-reading, BNT, 
WAIS Block design, Matrix reasoning, Line 
orientation judgment 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Schultz  
(2008) 626 
55  
(50-59) 100 - EM 
WMS Logical Memory, WMS Visual 
Reproduction 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3 vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 
Shin (2014) 
2401 45-54 36 - 
G Korean MMSE 
ε4- vs. ε4 He vs. ε4 Ho (ε2/ε2, 
ε2/ε3, ε3/ε3 vs. ε2/ε4, ε3/ε4 vs. 
ε4/ε4) 3919 55-64 39 - 
Sunderland 
(2004) 142 59 (-) 37 - G MMSE, BNT 
ε4- vs. ε4+ ( ε2/ε3, ε3/ε3 vs. ε2/ε4, 
ε3/ε4, ε4/ε4) 
Trachtenberg  
(2012) 72 
46  
(30-55) 48 - EM, EA 
Episodic retrieval-pictures; Counting Stroop 
task 
ε2 vs. ε3. ε4 He vs. ε4Ho (ε2/ε3 vs. 
ε3/ε3 vs. ε3/ε4 vs. ε4/ε4) 
Velichkovsky  
(2015) 35 50 (-) 26 - EM, EA 
AVLT, WMS Visual reproduction, Anti-
saccade task, Switching task, n-back task, 
Operation span 
ε3 Ho vs.  ε4 Hz (ε3/ε3 vs. ε3/ε4) 
Xu  (2009) 
74 59  (50-65) 27 - EM Recognition memory task ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3, vs. 
ε2/ε4, ε3/ε4, ε4/ε4) 43 58  (50-65) 30 - 
EM, EA, L, 
VF AVLT, TMT-A & B, COWAT, BNT 
 
Abbreviations: Domains: Global (G), Memory (M), Executive abilities (EA), Verbal Fluency (VF), Language (L), Visuospatial processing (VS), Processing Speed (PS). 
Tasks:  Mini-mental State Examination (MMSE), Wide Range Achievement Test (WRAT), Delayed Word Recall (DWR), Brief Visuospatial Memory test (BVMT), Rey's 
Auditory verbal learning task (AVLT), Californian verbal learning test (CVLT), Digit span (DS), Paced Auditory Serial Attention task (PASAT), Prospective memory (PM), 
Rapid Visual Information Processing task (RVIP), Trails-making test (TMT), Wisconsin Card Sort task (WCST), Complex figure test (CFT), Controlled oral association task 
(COWAT), Boston Naming Task (BNT), Digit-symbol Substitution (DSS). Zygosity: Heterozyous (He), Homozygous (Ho)	
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Table 2.2. Average effect size per study organised by cognitive domain, where a positive effect size 
represents better performance by the ε4+ group 
Domain Authors (year)  
Group n  
Age (M) ε4+ ε4- Hedge's d 
Global Bender (2012) 50 20 52 0.45 
 Donix (2010) 55 12 16 -0.02 
 Langbaum (2010) 55 11 16 0.00 
 Nichols (2012) 36 35 81 -0.21 
 Patel (2013) 45 14 22 0.21 
 Protas (2013) 56 73 76 0.00 
 Shin (2014) (45-54) - 380 1967 0.09 
 Shin (2014) (55-64) - 679 3240 -0.12 
 Sunderland (2004) 59 57 85 0.22 
Memory Blair (2005) (C) 56 1720 3648 0.00 
 Blair (2005) (A) 56 698 744 0.00 
 Caselli (2011) 59 265 356 -0.03 
 Caselli (1999) 56 50 50 -0.13 
 Donix (2010) 59 12 16 0.03 
 Evans (2013; 2014) 50 19 21 -0.45 
 Flory (2000) 47 61 159 -0.27 
 Greenwood (2000) 59 38 48 -0.26 
 Goveas (2013) 54 20 26 -0.48 
 Jorm (2007) - 611 1571 0.01 
 Langbaum (2010) 55 11 16 0.08 
 Levy (2004) 59 61 115 -1.94 
 Marioni (2016) 42 3807 8665 -0.01 
 Nichols (2012) 36 35 81 -0.18 
 Patel (2013) 45 14 22 -0.28 
 Protas (2013) 56 73 76 0.09 
 Sager (2005) 53 204 248 0.05 
 Trachtenberg (2012) 46 33 20 -0.16 
 Velichkovsky (2015) 50 13 22 -0.23 
 Xu (2009) 58 18 25 0.35 
Executive abilities Caselli (1999) 56 50 50 0.06 
 Caselli (2011) 59 265 356 0.05 
 Chen (2013) 42 9 9 0.20 
 Donix (2010) 59 12 16 -0.01 
 Evans (2013; 2014) 50 19 21 0.36 
 Flory (2000) 47 61 159 -0.09 
 Goveas (2013) 54 20 26 -0.54 
 Jorm (2010) - 611 1571 -0.06 
 Langbaum (2010) 55 11 16 0.26 
 Sager (2005) 53 204 248 -0.06 
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 Trachtenberg (2012) 46 33 20 -0.17 
 Velichkovsky (2015) 50 13 22 -0.15 
Verbal Fluency Blair (2005) (C) 56 1720 3648 0.00 
 Blair (2005) (A) 56 698 744 -0.06 
 Caselli (2011) 59 265 356 0.01 
 Donix (2010) 55 12 16 -0.02 
 Langbaum (2010) 55 11 16 0.34 
 Levy (2004) 59 61 115 0.05 
 Marioni (2016) 42 3807 8665 0.06 
 Protas (2013) 56 73 76 0.18 
 Sager (200) 53 204 248 0.05 
 Xu (2009) 58 18 25 -0.24 
Language Donix (2010) 59 12 16 0.07 
 Jorm (2007) - 611 1571 -0.02 
 Langbaum (2010) 55 11 16 -0.29 
 Levy (2004) 59 61 115 0.10 
 Marioni (2016) 42 3807 8665 0.05 
 Protas (2013) 56 73 76 -0.14 
 Sager (2005) 53 204 248 -0.12 
 Xu (2009) 58 18 25 -0.18 
Visuospatial Casell (2011) 59 50 50 0.12 
 Langbaum (2010) 55 11 16 -0.04 
 Levy (2004) 59 61 115 0.04 
 Protas (2013) 56 73 76 0.12 
 Sager (2005) 53 204 248 -0.10 
Processing speed Blair (2005) 56 1720 3648 0.01 
 Blair (2005) 56 698 744 -0.13 
 Goveas (2013) 54 20 26 0.08 
 Jorm (2007) - 611 1571 0.01 
 Levy (2004) 59 61 115 -0.11 
 Marioni (2016) 42 3807 8665 -0.01 
 Patel (2013) 45 14 22 0.33 
Notes: Caucasians (C), Afro-Americans (A) 
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2.4.1.7 Processing speed 
 
7 studies contributed effect sizes to a meta-analysis of genotype differences in 
processing speed. The average effect of carrying an ε4 allele was non-significant (d=-.01, 
p>.05). There was no significant heterogeneity in this sample of effect sizes, Q(6)=7.15, p>.05, 
I2=0%. 
 
Table 2.3. A summary of findings for the meta-analysis within each cognitive domain.  
Domain Studies (k) ε4+  (n) ε4- (n) d 95% CI Q 
Global 8 602 2315 0.09 -.01, .18 5.20 
Memory 19 7702 15814 -0.01 -.04, .02 17.40 
EA 12 2045 3615 -0.03 -.10, .03 8.60 
VF 10 6869 13909 0.02 -.02, .06 8.17 
Language 8 4797 10732 0 -.07, .07 6.81 
Visuospatial 5 399 505 -0.01 -.14, .12 2.78 
PS 7 6931 14791 -0.01 -.04, .02 7.15 
Notes: * p<.01, **p<.05 
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Figure 2.2 Forest plots of weighted effect sizes by cognitive domain. For each study, effect size 
is reported as Hedge’s d [95% CI], where a positive effect size represents greater performance 
by the ε4+ group. 
2.4.2 Systematic review 
 
2.4.2.1 Neuropsychological Assessment  
 
The majority of studies examining the effect of APOE ε4 in mid-adulthood have chosen 
to administer a compilation of neuropsychological assessment measures. These studies report 
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limited effects of APOE ε4 in mid-adulthood (e.g. Jorm et al., 2007; Marioni et al., 2016; Sager, 
Hermann, & La Rue, 2005; Shin et al., 2014; Zhao et al., 2005). Indeed, in a large community-
based sample, the effect of APOE status was non-significant in both mid-adulthood (40-44 
years), as well as groups aged 20-24 years and 60-64 years (Jorm et al., 2007), leading authors 
to conclude there are no preclinical effects of APOE genotype on cognition. Of interest, 
however, other studies suggest sample age is a key determinant in the expression of preclinical 
APOE ε4 effects. Age x APOE interactions were found both for scores on the Korean MMSE 
(Shin et al., 2014), and performance on measures of declarative memory and processing speed 
(Marioni et al., 2015). In both studies, detrimental effects of ε4 status emerged when analyses 
isolated volunteers aged in the latter half of the 5th decade (55+ years and 60+ years 
respectively).  
 
Mid-age studies investigating APOE differences across a broad range of 
neuropsychological measures typically observe ε4 effects, when present, within a select domain. 
For example, in the research of Sager et al. (2005) ε4+ selectively show worse performance on 
visuospatial processing tasks, driven by decrements on block design performance. In contrast, 
detrimental effects of ε4 status were limited to female participants on tasks probing memory and 
semantic fluency (Zhao et al., 2005), whereas ε4 advantages were reported in verbal fluency and 
language across the adult lifespan by Marioni et al., (2016). While the selectivity of effects 
agrees with reports of genotype effects in older adulthood (Small et al., 2004; Wisdom et al., 
2011), failure to identify a consistent pattern of ε4 effects within a cognitive domain in mid-
adulthood makes interpretation difficult.  
 
Results within the domain of memory offer the clearest profile of cognitive differences 
in ε4+, with several studies associating possession of an ε4 allele with poorer memory 
performance (Caselli et al., 1999; Flory, Manuck, Ferrell, Ryan, & Muldoon, 2000; Goveas et 
al., 2013; Levy et al., 2004; Schultz et al., 2008). Attempts have been made to link differential 
memory performance with neural differences. In adults aged 44-65, ε4+ showed a trend of 
worse performance on the Rey Auditory Verbal Learning Test (AVLT) (Goveas et al., 2013). 
Performance on this task correlated with observed reductions in the functional connectivity of 
medial temporal lobe (MTL) circuits, as well as differential connectivity of the default mode 
network (Li et al., 2014; Goveas et al., 2013), offering a possible neurobiological basis of 
genotype differences. In addition, two studies report an altered BOLD response in ε4+ during 
episodic memory tasks, despite no detectable genotype difference in behavioural performance 
(Trachtenberg, Filippini, Cheeseman, et al., 2012; Xu et al., 2009). Although this raises the 
question of how neural activations relate to cognition, identifying the neural basis of APOE 
differences will further mechanistic explanations of how APOE ε4 influences cognitive ageing.  
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Research has started to explore how carrying an APOE ε4 allele interacts with 
environmental factors in influencing performance on neuropsychological measures. Education 
was found to interact with APOE status in a cohort of adults aged 45-54 years, in that only ε4+ 
with no formal education showed cognitive advantages on a measure of global cognition 
compared to their ε4- peers (Shin et al., 2014). In contrast, APOE, education and socio-
economic status were reported to independently affect cognition (Zhao et al., 2005).  
 
Considering cardiovascular health factors, an APOE x Blood Pressure interaction has 
been reported for cognition in mid-adulthood. Although there was no main effect of APOE 
status or systolic blood pressure on performance across 3 cognitive domains; episodic memory, 
visual memory or EF, in ε4+ only, high blood pressure was associated with worse episodic 
memory performance (Oberlin et al., 2015). High blood pressure was also found to enhance the 
negative association of APOE ε4 with processing speed and working memory (WM), as well as 
reduced white matter integrity in frontal regions (Bender & Raz, 2012). In both studies, the 
relationship between APOE, blood pressure and cognition was absent in the ε4- group, 
suggesting cardiovascular health factors may exaggerate cognitive effects in ε4+.   
 
 
2.4.2.2 Behavioural paradigms 
 
Paradigms designed to detect subtle differences in cognition have predominantly been 
used to explore the sensitivity of executive abilities, including WM and attention, to APOE 
effects in mid-adulthood.  
 
On a measure of covert attention, there was a non-significant effect of APOE genotype 
on overall performance, and on the ability to benefit from valid cues in mid-adulthood 
(Greenwood, Sunderland, Friz, & Parasuraman, 2000). ε4+, however, showed increased 
response time costs following an invalid cue, relative to ε4- peers, interpreted as a deficit in 
attentional disengagement. In contrast, a more recent study reported equivalent performance 
between genotype groups on this task (Evans et al., 2013; Evans, Dowell, Tabet, Tofts, King & 
Rusted, 2014). Control of visual attention was explored in an attentional scaling task 
(Greenwood et al., 2000; Greenwood, Lambert, Sunderland & Parasuraman, 2005a). The 
dynamic scaling task measures the ability to constrict one’s attentional spotlight in response to 
top-down information cueing the spatial location of a target stimulus. ε4+ did not show the 
same benefit as their ε4- peers in response times following more precise cues. 
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Executive attention was explored in a cross-sectional comparison of mid-age (aged 43-
58) and young adults (aged 18-30) (Evans et al., 2013; 2014). On a measure of sustained 
attention, a trend of higher accuracy, coupled with slower reaction times, was found in mid-age 
ε4+ relative to their ε4- peers. When compared to the data from the young group, the mid-age 
ε4+ group showed exaggerated age-related slowing. In comparison, a second study found no 
effect of APOE genotype on a similar task in adults aged 50+ (M=59 years) (Greenwood et al., 
2000). A comparable pattern of results was seen on a prospective memory task, probing 
attentional monitoring and switching between goals. ε4+ demonstrated greater accuracy but 
slower response times on the prospective memory paradigm, suggestive of a speed-accuracy 
trade-off (Evans et al., 2013; 2014). Corresponding functional activations during this task 
indicated greater recruitment of frontal regions, but reduced recruitment of parietal and 
extrastriate visual regions in ε4+ relative to their ε4- peers. Specifically, left inferior frontal 
gyrus activity correlated with prospective memory accuracy in ε4+ only, consistent with an 
early compensatory shift towards reliance on more frontal systems. 
 
Genotype effects were explored using a selection of cognitive paradigms designed to 
probe the 3 components of executive function identified by Miyake et al. (2000): inhibition, 
switching and updating in WM (Velichkovsky, Roschina, & Selezneva, 2015). No genotype 
differences were recorded on either an anti-saccade inhibition measure, or two WM paradigms 
(n-back test, the operation span task).  A non-significant effect of APOE ε4 status on n-back 
performance has previously been reported in middle-aged adults (Chen et al., 2013; Yan, Wu, 
Chao, Chen, & Tseng, 2015). Both studies reported a differential pattern of neural change in 
ε4+, with this group showing an absence of neural activation increases in correspondence to 
greater WM load (Chen et al., 2013; Yan et al., 2015). This was interpreted as ε4+ maximally 
recruiting processing resources at a lower level of load, which cannot be further increased under 
greater demands. Hence, it may be that on more demanding tasks, significant effects of carrying 
an ε4 allele may be observable. On the switching paradigm administered by Velichovsky et al., 
(2015), ε4+ showed significantly larger switching costs than their ε4- counterparts.  
 
Greenwood et al., (2005a) assessed spatial WM in adults, aged 41-85. Relative to ε4-, 
only homozygous ε4+ displayed a disadvantage on spatial WM tasks, driven by performance on 
trials placing the greatest load on spatial WM. In a further study of spatial WM, no genotype 
difference was seen in mid-age adults (Greenwood, Espeseth, Lin, Reinvang, & Parasuraman, 
2014) 
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2.4.2.3 Longitudinal assessments 
 
Several studies have explored how cognition changes longitudinally as a function of 
APOE genotype (Table 2.4). Schultz et al. (2008) compared the cognitive test performance of 
army cadets in the 6th decade of life, to their scores on the same measure at age 20, and found 
ε4+ showed greater decline. Across a period of 6 years, relatively limited effects of APOE 
genotype were reported across a selection of cognitive domains (Zhao et al., 2005), with only 
semantic fluency being negatively associated with ε4 status in females aged 40-49; this study 
reported no genotype differences in a slightly older sample (aged 50-59). 
 
The dominant focus of  longitudinal research has been establishing if ε4+ show a 
differential rate of memory change over time. Several studies suggest that ε4+ show 
significantly greater memory decline from mid-adulthood (Caselli et al., 2009; Kozauer, 
Mielke, Chan, Rebok, & Lyketsos, 2008), with this effect isolated to delayed memory in two 
studies (Greenwood, Sunderland, Putnam, Levy, & Parasuraman, 2005b; Greenwood et al., 
2014). Performance change across an average of 3.8 years was investigated for measures of 
memory (Jochemsen et al., 2012), with participants stratified by age. Of interest, it was found 
ε4+ aged 47-57 years showed improvements in recall performance, whilst ε4+ aged 58-67 years 
showed significant decline by the follow-up assessment. How change in memory is influenced 
by the interaction between APOE genotype, ethnicity and cardiovascular health has also been 
explored over a 6 year interval (Blair et al., 2005). Negative associations between ε4+ and 
memory change were small and limited to Caucasian adults. There was no interaction between 
cardiovascular health factors (diabetes, hypercholesterolemia, hypertension), APOE genotype 
and memory change. 
 
Two papers found a non-significant effect of APOE genotype on change in executive 
abilities over time (Greenwood et al., 2014; Jochemsen et al., 2012). There is support, however, 
for the ε4 allele being associated with greater decline in processing speed (Blair et al., 2005; 
Caselli et al., 2011). In a group of Caucasian adults, ε4+ also diagnosed with 
hypercholesterolemia or diabetes showed increased decline on the digit-symbol substitution 
measure of processing speed (Blair et al., 2005). No APOE x Hypertension interaction was 
found for change in processing speed. Verbal fluency scores were maintained in both the 
Caucasian and Afro-American groups included in Blair et al. (2005). 
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Table 2.4. A summary of longitudinal studies investigating APOE differences in mid-adulthood 
First Author 
(year) n 
Age: M 
(range) 
Gender                 
(% M) Ethnicity 
Cognitive 
domain 
Neuropsychological 
tasks Follow-up Attrition Genotype comparison 
Blair (2005) 6810 56  (45-64) 
51 6202 Caucasian 
M, EA, VF DWR, DSS, VF 6 yrs (2-yr intervals) 24% 
1.  ε2+ vs. ε3 vs. ε4 He 
vs. ε4 Ho (ε2/ε2; ε2/ε3 
vs. ε3/ε3 vs. ε2/ε4, ε3/ε4 
vs. ε4/ε4) 2. ε4- vs. ε4+ 38 
1693 African-
American 
Caselli (2009) 815 60  (21-97) 31 
85% Caucasian, 
12 % Latino, 3% 
Other, 
G, M, VF, 
VS 
MMSE, AVLT, 
COWAT, JLO 
5 yrs (1-2 yr 
intervals - 
ε4- vs. ε4+ (ε3/ε3, vs. 
ε3/ε4, ε4/ε4) 
Caselli (2011) 621 57 (21-97) 30 - M, EA, VF 
AVLT, COWAT, 
PASAT, DSS, WCST, 
Iowa Gambling task 
6.3 yrs (2-yr 
intervals) 23% 
ε4- vs. ε4+ (ε3/ε3, vs. 
ε3/ε4, ε4/ε4) 
Greenwood et al 
(2005b) 139 
60 
(33-85) 31 - M, EA 
WMS-G, WMS-D, 
Cued Visual Search task 
3 yrs (1-yr 
intervals)  
ε4- vs. ε4 He vs. ε4 Ho 
(ε2/ε2, ε2/ε3, ε3/ε3 vs. 
ε2/ε4, ε3/ε4 vs. ε4/ε4) 
Greenwood 
(2014) 249 
- 
(40-59) - 97% White G, M EA 
MMSE, WAIS logical 
memory,WAIS letter-
number sequencing, 
Delayed match-sample 
task 
3 yrs (1-yr 
intervals) - 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, 
ε3/ε3 vs. ε2/ε4, ε3/ε4, 
ε4/ε4) 
Jochemsen 
(2012) 188 
57  
(27-79) 80 - 
G, M, EA, 
VF 
RAVLT, ROCF, 
Elevator task, Brixton 
spatial task, MMSE, VF 
3.8 yrs 44% ε4- vs. ε4+ (ε2/ε2, ε2/ε3, ε3/ε3 vs. ε3/ε4, ε4/ε4) 
Kozauer (2008) 492 53 (18-65) - - G, M 
MMSE, Immediate 
recall, Delayed recall, 
Recognition 
22 yrs (3 
follow-ups_ - 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, 
ε3/ε3 vs. ε2/ε4, ε3/ε4, 
ε4/ε4) 
Schultz (2008) 626 55  (50-59) 100 
95.5% Caucasian, 
3.8% African-
American, 0.3% 
Hispanic, 0.3% 
“other.” 
G AFQT 35 yrs - 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, 
ε3/ε3 vs. ε2/ε4, ε3/ε4, 
ε4/ε4) 
Zhao   (2005) 1128 - (40-49) 77 European descent G, M, VF, L 
Verbal memory, AH4-1, 
MHV, VF (letter, 6 yrs - 
ε4- vs. ε4+ (ε2/ε2, ε2/ε3, 
ε3/ε3 vs. ε2/ε4, ε3/ε4, 
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2601 - (50-59) 74 European descent 
category) 6 yrs - ε4/ε4) 
Abbreviations: Domain- Global (G), Memory (M), Executive ability (EA), Verbal Fluency (VF), Language (L) Visuospatial (VS). Tasks-Mini-Mental State Examination 
(MMSE), Weschler Adult Intelligence Scale (WAIS), Weschler Memory Scale (WMS), Delayed Word Recall (DWR), Rey's Auditory Verbal Learning Task (AVLT), 
Controlled Oral Association Task (COWAT), Digit-symbol Substitution (DSS), Paced auditory serial attention task (PASAT), Wisconsin Card-sort task (WCST), Armed 
Forces Qualification task (AFQT), Rey-Osterrich Complex figure (ROCF), Judgement of Line Orientation (JLO), Mill Hill Vocabulary test (MHV). Zygosity: Heterozygous 
(He), Homozygous (Ho). 
 	
		
51	
 
Longitudinal measures (Greenwood et al., 2014) revealed no genotype difference across 
trials with relatively low WM demand. On trials incorporating a mismatch between encoded and 
target stimuli, and hence placing greater demand on WM resources, however, performance of 
ε4+ improved over 3 years, whilst performance of the ε4- group remained stable. The observed 
practice effects in ε4+ were interpreted by the authors to represent compensatory mechanisms 
during mid-adulthood, and as a result of the increased cognitive effort in this group, some ε4 
benefits were still observed. 
 
2.5 Discussion  
 
This review highlights the inconsistencies reported for APOE ε4 effects on cognition in 
mid-adulthood. Synthesising the results through meta-analyses, the effect of carrying an ε4 
allele was non-significant across the 7 cognitive domains examined (global cognition, memory, 
executive ability, verbal fluency, language, visuospatial processing, and processing speed). 
Closer inspection of individual studies, however, indicates ε4 effects may emerge under certain 
conditions, and when probed with measures designed to maximise sensitivity.  
 
The results of the meta-analyses offer limited support for ε4+ showing cognitive 
differences in mid-adulthood; ε4+ show relatively sustained performance until the end of the 5th 
decade. This is not inconsistent with the antagonistic pleiotropy position whereby the ε4 allele 
has opposing effects on fitness across the lifespan (Han & Bondi, 2008), with mid-adulthood as 
a transition point between ε4 behavioural advantages in youth switching to disadvantages in 
older adulthood. 
 
When considering individual studies in more detail, the age range of participants is a 
likely factor in the inconsistency between study outcomes. Critically, existing research lacks a 
precise and consistent definition of mid-adulthood, reflected in the diverse and often broad age 
ranges of volunteers participating in the research reviewed here (see Table 1). For example, 
mid-adulthood was defined as 24-69 years in one study (Flory et al., 2000) and 41-85 years in 
another (Greenwood et al., 2005a). To draw conclusions of genotype effects at any precise 
window of the lifespan is difficult with such large age inclusion criteria, and the disparity in age 
groups may relate to the inconsistency of results presented. In cases where samples were 
stratified by age, Age x APOE interactions were reported, indicating emergence of the 
detrimental effects of APOE ε4 in the latter half of the 5th decade (Jochemsen et al., 2012; 
Marioni et al., 2016; Shin et al., 2014).  This highlights the importance of controlling for age. 
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Age was not included as a moderator in the current meta-analyses due to the small number of 
studies in each domain, but this is certainly an important avenue for future research.  
 
A key question for this review was whether process-specific cognitive measures show 
increased sensitivity to APOE genotype effects in mid-adulthood. Although the results of the 
meta-analyses failed to report a robust effect of ε4 status on memory, looking across studies 
there is a relatively consistent pattern of emerging detriments in ε4+ performance (11/20 
studies). Detrimental effects of ε4 status on memory were also supported by longitudinal 
studies, suggesting this genotype group shows an accelerated trajectory of memory decline 
(Caselli et al., 2009; Greenwood et al., 2005; Greenwood et al., 2014; Kozauer et al., 2008). The 
sensitivity of memory to the effects of APOE ε4 from mid-adulthood is further supported by 
imageing evidence of genotype differences in MTL regions, implicating this region as a neural 
basis for behavioural changes (Goveas et al., 2013; Li et al., 2014). Memory is over-represented 
in studies probing the effects of APOE, and with more careful consideration of other cognitive 
domains, effects may emerge. 
 
It is important to consider that many of the study outcomes included in the meta-
analyses were based on neuropsychological assessment performance. It may be that the 
preclinical effects of APOE ε4 are too subtle for detection with neuropsychological measures, 
more commonly used for clinical assessment. In support of this, studies using computerized 
paradigms designed to target specific cognitive processes, report APOE ε4 differences in mid-
adulthood within the domains of EF, attention and WM (Evans et al., 2013, 2014; Greenwood et 
al.,, 2000; 2005; 2014; Velichkovsky et al., 2015). These domains have also been linked to 
cognitive advantages in early adulthood (Marchant et al., 2010b; Rusted et al., 2013; Taylor et 
al., 2016), and so may show early sensitivity to genotype effects. Future research should focus 
on specific cognitive processes in order to establish the pattern of age-related change more 
clearly. Identifying replicable cognitive markers of those at heightened risk of poor cognitive 
ageing would make a substantial contribution to the development of early intervention 
strategies, independently and in association with the study of biomarkers and additional risk 
factors for dementia. 
 
An additional methodological issue is the role of individual differences in moderating 
the effects of APOE. Several studies attempt to control for differences in ethnicity, education, 
socio-economic status (SES), and health factors; however, these factors are not uniformly 
included. Investigation of how these factors interact with APOE ε4 to alter the initial stages of 
ageing is limited to date. Although methodological shortcomings contribute to the inconsistency 
of findings, it is important to recognise that mid-age itself will play an important role.  Mid-age 
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brings with it other risk factors for poor cognitive ageing (e.g. hypertension, cholesterol and 
diabetes (Atzmon et al., 2002; Köhler et al., 2014; van Exel et al., 2002; Whitmer, Sidney, 
Selby, Johnston, & Yaffe, 2005), and interactions between vascular health, APOE and cognition 
are reported (de Frias, Schaie, & Willis, 2014; Peila et al., 2001; Puttonen, Elovainio, Kivimäki, 
Lehtimäki, & Keltikangas-Järvinen, 2003; Zade et al., 2010). Current behavioural research is 
neither considering the potential modifying effects of wider risk factors nor adequately 
controlling for them, though they undoubtedly contribute to the cognitive ageing trajectory 
(Herrup, 2010). One account for the role of APOE ε4 in cognitive ageing is that this allele 
represents a genetic susceptibility, increasing vulnerability to both detrimental and protective 
factors in cognitive ageing (Wirth, Villeneuve, La Joie, Marks, & Jagust, 2014). Mid-adulthood 
represents a period of the lifespan where ε4+ are particularly susceptible to cognitive insults and 
benefits, and this underlines the need to consider the cognitive profile of ε4+ in relation to other 
potential modulators for cognitive health when establishing the preclinical effects of this gene. 
 
2.6 Conclusions 
 
It remains difficult to untangle the effects of APOE ε4 on cognition in mid-adulthood; 
methodological issues including imprecise criteria for age of volunteers and differential 
sensitivity of the measures used make it hard to form concrete conclusions. Results reviewed 
here, however, suggest ε4+ show relatively sustained performance in mid-adulthood, with 
subtle differences apparent in memory and executive abilities. Future research should focus on 
administering cognitive paradigms specifically chosen for their ability to sensitively measure 
the more nuanced processes of a particular domain, rather than relying on assessment measures 
more traditional of clinical settings. Since mid-age is a time when the trajectory of cognitive 
ageing will be influenced by multiple factors, these must also be incorporated into any lifespan 
model of the effects of this gene. Through the consideration of these factors in future study 
design; reliable cognitive markers of those showing accelerated cognitive ageing may be 
developed in mid-adulthood.  
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3. Article 2  
 
Putting attention in the spotlight: The influence of 
APOE genotype on visual search in mid adulthood 
 
Article 2 is published in Behavioural Brain Research as: 
Lancaster, C., Forster, S., Tabet, N., & Rusted, J. (2017). Putting attention in the 
spotlight: The influence of APOE genotype on visual search in mid adulthood. 
Behavioural Brain Research, 334. http://doi.org/10.1016/j.bbr.2017.07.015 
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3.1 Abstract 
 
The Apolipoprotein E ε4 allele is associated with greater cognitive decline with age, yet effects 
of this gene are also observed earlier in the lifespan. This research explores genotype 
differences (ε2, ε3, ε4) in the allocation of visuospatial attention in mid-adulthood. Sixty-six 
volunteers, aged 45-55 years, completed two paradigms probing the active selection of 
information at the focus of attention (a dynamic scaling task) and perceptual capacity 
differences. Two methods of statistical comparison (parametric statistics, Bayesian inference) 
found no significant difference between ε4 carriers and the homozygous ε3 group on either the 
dynamic scaling or perceptual load task. Ε2 carriers, however, demonstrated less efficient visual 
search performance on the dynamic scaling task. The lack of an ε4 difference in visuospatial 
attention, despite previous suggestion in the literature of genotype effects, indicates that select 
attentional processes are intact in ε4 carriers in mid-adulthood. The association of ε2 genotype 
with slower visual search performance complicates the premised protective effects of this allele 
in cognitive ageing.  
 
Keywords: APOE, Cognitive Ageing, Alzheimer’s disease, Attention, Visuospatial, Mid-
adulthood 
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3.2 Introduction 
 
The Apolipoprotein E (APOE)2 gene is associated with individual differences in cognitive 
ageing. The three allelic variants (ε2, ε3, and ε4) differ in prevalence, estimated at 12%, 60% 
and 23% of Caucasian populations respectively (Raber, Huang, & Ashford, 2004). While 
homozygous ε3 carriers are considered the population norm, possession of an ε4 allele increases 
risk of Alzheimer’s disease (AD) (Corder et al., 1993; Farrer et al., 1997). In addition, negative 
effects of carrying an ε4 allele are reported in a number of domains in healthy ageing (65 years 
and older), including global cognition, episodic memory, attention, and executive function 
(Berteau-Pavy, Park, & Raber, 2007; Espeseth et al., 2006; Marioni et al., 2015; Packard et al., 
2007; Reinvang, Winjevoll, Rootwelt, & Espeseth, 2010; Staehelin, Perrig-Chiello, Mitrache, 
Miserez, & Perrig, 1999; for reviews see: Small, Rosnick, Fratiglioni, & Bäckman, 2004, 
Wisdom, Callahan, & Hawkins, 2011). Of interest, the ε2 variant is suggested to offer some 
protection against pathological ageing (Farrer et al., 1997; Lippa et al., 1997; Wilson, Bienias, 
Barry-Kravis, Evans & Bennett, 2002), but fewer studies have considered the effects of this 
allele in healthy cognitive ageing, with reported effects limited to tasks engageing memory 
(Helkala et al., 1996; McFall et al., 2015; Wilson et al., 2002).  
  
Carriers of the ε4 allele demonstrate subtle cognitive differences earlier in the lifespan, but at 
present genotype differences observed prior to 65 years of age lack consistency (for reviews 
see: Ihle, Bunce, & Kliegel, 2012; Lancaster, Tabet, & Rusted, 2017; Rusted & Carare, 2015; 
Salvato, 2015). A likely factor in this inconsistency is the cognitive process under study, with 
the strength of genotype effects premised to vary by cognitive domain. To date, many studies 
have explored the association between APOE and episodic memory, in line with the prevalence 
of memory loss in dementia. A meta-analysis, however, found attention differences to be a more 
reliable marker of preclinical dementia than measures of delayed recall (Twamley, Ropacki, & 
Bondi, 2006). Hence, we predict attention may be a more sensitive marker than episodic 
memory of cognitive decline from mid-adulthood, facilitating the early identification of those 
shifting to a disadvantageous trajectory of cognitive ageing.  
 
Here we explore APOE genotype differences in visual search, defined as the efficient 
deployment of selective attention to a relevant target within the visual scene (Awh et al., 2006). 
Selective attention is often analogised to a ‘spotlight’, conceptualised as a gradient of 																																																								2	Abbreviations: Analysis of variance (ANOVA), Apolipoprotein E (APOE), Alzheimer’s 
Diseases (AD), Bayes factor (B), Blood pressure (BP), Body mass index (BMI), Independent 
variables (IV), Irrelevant distractor (ID), National Adult Reading Test (NART), No distractor 
(ND), Response time (RT), Simple response time (SRT), Standard deviation (SD). 
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heightened processing surrounding a central fixation; with individuals able to shift this spotlight 
across the visual scene (Posner, 1980). Greenwood & Parasuraman (2004) argue selective 
attention is characterised by an additional ability to scale the breadth of this attentional 
‘spotlight’ on the basis of top-down information. Selective attention and working memory are 
sometimes viewed as overlapping constructs, with working memory acting as an interface for 
the active maintenance and manipulation of information at the forefront of attention (Awh et al., 
2006; Chun, 2011b; Cowan, 1999; Gazzaley & Nobre, 2012). Hence, early genotype differences 
should be considered in the context of the expected pattern of age-related decline in both of 
these processes.  
 
The dynamic scaling paradigm (Greenwood & Parasuraman, 1999) probes individual 
differences in the ability to adjust the breadth of attentional ‘spotlight’ during visual search. 
Participants’ attention is guided to a region of the visual scene by a spatial cue presented before 
the search array. This cue facilitates visual search by indicating where the target stimulus will 
appear, if present, hence promoting greater perceptual processing at this location (Hawkins, 
Goyal, & Sergio, 2015). The size of the cue varies across trials, with smaller cues 
(encompassing fewer stimuli from the visual array) providing more localised target information. 
Decreasing cue size is associated with shorter search response times (RTs), indexing the benefit 
of dynamically restricting attentional focus on the basis of this top-down information. The 
greatest benefit of spatial cueing is observed on conjunction search trials, characterised by a 
target letter being distinct in a combination of features, as opposed to feature or ‘pop-out’ trials 
where the target is identifiable by one feature (i.e. colour) (Parasuraman, Greenwood, & 
Alexander, 2000). 
 
Performance on the dynamic scaling paradigm shows sensitivity to both age-related change, and 
pathological change associated with AD (Parasuraman et al., 2000). In adults aged 65-74 years, 
more localised spatial cues clearly benefit the efficiency of visual search, however, this effect is 
reduced in a sample of healthy older adults, aged 75-85 years, and is present only following the 
most localised spatial cue for a group with AD (Parasuraman et al., 2000). Hence it is 
interpreted that the spatial flexibility of attentional focus is sensitive to age-related decline.  
 
The dynamic scaling task has also been used to explore APOE genotype effects in late-mid 
adulthood. In comparison to both a homozygous ε3 group and an ε2 group, ε4 carriers aged 50 
years and older demonstrated reduced benefit of smaller, more localised spatial cues 
(Greenwood, Sunderland, Friz & Parasuraman, 2000). Additionally, in a population of healthy 
adults (mean age 60 years), homozygous ε4 carriers showed significant declines in the use of 
spatial cueing across three years (Greenwood et al., 2005). This pattern was not seen in 
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heterozygous ε4 carriers, or non-carriers. These results suggest that ε4 carriers demonstrate a 
profile of accelerated ageing, with comparable reductions in the spatial flexibility of attentional 
focus seen in this group and adults aged 75 years and older. Therefore, reduced visuospatial 
attentional scaling may be a sensitive marker for those in the initial stages of cognitive decline. 
 
APOE genotype differences have also been reported using variants of the Posner spatial cueing 
task (Posner, 1980). While visual search paradigms probe the selection of information within 
attentional focus, this task provides an index of both the efficiency of attentional shifts across 
the visual field and the ability to process information at the periphery of the attentional 
‘spotlight’. On trials of the Posner spatial cueing task, a directional spatial cue is presented prior 
to target onset, which guides attention to one half of the visual scene. The majority of cues are 
valid, leading to more efficient perceptual processing of the visual target. Some trials however, 
contain invalid cues; these trials are associated with a cost to the speed of target identification as 
following target onset in the periphery, attentional focus must be disengaged from the incorrect 
location and shifted across the visual scene (Pesce & Bösel, 2001; Posner & Petersen, 1989).  
 
In agreement with ε4 carriers demonstrating a profile of accelerated ageing in visuospatial 
attention, ε4 carriers aged 41-85 years, and 50 years and older respectively, showed greater cost 
of invalid cueing to target item location (Greenwood et al., 2000; Greenwood et al., 2005). This 
was interpreted by the authors as representing deficits in the reorientation of attentional focus 
across the visual scene, similar to the behavioural profile shown by those in the early stages of 
AD on this task (Parasuraman, Greenwood, Haxby & Grady, 1992). In a group of middle-aged 
adults, aged 43-58 years, however, no genotype differences in attentional shifting were 
observed (Evans et al., 2014), questioning at what point in the lifespan ε4 detriments in 
visuospatial attention emerge. Indeed, in a sample of young adults, aged 18-30 years, ε4 carriers 
showed reduced cost of invalid cueing compared to homozygous ε3 carriers, suggesting this 
group are less disadvantaged by directing their attention to an incorrect region of the visual 
scene (Rusted et al., 2013). This may represent ε4 carriers approaching the task with a larger 
‘spotlight’ of perceptual attention, allowing for greater processing of targets in the periphery. Of 
note, reports of differential APOE genotype effects across age-groups may reflect changing 
gene expression over the lifespan, rather than contradictions across research reports (Han & 
Bondi, 2008). 
 
The overarching aim of this research is to establish if there are APOE genotype differences in 
the allocation of selective attention during visual search in mid-adulthood. The study 
administers two complementary tasks; the dynamic scaling paradigm (Greenwood & 
Parasuraman, 1999) (used previously), and a perceptual load task (Forster & Lavie, 2007). 
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Whilst the dynamic scaling task probes the active selection of information at the locus of 
attention, the perceptual load task explores another important determinant of selective attention: 
perceptual capacity. Together these tasks provide a broad investigation of differences in 
attentional ‘spotlight’ processes during visual search.   
 
Over the past two decades a large body of evidence supporting Load Theory has highlighted 
that the involuntary allocation of attention to irrelevant information depends on the availability 
of perceptual capacity (Lavie, Hirst, de Fockert, & Viding, 2004; Lavie, 1995; for review see: 
Lavie, 2005; 2010). Load Theory accommodates both early and late selection accounts of 
attention, with selection at the stage of perception defined as early and post-perceptual selection 
as late (Benoni & Tsal, 2013; Lavie et al., 2004). Load theory suggests that information will be 
attentionally processed until our fixed perceptual capacity limit is reached, after which point 
task-irrelevant information will be passively filtered out (early selection). When the limit of 
perceptual capacity has not been reached, attentional control mechanisms are applied to bias 
processing of goal-relevant stimuli in cases where the distractor has reached attentional 
awareness (late selection). This theory has been supported by measures of distractor processing 
in healthy adults (Forster & Lavie, 2007, 2008). A consistent cost of peripheral distractor 
presence has been found in visual search trials of low perceptual load. This cost is eliminated in 
trials of high perceptual load, as there is no capacity left to process the distractor. The level of 
load in which the cost disappears is indicative of the perceptual attentional capacity.  
 
Recruiting individuals from a narrow age-range (45-55 years) we sought to avoid any potential 
influence of preclinical pathological change. The study explores two possibilities: whether 
visuospatial attention is sensitive to accelerated ageing in ε4 carriers, indicated by either a 
reduction in perceptual capacity or in the spatial flexibility of ‘spotlight’ mechanisms; or 
alternatively, whether, as in early adulthood, ε4 carriers differentially approach visual search 
with a broader ‘spotlight’ of perceptual attention that persists into mid-adulthood.  
 
In line with previous research using the same dynamic scaling paradigm (Greenwood et al., 
2000; Greenwood et al., 2005), ε4 carriers are expected to show less efficient attentional scaling 
on this task, consistent with reduced spatial flexibility of attentional ‘spotlight’ mechanisms. 
Carriers of the ε3 and ε2 alleles are expected to show equal benefit of increasingly localised 
spatial cues on the dynamic scaling paradigm, indicative of an efficient use of attentional 
scaling. Detrimental effects of ε4 status may be absent, however, due to the younger group 
included here compared with previous research (Greenwood et al., 2000, 2005). 
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Like dynamic scaling, the perceptual load task has demonstrated sensitivity to cognitive ageing. 
In healthy older adults (aged 65-79 years), distractor compatibility effects were significantly 
reduced between low (set size: one stimulus) and mid (set size: four stimuli) levels of perceptual 
load. By contrast, distractor effects were still present on trials of mid perceptual load in young 
adults, although both age groups showed an elimination of distractor effects on trials with high 
perceptual load (set size: six stimuli) (Maylor & Lavie, 1998). The elimination of distractor 
processing at a lower level of perceptual load is consistent with an age-related reduction in 
perceptual capacity. If ε4 carriers were demonstrating a profile of accelerated ageing on this 
task, by mid-adulthood this group may show no distractor effects on mid-perceptual load trials 
(i.e. showing the reduced capacity found in older adults in Maylor & Lavie’s (1998) study). If, 
however, the widened attentional ‘spotlight’ suggested by performance on the Posner spatial 
cueing task in younger adults (Rusted et al., 2013) persists into mid-adulthood, distractor cost 
may persist on trials of higher perceptual load in ε4 carriers. As the effect of ε2 status is less 
commonly studied, no predictions are made for this genotype group.  
 
3.3. Method 
 
3.3.1 Participants. 
 
One hundred and sixty-five healthy adult volunteers (aged 45-55 years), recruited through 
advertisement at local universities, clubs and community centres, completed the initial screening 
phase of the study. Volunteers were required to be non-smokers and fluent in English. 
Furthermore, volunteers were screened for a history of vascular health problems, untreated high 
blood pressure (BP), psychoactive medication use, or recorded neurological/psychiatric 
condition within the past 5 years.  
 
The initial screening allowed for prior collection of a genotype sample from each volunteer. 
Screening procedures followed Human Tissue Authority (HTA) procedures, and the full study 
followed a protocol approved by the research ethics committee of the school of Psychology and 
Life Sciences, University of Sussex. All procedures were in accordance with the Helsinki 
declaration. Volunteers first provided written informed consent, including acknowledgment that 
the results of the genotype analysis would not be made available to them, before DNA was 
collected by buccal swab. Genotyping followed triangulated anonymization procedures, with 
two anonymized codes used per sample. Samples were analysed to determine APOE gene 
variant by LGC Genomics (Hertfordshire, www.lgcgroup.com/genomics). A fluorescence-based 
competitive allele-specific polymerase chain reaction determined the combination of three 
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major APOE alleles (ε2, ε3, and ε4) based on two APOE single nucleotide polymorphisms 
(rs429358, rs7412).  
 
Sixty-six volunteers completed the experimental phase of the research. Post-screening, 
invitation to participate was pseudo-random to ensure a suitable sample size in each genotype 
group, rather than selection being representative of the expected frequencies of each allele 
within the population. The distribution of genotypes within the sample was as follows: 16 ε2 
carriers (1 ε2/ε2; 15 ε2/ε3), 26 homozygote ε3 carriers, and 25 ε4 carriers (17 ε3/ε4; 7 ε4/ε4). 
Throughout the study both the participant and the experimenter were kept blind to genotype 
information. Characteristics of the final sample are shown in Table 3.1. 
 
3.3.2 Materials. 
  
3.3.2.1 Demographics and baseline cognitive measures. 
 
 
Medical history, medication use and general state of health were assessed using a shortened 
version of the Nuffield Medical History Questionnaire. Additionally, baseline measures of IQ 
(National Adult Reading Test (NART)(Nelson & Willison, 1991)), working memory 
(backwards digit-span), and simple response time (SRT) were obtained. To index response time 
(RT), participants were required to make a keyboard response as soon as possible following 
presentation of a stimulus on screen. Response time was averaged over 48 trials, excluding RTs 
more than 3 standard deviation (SD) away from the mean. 
 
3.3.2.2 The dynamic scaling task. 
 
The dynamic scaling task (Greenwood & Parasuraman, 2004) required participants to search for 
a pink T within a 15 letter array (5 across x 3 down), and make a speeded response as to 
whether the target letter is present (‘2’ keyboard response) or absent (‘6’ keyboard response). 
Before each array is presented, a black box cues where the target may or may not appear.  
 
In total, the task consisted of 240 trials split randomly into 3 blocks. In each trial, a central 
fixation cross was presented for 1000ms, followed by a cue for 500ms prior to the onset of the 
letter array. The letter array and the cue were then presented simultaneously until a response 
was detected. The array could appear on either the right (120 trials) or left (120 trials) of the 
fixation cross, and consisted of the characters T, G, and N presented in either pink, blue or 
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green. Letter-colour combinations of non-target items in the array were generated randomly, 
following constraints of the search type (conjunction, feature) for that trial.  
 
The task had 3 IVs integrated into its design: search type, cue size and cue validity. Search trials 
were split into feature search (120 trials), where the target letter in the only pink letter in the 
display, and conjunction search (120 trials), where the participant searched for the pink ‘T’ 
among an array of letters of the same type (‘T’) and colour (pink). Physical cue size varied 
across trials, encompassing either 1, 3, 9, or 15 letters from the search array, with 60 trials at 
each size of cue.  Cues were classed as valid (200 trials) or invalid (40 trials) depending on 
whether the target letter was enclosed within. An example trial of the dynamic scaling task is 
presented in Figure 3.1.  
 
 
Figure 3.1. A representation of experimental tasks: A) The dynamic scaling task showing two 
conjunction search trials with spatial cues encompassing 1 and 9 search array stimuli 
respectively, B) The perceptual load task with example low and high load distractor trials. Note- 
the distractor is an example rather than the actual cartoon stimuli used in task. 
 
 
 
 
		
63	
3.3.2.3 The perceptual load task. 
 
The perceptual load task (Forster & Lavie, 2007; 2008) is a visual search paradigm including 
two independent variables (IVs): perceptual load (low, high and medium) and distractor 
presence (blank, capture).  
 
Participants were required to indicate the presence of either an ‘X’ or an ‘N’ target letter in each 
trial, by making a ‘0’ key press response for X and ‘2’ key press response for N. Each trial 
initiated with the presentation of a central fixation cross for 500ms, followed by the presentation 
of a stimuli display for 200ms. Each stimuli display consisted of 6 white letters, one of which 
was always a target letter, arranged circularly on a black background. Identity of target letter 
and position of target within circle was counterbalanced across trials. Participants were 
requested to respond as quickly and accurately as possible. An auditory tone was used to 
provide feedback for incorrect responses or if no response was made within 2000ms.  
 
Perceptual load was manipulated across trials. In trials of low perceptual load (set size 1), non-
target letters in the stimulus display consisted of small ‘O’s. In trials of medium perceptual load 
(set size 4) there was 1 target letter, 3 non-target letters and 2 small ‘O’s in the stimulus display. 
In trials of high perceptual load (set size 6), in addition to the target, there were 5 non-target 
letters in the display. Non-target letters consisted of  ‘H’, ‘K’, ‘Z’, ‘M’, ‘W’; chosen to be 
similar to target letters in angular shape. 720 trials were presented in 12 blocks of 60, with each 
block containing trials of a single level of perceptual load. Each participant completed 4 
repetitions of a counterbalanced perceptual load sequence. In addition, participants completed a 
practice block for each level of perceptual load, with feedback on performance accuracy 
provided. An accuracy level of 65% was required for participants to proceed to experimental 
trials to ensure each participant was able to perform the task above chance level (50%). 
 
Trials were classified according to whether a task-irrelevant distractor image (Spongebob, 
Spiderman, Superman, “Pokemon”, Donald duck and Mickey) was presented in the periphery of 
the screen. 10% of trials featured a distractor image and were hence considered ‘capture’ trials, 
whilst 90% of trials had no distractor, and so were considered ‘blank’. An example of distractor 
trial can be seen in Figure 1. Participants were instructed to ignore the distractors, as these 
would impede their performance. 
 
3.3.3 Procedure 
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Volunteers selected from the screening phase took part in a single study session. First, 
demographic and health measures including age, family history of dementia, height, weight, and 
BP were collected. A measure of systolic and diastolic blood pressure was collected whilst 
seated, using an automatic arm-cuff machine on the right arm. Participants then completed a 
selection of experimental tasks and questionnaires in a fixed order. 
 
3.3.4 Analysis 
 
Differences in demographics and baseline cognitive performance were analysed between 
genotype groups (ε2, ε3 and ε4) using a series of one-way analysis of variances (ANOVAs) for 
continuous variables, and chi-squared tests for categorical measures (gender, family history).  
 
For each experimental task data was first analysed using parametric statistics, then using 
Bayesian statistics. All three genotype groups were compared using parametric statistics; 
following this, if there was suggestion of a genotype difference, separate analyses were run 
comparing ε4 carriers and ε2 carriers individually to the ε3 group. Bayesian statistics 
independently compared ε2 and ε4 genotype groups to homozygote ε3 carriers.  
 
Bayesian statistics were included to establish the strength of evidence for either the null (H0) or 
alternative hypothesis (H1). A Bayes factor (B) of  > 3 indicates substantial evidence for H1, 
whereas a B of < 1/3 indicates substantial evidence for H0. A B in the range 1/3 – 3 indicates 
the data may be insensitive for distinguishing between the two hypothesis (Dienes, 2014). Bs 
were modelled from 3 distributions in the current analysis. Directional predictions were 
modelled from a half-normal distribution (BH(0, x)), with x representing the prior estimate of 
effect size. Non-directional predictions were modelled from a normal distribution (BN(0, x)), with 
x representing half the prior effect size. In addition, when all effects in a specified range were 
equally likely Bs were modelled as a uniform distribution (BU(0, x)), with x representing the 
maximum expected effect.  
 
3.3.4.1 The dynamic scaling task. 
 
3.3.4.1.1 Overall task performance. 
 
Accuracy and median RTs for each search type (feature, conjunction) and cue size (1, 3, 9, 15 
letter stimuli) were analysed for valid trials. Across all volunteers, a repeated measures 
ANOVA (search type x cue size) was completed for search RTs.  The slope of attentional 
scaling (an index of RT change with decreasing cue size) was used to probe this interaction 
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further using Bayesian inference, with a greater scaling slope predicted for conjunction trials 
compared to feature search trials. The prior effect size was based on the feature and conjunction 
scaling slopes reported in a late-mid age homozygous ε3 group (Greenwood et al., 2000).  
 
3.3.4.1.2 Genotype effects. 
 
To explore genotype differences in RT a mixed ANOVA with cue size (1, 3, 9, and 15 letter 
stimuli) as the within-subject factor and genotype (ε2, ε3, ε4) as the between-subject factor was 
conducted for both feature and conjunction search trials. Individual Bonferroni-adjusted t-tests 
were used to probe significant effects of genotype where present, comparing ε4 and ε2 carriers 
to the ε3 group. A B for the Genotype x Cue Size interaction was modelled from the current 
data for both feature and conjunction search trials (see Dienes (2014) for further explanation of 
using Bayesian statistics to explore interactions). The population interaction effect (effect of cue 
size in group 1- effect of cue size in group 2) was modelled as a uniform distribution for each 
search type, varying from 0 (i.e. when both groups show an equivalent effect of cue size) and 
the maximum effect of cue size reported for the two groups (i.e. when one group demonstrates 
an effect of cue size, and one group demonstrates no effect). In addition, following a significant 
Genotype x Cue Size interaction (indicated by parametric statistics), Bs were computed for each 
post-hoc comparison. Prior effect sizes were based on previously reported genotype differences 
(Greenwood et al., 2000). It was predicted that ε4 and ε2 carriers would demonstrate greater 
search RTs at cue size 3 and 1. All other predictions were non-directional.  
 
The scaling slope for conjunction search trials was compared between genotype groups using a 
one-way ANOVA. Again, individual Bonferroni adjusted t-tests were used to probe significant 
effects of genotype where present, comparing ε4 and ε2 carriers to the ε3 group. For the 
Bayesian analysis of scaling slope on conjunction search trials, no directional prediction was 
made for an ε2 difference, however, ε4 carriers were predicted to show a reduced slope 
compared to the ε3 group. Prior effect sizes were estimated from the genotype differences in 
slope reported in Greenwood et al., (2000). 
 
A one-way ANOVA was used to test genotype differences in accuracy. There was no 
directional prediction for a genotype difference in accuracy, hence Bs were modelled from a 
normal distribution. The prior effect size was based on the maximum difference in accuracy 
previously reported (Greenwood et al., 2000). 
 
3.3.4.1 The perceptual load task. 
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RTs less than 100ms or more than 3000ms were removed prior to analysis. Mean RT for correct 
trials and accuracy were considered separately. Mixed 3 x 3 x 2 ANOVAs were performed on 
both RTs and accuracy, with genotype (ε2, ε3, ε4) as the between-subjects factor, and 
perceptual load (low, mid, high) and distractor (blank, capture) as the within-subjects factors. 
Interactions were probed using Bonferroni-adjusted t-tests.  
 
3.3.4.1.2 Bayesian analysis 
 
Bayesian analysis of the main effect of perceptual load followed the same approach for RTs and 
accuracy. For blank trials, a B for each pairwise comparison of perceptual load was modelled 
from a half normal distribution, based on the prediction that RTs would increase and accuracy 
decrease with increasing perceptual load. The neutral distractor condition in young adults3 (set 
size 1, 4 and 6) was used for prior effect sizes (Maylor & Lavie, 1998).   
 
The Load x Distractor interaction was analysed by calculating a B for the difference in distractor 
cost, defined as the difference between blank and capture trials, for all pairwise comparisons of 
perceptual load. For RTs, the prior effect size was based on the difference in irrelevant 
distractor cost between trials of low (set size 1) and high (set size 6) perceptual load 
(Experiment 2b: Forster & Lavie, 2008). In addition, the presence of RT distractor costs at each 
level of perceptual load was probed, modelled as a half normal distribution with a prior effect 
size based on the maximum distractor cost reported in Experiment 2b; Forster & Lavie (2008). 
Perceptual load differences in distractor cost for task accuracy were modelled from a full-
normal distribution, as load was not predicted to modulate distractor effects.  
 
Multiple Bs for the Load x Distractor x Genotype interaction were computed to assess the 
strength of evidence for distractor costs at each level of perceptual load in each genotype group. 
For both RTs and accuracy, prior effect sizes were again based on Experiment 2b, Forster & 
Lavie (2008).  
 
 
 
 
 																																																								3	The effect of perceptual load in our dataset, both for RT and accuracy, more closely resembled 
the effect reported in young adults than the older group included in Maylor and Lavie (1998). 
Hence this group was used for the prior. Recalculating the Bs with prior effect sizes based on 
the older population did not change the results.  
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3.4 Results 
 
3.4.1 Demographics & baseline cognitive measures. 
 
No genotype difference was found across demographic measures (p>.05). Furthermore, no 
group differences were found in WM span, or SRT (p>.05). The demographic and baseline 
characteristics of each genotype group are shown in Table 3.1. 
 
Table 3.1. Demographics and performance on baseline cognitive measures  
 Genotype Group 
Measure ε2 ε3 ε4 
n 16 26 24 
Age 50.44 (3.58) 49.04 (2.68) 49.17 (3.07) 
Gender (% female) 75 73 63 
Family History (%Yes) 25 35 54 
Education 17.22 (3.24) 17.23 (3.13) 17.85 (4.32) 
NART 119.06 (2.84) 118.56 (2.93) 116.87 (4.62) 
    
BMI 24.02 (3.44) 26.24 (4.37) 25.15 (3.78) 
Systolic BP 115.63 (7.55) 118.23 (8.47) 115.00 (8.76) 
Diastolic BP 77.31 (9.99) 81.77 (10.63) 79.13 (7.77) 
    
SRT (ms) 272.24 (44.15) 265.24 (32.39) 266.90 (27.84) 
Digit-span 4.31 (1.30) 4.19 (1.50) 4.00 (1.65)  
Notes: Mean (SD). Body mass index (BMI) 
 
3.4.2 Dynamic scaling task. 
 
3.4.2.1 Overall task performance. 
 
Accuracy on task was consistently high, with scores ranging from 84% to 100% (Mean=97%) 
correct across valid trials. Accuracy of one volunteer was below chance (43%) on this task, and 
so their data was removed prior to analysis.  
 
Across participants, median RTs were significantly longer for conjunction search trials than 
feature search trials, F(1,63)=458.19, p<.001, η2ρ =.879. A significant effect of cue size, F (1.99, 
125.65)=202.53, p<.001, η2ρ =.763, was also found, with RTs decreasing as a function of 
smaller cue. There was a Search type x Cue size interaction, F(1.99, 125.65)=115.73, p<.001, 
η2ρ =.648, shown in Figure 3.2. This was driven by a greater slope of RT decrease with reducing 
cue size for conjunction search trials (b=15.44) than feature search trials (b=3.98), t(64)=-14.83, 
p<.001, BH (0, 7.5) = 8.09374E+46.  
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3.4.2.2 Genotype differences. 
 
No significant genotype difference was found for accuracy across valid trials, F(2, 61)=.979, 
p=.381. Both the ε2 to ε3 comparison (BN (0, 2.35)=.97) and the ε4 to ε3 comparison (BN (0, 
2.35)=.95) are insensitive for determining a genotype difference in accuracy.  
 
For feature search trials, there was a significant main effect of cue size on RT, F(2.26, 
137.82)=50.81, p<.001, η2ρ=.454, but the main effect of genotype (p=.243) and the interaction 
between genotype and cue size (p=.290) were both non-significant. Bayesian analysis of the 
Genotype (ε2, ε3) x Cue Size (1, 3, 9, 15 letters) interaction provides anecdotal support for H0: 
F(3, 117)=.56, p=.646, η2ρ =.014, BU(0, 56.80)=.57. Data was insensitive for determining a 
Genotype (ε4, ε3) x Cue size (1, 3, 9, 15 letters) interaction, F(3, 141)1.98, p=.120, η2ρ =.040, 
BU(0, 74.13)=.1.58. 
 
 
Figure 3.2.  Median response time for each cue size presented by search type. 
 
Search RTs and the slope of attentional scaling on conjunction search trials are shown in Table 
3.2. There was a significant main effect of both cue size, F(2.04 , 124.50)=213.26, p<.001, 
η2ρ=.778, and genotype, F(2, 61)=3.69, p=.031, η2ρ=.108, on conjunction search RTs. The effect 
of genotype was driven by ε2 carriers responding significantly slower than the ε3 group 
(p=.042). In addition, there was a significant Genotype x Cue Size interaction, F(4.08, 
124.50)=2.53, p=.043, η2ρ=.077. The comparison of ε2 and ε3 genotype groups provide 
sensitive support for a Genotype x Cue Size interaction, F(3, 117)=4.53, p=.005, η2ρ =.104, 
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BU(0, 279.67)=4.33. The comparison of ε4 and ε3 genotype groups provide sensitive support for 
no Genotype x Cue Size interaction, F(3, 141)=.239, p=.869, η2ρ =.005, BU(0, 221.70)=.26.  
 
Results of the post-hoc analysis of genotype differences at each cue size on conjunction search 
trials are shown in Table 3.3 (Bonferroni corrected α=.006). Ε2 carriers demonstrated 
significantly longer RTs than the ε3 group at cue size 15 (p=.004, BN (0, 30)=4.32). There was 
also support for this group showing significantly longer RTs at cue size 1 (p=.068, BH (0, 
60)=.3.47). Ε4 carriers did not significantly differ in search RTs from the ε3 group at any cue 
size (p>.006) however; data appears insensitive for supporting either the null or alternative 
hypothesis.  
 
To further probe the interaction between genotype group and cue size on conjunction trials, the 
slope of change in RT with reducing cue size was considered. At trend level there was an effect 
of genotype, F(2, 63)=2.66, p=0.78, driven by the difference between the ε3 and ε2 groups 
(p=.035; BN (0, .1)=1). The genotype difference between ε3 and ε4 carriers was non-significant, 
(p=.525; BN (0, 1.75)=1.07). Genotype differences in slope are also shown in Figure 3.3 
 
 
Figure 3.3 Benefit of reducing cue size on RT for conjunction search trials by genotype group. 
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Table 3.2. For each genotype group, RT (ms)(SD) to detect target presence and the slope of 
attentional scaling is shown.  
Genotype 
Cue size Slope 
1  3  9  15  B 
ε2 537 (73) 612 (74) 696 (80) 817 (85) 18.80 
ε3 484 (73) 565 (75) 646 (80) 691 (85) 13.83 
ε4 481 (73) 563 (75) 654 (80) 703 (85) 14.93 
Note: Cue size represents the number of letter stimuli encompassed within each spatial cue 	
Table 3.3. p values and Bs for the post hoc comparisons of the Genotype x Cue Size interaction 
for conjunction search trials 
Genotype group 
comparison 
 
Cue Size 
 1 3 9 15 
ε2 and ε3 p .068 .114 .156 .004 
 
B B H (0, 60)=.3.47 B H (0, 65)=2.27 BN (0, 22.5)=1.14 BN (0, 30)=4.32 
ε3 and ε4 p .899 .932 .748 .687 
  B B H (0, 45)=.39 B H (0, 35)=.53 BN (0, 2)=1 BN (0, 2.5)=1 
Note: Bonferonni corrected alpha=.006. B's <1/3 or >3 or sensitive.  
 
3.4.3 The perceptual load task. 
 
Performance on this task is shown according to genotype group in Table 3.4. 
 
3.4.3.1 RT. 
 
Assumptions of sphericity were violated so a Greenhouse-Geisser correction was applied for the 
main effect of perceptual load. With increasing perceptual load, RTs significantly increased, 
F(1.27, 78.62)=352.16, p<.001, η2ρ=.850. The Bayes analysis supports a sensitive increase in 
RT with increasing perceptual load (low to mid : B H (0, 118)= 9.80017E+90; low to high: B H (0, 
230)= 1.54409E+92; mid-high: B H (0, 52)= 2.93020E+22). 
 
The main effect of distractor was significant, F(1, 62)=17.81, p<.001, η2ρ=.223, with RTs longer 
for capture trials than blank trials. Sphericity was again violated for the interaction between 
perceptual load and distractor presence, so degrees of freedom were corrected using a Huynh-
Feldt correction (ε=.92). A significant interaction between perceptual load and distractor 
presence was found, F(1.84, 113.98)=8.55, η2ρ=.223. This interaction is shown in Figure 3.4., 
and was driven by there only being a main effect of distractor presence at low-load, Bonferroni 
corrected α = .017, t(64)=-8.87, p<.001, BH (0, 61)= 1.03191E+16. At mid and high perceptual 
load the effect of the distractor was eliminated (p>.017; mid: BH (0, 61)= .29; high: BH (0, 61)= 
		
71	
.16). Distractor cost was reduced at both mid (BH (0, 50)= 573.01), and high levels of perceptual 
load (BH (0, 50)= 292.22) compared to low perceptual load. There was no difference between 
the distractor cost at mid and high perceptual load (BH (0, 50)= .23).  
 
The main effect of genotype was non-significant (p=.262) as were all interactions between 
genotype, perceptual load and distractor (p>.05). All 3 genotype groups show a sensitive 
distractor cost on trials of low perceptual load (ε2: BH (0, 61)= 86169, ε3: BH (0, 61)= 356206, 
ε4: BH (0, 61)= 43112), however, there suggestion of no distractor cost at mid (ε2: BH (0, 61)= 
.74, ε3: BH (0, 61)= .50, ε4: BH (0, 61)=.14) and high levels (ε2: BH (0, 61)=.97, ε3: BH (0, 
61)=.39, ε4: BH (0, 61)=.17) of perceptual load, with sensitive nulls reported in the ε4 group.  
 
 
Figure 3.4. The interaction between perceptual load and distractor presence on RTs. 
	
 
3.4.3.1 Accuracy. 
 
Perceptual load again violated assumptions of sphericity, so a Greenhouse-Geisser correction 
was applied. Accuracy significantly decreased as perceptual load increased, F(1.46, 
91.08)=71.62, p<.001, η2ρ=.536. The Bayes analysis supports a sensitive decrease in accuracy 
with increasing perceptual load (low to mid: B H (0, .05)=157.06; low to high: B H (0, 
.01)=1.86562E+22; mid-high: BH (0, .07)=1.60033E+21).  
 
The main effects of distractor and genotype on task accuracy were both non-significant, as were 
all interaction terms (p>.05). Bayesian analysis indicated data was insensitive for detecting a 
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change in distractor cost on accuracy with increasing perceptual load (BN (0, .03) < 1/3 and > 3). 
The perceptual load x distractor x genotype interaction approached significance, F(4, 
124)=2.11, p=.084, η2ρ=.064, but further examination using pairwise comparisons revealed no 
significant differences (p>.05). Data was insensitive for detecting a distractor cost in task 
accuracy at each level of load when separately considered between genotype groups (BN (0, .03) 
< 1/3 and > 3) 
 
Table 3.4.  Mean RT (ms) and accuracy (proportion of trials correct) on the perceptual load 
task, presented by genotype group, with SD shown in brackets. 
Genotype Load   ND ID Cost 
ε2 Low RT 552 (48) 579 (63) 27 (21) 
  
Accuracy .93 (.04) .94 (.05) 
 
 
Mid RT 770 (69) 780 (69) 10 (40) 
  
Accuracy .89 (.07) .89 (.07) 
 
 
High  RT 827 (81) 829 (81) 2 (48) 
  
Accuracy .82 (.09) .79 (.12) 
 ε3 Low RT 524 (42) 542 (42) 19 (18) 
  
Accuracy .93 (.05) .92 (.07) 
 
 
Mid RT 716 (100) 724 (101) 8 (27) 
  
Accuracy .90 (.07) .91 (.07) 
 
 
High  RT 780 (132) 788 (134) 8 (34) 
  
Accuracy .83 (.11) .82 (.11) 
 ε4 Low RT 549 (85) 573 (90) 24 (23) 
  
Accuracy .94 (.04) .94 (.05) 
 
 
Mid RT 750 (121) 749 (126) -1 (38) 
  
Accuracy .90 (.07) .88 (.12) 
 
 
High  RT 825 (156) 826 (160) 1 (28) 
    Accuracy .83 (.10) .82 (.13)   
Notes: ND= no distractor, ID= irrelevant distractor, Cost = ID-ND 
 
3.5. Discussion 
 
This study sought to explore how APOE genotype influences performance on visuospatial 
search paradigms in mid-adulthood. Both of the experimental tasks administered here 
sensitively demonstrated the variation in cognitive performance appropriate to within-task 
manipulations, supporting the theoretical underpinnings of these paradigms. Of interest, 
distractor effects were eliminated at both mid and high levels of perceptual load, supporting a 
reduction in perceptual capacity in a mid-age cohort, an age-range that has not previously been 
tested (Maylor & Lavie, 1998).  
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The two tasks included here were selected to investigate if ε4 carriers show attentional 
‘spotlight’ differences during visual search in mid-adulthood. Ε4 carriers, however, 
demonstrated comparable performance to the homozygous ε3 group on both the dynamic 
scaling task and the perceptual load task. This provides no support for the risk factor being 
associated with either a less responsive ‘spotlight’ mechanism in mid-adulthood, or a widened 
perceptual window of attention. Carriers of the less commonly studied ε2 allele, however, did 
show performance disadvantages. This group were slower overall to detect the target on 
conjunction search trials in the dynamic scaling task, with sensitive differences confirmed on 
trials including both the maximum and minimum size of spatial cue. These results are not 
consistent with the simple view that ε2 status is protective against cognitive ageing, whilst ε4 
status is disadvantageous.  
 
In contrast to Greenwood and colleagues’ (2000, 2005) findings, our mid-age ε4 carriers 
showed no difference in the ability to modify attentional ‘spotlight’ in light of top-down 
information. This does not support a trajectory of accelerated ageing being present by mid-
adulthood. Failure to replicate this earlier finding may in part be accounted for by differences in 
sample selection, highlighting a methodological concern in the existing mid-age APOE 
literature (Lancaster et al., 2017). The age-range of participants’ included in Greenwood et al.’s 
(2000) study was wider, and as a consequence of including older individuals, later-life ε4 
disadvantages may have impacted overall group differences. The narrow age range included 
here (aged 45-55 years) importantly, precludes the potential confound of preclinical 
pathological change. Furthermore, while Greenwood et al. (2000) selected individuals on the 
basis of an immediate family history of AD, family history of AD was not a selection criterion 
of the current study meaning the sample may be more representative of a healthy ageing 
population. In addition, the tightly controlled age-range included here acknowledges the 
expectation that expression of APOE genotype effects is not constant across the lifespan. 
 
Performance on the perceptual load task was equivalent between APOE genotype groups, 
supporting intact perceptual attention in mid-age ε4 carriers. Distractor effects were absent in all 
three genotype groups on trials of both mid and high perceptual load, suggesting reductions in 
perceptual capacity, comparable to those seen in an older group (aged 65-79 years) (Maylor & 
Lavie, 1998), occur by mid-adulthood regardless of genotype. Future research could apply the 
present perceptual load paradigm to test whether young ε4 carriers might show this reduction at 
an earlier point. Previous research reported ε4 genotype differences on the Posner spatial cueing 
task in both young (Rusted et al., 2013) and older adults (Greenwood et al., 2000; Greenwood et 
al., 2005), perhaps indicating a difference in the breadth of attentional ‘spotlight’. No genotype 
differences on this task, however, were found in a group of similar age (43-58 years) to the 
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current participant sample (Evans et al., 2014). This may suggest that in mid-adulthood at least, 
there is little effect of APOE genotype on breadth of perceptual attention. One explanation for 
why no genotype differences in perceptual threshold were seen could be that task sensitivity 
was poor - load increased in jumps of one item, four items, and six items; a more gradual 
increase in load may have improved sensitivity to any subtle genotype differences. 
 
Overall, the present results suggest that relative to the ε3 population ‘norm’, ε4 carriers show 
equivalent attentional scaling and perceptual capacity in mid-adulthood, countering the 
argument that the ε4 genotype represents a detrimental cognitive phenotype right across the 
lifespan. There is some support in the literature for an age x APOE interaction, with several 
studies identifying the end of the 5th decade as a point when detrimental performance effects of 
APOE ε4 emerge (Caselli et al., 2009; Jochemsen, Muller, van der Graaf, & Geerlings, 2012; 
Marioni et al., 2015; Shin et al., 2014). It would seem behavioural performance is preserved in 
ε4 carriers up until 5th decade despite evidence for structural and functional changes prior to this 
(e.g Dowell et al. 2016; Trachtenberg et al., 2012a; 2012b). Given the reported attentional 
detriments in a late-mid age sample (Greenwood et al., 2000; 2005a; 2005b), research probing 
additional factors that may mediate the emergence of decline in this genotype, is important. In 
respect of the antagonistic pleiotropy position (Han & Bondi, 2008), if the effects of this gene 
are transitioning from advantages in young adulthood, to disadvantages in later life, the absence 
of genotype differences recorded here are consistent with a transitioning stage in which the 
allele is exerting neither a positive nor a negative effect of cognition. Stronger evidence of 
dissociative effects with longitudinal data across the age span is needed, however, to 
substantiate this model.  
 
Contrary to expectations, the current study reported performance disadvantages in carriers of the 
premised ‘protective’ ε2 allele. Although cognitive effects of ε2 in mid-adulthood have not been 
well characterised to date, Greenwood and colleagues (2000; 2005) included an ε2 group, and 
found no performance differences on the dynamic scaling task. Again, our results may differ 
due to discrepancy in population selection. Our results suggest that ε2 carriers are approaching 
the visual search paradigms differently, showing less efficient visual search strategies.  
 
In line with the differential performance of ε2 carriers seen in this task, neural data has 
suggested both ε2 and ε4 carriers show corresponding differences in function BOLD response 
compared homozygous ε3 carriers (Trachtenberg et al., 2012a; 2012b). Despite equivalent 
performance on both an episodic memory and Stroop task, both ε2 and ε4 groups showed 
overlapping profiles of over-activation in a mid-age group (Trachtenberg et al., 2012a), and 
similar profiles in a resting-state connectivity analysis (Trachtenberg et al., 2012b).  These 
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results, again, confuse the clear dichotomy between cognitive risk and variants of the APOE 
gene, and support the need for further profiling that directly compares all three variants across a 
wider age span.  
 
There are limitations in the current study. The sample size of each genotype group, in particular 
the number of ε2 carriers, completing the behavioural paradigms was relatively small. However, 
Bayesian analysis was used to confirm the sensitivity of both ε4 equivalence and ε2 differences 
in cognitive performance. Further, although overall group performance on the perceptual load 
task replicated those suggested by perceptual load theory, standard deviations were large, and 
this may have reduced sensitivity of the task for detecting genotype differences. 
 
3.6. Conclusions 
 
The results suggest that in healthy mid-age individuals, carrying the ε4 variant of APOE is not 
associated with disadvantaged performance on dynamic scaling and perceptual load measures of 
visuospatial attention, despite the established detrimental effects of this gene in older adults. 
Attentional ‘spotlight’ differences did not emerge as a potential marker of cognitive decline in 
this ‘at-risk’ group. Carriers of the ε2 allele showed performance disadvantages on the measures 
tested here, stressing the need to consider all three variants of APOE individually when 
assessing its impact on cognition. The distinction between ‘protective’ ε2 and ‘detrimental' ε4 
status is not as clear-cut as supposed, and longitudinal studies of how both of these variants 
impact the trajectory of cognitive ageing is a vital next step.  
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4. Article 3 
 
The APOE paradox: how do attentional control 
differences in mid-adulthood reflect risk of late-life 
cognitive decline.  
 
Article 3 is published in Neurobiology of Ageing as: 
Lancaster, C., Tabet, N., & Rusted, J. (2016). Neurobiology of Ageing The APOE 
paradox : do attentional control differences in mid-adulthood reflect risk of late-life 
cognitive decline. Neurobiology of Ageing, 48, 114–121. 
http://doi.org/10.1016/j.neurobiolageing.2016.08.015 
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4.1. Abstract 
 
Possession of an APOE ε4 allele is an established risk factor for Alzheimer’s disease, while the 
less commonly studied ε2 variant is premised to offer some protection. This research explores 
the purported deleterious-protective dichotomy of APOE variants on attentional control in mid-
adulthood. 66 volunteers, aged 45-55 years, completed three tasks that provided complementary 
measures of attentional control: prospective memory, sustained attention and inhibition.  
Performance was compared between ε2 carriers, ε4 carriers and ε3 homozygotes (the population 
norm). Carriers of the ε4 allele showed subtle disadvantages, compared to the ε3 group, in 
accuracy of Stroop task and prospective memory performance. Contrary to expectations, ε2 
carriers showed performance disadvantages in sustained attention. The finding of detrimental 
effects in attentional control for both ε4 and ε2 complicates the current model that proposes 
opposing effects of these variants on later-life cognition. Future research is needed to 
understand how cognitive differences develop with increasing age, and the physiological 
mechanisms that underpin these changes.  
 
Keywords: APOE, Cognitive Ageing, Alzheimer’s disease, Attention, Executive Function, 
Mid-adulthood 
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4.2. Introduction 
 
Cognitive ageing is differentially associated with the three variants (ε2, ε3, and ε4) of the 
Apolipoprotein E (APOE) gene, a single nucleotide polymorphism. The ε4 allele, present in 
approximately 25% of the population, is associated with increased risk of Alzheimer’s disease 
(AD) (Corder et al., 1993). While the ε3 allele is positioned as the population norm, possession 
of an ε2 allele, prevalent in ~15% of the population (Raber et al., 2004) is hypothesised to be 
protective against AD risk (e.g. Farrer et al., 1997; Lippa et al., 1997; Wilson et al., 2002).   
 
In addition, carrying at least one copy of the APOE ε4 allele has been associated with poorer 
cognition in healthy older adults, with effects most commonly reported in episodic memory 
(e.g. Caselli et al., 1999; O’Hara et al., 1998; Staehelin et al., 1999; Packard et al., 2007), but 
not isolated to this domain (e.g. Berteau-Pavy et al., 2007; Reinvang et al., 2010; Small et al., 
2004; Wisdom et al., 2011). Not all studies have been consistent in reporting an effect of APOE 
ε4 in older adulthood, however (e.g. Bunce et al., 2014; Bunce et al., 2004; Juva et al., 2000; 
Kim et al., 2002; Salo et al., 2001). 
 
Significantly, effects of carrying an APOE ε4 allele are not isolated to ageing populations, with 
reports of subtle cognitive differences in ε4 carriers from childhood (Acevedo et al., 2010; 
Bloss et al., 2008).  Evidence for cognitive advantages in young ε4 carriers has been reported 
within the domains of episodic memory, executive function (EF) and attention (Marchant et al., 
2010; Mondadori et al., 2007; Rusted et al., 2013; Taylor et al., 2016), contrasting with the 
detrimental associations of APOE ε4 in later adulthood. As effects of ε4 are detectable in youth, 
however, this highlights the need to consider APOE genotype earlier in the ageing trajectory.  
 
The cognitive effects of APOE in mid-adulthood are of crucial interest as this may be when the 
ε4 allele is first exerting detrimental effects on the ageing trajectory. To date, reported effects of 
APOE ε4 in mid-adulthood are inconsistent (for review; Lancaster et al., 2017; Rusted & 
Carare, 2015; Salvato, 2015), with many studies reporting null effects. The exceptions are 
studies within the domain of memory, where detrimental effects are reported from the end of the 
fifth decade (Caselli et al., 2004; Jochemsen et al., 2012; Schultz et al., 2008). The 
inconsistency of reported findings is likely to stem from several methodological issues, 
including variation in age group included, control of potential moderators and sensitivity of 
cognitive tasks used. Moreover, as the effect of APOE ε4 is non-uniform across cognition, the 
domain under study represents another factor in the inconsistency. 
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Aside from memory, attentional control, necessary to complete any goal-driven behaviour, may 
show sensitivity to APOE status in mid-adulthood. Both attentional control mechanisms and EF 
deficits have been associated with the preclinical stages of dementia (Carlson et al., 2009; 
Harrington et al., 2013; Twamley et al., 2006). Frontal regions, the predominant neural focus of 
executive attention, are vulnerable early in the ageing trajectory to both a loss of neural integrity 
and the deposition of amyloid, with this pattern reported in both healthy and pathological ageing 
(Bartzokis et al., 2003; Raz, 2000; Rowe et al., 2007; Villemagne et al., 2011). Further 
supporting the sensitivity of attentional control to ageing processes, amongst a battery of 
neuropsychological measures, the profile of errors and response time (RT) on a computerized 
Stroop-switch paradigm, an established measure of attentional selection and distractor 
inhibition, was found to best distinguish the cognitive profile of mild AD (Hutchison et al., 
2010). In addition, performance on this task predicted the subsequent development of AD in a 
sample of older adults (Balota et al., 2010). 
 
Neuropsychological assessments have not consistently found an effect of APOE ε4 on attention 
or EF in mid-adulthood (Flory et al., 2000; Jochemsen et al., 2012; Sager et al., 2005), although 
genotype differences have been found using computerized research paradigms developed for 
maximum sensitivity. On a measure of sustained attention, ε4 carriers (aged 45-55 years) 
demonstrated greater accuracy for detecting target strings, but slower RTs relative to a 
homozygous ε3 group (Evans et al, 2014). This pattern of performance was replicated on a 
prospective memory (PM) measure in the same cohort, with ε4 carriers demonstrating more 
accurate retrieval of PM intentions, but slower RTs on the ongoing task. Imaging data collected 
during the PM task found that in ε4 carriers only, left inferior frontal gyrus activity correlated 
with retrieval accuracy. This was interpreted as evidence of a compensatory response within 
top-down attentional control mechanisms.  
 
Failure to account for the effect of APOE ε2 is likely a key factor in the reported inconsistency 
of APOE-related cognitive change in the literature to date. Predominantly, research either 
excludes ε2 carriers, or considers ε2 and ε3 variants collectively as a non-ε4 group, despite 
purported protective effects. In light of the opposing effects of APOE variants on dementia risk, 
intuitively differences are expected in the cognitive profile of ε4 and ε2 carriers. Recent 
research, however, has found overlapping patterns of task-related functional activity in mid-age 
ε2 and ε4 carriers, compared to an ε3 group, during both a Stroop task, and an episodic memory 
task (Trachtenberg et al., 2012a). Both genotype groups also showed differences in resting-state 
activity compared to an ε3 group (Trachtenberg et al., 2012b). This calls into question how the 
assumed dichotomy in APOE associated cognitive ageing manifests, and highlights APOE ε2 as 
a crucial area for future research.  
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The current study provided a detailed investigation into the association between APOE and 
attentional control in mid-adulthood. The study aimed to extend previous findings of genotype 
differences within this domain (Evans at al., 2014) by administering a broader range of 
attentional tasks, allowing for a more in-depth exploration of the specific cognitive processes 
showing genotype sensitivity. The research also provided novel investigation into the 
hypothesised ‘protective’ ε2 allele.  
 
The behavioural session administered a rapid visual information processing task (RVIP; Wesnes 
& Warburton, 1983) and a PM measure (Rusted & Trawley, 2006), to establish if a speed-
accuracy trade-off in ε4 carriers is reliably observed. Specifically, the research expected to 
replicate the ε4 advantage in PM retrieval, and target detection on the RVIP, in comparison to 
the population norm (ε3 homozygotes), at the cost of response latency in this group. The 
processes targeted by these tasks include goal maintenance, switching, monitoring and updating, 
all of which burden executive attention and load on frontal lobes (Cona et al., 2015; Coull et al., 
1996). In addition, a computerized Stroop-switch task (Hutchison et al., 2010) was used to 
explore if errors on this task differentiate carriers of a genetic risk for AD as early as mid-
adulthood. As this task has previously been shown to distinguish older adults at heightened risk 
of developing Alzheimer’s disease (Balota et al., 2010), by mid-age ε4 carriers may show 
similar costs of incongruency on the proportion of errors made. Differences in task accuracy are 
linked to the ability to hold relevant information at the forefront of attention, and resist 
interference. 
 
Despite reported protective effects of carrying an APOE ε2 allele on longevity (Blanché et al., 
2001; Frisoni et al., 2001) and cognition in older adulthood (Helkala et al., 1996; Wilson et al., 
2002), understanding of how this variant affects cognition is limited at present. In light of recent 
research (Trachtenberg et al., 2012a; Trachtenberg et al., 2012b), it is unclear whether ε2 
carriers will show equal or advantaged performance compared to homozygous ε3 carriers. This 
study took an exploratory look at the ε2 effects on attentional control mechanisms, to provide 
the foundation for future work establishing the profile of this genotype in mid-adulthood.  
 
Furthermore, the study addresses many of the methodological shortcomings within existing 
mid-age literature. The tasks record trial-by-trial response time data, as well as accuracy, to 
allow detailed analysis of performance on task. Additionally, the study recruits individuals from 
a narrow range of the lifespan (aged 45-55 years), and measures participant variables including 
education and cardiovascular health, which may moderate the influence of APOE on cognition.  
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4.3. Methods 
 
4.3.1. Participants 
 
165 healthy volunteers were recruited for the initial screening phase of this study, through 
advertisement at local universities, clubs, and community centers. For inclusion, volunteers 
were required to be aged 45-55 years, a non-smoker and using English as their daily-language. 
Exclusion criteria consisted of: a history of vascular health problems, untreated high blood 
pressure, psychoactive medication use, or a history of neurological trauma or psychiatric 
condition within the past 5 years.  
 
The initial screening phase followed Human Tissue Authority (HTA) procedures, and the 
research ethics committee of the school of Psychology and Life Sciences, University of Sussex 
approved the full study. In line with ethical guidelines, volunteers first provided written 
informed consent, including acknowledgment that the results of the genotype analysis would 
not be made available to them. DNA was collected with a buccal swab, using an Isohelix SK1 
kit. Genotyping followed triangulated anonymisation procedures, with two anonymised codes 
used per sample. Samples were analysed to determine APOE gene variant by LGC Genomics 
(Hertfordshire, www.lgcgroup.com/genomics). A fluorescence-based competitive allele-specific 
polymerase chain reaction determined the presence of three major APOE alleles (ε2, ε3, and ε4) 
based on two APOE single nucleotide polymorphisms (SNPs) (rs429358, rd7412).  
 
 
66 volunteers were invited to complete the behavioural session. Selection was made pseudo-
randomly, in that efforts were made to ensure an approximately even numbers of participants in 
each genotype group (ε2, ε3, ε4). Double-blind procedures were followed in that both the 
experimenter and participants remained blind to genotype. Distribution within genotype groups 
was as follows: 16 ε2 carriers (2 ε2/ε2, 14 ε2/ε3), 26 ε3 homozygotes, and 24 ε4 carriers (17 
ε3/ε4, 7 ε4/ε4). Volunteer characteristics are shown in Table 4.1. 
 
4.3.2. Materials 
 
4.3.2.1. Demographics and Baseline Cognitive Measures 
 
A shortened version of the Nuffield Medical History Questionnaire assessed general state of 
health, recent medical history, medication use, and alcohol consumption.  Additionally, the 
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National Adult Reading Test (NART) (Nelson & Willison, 1991), a backward digit-span task 
and a visual simple response time task (SRT) were administered to provide baseline cognitive 
characteristics. For the SRT, participants were required to make a keyboard response (‘space 
bar’) as quickly as possible when presented with a visual target stimulus. The task consisted of 
48 trials, with a mask of varying length (300ms-1000ms) present between each target stimulus. 
RTs greater or less than 3 standard deviation (SD) from a participant’s mean RT were removed 
prior to analysis.  
 
4.3.2.2. RVIP task 
 
The RVIP task (Wesnes & Warburton, 1983) was administered for 4 minutes. A continuous 
stream of digits was presented to participants at a rate of 80 per minute, centrally on a computer 
monitor. Participants were required to monitor the digits, and respond when either 3 odd or 3 
even digits appeared consecutively. Per each minute of the task, there were 8 target strings. 
Correct detections were recorded up to 1500ms after presentation of the third digit in the target 
string. Measures of response accuracy, response latency and number of false alarms (FA) 
(pressing when no target occurred) were recorded. Responses greater or less than 3 SD from 
each participant’s mean RT were removed prior to analysis. 
 
4.3.2.3. Card-sort PM task 
 
The card-sort task (Rusted, Sawyer, Jones, Trawley, & Marchant, 2009)required participants to 
respond to a succession of playing card stimuli, displayed in a pseudo-random order on screen. 
In each trial, a card back was displayed for a variable duration (100-1000ms), followed by a 
card face, which was displayed for 1000ms. The on-going component of the task required 
participants to sort cards according to suit, pressing ‘1’ for a spade and ‘3’ for a hearts, as 
quickly and accurately as possible. Participants were asked to give no response if presented with 
a diamond or a club. Participants initially sorted one deck of 52 cards (26 sort trials, 26 non-sort 
trials) to provide a baseline measure of decision-making performance. Participants then received 
the PM instruction to press ‘space’ in response to the presentation of a specific target card, 
which was any card with the number ‘7’. Participants were asked to repeat this instruction back 
to the experimenter in their own words to check understanding. They then completed 2 further 
decks of the on-going task with the additional PM instruction, containing 48 sort trials, 48 non-
sort trials, and 8 PM trials.  
 
Sort accuracy and RT was recorded for the baseline deck, and the 2 decks following the 
introduction of the PM instruction. For each volunteer, RTs more than 3 SD from their own 
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mean were removed. Comparison of performance between these 2 conditions provides a 
measure of the cost of carrying a PM intention on ongoing sort performance. Accuracy of PM 
retrieval was also recorded.  
 
4.3.2.4. Stroop-switch task 
 
A computerised version of the Stroop-switch task was administered (Hutchison et al., 2010). 
Stimuli were presented on a black background and consisted of 4 colour words (blue, green, red 
and yellow) and 4 neutral words (bad, deep, legal, and poor) written in either blue, green, red or 
yellow font. Participants were required either to name the font colour or to read the word aloud. 
The naming rule (colour, word) switched throughout the task after every 2 trials. Trials were 
classified as either neutral (40 trials), when a neutral word appeared in any of the 4 font colours 
or incongruent (48 trials), when a colour word appeared in a non-matching font colour.  
 
Participants completed 24 practice trials and 88 experimental trials. For each trial, a precue of 
‘word’ or ‘colour’ in white font was presented for 1500ms, followed by a wait of 200ms, 
followed by the stimuli. Participants made a verbal response, with latency recorded using a 
microphone-connected serial response box. Stimuli remained on screen until a response was 
detected or 8000ms had elapsed. Accuracy of response was coded by the experimenter for each 
trial as correct, self-corrected error (e.g. ‘bl..green’) or intrusion error (i.e. if the participant says 
incongruent response). For each volunteer, only RTs for correct trials, and within 3 SD of their 
personal mean were considered for analysis.  
 
4.3.3. Procedure 
 
Volunteers selected from the screening phase took part in a single study session lasting 90 
minutes. First, demographic and health measures including age, family history of dementia, 
height, weight, and blood pressure were collected. A measure of systolic and diastolic blood 
pressure was collected whilst seated, using an automatic arm-cuff machine on the right arm. 
Participants then completed a selection of experimental tasks and questionnaires in a fixed order 
(see Figure 4.1).   
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Figure 4.1. A timeline of the experimental tasks included in the behavioural session. The results 
of several experimental tasks administered in the session fell outside the scope of this paper and 
will be reported separately. 
 
4.3.4. Design 
 
Differences in the demographic and health characteristics of the genotype groups (ε2, ε3, ε4) 
were analysed using a series of one-way analysis of variances (ANOVAs) for continuous 
variables, and chi-squared tests for categorical measures (gender, family history).  
 
Across experimental tasks, analyses were first run to compare performance across all 3 
genotype groups. All analyses were two-tailed. Gender was also included in parametric analyses 
to explore possible APOE X Gender interactions: as no interactions were found the effect of 
gender is not reported in the main body of results (main effects of gender are included as 
footnotes). For non-parametric analyses, data was screened for any differences by gender.    
 
Secondary analyses were run selectively comparing ε2 carriers and ε4 carriers independently to 
the population norm (homozygous ε3 carriers) where a main effect of genotype or genotype 
interaction term were significant or at trend level, or where specific predictions were made 
based on previous findings. The decision to run these secondary analyses were based on recent 
suggestions of similarity in the profile of ε2 and ε4 carriers, so separately comparing both 
groups to the population norm is needed for more detailed exploration.  
 
4.3.4.1 Card-sort task 
 
All volunteers retrieved at least 1 PM intention, taken as an indication that they had encoded 
and retained the PM intention, and so no volunteers were excluded from the analysis. Sort 
accuracy and RTs for correct sort responses were analysed, as well as accuracy of PM retrieval. 
A one-way ANOVA was used to assess group differences in baseline sort RT and accuracy, 
followed up by Bonferroni corrected independent t-tests to assess pair-wise genotype 
differences. A mixed ANOVA was conducted with deck (baseline, PM) as the within-subjects 
factor, and genotype group as the between-subjects factor, for both sort RT and accuracy, to 
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assess performance change following introduction of the PM intention. Non-parametric tests 
were used to assess genotype differences in PM retrieval as the data violated assumptions of 
normality. A Kruskal-Wallis analysis was used to assess differences between all 3 genotype 
groups, followed by two separate Mann-Whitney U tests to compare both ε4 and ε2 variants to 
the ε3 group, with a conservative alpha (α=. 025) applied. 
 
4.3.4.2 RVIP 
 
Number of target hits, hit latency, and number of FAs were analysed using separate ANOVAs, 
with time on task as the within-groups factor (time bins: minute 1-4) and genotype group (ε2, 
ε3, ε4) as the between-groups factor. Separate analyses for both ε2 and ε4 were then completed 
to explore any suggested genotype effects.  
 
4.3.4.3. Stroop-switch task 
 
The distribution of RTs for Stroop-switch trials deviated from normality and hence a log 
transformation was applied to this variable prior to analysis. Initially, data was checked to 
search for an effect of rule switching (switch prior to trial, no switch prior to trial) on RTs and 
errors. There was no significant effect of switching, and switching did not interact with stimuli 
type, congruency or genotype (p>.05), and so these trials were considered collectively. For both 
RTs (correct trials) and proportion of errors, a mixed ANOVA was run with rule (colour, word) 
and congruency (incongruent, neutral) as the within-subjects factors, and genotype (ε2, ε3, ε4) 
as the between-subject factor. Where present, interactions were probed with Bonferroni 
corrected t-tests. Separate analyses were then run comparing ε2 and ε4 variants to the ε3 
population norm to further explore suggested genotype effects.  
 
4.4. Results 
 
4.4.1. Demographics & Baseline Cognitive Measures 
 
There were no significant genotype differences across the demographic measures (p>.05). 
Furthermore, no group differences were found in working memory (WM) span, or SRT (p>.05). 
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Table 4.1. Demographics and baseline cognitive performance presented by genotype group. 
 Genotype Group 
Measure ε2 ε3 ε4 
n 16 26 24 
Age 50.44 (3.58) 49.04 (2.68) 49.17 (3.07) 
Gender (% female) 75 73 63 
Family History (%Yes) 25 35 54 
Education 17.22 (3.24) 17.23 (3.13) 17.85 (4.32) 
NART 119.06 (2.84) 118.56 (2.93) 116.87 (4.62) 
    
BMI 24.02 (3.44) 26.24 (4.37) 25.15 (3.78) 
Systolic BP 115.63 (7.55) 118.23 (8.47) 115.00 (8.76) 
Diastolic BP 77.31 (9.99) 81.77 (10.63) 79.13 (7.77) 
    
SRT (ms) 272 (44) 265 (32) 266 (27) 
Digit-span 4.31 (1.30) 4.19 (1.50) 4.00 (1.65)  
Note: Mean (sd) 
 
4.4.2. Card-sort task 
For a summary of performance on this task by each genotype group see Table 4.2. 
 
4.4.2.1. Baseline decision-making  
 
Across participants, accuracy on the control ‘decision-making’ deck was at ceiling, with scores 
ranging from 50-52 correct (M=51.65) out of a maximum score of 52, with no significant 
difference between groups (p>.05). The genotype difference in decision-making RT approached 
significance, F(2, 62)=2.92, p=.061, n2p=.086. The ε2 group trended towards being slower than 
the ε3 comparison group (p=.072), whereas the ε4 and ε3 groups did not differ in RT (p>.05). 
 
4.4.2.2. PM performance 
Introducing the PM intention was associated with a significant slowing of RTs on card-sort 
trials, F(1, 62)=107.77, p<.001, n2p=.635. The main effect of genotype and the interaction 
between deck and genotype group were non-significant, (p>.05). For sort accuracy, again 
introducing the PM intention was associated with a significant drop in accuracy, F(1,62)=37.94, 
p<.001, n2p=.380. The effect of genotype and the interaction between genotype and deck were 
both non-significant, (p>.05).   
Across the 3 genotype groups there was no significant difference in retrieval of the PM targets 
(p>.05), although secondary analyses indicated ε4 carriers (M=6.75, mean rank=21.46) retrieved 
fewer PM intentions than the ε3 group (M=7.31; mean rank=29.23), and this difference 
approached significance, U=215, p=.040. There was no significant difference in the PM 
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retrieval accuracy of ε2 carriers (M=7.13, mean rank=20.62) compared to the ε3 group (mean 
rank=22.04), U=222, p>.05. 
 
Table 4.2. Performance on the Card-sort task displayed by genotype group. 
 
Genotype Control deck PM decks 
RT (ms) ±sd Accuracy/52 RT (ms)±sd Accuracy/96 PM retrieval/8 
ε2 606 ± 67 51.8 736 ± 64 93.00  7.13 
ε3 560 ± 77 51.5  710 ± 85 92.35  7.31 
ε4 590 ± 38 51.7  710 ± 69 93.13  6.75 
4.4.3 RVIP 
The data of 4 volunteers was removed prior to analysis due to comparable levels of hits and 
FAs, or a FA rate greater than 2 sd above the norm. For a summary of performance on this task 
by genotype group see Table 4.3.  
Table 4.3. Overall performance on RVIP task by genotype, sd shown in brackets. 
Genotype Mean hit detection/ 32 Mean hit latency (ms) Mean false alarms 
ε2 19.29 (6.28) 558 (69) 1.14 (1.41) 
ε3 23.52 (4.88) 510 (72) 2.09 (0.42) 
ε4 21.18 (7.20) 514 (77) 1.65 (0.35) 
4.4.3.1. Hits 
 
Accuracy decreased with time on task, F(3, 171)=5.09, p=.002, n2p=.082. Both the main effect 
of genotype, F(2, 57)=2.72, p=.087, n2p=.087, and the Time on task x Genotype interaction 
approached significance for number of hits, F(6, 171)=5.09, p=.074, n2p=.064.4 The interaction 
between time on task and genotype is shown in Figure 4.2. 
 
Secondary analysis found the effect of genotype was driven by ε2 carriers making significantly 
less hits than the ε3 group, F(1, 36)=5.51, p=.024, n2p=.133. There was no significant difference 
between ε4 carriers and ε3 carriers (p>.05).  
 
Further probing of the Time x Genotype interaction found ε2 carriers made fewer hits than the 
ε3 group only in minute 1, and this difference approached significance, t (17.7)=-2.72, p=.014. 
Ε4 carriers did not significantly differ from ε3 carriers at any minute of the task.  
																																																								4	The effect of gender on RVIP hit performance approached significance, F(1, 57)=3.71, p=.059,  
n2p=.061: males (mean=23.68) made more correct hits than females (mean=20.81).	
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Figure 4.2. The Genotype x Time on task interaction for RVIP hit performance. 
 
4.4.3.2. Hit Latency 
 
With all 3 genotype groups included in the model, the effect of time on task on hit latency was 
non-significant (p>.05). The main effect of genotype and the Genotype x Time interaction were 
both non-significant (p>.05). 
4.4.3.3. False Alarms 
Both the main effects of time on task and genotype, and the interaction between Time x 
Genotype were non-significant (p>.05).  
4.4.4. Stroop 
4.4.4.1 Overall task performance 
4.4.4.1.1. RTs 
RTs were significantly slower for colour naming than word naming, F(1, 60)=11.10, p=.001, 
n2p=.156. Incongruency also led to significantly slower naming, F(1, 60)=34.65, p<.001, 
0	1	
2	3	
4	5	
6	7	
8	
1	 2	 3	 4	
H
it
s	
	
Minute	
e2	
e3	
e4	
		
89	
n2p=.366, and this effect was larger for colour naming than word naming, F(1, 60)=7.78, 
p=.007, n2p=.115.5 
4.4.4.1.2 Errors 
There was no significant difference in the number of errors made for colour vs. word stimuli 
(p>.05). At trend level, more errors were made for incongruent stimuli than neutral stimuli, F(1, 
60)=3.10, p=.089, n2p=.049. Again, there was a significant Rule x Congruency interaction, F(1, 
60)=12.17, p=.001, n2p=.169. More errors were made for incongruent colour naming trials 
(M=.067) than neutral colour naming (M=.018), t(63)=5.13, p<.001. For word naming, more 
errors were made for neutral trials (M=.038) than incongruent trials (M=.017), t(63)=-2.98, 
p=.004 (Bonferroni corrected α=.013). 6 
4.4.4.2. Genotype effects 
Performance on the Stroop-switch task is summarised by genotype group in Table 4.4. 
4.4.4.2.1. RTs 
There were no genotype differences in RT (p>.05), and genotype status did not interact with 
either rule or congruency in affecting RT (p>.05).  
4.4.4.2.2. Errors 
The effect of genotype was non-significant (p >.05), as was the Congruency x Genotype 
interaction, F(2, 60)=2.32, p=.107, n2p=.072. The Genotype x Rule interaction, and the 3-way 
Genotype x Rule x Congruency interaction were both non-significant (p>.05).  
The Congruency x Genotype interaction, displayed in Figure 4.3., was probed in secondary 
analysis comparing ε2 and ε4 groups to the homozygous ε3 group in separate models due to an 
a priori hypotheses of a genotype difference. There was no significant difference in the overall 
number of errors between the ε3 group and ε4 carriers  (p>.05), but there was a significant 
Genotype x Congruency interaction, F(1, 46)=4.27, p=.044, n2p=.085, further explored with 
Bonferroni corrected t-tests (α=.013). There was no significant difference between errors on 
incongruent stimuli (M=.038) and neutral stimuli (M=.037) for ε3 carriers (p>.0125), but ε4 
carriers made significantly more errors for incongruent (M=.052) than neutral stimuli (M=.022), 																																																								5	A main effect of gender on Stroop RTs was found with males slower in all trials, F(1, 60)=5.90, p=.029, 
n2p=.077. The effect of gender was more pronounced for trials with the rule ‘word’, than trials with the 
rule ‘colour’, F(1, 60)=5.79, p=.019, n2p=.088.	6	There was a significant effect of gender on the proportion of errors made on the Stroop task, F(1, 
60)=9.64, p=.003, n2p=.138, with males consistently making more errors.	
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t(22)=2.73, p=.012. There was no significant difference between ε4 carriers and the ε3 group in 
the proportion of errors made for neutral trials, or incongruent trials (p>.0125).  
ε2 carriers did not significantly differ from the ε3 groups in the number of errors made (p>.05), 
and the Genotype x Congruency interaction was non-significant (p>.05). Additionally, ε2 
carriers did not show a significant cost of congruency on number of errors made (p>.05). 
Table 4.4. Mean naming RT and the proportion of errors recorded, shown by condition and 
genotype for performance on the computerized Stroop task. 
   
Genotype 
Stimuli Congruency 
 
ε2 ε3 ε4 
Colour 
     
 
Neutral RT (ms) 729 (126) 669 (123) 708 (107) 
  
Errors .01 .02 .02 
 
Incongruent RT (ms) 815 (131) 800 (177) 818 (128) 
  
Errors .06 .06 .08 
Word 
     
 
Neutral RT (ms) 683 (130) 623 (144) 662 (135) 
  
Errors .03 .05 .03 
 
Incongruent RT (ms) 715 (144) 662 (246) 674 (167) 
  
Errors .01 .02 .02 
Note: RTs shown as mean (sd) 
 
 
Figure 4.3. The proportion of errors made for congruent and incongruent stimuli shown by 
genotype group. 
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4.5. Discussion 
 
The aim of current study was to establish whether APOE genotype is associated with 
differences in attentional control in mid-adulthood. By including all three genotype groups, 
results provide a novel exploration into the opposing effects of APOE status on cognitive 
ageing.  
 
The current findings suggest deficits in attentional control are detectable by mid-adulthood in ε4 
carriers, however, effects were not uniform across cognitive measures. Carriers of this allele 
demonstrated a larger effect of incongruency on errors during a computerized Stroop-switch 
task. Similarly, there was a trend for ε4 carriers to show reduced accuracy of PM retrieval in 
comparison to the population norm (ε3 homozygotes). Despite the expectation that ε2 carriers 
would show cognitive advantages in mid-adulthood, in line with the suggested protective effects 
of this allele, results did not consistently support performance advantages. On the RVIP 
measure of sustained attention, compared to both homozygous ε3 carriers and the ε4 group, ε2 
carriers detected fewer target strings. On the control deck of the PM task ε2 carriers trended to 
sort cards with slower RTs. These differences were found despite there being no genotype 
differences in simple RTs, suggesting differences specifically relate to decision-making RT.  
 
The study administered versions of the RVIP and card-sort PM tasks comparable to those 
previously reported to show a speed-accuracy trade-off in mid-age ε4 carriers (Evans et al, 
2014).  Our results did not replicate this pattern, and this is unlikely to be a factor of the subtle 
differences in paradigms used. Although the Evans study used a 6-minute version of the task, 
the reported genotype differences were observed in the first 3 minutes, so this should have been 
replicable in the 4-minute version. Across these tasks, with the exception of PM retrieval, ε4 
carriers showed equivalent performance to the ε3 group. This could be interpreted as ε4 carriers 
having relatively sustained cognitive performance in mid-adulthood. This over-arching pattern 
is not inconsistent with the antagonistic pleiotropy hypothesis (Han & Bondi, 2008), that the  ε4 
variant transitions from having advantageous to disadvantageous consequences in mid-
adulthood. 
 
Importantly, ε4 carriers did show subtle deficits within select processes, prominently a marked 
congruency effect in the number of errors made on the Stroop task. Similarly, a marked increase 
in errors for incongruent trials was found to both predict and characterize AD (Balota et al., 
2010; Hutchison et al., 2010). These parallel results indicate that performance on this task is an 
important early identifier of cognitive decline, with the task showing sensitivity by mid-
adulthood. Although previous research has reported no effect of APOE ε4 on Stroop-task 
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performance in mid-age (Sager et al., 2005; Trachtenberg, Filippini, Cheeseman, et al., 2012), 
the paradigm used here collected data on a trial-by-trial basis, providing a more sensitive 
measure.  
 
In terms of specific cognitive processes, the computerized Stroop task requires both goal 
maintenance and response inhibition. Previous research suggests that RT distributions on this 
task are linked to detriments in inhibitory control, whereas errors represent failures to maintain 
task goals (Kane & Engle, 2003). Accordingly, ε4 carriers showed decrements in the executive 
attention required for active goal maintenance. Notably, they also showed deficits in PM 
retrieval, in which both active maintenance of the PM intention, and monitoring of the 
environment for the opportunity to act are required, consistent with detriments in sustaining 
information at the forefront of attention.  
 
Attentional control, as indexed by Stroop errors and PM performance, has been linked to WM 
span (Kane & Engle, 2003). Likewise, active updating and monitoring, the component of EF 
most closely assessed by the three paradigms administered in the current study, is described as 
being closely associated with WM (Miyake et al., 2000). In this study however, no genotype 
difference was found on a backward digit-span measure. It may be that future study, including a 
more detailed exploration of WM ability, would demonstrate sensitivity to APOE effects in 
mid-adulthood, for example the Operation Span task (Turner & Engle, 1989). In a slightly older 
sample (50-79 years), ε4 carriers showed deficits on this task (Rosen et al., 2002). An important 
avenue for future research is establishing a reproducible effect of APOE ε4 genotype on the 
active processing of information in attention, and the neural basis of this difference.   
 
Results from previous fMRI research suggest reported correlations between advantaged PM 
retrieval in ε4 carriers and heightened inferior frontal gyrus activity might represent an early 
compensatory frontal shift (Evans et al., 2014). As activity of the inferior frontal gyrus has 
previously been associated with detection of salient stimuli (Hampshire et al., 2010), increased 
activity in this area fits with heightened PM accuracy. No evidence was provided in this study 
for ε4 carriers showing any advantages in performance measures, however.  
 
An important avenue for future research is to establish the mechanisms behind the APOE ε4 
effects on attentional control. APOE ε4 is known to influence the profile of amyloid deposition 
in the brain (Morris et al., 2010; Villemagne et al., 2011). The detrimental effect of APOE ε4 on 
executive attention in older adulthood and the very early stages of AD is likely mediated in part 
by amyloid deposition in regions including the prefrontal cortex (Aschenbrenner et al., 2014). 
Research probing the relationship between APOE ε4 and amyloid across the lifespan found that 
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despite no episodic memory performance difference, ε4 carriers showed accelerated deposition 
of amyloid, with 10% of the population defined as amyloid positive by halfway through the fifth 
decade (Jack et al., 2015).  This may also be the route by which APOE ε4 impacts functional 
connectivity (Sheline et al., 2010), demonstrated in the earlier research of Trachtenberg et al 
(2012a; 2012b). These changes may be particularly relevant for executive attention, which 
requires communication between multiple processing regions. Imaging techniques should be 
used to explore which neural mechanisms are most relevant for the initial stages of cognitive 
ageing in ε4 carriers.  
 
At present, there is insufficient research on the cognitive profile of healthy ε2 carriers. The 
current results, however, contrast with past research suggesting ε2 is protective (Chiang et al., 
2010; Farrer et al., 1997; Helkala et al., 1996; Lippa et al., 1997; Wilson et al., 2002). The 
results reported here are based on a small sample of ε2 carriers, but contribute to the small 
number of studies that have explored ε2 effects on cognition prior to older-adulthood 
(Alexander et al., 2007; Alexopoulos et al., 2011).  Recent papers have reported differential 
spatial navigation strategies in ε2 carriers in youth (Konishi et al., 2016), as well as altered 
memory function in individuals diagnosed with post-traumatic stress disorder (Freeman et al., 
2005; Johnson et al., 2015; Kim et al., 2013). Therefore, although it may be possible to detect ε2 
differences earlier in the lifespan, the link between APOE ε2 and executive attention is also 
relatively unexplored.  
 
Recent research, however, reported overlap in the functional activation patterns of ε2 and ε4 
carriers compared to ε3 carriers, despite no behavioural differences (Trachtenberg et al., 2012a; 
Trachtenberg et al., 2012b). Whereas, the behavioural profile of ε2 carriers and ε4 in the current 
study did not overlap, both groups showed some disadvantage in attentional control. This 
encourages a closer examination of the hypothesised polarity in APOE effects. Our behavioural 
results suggest late-life dementia risk might not equate with cognitive performance in mid-
adulthood, with both ε2 and ε4 carriers showing process-specific detriments. It may be that ε4 
carriers show increased vulnerability to cognitive insult (Wirth et al., 2014), whereas ε2 carriers 
are better able to employ protective mechanisms. In support of a compensatory mechanism in ε2 
carriers, in adults aged 90+ years, carriers of this variant were significantly less likely to meet 
clinical criteria for AD diagnoses, despite similar levels of AD neuropathology between ε2 and 
ε4 genotypes at autopsy (Berlau et al, 2009). Reports have also been made, however, that ε2 is 
protective against amyloid deposition in later life (Morris et al., 2010), and in AD (Nagy et al., 
1995). 
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Several limitations of the current study must be acknowledged. First, the number of participants 
within each genotype group was relatively small, meaning analysis may have lacked statistical 
power. This also limited exploration of gene dose effects. Effects of ε4 gene dose (i.e. increased 
impact with 0, 1, and 2 ε4 alleles) have been reported (Farrer et al., 1997; Raber et al., 2004; 
Wilson et al, 2011), however, the effects of ε2 zygosity are less clearly demonstrated (Farrer et 
al., 1997).  An additional analysis to the results reported here found no differences by APOE 
haplotype, but this would need to be further determined in future research. In addition, 
performance on the PM task was close to ceiling, and so the task may have lacked sensitivity for 
discriminating between genotype groups. Future research would benefit from increasing the 
demands placed on the attentional control system, for example by increasing the resource needs 
of the ongoing task.  
 
4.6 Conclusions 
 
In this study, both those carrying detrimental and protective variants of APOE showed 
decrements in executive attention by mid-adulthood. In ε4 carriers, subtle disadvantages on a 
Stroop task and in PM retrieval were apparent, suggestive of deficits in goal-maintenance in the 
face of irrelevant information processing. This indicates that through the application of sensitive 
research paradigms, it is possible to identify those at genetic risk of cognitive decline from mid-
adulthood. Surprisingly, behavioural disadvantages were identified in ε2 carriers, despite the 
premised benefits of carrying this allele for cognitive health in older adulthood. Of critical 
importance, results illustrate the importance of including ε2 carriers as an independent group, 
and the need to establish both how this variant influences cognition and neural function across 
the lifespan, and how it interacts with environmental factors to promote protection against age-
related cognitive decline.  
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in mid-adulthood: moderation of early executive 
attention differences 
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5.1 Abstract 
 
Objective: To investigate how environmental factors impact age-related cognitive deficits by 
mid-adulthood, both independently and in interaction with APOE genotype. 
Method: Cognitive data from 66 adults (aged 45-55 years), representing executive attentional 
processes (goal maintenance, updating, and inhibition) and subjective reports of cognitive 
failures, were included in multiple regression analyses. Genotype (ε2, ε3, ε4), cognitive reserve 
(education, occupation and leisure activities, estimated IQ), self-reported physical activity, and 
metabolic and cardiovascular health (body mass index, mean arterial blood pressure) were 
included as predictors. 
Results: In ε4 carriers, protective effects of cognitive reserve were selectively observed for goal 
maintenance abilities. In ε2 carriers, counter-intuitively, increased cognitive reserve was 
associated with greater self-report of cognitive errors. 
Conclusions: Cognitive reserve appears to protect against the emergence of early goal 
maintenance impairments in ε4 carriers. Across objective cognitive measures, ε2 carriers appear 
less sensitive to the protective effects of cognitive reserve. We conclude that ε4 carriers may 
show greater plasticity to factors modifying age-related cognitive deficits in mid-adulthood, 
highlighting the importance of taking preventative steps against cognitive decline earlier in the 
lifespan.  
 
Key words: APOE, Cognitive Ageing, Executive function, Cognitive Reserve, Mid-adulthood 
 
 
 
 
 
 
 
 
 
 
 
5.2 Public Significance Statement 
The study revealed a protective effect of cognitive reserve in mid-age adults carrying a genetic 
risk for dementia, indicating this group may show increased plasticity to the modifying effects 
of environmental factors that mitigate against age-associated deficits. Environmental factors 
with the potential to modify genetic susceptibility to age-related cognitive decline advance our 
understanding of protective strategies. In addition, by demonstrating effects in mid-adulthood, 
the results emphasize the importance of implementing potential interventions early. 
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5.3 Introduction 
 
Apolipoprotein E (APOE) is a single nucleotide polymorphism with six possible genotypes 
determined by the combination of three alleles: ε2, ε3 and ε4. Possession of the ε4 allele is a 
well-established risk factor for late onset Alzheimer’s disease (LOAD) (Corder et al., 1993; 
Farrer et al., 1997). The prevalence of the ε4 allele, carried by ~ 23% of Caucasian individuals 
(Raber et al., 2004), makes this variant an important target for interventions that help prevent 
cognitive decline. By contrast, the ε2 allele is held to offer protection against LOAD (Farrer et 
al., 1997; Lippa et al., 1997; Wilson et al., 2002). 
 
Opposing influences of the ε4 and ε2 variants are also reported in healthy cognitive ageing. The 
ε4 allele is associated with cognitive deficits across various domains in older adulthood, 
including global cognition, episodic memory, attention, and executive function (e.g. Berteau-
Pavy, Park, & Raber, 2007; Espeseth et al., 2006; Marioni et al., 2015; Packard et al., 2007; 
Reinvang, Winjevoll, Rootwelt, & Espeseth, 2010; Staehelin, Perrig-Chiello, Mitrache, 
Miserez, & Perrig, 1999; for reviews see: Small, Rosnick, Fratiglioni, & Bäckman, 2004, 
Wisdom, Callahan, & Hawkins, 2011). Although less frequently studied, possession of an ε2 
allele is associated with benefits to memory and executive function in older adulthood (Bonner-
Jackson, Okonkwo, & Tremont, 2012; Deary et al., 2004; Helkala et al., 1996), coupled with 
reduced longitudinal cognitive decline (Blair et al., 2005).  
 
The opposing effects of APOE variants in later life highlight the possibility that the ε2 and ε4 
alleles differ in their behavioural and neural effects across the lifespan, and in their respective 
trajectories of cognitive ageing. To date, the bulk of research focuses on isolating the effects of 
the ε4 allele, whilst collectively considering carriers of the ε2 and ε3 alleles as a low risk group, 
or excluding ε2 carriers from the sample. Previous research comparing all APOE variants, 
surprisingly reports similar patterns of brain activation in ε2 and ε4 carriers from mid-
adulthood. In adults aged 32-55 years, both genotype groups displayed increased task-unrelated 
neural activity during executive attention and episodic memory tasks, compared to an ε3 group, 
despite no performance differences (Trachtenberg et al., 2012a). Likewise, comparable 
differences in resting-state activity are reported in mid-age ε2 and ε4 carriers (Trachtenberg et 
al., 2012b). In an older sample (aged 54-80 years), groups of ε2 and ε4 carriers both show 
diminished functional connectivity in the default mode network, that correlated with measures 
of processing speed (Shu et al., 2016). Importantly, cross-sectional comparisons across the age-
range suggest the genotype groups are associated with opposing trajectories of change in 
functional connectivity, with increasing connectivity in ε2 carriers and decreasing connectivity 
in ε4 carriers observed with age. These results call into question the assumption made by many 
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studies, that the ε2 and ε4 alleles have differential effects across the lifespan, and hence a key 
question for future research is how these opposing late-life effects develop.  
 
Although ε4 and ε2 alleles may independently confer a differential vulnerability for cognitive 
decline, interactions between APOE genotype and additional mitigating factors are important to 
consider. Variants of the APOE gene may differ in their susceptibility to the influence of factors 
associated with age-related cognitive decline.  In addition, the strength of genotype effects on 
cognition may be influenced by an individual’s brain reserve (e.g., Bunce, Kivipelto, & Wahlin, 
2004; Lindenberger, 2008), and hence factors that modify brain reserve may modulate the 
influence of APOE variants on the early ageing trajectory. In the present study we present an 
exploratory analysis of the effects of cognitive engagement, physical activity, and indices of 
cardiovascular and metabolic health (arterial pressure and body mass index (BMI)) on APOE 
genotype differences in mid-adulthood.  
 
5.3.1 APOE and Cognitive Reserve 
 
Cognitive reserve suggests that the threshold at which cognitive deficits emerge as a function of 
age-related neural decline is actively modified through lifetime cognitive engagement (for 
review see Barulli & Stern, 2013; Scarmeas & Stern, 2003; Stern, 2002). Education and IQ, as 
well as occupation and ongoing leisure activities, have been used as proxies of cognitive reserve 
(Barnes & Yaffe, 2011; Cheng, 2016). APOE ε4 carriers are reported to show increased benefit 
of high cognitive reserve on later-life cognition (Brewster et al., 2014; Bunce, Kivipelto, et al., 
2004; Carlsson, Gleason, Hess, & Moreland, 2008; Forstmeier et al., 2012; Vemuri et al., 2014; 
Wirth et al., 2014). Furthermore, young and mid-life cognitive activity has been associated with 
biomarkers of Alzheimer’s disease pathology (amyloidosis, brain metabolism) in APOE ε4 
carriers (Vemuri et al., 2016; Wirth et al., 2014). Research exploring how cognitive reserve 
impacts APOE ε4 behavioural differences earlier in the lifespan, however, is limited. 
 
To date, there has been minimal research exploring the interaction between APOE ε2 and 
cognitive reserve. One longitudinal study (mean follow-up 9.2 years) found enhanced benefits 
of cognitive reserve, indexed through years of education, vocabulary and reading level, on the 
emergence of pathological cognitive change in ε2 carriers (Soldan et al., 2013). This research 
found independent associations of ε4 status and cognitive reserve on later-life risk, but contrary 
to previous research, found no interaction between the two factors. Variation in the method of 
assessing cognitive reserve and which epoch of the lifespan is targeted could account for 
inconsistency in the reported relationship between cognitive reserve and APOE ε4.  The 
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question of whether ε4 and ε2 carriers show similar benefits of cognitive reserve, and the age at 
which these effects emerge, however, remains unclear.  
 
5.3.2. APOE and Physical Activity 
 
Ε4 carriers demonstrate greater vulnerability to the adverse effects of low physical activity, here 
collectively referring to both purposeful exercise and active leisure time (e.g., gardening, 
housework). Several studies report greater benefits of physical activity on the cognitive 
performance of older ε4 carriers compared to their non-ε4 peers (Etnier et al., 2007; Woodard et 
al., 2012; Niti, Yap, Kua, Tan, & Ng, 2008; Schuit, Feskens, Launer, & Kromhout, 2001). 
Inactivity in ε4 carriers is associated with longitudinal declines in hippocampal volume, (Smith 
et al., 2014). Importantly, from mid-adulthood a sedentary lifestyle has been linked to increased 
amyloid deposition in ε4 carriers (Smith, Nielson, Woodard, Seidenberg, & Rao, 2013; Head et 
al, 2012), providing a potential mechanism for the relationship between APOE ε4, physical 
activity and cognitive decline. Physical activity in mid-adulthood exerted the greatest protective 
effect in ε4 carriers on cognitive ageing 21 years later (Rovio et al., 2005), highlighting the 
importance of physical fitness earlier in the lifespan. As yet, the link between APOE ε2 and 
physical activity is not well established.   
 
5.3.3. APOE, cardiovascular health and metabolic function  
 
Cardiovascular factors, including hypertension, hypercholesterolemia, and obesity, are risk 
factors for cognitive decline (Anstey, Cherbuin, Budge, & Young, 2011; Atzmon et al., 2002; 
Köhler et al., 2014; van Exel et al., 2002; Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005). 
Ε4 carriers are predisposed to poorer cardiovascular health (Bennet et al., 2007; de Frias et al., 
2007; Haan & Mayeda, 2010). In turn, the relationship between vascular heath and cognitive 
decline appears more marked in older ε4 carriers (e.g. de Frias et al., 2007; Zade et al., 2010).  
 
Importantly, blood pressure differentially impacts the relationship between APOE genotype and 
cognition from mid-life. Systolic blood pressure moderates the association between ε4 and 
cognitive performance in mid-adulthood (Bender & Raz, 2012; Oberlin et al., 2015). High pulse 
pressure negatively impacted longitudinal change in episodic memory in ε4 carriers and 
homozygous ε3 carriers aged 53 years and older, but not in ε2s (McFall et al., 2015). This 
supports greater vulnerability in ε4 carriers to cognitive insult from mid-adulthood, whilst ε2 
carriers appear to show reduced sensitivity.  
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Body mass index (BMI) is a marker of health status, with high BMI associated with increased 
risk of vascular-related disease (Kivipelto & Solomon, 2008; Qiu, Kivipelto, & Von Strauss, 
2009). In a cross-sectional study, high BMI was associated with lower cognitive performance 
(Corley, Gow, Starr, & Deary, 2010; Nilsson & Nilsson, 2009), as well as greater decline in 
cognition from 40 years of age (Dahl et al., 2013; Dahl, Hassing, Fransson, & Pedersen, 2010). 
How BMI interacts with APOE status is less well established; in older adults (aged 65 plus), the 
negative effects of ε4 status increase with lower BMI (Rajan, Skarupski, Rasmussen, & Evans, 
2014; Sachs-Ericsson, Sawyer, Corsentino, Collins, & Blazer, 2010). Low BMI in later life, 
however, is associated with increased illness (Newman et al., 2005), which may contribute to 
exaggerated ε4 effects in older-adulthood. In a mid-age sample, however, the relationship 
between BMI, APOE ε4 and cognition may be reversed.  
 
5.3.4. Current aims and hypotheses 
 
The present research explores the potential impact of APOE allelic variation on cognition in 
mid-adulthood, addressing previous shortcomings in considering how cognitive reserve, 
physical activity, cardiovascular and metabolic health moderate the effects of both ε4 and ε2 
alleles. By focusing on mid-adulthood, the research aims to capture how key modifiers of 
cognitive ageing influence the emergence of early cognitive differences between APOE 
genotypes, progressing our understanding of what might protect or promote cognitive health in 
mid-age.  
 
A series of hierarchical regression analyses explore the independent and interactive effects of 
these factors on components of executive attention, as well as subjective ratings of cognitive 
errors. Executive attention is a cognitive domain sensitive to APOE genotype effects in mid-
adulthood (Chen et al., 2013; Evans et al 2013, 2014; Velichkovsky, Roschina, & Selezneva, 
2015; Yan, Wu, Chao, Chen, & Tseng, 2015). It is also sensitive to both the effects of physical 
activity and cognitive reserve (Smith et al., 2011). Here we derive a composite index of 
executive attention from performance across three tasks (a prospective memory task, rapid 
visual information processing task (RVIP) and a Stroop-switch task). Following Miyake & 
Friedman (2012), these tasks combine online maintenance of goals, updating, shifting and 
inhibition, and have been shown to load on frontal lobe function (Cona, Bisiacchi, Sartori, & 
Scarpazza, 2016; Evans et al., 2014; Kane & Engle, 2003; Neale, Johnston, Hughes, & Scholey, 
2015). 
 
We predicted that carrying an ε4 allele would increase vulnerability to the impact of risk factors 
for cognitive decline, namely low physical activity, increased BMI and high blood pressure. In 
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addition, we expected that ε4 carriers would show enhanced protective effects of lifetime 
cognitive engagement. At present, there is little to guide our predictions of how these factors 
may modify cognition in ε2 carriers, but we anticipated differences in the sensitivity of the two 
groups, in line with the reported divergence of cognitive ageing trajectories between APOE 
genotypes. 
 
5.4. Methods 
 
5.4.1. Participants 
 
165 volunteers were recruited for a mid-age APOE genotype database via advertisement at local 
universities, community centers and clubs. For participation, volunteers were required to be 45-
55 years of age, non-smokers, fluent in English, and with no diagnosed history of vascular, 
psychiatric or neurological illness within the past 5 years. In addition, volunteers were screened 
for current medication use. 
 
From this database, a smaller number of volunteers (n=66) participated in the cognitive test 
session. As the distribution of allelic variants in the APOE-screened database was heavily 
biased towards ε3 homozygotes (consistent with population norms (Raber et al., 2004)), a third 
party randomly selected approximately equal numbers of each genotype group, ε2 carrier 
(ε2/ε2, ε2/ε3), homozygous ε3, and ε4 carrier (ε3/ε4, ε4/ε4), for recall; ε2/ε4 carriers were 
excluded from participation as understanding of these variants in combination is limited. The 
study followed double-blind procedures in that both the participant and experimenter were blind 
to genotype information. Demographic information, including National Adult Reading Test 
(NART) (Nelson & Willison, 1991), is displayed in Table 5.1. The University of Sussex, School 
of Psychology and Life Sciences Research Ethics Committee approved the study, with 
procedures adhering to the Code of Ethics of the World Medical Association (Declaration of 
Helsinki). 
 
5.4.2. Materials  
 
Physical measures were recorded for each volunteer including height and weight measurements, 
and seated systolic and diastolic blood pressure (using an upper-arm automatic monitor). In 
addition, physical activity was assessed using a scale taken from the Nurses Health Study 
(Colditz & Hankinson, 2005; Colditz, Manson, & Hankinson, 1997). Average frequency of 10 
listed activities, over the past 6 months, was scored on a 10-point scale ranging from 0 minutes 
per week, to 11+ hours per week. A single score was derived for each participant by summing 
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responses for each ordinal scale with higher values representing greater engagement with 
physical activities.   
 
The Cognitive Reserve Index quotient (CRIq) (Nucci, 2012), a 20-item questionnaire assessing 
education, occupational background and adult leisure activities, was administered. A score for 
each of these components, as well as an overall cognitive reserve score was produced. The 
education sub-score was based on the number of years in education and/or vocational training. 
Occupational background was measured as the number of years working (part-time, full-time) 
across 5 levels of employment, split as a function of presumed intellectual demand and personal 
responsibility (unskilled manual work, skilled manual work, skilled non-manual work, 
professional occupation or highly intellectual occupation). Examples of each were included. 16 
items measuring leisure time activity were included, divided by frequency (weekly, monthly, 
annual). Frequency of each item was rated: never/rarely or often/always. If the activity was 
carried out ‘often/always’, participants were asked to provide an estimate of the number of years 
of activity since reaching adulthood. Number of children was also included in the leisure 
activity domain. Higher scores represented greater engagement with cognitively stimulating 
activities. 
 
Table 5.1. Sample characteristics shown grouped by APOE status 
 
Genotype  
ε2 ε3 ε4 p 
n 16 26 24  
Age 50.4 (3.6) 49.0 (2.7) 49.2 (3.1) .319 
Gender (% f) 75 73 63 .624 
Family History (%) 25 35 58 .077 
NART 119.1 (2.8) 118.6 (2.9) 116.9 (4.6) .258 
Education (years) 17.2 (3.2) 17.2 (3.1) 17.9 (4.3) .804 
CRIq (total) 128.4 (8.6) 119.5 (9.7) 122 (12.0) .030 
BMI (kg/m2) 24.0 (3.4) 26.2 (4.4) 25.2 (3.8) .341 
Systolic BP (mmHg) 115.6 (7.6) 118.2 (8.5) 115.0 (8.8) .365 
Diastolic BP (mmHG) 77.3 (10.0.) 81.8 (10.6) 79.1 (7.8) .320 
Physical activity (/90) 19.3 (6.4) 17.8 (9.0) 17.3 (10.6) .785 
 Notes: Family history is coded as the number of volunteers with a first-degree relative 
diagnosed with dementia. Values represent mean (sd) unless otherwise stated. Abbreviations: 
National adult reading test (NART), Cognitive reserve quotient index (CRIq), body mass index 
(BMI), blood pressure (BP).   
 
5.4.2.1. Composite predictors 
 
The following variables were considered as moderators of the relationship between APOE 
genotype and cognition: estimated IQ (taken from NART), total CRIq, BMI, mean arterial 
pressure (MAP), and physical activity score. Note, arterial pressure was calculated using the 
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formula: diastolic pressure + ⅓ (systolic pressure – diastolic pressure) (e.g. Salvi, 2012; Tian et 
al., 2013; Zheng et al., 2008), and represents the steady component of blood pressure (Sesso et 
al., 2000).  
 
Data for each potential moderator was screened for normality prior to analysis. Two scores on 
individual measures were identified as outliers (3 standard deviations (SD) or more away from 
the group mean). These scores were removed but the remaining data for these two participants 
were included in the analysis.  
 
To assess the independent effects of physical activity this variable was treated as an individual 
predictor. The remaining moderator variables were submitted to principle components analysis 
(PCA) with varimax rotation; extraction was based on Eigenvalues greater than 1 (component 
loadings are shown in brackets). Estimated IQ (.71) and CRIq score (.85) significantly 
correlated (r(63)=.26, p=.022) and loaded on a single component, henceforth named ‘Cognitive 
reserve’. MAP (.80) and BMI (.79) loaded onto the same component, henceforth called 
‘metabolic and vascular health’, and were again, significantly correlated, r(63)=.30, p=.010.  
 
All predictors were converted into standardized Z-scores, and the average of these standardized 
scores were used to form composites of ‘cognitive reserve’ and ‘metabolic and vascular health’. 
For participants with incomplete data (N=2) (i.e. those identified as having an outlier), scores 
were created based on the remaining standardized variable. 
 
5.4.2.2. Cognitive outcomes 
 
The executive attention tasks used in the current analyses have previously been described in 
Lancaster, Tabet and Rusted (2016). Performance on a prospective memory task (PM) (with 
ongoing speeded decision-making component) (Rusted & Trawley, 2006), rapid visual-
information processing (RVIP) task (Wesnes & Warburton, 1983), and Stroop-switch paradigm 
(Hutchison et al., 2010) were included.  
 
In addition, volunteers were asked to complete 2 subjective measures of everyday cognition. 
The Cognitive Failures Questionnaire (CFq) (Broadbent, Cooper, FitzGerald, & Parkes, 1982) 
asks volunteers to rate how often they make 25 common ‘cognitive failures’, on a scale from 
‘Never’ (0) to ‘Very often’ (5). Cognitive failures are premised to represent 4 subscales: 
memory, attention, perception and motor ability. A total score for each volunteer was produced, 
with higher scores representing greater reported failures. The Attentional Control scale 
(Derryberry & Reed, 2002) was also used, consisting of 20 items targeting 3 processes; mind 
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wandering, susceptibility to boredom and distractibility. Scores for each question were based on 
a 4-point Likert Scale from ‘Almost never’ (1) to ‘Always’ (4). Responses were scored so 
higher values represented worse attentional control. Internal consistency for both the CFq and 
Attentional Control scale in this group was high (CFq: Cronbach’s α = .906; Attentional Control 
scale: Cronbach’s α = .833). 
 
5.4.2.3. Cognitive composites 
 
Objective indices of executive attention (decision-making RT, PM retrieval, RVIP performance, 
Stroop effect (RT, errors)) were subject to a PCA with varimax rotation. Note, data for both 
target hits and latency on the RVIP task was combined into a single inverse efficiency score 
(Bruyer & Brysbaert, 2011; Townsend & Ashby, 1978). Performance on these measures was 
screened for outliers (M ± 3SD) prior to inclusion in the analysis. 
Components were extracted on the basis of Eigenvalues > 1 and the scree plot. The PCA of 
objective indices suggested 3 components accounting for 60.56% of the variance. Component 1 
accounted for 21.36% of the variance with the following loadings: decision-making RT (.82), 
RVIP inverse efficiency score (.83). Component 2 comprised the Stroop effect (RT) for both 
colour naming trials (.86) and word naming trials (.81), and accounted for 20.83% of the 
variance. Component 3 accounted for 18.34% of the variance, with PM retrieval (.56) and 
Stroop errors for both colour (.46) and word rule trials (-.85) loading on this factor. 
Theoretically these components were interpreted as representing 1) updating, 2) inhibition and 
3) mental-set or goal maintenance, overlapping with the factors identified by (Miyake & 
Friedman, 2012). Performance on the components measures was standardized and averaged for 
variables loading on the same factor to form composite measures. All 3 composites were created 
so that a greater value represented worse performance.  
 
Subjective cognitive indices (CFq, ACs) were considered separately. Scores on these measures 
were highly correlated, r(65)=.470, p <.001, and a PCA confirmed both scales loaded onto one 
factor accounting for 73.5% of the variance. A composite of standardized scores on these scales 
was created, with higher values representing worse ratings of cognition.  
 
5.4.2.4. APOE genotyping 
 
DNA samples, collected by a buccal swab of the inner-cheek, were used to screen for APOE 
genotype, in line with HTA procedures. Samples were analysed by LGC Genomics 
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(Hertfordshire, www.lgcgroup.com/genomics), using a fluorescence-based competitive allele-
specific polymerase chain reaction. The presence of three major APOE alleles (ε2, ε3, and ε4) 
was determined using two APOE single nucleotide polymorphisms (SNPs) (rs429358, rd7412).  
 
5.4.3. Statistical analyses 
 
A series of 12 multiple regression models were used to explore the relationship between APOE 
status, each additional predictor of cognitive decline (cognitive reserve, physical activity, and 
cardiovascular and metabolic health), and cognitive performance. Separate regressions were 
used to explore performance on each of the 4 cognitive composites: (1) updating (2) goal 
maintenance (3) inhibition and, (4) subjective cognition.  
 
APOE genotype was entered into the analysis as two dummy coded variables. The first variable 
coded ε4 carriers against ε4 non-carriers, while the second variable coded ε2 carriers against ε2 
non-carriers, positioning homozygous ε3 carriers as the reference variable. For each cognitive 
outcome, each potential moderator was included in separate models, as well as their interaction 
terms with the two APOE dummy variables.  
 
5.5 Results 
 
Demographics are presented by genotype in Table 5.1. One-way Analyses of Variances 
(ANOVAs) or chi-squared (Χ2) tests were used to check for genotype differences in 
demographic measures. The only significant genotype difference was in total CRIq score, F(2, 
62)=3.70, p=.030, driven by ε2 carriers scoring higher on this measure than the ε3 group 
(Bonferroni corrected p=.026). In addition, the genotype difference in family history of 
dementia approached significance, Χ2 (66)=5.11, p=.077. Genotype differences in the 
standardized predictor and cognitive composites are shown in Table 5.2. The genotype 
difference in cognitive reserve composite approached significance, F(2, 61)=2.47, p=.093. 
 
For each potential moderator (cognitive reserve, physical activity, cardiovascular and metabolic 
health), step 1 of the hierarchical regression included the primary effects of ε4 status, ε2 status 
and the moderator. Interaction terms were added in Step 2. At each step of the regression model, 
the significance of the change in explained variance (R2 ) was tested using a F-ratio statistic. A 
significant change at step 2 indicated that the model including the interaction terms provided a 
better fit for the data. In addition, the significance of individual regression coefficients was 
considered. Changes in R2 (ΔR2) and the β values for each regression model are presented in 
Tables 5.3, 5.4, and 5.5. A conservative α of .01 was applied to correct for Type 1 error.  
		
106	
 
Table 5.2. Scores on standardized composite measures of cognition and lifestyle shown by 
genotype group. 
  
Composite 
  
  
Genotype  
ε2 ε3 ε4 p 
Cognitive GM -.05 (.59) -.20 (.48) .26 (.67) .027 
 
Updating .43 (.79) -.31 (.83) .07 (.80) .022 
 
Inhibition -.13 (.43) .16 (1.19) -.08 (.59) .482 
 
Subjective  -.34 (.86) -.02 (.72) .26 (.94) .095 
Lifestyle CR .38 (.46) -.10 (.56) -.06 (.58) .093 
  PA .15 (.71) -.02 (1.00) -.08 (1.18) .785 
 CMH -.26 (.89) .25 (.82) -.04 (.77) .149 
Notes: Mean (sd). Abbreviations: Goal Maintenance (GM), Cognitive reserve (CR), Physical 
activity (PA), Cardiovascular and metabolic health (CMH). 
 
5.5.1 Cognitive Reserve 
In step 1, ε4 status significantly predicted lower performance on the goal maintenance 
composite (β=.39, p=.003). Possession of an ε2 allele was predictive of lower performance on 
the updating composite (β=.38, p=.010). In addition, primary effects of cognitive reserve were 
found on both the goal maintenance (β=-.36, p=.008) and subjective composites (β=-.39, 
p=.002), in that higher reserve was predictive of better performance.  
 
At step 2, adding the APOE x Cognitive reserve interaction terms accounted for marginally 
more variance in predicting subjective ratings  (p=.017). An ε2 x Cognitive reserve interaction 
suggested that subjective report of cognitive failures by ε2 carriers was predicted by higher 
cognitive reserve according to their subjective ratings of cognition (β=.44, p=.006).   
 
There was a trend towards significantly greater variance in goal maintenance scores being 
accounted for in Step 2 of the model (p=.055), driven by a marginal ε4 x Cognitive reserve 
interaction (β=-.43, p=.019); high cognitive reserve was more positively associated with better 
goal maintenance in ε4 carriers relative to the ε3 reference group. This relationship is shown in 
Figure 5.1. 
 
5.5.2. Physical activity  
 
In step 1, ε4 status was marginally predictive of lower performance on the goal maintenance 
composite (β=.34, p=.014). Possession of an ε2 allele was predictive of lower performance on 
the updating composite (β=.36, p=.010). The primary effect of physical activity was non-
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significant across the 4 domains of cognition (p>.01). Adding the interaction terms in step 2 of 
the models did not account for significantly more variance (p>.01). 
 
5.5.3. Cardiovascular and Metabolic Health 
 
Across cognitive outcomes, regression models including APOE genotype and the composite of 
cardiovascular and metabolic health did not account for significant variance (R2) in performance 
(p>.01). Adding the interaction terms in step 2 of the models did not add significantly to the 
variance accounted for (p>.01).  
 
 
Figure 5.1. The interaction between APOE genotype and cognitive reserve in predicting goal 
maintenance performance 
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Table 5.3. Hierarchical Regression Analyses: Cognitive Performance regressed on APOE status, cognitive reserve and the interaction  
 
Goal Maintenance Updating Inhibition Subjective Cognition 
Predictor β ΔR2  β ΔR2  β ΔR2  β ΔR2  
Step 1 
 
.23* 
 
.12 
 
.03 
 
.20* 
ε4 .39* 
 
.21 
 
-.15 
 
.13 . 
ε2 .22 
 
.38* 
 
-.13 
 
-.06 
 Cognitive Reserve  -.36* 
 
-.01 
 
-.07 
 
-.39* 
 Step 2 
 
.06 
 
.04 
 
.01 
 
.11 
ε4 x Cognitive Reserve -.43 
 
.25 
 
.02 
 
-.02 
 ε2 x Cognitive Reserve -.08 
 
-.05 
 
.17 
 
.44* 
 Notes: *p<.01. Step 1- df ( 3, 60), Step 2- df (2, 58) 
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 Table 5.4. Hierarchical Regression Analyses: Cognitive Performance regressed on APOE status, physical activity (PA), and the interaction
 
Goal Maintenance Updating Inhibition Subjective Cognition 
Predictor β ΔR2  β ΔR2 β ΔR2 β ΔR2 
Step 1 
 
.13 
 
.16 
 
.03 
 
.12 
ε4 .37* 
 
.22 
 
-.14 
 
.15 
 ε2 .10 
 
.36* 
 
-.16 
 
-.14 
 PA .12 
 
.19 
 
.10 
 
-.22 
 Step 2 
 
.09 
 
.03 
 
.02 
 
.05 
ε4 x PA .37 
 
-.27 
 
.15 
 
.08 
 ε2 x PA -.09 
 
.-.11 
 
-.05 
 
-.22 
 Notes: * p<.01. Step 1- df(3, 57), Step 2- df (2, 55) 
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Table 5.5. Hierarchical Regression Analyses: Cognitive Performance regressed on APOE status, cardiovascular and metabolic health, and the interaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 									
 
Goal Maintenance Updating Inhibition Subjective Cognition 
Predictor β ΔR2  β ΔR2 β ΔR2 β ΔR2 
Step 1 
 
.12 
 
.11 
 
.03 
 
.07 
ε4 .34 
 
.18 
 
-.15 
 
.16 
 ε2 .06 
 
.34 
 
-.16 
 
-.16 
 CMH -.14 
 
-.08 
 
-.05 
 
-.03 
 Step 2 
 
.01 
 
.00 
 
.00 
 
.03 
ε4+ x CMH -.02 
 
.03 
 
.02 
 
.25 
 ε2+ x CMH -.14 
 
.08 
 
.02 
 
.10 
 Notes: * p<.01. Step 1- df(3, 57), Step 2- df (2, 55) 
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5.6 Discussion 
 
The ε4 and ε2 variants of APOE have differential effects on cognitive fitness in later life 
(Corder, et al., 1994; Farrer et al., 1997), yet in this mid-aged sample, both ε4 and ε2 
participants demonstrated subtle impairments on executive attention measures. The present 
research provides a preliminary exploration of how key factors implicated in cognitive ageing 
moderate the presence of APOE genotype effects in mid-adulthood.  
 
The results support both independent and interactive effects of cognitive reserve on executive 
attention in mid-adulthood. Higher levels of cognitive reserve were associated with performance 
benefits in the ‘online’ maintenance of goals and fewer subjective reports of cognitive errors. 
After accounting for interactions with APOE genotype, cognitive reserve appears to exert a 
protective influence on goal maintenance abilities in ε4 carriers only. For subjective ratings of 
cognition, the positive effect of cognitive reserve for the ε3 control group remained significant, 
however the reverse was seen in ε2 carriers, in that higher levels of cognitive reserve were 
associated with more reported cognitive failings. In this sample of mid-age adults, neither 
physical activity nor indices of cardiovascular and metabolic health exerted independent or 
interactive effects on cognition.  
 
Previous research has demonstrated an effect of mid-life cognitive reserve on later-life 
cognition and biomarkers of ageing (Tolppanen et al., 2015; Vemuri et al., 2014; Wirth et al., 
2014). The present results, however, are important in suggesting cognitive reserve may 
influence the trajectory of cognitive ageing from at least the 5th decade. Support for a beneficial 
effect of cognitive reserve earlier in the lifespan indicates a potential neuroprotective role for 
factors, such as education, occupational complexity and cognitively engageing leisure activities, 
which increase reserve. This fits with recent evidence that cognitive reserve can both modulate 
the development of neuropathology across the lifespan and impede the behavioural 
manifestations of existing AD-related pathology (Arenaza-Urquijo, Wirth, & Chételat, 2015).  
 
Of interest, the protective effect of cognitive reserve was selectively enhanced in ε4 carriers for 
performance on measures of active goal maintenance, an important result given that goal 
maintenance was sensitive to impairment in mid-age ε4 carriers. The observed interaction 
between APOE ε4 and cognitive reserve is in line with past research suggesting the protective 
effects of cognitive reserve are enhanced in ε4 carriers later in life (e.g Carlsson et al, 2008; 
Vemuri et al., 2014; Wirth et al, 2014, Brewster et al., 2014). A recent meta-analysis of fMRI 
studies including healthy older adults found increased cognitive reserve was associated with 
activation differences within bilateral frontoparietal regions, including the anterior cingulate, 
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precuneus and dorsolateral prefrontal cortex (Colangeli et al., 2016).  These regions are 
implicated in executive control functions, and sensitive to ε4 differences in function prior to old 
age (Chen et al., 2016; Evans et al., 2014), aligning with the APOE ε4 x cognitive reserve 
interaction observed here in mid-adulthood. Importantly, this interaction at mid-adulthood 
suggests lifestyle cognitive enrichment may shift the emerging ageing trajectory of this group.  
 
Links to the deposition of amyloid provides a potential mechanism for the protective effects of 
cognitive reserve in mid-age ε4 carriers. Cognitive reserve is reported to impact amyloid 
neuropathology (Jagust & Mormino, 2011; Landau et al., 2012; Rentz et al., 2010), with the 
relationship exaggerated in healthy older ε4 carriers (Schreiber et al., 2016; Wirth et al., 2014). 
Relative to ε3 carriers, a higher percentage of ε4 carriers show significant amyloid build-up by 
the 5th decade (Jack et al., 2015; Morishima-Kawashima et al., 2000). In addition, frontal 
regions (which support goal maintenance) show loss of neural integrity and amyloid build up 
early in the ageing process (Bartzokis et al., 2003; Raz, 2000; Villemagne et al., 2011) . The 
directional nature of these relationships need to be established, however. 
 
In contrast to the findings of Soldan et al. (2013), the current study did not demonstrate 
cognitive benefits of higher cognitive reserve in ε2 carriers. The discrepant results may reflect 
the younger age group in the present study, or the particular measure of cognitive reserve 
(estimated from occupation and leisure activities). Alternatively, the results may simply indicate 
that ε2 carriers are less sensitive to modulation by both detrimental and protective factors 
associated with cognitive decline (McFall et al., 2015). The findings reported here should be 
interpreted with caution, due to the small number of ε2 carriers in the present analysis.  
Surprisingly, cognitive reserve was associated with greater reported cognitive failings in the ε2 
group, though they had a higher mean cognitive reserve score than the ε3 group. It may be that 
diminished gains are measurable in those with high baseline scores. Across the sample, 
cognitive reserve was generally high with all participants having a CRq score classed in the 
mid-band or above (mid: n=15, mid-high n=33, high: n=17), hence, the protective effects of 
cognitive reserve may be greater in a more diverse sample.   
 
The majority of research has demonstrated increased vulnerability in older ε4 carriers to the 
detrimental effects of risk factors associated with cognitive decline (e.g. physical inactivity, 
hypertension) (e.g. Woodard et al., 2012, Schuit et al., 2001; Etnier et al., 2007; Bunce et al, 
2004; de Frias et al., 2007; Zade et al., 2010). The current study explored those relationships in 
a mid-age cohort, anticipating that negative risk factors would exacerbate the detrimental effects 
of ε4 genotype on executive attention. It may be that the age-range included here was too 
young, and that the participants, being reasonably healthy and normotensive, did not generate 
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the spread of scores needed to see modulatory effects. In support, Oberlin et al (2015) only 
observed the negative association between ε4 status and cognition in prehypertensive or 
hypertensive mid-age adults (systolic blood pressure > 130mm hg).  
 
Several limitations of the current study must be addressed when considering the implications of 
these results. The number of participants in each genotype group was relatively small, and 
hence the analysis may be underpowered for detecting subtle effects, particularly relating to 
differences within the normal range of physiological functioning. In addition, the study used a 
self-report scale of exercise frequency. Previous studies have considered exercise as a function 
of average metabolic expenditure rather than weekly duration (Head et al., 2012), or objectively 
measured fitness (Etnier et al., 2007), which may provide a more indepth measure of physical 
activity. Also caution must be taken with attempting to infer the long term moderation of 
genotype effects by additional factors when the data is cross-sectional. The findings from this 
study, however, provide motivation for larger studies exploring the moderation of APOE 
genotype effects in mid-adulthood. 
 
5.7 Conclusions 
 
In this study, increased cognitive reserve, indexed through education, occupation and 
engagement in leisure activities, protected ε4 carriers against subtle impairments in goal 
maintenance abilities. Although reported physical activity did not interact with APOE ε4 status 
in this mid-age group, the results are consistent with the suggestion that APOE ε4 represents a 
plasticity gene, such that carriers from mid-adulthood show increased sensitivity both to 
protective and risk factors for cognitive ageing. This highlights the potential importance of 
taking steps to prevent cognitive decline earlier in the lifespan for those at increased risk. In 
contrast, the relative lack of ε2 interactions with cognitive reserve or current reported physical 
activity may suggest this variant shows reduced susceptibility to both positive and adverse 
influences.  
  
		
114	
6. Article 5 
 
Prospective Memory: Age related change is influenced 
by APOE genotype 
 
 
Article 5 is submitted to Neurobiology of Ageing as: 
Lancaster, C., McDaniel M., Tabet, N., & Rusted, J. (under review). Prospective 
Memory: Age related change is influenced by APOE genotype  
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6.1. Abstract 
 
Non-focal prospective memory (PM) is sensitive to age-related decline; an additional 
impairment in focal PM is characteristic of Alzheimer’s disease. This research explores if 
differences in the demands of focal and non-focal PM retrieval expose cognitive differences in 
carriers of an APOE ε4 allele, a genetic risk factor for Alzheimer’s disease, by mid-adulthood. 
33 young and 55 mid-age adults, differentiated by APOE genotype, completed a category-
decision task with a concurrent focal or non-focal PM task. In addition, ongoing WM load was 
manipulated to investigate whether genotype differences were more likely to be observed under 
high cognitive demand.  Only mid-age ε4 carriers show a cost of carrying a focal PM intention. 
All groups showed a significant cost of carrying a non-focal PM intention; however, mid-age ε4 
carriers showed greater cost than both the young ε4 group and mid-age ε3 group, consistent 
with compromised processing in this group by mid-adulthood. The profile of cost differences is 
consistent with that observed in pathological ageing, indicative of early vulnerability in the ε4 
group.   
 
Keywords: APOE, Prospective memory, Cognitive Ageing, Alzheimer’s disease, Mid-
adulthood 
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6.2. Introduction7 
 
Prospective memory (PM) refers to the timely recall of a previously formed intention whilst 
being engaged in ongoing cognitive activity. Importantly, what distinguishes PM from 
retrospective memory is that retrieval of the intention is self-initiated (McDaniel et al., 2015), 
and hence it relies on a somewhat different subset of cognitive processes. Each day includes 
numerous examples of PM, such as remembering to take medications on time or to pass on a 
message to a family member, and hence PM is important for maintaining independent living in 
older adulthood (Kliegel et al., 2016; McDaniel et al., 2008).  
 
6.2.1. Age-related change in prospective memory 
 
Healthy ageing is associated with decline in PM performance, with the greatest change seen in 
situations where carrying the PM intention burdens available cognitive processing resources 
(Henry et al., 2004; Kliegel et al., 2008). The cognitive demand of PM is, in part, dependent on 
how central the cue initiating PM retrieval is to the ongoing task (Scullin et al., 2010). The 
multi-process framework of PM (McDaniel & Einstein, 2000) argues that focal cues, defined as 
those that are processed directly as part of the ongoing task, activate spontaneous, relatively 
automatic retrieval processes. In contrast, features of non-focal PM cues are not processed as 
part of the ongoing task, and hence cognitive control is required to maintain the intention at the 
forefront of attention and actively monitor for its presence (Einstein et al., 2005; McDaniel et 
al., 2015; Scullin et al., 2010). As ageing is associated with reduced cognitive processing 
resources (Salthouse, 1991), non-focal PM is subject to substantially greater impairment than 
focal PM with increasing age. Aligned with this pattern, non-focal PM is supported by frontal 
regions of the brain (Cona et al., 2016; Cona et al., 2015; McDaniel et al., 2013), which show 
early sensitivity to age-related change (Bartzokis et al., 2003; Raz, 2000; Villemagne et al., 
2011). Pathological cognitive ageing is distinguished by an additional impairment in focal PM 
(Blanco-Campal et al., 2009; Costa et al., 2011; Duchek et al., 2006; McDaniel et al. 2011). 
This may be due to greater reliance of retrieval on ‘bottom-up’ attention and associative 
memory processes, mediated by occipital, parietal (Cona et al., 2016) and temporal lobe regions 
(McDaniel et al., 2013). 
 
 
 
 																																																								7	Abbreviations: Prospective Memory (PM), Apolipoprotein E (APOE), working memory 
(WM) 
		
117	
6.2.2. Does APOE influence age-related change in prospective memory?  
 
The distinct profiles of PM impairment associated with healthy and pathological cognitive 
ageing provide an interesting framework for exploring the effects of Apolipoprotein E (APOE) 
ε4 across the lifespan. APOE ε4, one of the three variants of the APOE single nucleotide 
polymorphism (ε2, ε3, ε4), is a well established risk factor for Alzheimer’s disease (AD) 
(Corder et al., 1993). In addition, carrying at least one copy of the ε4 allele is linked to poorer 
cognition in healthy older adults (e.g. Jack et al., 2015; Marioni et al., 2015; Reinvang et al., 
2010; for reviews see: Small et al., 2004; Wisdom et al., 2011), although this result has not 
consistently been found (e.g. Bunce et al., 2014; Bunce et al., 2004; Salo et al., 2001). One 
reason behind this inconsistency may be the non-uniformity of ε4 effects across cognitive 
domains (Lancaster et al., 2017; Small et al., 2004; Wisdom et al., 2011).  
 
Evidence for the sensitivity of PM to APOE genotype effects in later life is mixed. Whilst 
carrying an ε4 allele was associated with increased impairment on a focal PM task in adults 
with mild AD, healthy older ε4 carriers demonstrated performance advantages compared to 
their non-ε4 peers (Duchek et al., 2006). Other research however, reported a non-significant 
effect of APOE status in both focal and non-focal PM conditions in a group of healthy older 
adults (McDaniel et al., 2011).  
 
Reports of an association between APOE genotype and cognition are not restricted to later life 
(for reviews see: Ihle et al., 2012; Lancaster et al., 2017; Rusted & Carare, 2015; Salvato, 
2015). A cross-sectional comparison of mid-age (45-55 years) and young adults (18-30 years) 
suggested a speed-accuracy trade-off in mid-age ε4 carriers, with greater non-focal PM retrieval 
accuracy coupled with slower ongoing task response times (RTs) (Evans et al., 2014). In this 
study, task-related BOLD activity in the left inferior frontal gyrus correlated with PM accuracy 
in ε4 carriers, interpreted as a premature shift towards a reliance on frontal lobe activation to 
support cognitive performance. 
 
Lancaster et al. (2016) reported that mid-age ε4 carriers showed subtle impairments in non-focal 
PM retrieval accuracy. In addition, ε4 carriers demonstrated reduced accuracy selectively for 
incongruent trials of a Stroop-switch paradigm. The updating of goals within executive attention 
has consistently been linked to successful non-focal PM retrieval (Schnitzspahn et al., 2013; 
Zuber et al., 2016). In addition the profile of errors on the Stroop task supported impairments in 
the flexible control of multiple goals at the forefront of attention (Conway & Kane, 2001; Kane 
& Engle, 2003). Hence, ε4 carriers may be showing early differences in this component of 
executive attention by mid-adulthood. This is an important avenue for future exploration, as by 
		
118	
identifying which cognitive processes differentiate those at heightened risk of cognitive decline 
in mid-adulthood, steps can be made towards developing early intervention strategies.  
 
6.2.3. Aims and hypotheses 
 
The principle aim of this study is to explore age-related APOE genotype differences in focal and 
non-focal PM to help illuminate which cognitive processes are potentially more sensitive to 
premature age-related change in those at heightened genetic risk of cognitive decline. The PM 
task (McDaniel et al., 2011) was embedded within an ongoing category decision task, and  the 
type of PM cues (focal versus non-focal) were manipulated . Both PM retrieval accuracy and 
prospective interference (Marsh et al., 2003) or cost of carrying a PM intention on ongoing task 
performance, will be used in conjunction to index how well volunteers are completing the task. 
For both the ‘at-risk’ ε4 group and homozygous ε3 carriers (the population ‘norm’), cross-
sectional age-related differences in performance will be used to explore the prediction that ε4 
carriers show a profile of accelerated ageing. In addition, in mid-adulthood, performance of ε4 
carriers will be directly compared with their ε3 peers to address whether this group is 
demonstrating disadvantages by the 5th decade.  
 
Following Henry et al. (2004) and Kliegel et al. (2008), we anticipated that mid-age adults 
would find the non-focal PM condition more challenging than younger adults due to the demand 
this places on executive attention resources. This may be reflected in increased interference for 
ongoing task performance or reduced PM retrieval accuracy. The effect of age on focal PM 
performance was predicted to be substantially smaller, in agreement with the suggestion that 
focal PM intentions can be successfully retrieved using automatic ‘stimulus-driven’ processes 
(Harrison & Einstein, 2010; Scullin et al., 2010). 
 
Following Lancaster et al. (2016), we predicted that mid-age ε4 carriers’ premature decline in 
executive attention would increase their age-related deficit in non-focal PM, while focal PM 
performance would be equivalent. As an additional measure, subjective indices of task demand 
and motivation were included as an exploratory means of assessing if APOE genotype 
differences can be accounted for by different approaches to performing the task. 
 
A second goal of the study was to probe the effect of adding a working memory (WM) load 
within the ongoing task on PM performance. The WM load manipulation was designed to place 
an additional tax on executive functioning, and hence exaggerate any genotype differences 
present by mid-adulthood. WM and non-focal PM are hypothesized to draw on distinct yet 
overlapping frontal lobe systems (Basso et al., 2010, Reynolds et al., 2009) and hence tasks 
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loading on the central executive of WM disrupt PM performance (Marsh et al., 2002; West et 
al., 2006).  With age-effects reported previously for PM under WM load (Bisiacchi et al., 2013), 
it was predicted WM load would exacerbate emerging non-focal PM impairments in the mid-
age group. 
 
6.3. Methods 
 
6.3.1 Participants 
 
Participants were recruited from an existing database of young and mid-age volunteers who had 
previously provided swabs for APOE genotyping, or via advertisement in the local community. 
An independent third party pseudo-randomly selected the participants from the database, to 
maintain the population bias towards homozygous ε3, while recruiting a suitable sample size of 
ε4 carriers. No genotype information was provided directly to the researcher; genotype was 
added to the anonymised dataset provided by the researcher at the end of the study. For 
inclusion, participants had to be aged 18-30 years or 45-56 years and using English as their 
daily language.  Exclusion criteria were: a self-reported history of neurological or psychiatric 
illness within the past 5 years and self-reported psychoactive medication use.  
 
All genotyping procedures followed UK Human Tissue Authority (HTA) guidelines, with 
ethical approval for the study granted by the Research Ethics committee of the School of 
Psychology and Life Sciences, University of Sussex. Volunteers were first asked to provide 
written informed consent, including acknowledgment that the results of the genotype analysis 
would not be made available to them. DNA was then collected with a buccal swab, using an 
Isohelix SK1 kit. Genotyping followed triangulated anonymisation procedures, with two 
anonymised codes used per sample. Samples were analysed to determine APOE gene variant by 
LGC Genomics (Hertfordshire, www.lgcgroup.com/genomics). A fluorescence-based 
competitive allele-specific polymerase chain reaction determined the presence of three major 
APOE alleles (ε2, ε3, and ε4) based on two APOE single nucleotide polymorphisms (SNPs) 
(rs429358, rs7412).  
 
The final sample consisted of 37 young volunteers (2 ε2/ε3, 1 ε2/4, 16 ε3/ε3, 12 ε3/ε4, 5 ε4/ε4, 
1 unknown), and 58 mid-age volunteers (3 ε2/ε2, 1 ε2/ε4, 36 ε3/ε3, 14 ε3/ε4, 4 ε4/ε4). Prior to 
analysis individuals with ε2/ε2 or ε2/ε3 genotypes were excluded. Volunteers with ε3/ε3 
genotype, henceforth referred to as ε3 carriers, were treated as the control group, justified by 
this genotype being most prevalent in the population (Farrer et al., 1997). All volunteers 
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carrying an ε4 allele (ε2/ε4, ε3/ε4, ε4/ε4) were grouped together, henceforth referred to as ε4 
carriers8. Volunteer characteristics for the analysed dataset are shown in Table 6.1. 
 
Table 6.1. Demographic characteristics of participants 
 
Age Gender (% F) IQ 
Youngs 
   ε3 (n=16) 20.75 (1.81) 69 112.34 (6.07) 
ε4 (n=18) 21.33 (2.61) 83 109.88 (6.14) 
Mids  
   ε3 (n=36) 50.22 (2.74) 69 122.03 (2.76)* 
ε4 (n=19) 49.74 (3.53 68 119.44 (3.59) 
* Denotes a significant genotype group difference (p>.05). 
 
6.3.2 Materials 
 
6.3.2.1. Demographics and baseline measures 
 
A short demographic questionnaire was administered establishing age, gender, occupation and 
general health (smoking status, medication use, blood pressure). Blood pressure and pulse rate 
were measured using an automatic upper-arm cuff machine. The National Adult Reading test 
(Nelson & Willison, 1991) was administered to provide a baseline measure of IQ.  In addition, 
the 12-item Grit Scale (Duckworth et al., 2007) was used to measure individual differences in 
trait-level perseverance and adherence to long-term goals.  
 
6.3.2.2. Category decision PM task 
 
Ongoing category decision trials consisted of on-screen item and category pairings, with 
participants required to indicate if the lowercase word on the left (e.g. dentist) belonged to the 
same category as the uppercase word on the right (e.g. PROFESSION). Participants pressed a 
‘y’ button or ‘n’ button, representing ‘yes’ and ‘no’ respectively to make this judgment.  
 
The task was divided into 3 blocks (control, focal PM and non-focal PM), counterbalanced 
across participants. In each block (control, focal PM and non-focal PM) there were 106 category 
decision-pairings (53 congruent, 53 incongruent) taken from Einstein et al. (2005). Three lists of 
category pairings were used across the 3 task blocks, with the order of lists counterbalanced 
across participants, independent of the order of PM conditions.   																																																								8	Volunteers with ε2/ε4 genotype were retained in the present analysis, however, the effect of 
these two alleles in combination is not well established. The results of an additional analysis 
removing these two volunteers were not significantly different. 	
		
121	
 
In the focal PM block participants were given an additional instruction to make a ‘Q’ keyboard 
press if a target word was presented as part of a category decision trials. The focal PM target 
was either: tortoise, raspberry or aluminum, counterbalanced across participants. The focal PM 
target was always presented 3 times, embedded in the 31st, 72nd and 102nd category decision 
trials. In the non-focal PM condition, participants were instructed to make a ‘Q’ keyboard press 
at any point during the category decision trials if a target syllable was presented: tor, ras, min. 
Again, the non-focal PM target was counterbalanced across participants to ensure no individual 
received the same target for both conditions (e.g. tortoise, tor). The non-focal PM cue was 
presented three times (tor: tortoise, history, motorcycle; ras: raspberry, harassment, grasshopper; 
min: aluminum, peppermint, minister), embedded in category decision trials 31, 72 and 102. In 
both focal and non-focal PM blocks, the PM cue was always presented on the left of the 
category decision pairing in lower case font. The addition of 3 PM trials led to a total of 109 
trials in these two blocks. In the control condition participants were not given an additional PM 
instruction, and hence were only instructed to respond to the 106 category-decision pairings. 
 
At the start of the task, participants were instructed to make their category decision judgments 
as quickly and as accurately as possible. There were 12 practice trials, including 6 trials 
providing feedback on response time and accuracy. Before each PM block (focal, non-focal) 
participants were given the PM instructions, with an additional point being that if they were 
unable to press the ‘Q’ key on the PM trial, they could make this response as soon as possible 
after the trial concluded. Participants were then asked to repeat these instructions back to the 
experimenter in their own words to ensure they had understood the task before being allowed to 
proceed. Between summarizing the PM instruction and beginning the PM block there was a 1-
minute delay task to create a break between encoding and retrieval. Following this delay, 
participants were reminded of the ongoing category decision instructions but there was no 
mention of the PM instruction. Upon completion of each PM block, participants were told the 
PM cue would not appear again in the subsequent blocks.  
 
6.3.2.2.1 WM manipulation 
 
The full category decision task was administered a second time with an additional WM load. 
The task was presented in the format described previously, but each participant had a different 
counterbalanced order of blocks (control, focal and non-focal) and lists of category-decision 
pairings.  
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The WM task asked participants to monitor how many times the word ‘fish’ appeared as part of 
a category-decision pairings. ‘Fish’ could be presented as either the example (lowercase, left-
hand side) or the category (uppercase, right-hand side). Participants were not allowed to make a 
record of targets, but were instructed to keep a count mentally. The number of WM targets (3, 4, 
6) varied for each block, dependent on the counterbalanced order of category-decision lists 
presented. At the end of each block, participants were prompted to recall the number of targets.  
 
6.3.2.3 The NASA task load index 
 
Perceived workload was measured at the end of each version of the category decision task using 
a pen-and-paper version of the NASA task load index. This consists of 6 visual analogue scales 
measuring: mental demand, physical demand, temporal demand, performance, effort, and 
frustration. Participants were instructed to mark along the scale to indicate how they had 
experienced the category decision task (No load, WM load).  Only data from two subscales: 1) 
mental demand, 2) effort were relevant to the current research questions. 
 
6.3.4. Procedure  
 
Volunteers took part in a single study session lasting 60 minutes, outlined in Figure 6.1. Mood, 
blood pressure and pulse were measured both before and after completing each version of the 
category decision task (no WM load, WM load). During the category decision task, a one-
minute interval after receiving the instructions for each condition (control, focal and non-focal) 
was filled by a single verbal fluency trial in which volunteers were asked to generate as many 
words beginning with a select letter (F, A, S) as possible in 60 seconds (Strauss, Sherman, & 
Spreen, 2006). Participants were not reminded of the PM instruction before resuming the 
category-decision task. At the end of each version of the category decision task, participants 
were asked to complete a NASA task load index reflecting on all three conditions (control, focal 
and non-focal). Participants who were not recruited from the pre-genotyped APOE database 
provided a buccal swab at the end of the session.  
 
6.3.5. Statistical Analysis 
 
For each age group, genotype differences in demographic characteristics were screened using 
either an independent t-test (age, IQ) or a chi-squared test (gender). 
 
6.3.5.1. Category decision PM task 
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Prior to analysis, category decision performance in each age group was screened for outliers, 
and RTs more than 3 standard deviation (SD) away from each individual’s mean were removed. 
In the mid-age group, accuracy was above 85% and there were no consistent outliers across 
conditions for decision-making RT. In the young group one participant was removed, with their 
average accuracy falling below 80%, and their RTs classed as outliers in 5/6 conditions.  
 
The between-subjects factors considered in the following analysis were Age (young, mid) and 
APOE genotype (ε3, ε4). Condition (control, focal, non-focal) and Load (no load, WM load) 
were considered as within-subject factors. 
 
For PM retrieval accuracy, effects of Age and Genotype on focal and non-focal PM were 
analysed using a mixed 2 (Condition: focal, non-focal) x 2 (Age) x 2 (Genotype) ANOVA.  
 
A preliminary analysis comparing category decision accuracy across conditions was completed 
using separate one-way ANOVAs for the no load and WM load versions of the task. RTs in the 
control condition (no PM intention, no WM load) of the category decision task were analysed 
using a 2 (Age) x 2 (Genotype) ANOVA.  
 
The cost of carrying a PM intention for ongoing category decision performance was indexed by 
a significant difference between RT in the PM condition and the control condition, with 
separate analyses completed for focal and non-focal PM intentions. For category decision RTs, 
a 2 (Condition: control, PM condition) x 2 (Age) x 2 (Genotype) ANOVA was run to 
investigate group differences in the presence of PM interference costs. Following a significant 
Condition x Age x Genotype interaction, differences were probed using a single cost measure 
(PM condition–control condition), with a Bonferonni adjustment used to control for multiple 
comparisons. 
 
The impact of adding a WM load to PM retrieval was analysed using a 2 (Load) x 2 (Condition: 
focal, non-focal) x 2 (Age) x 2 (Genotype) mixed ANOVA. Prospective interference following 
the addition of a WM load was analysed separately for focal and non-focal conditions, using a 2 
(Condition: control, PM condition) x 2 (Age) x 2 (Genotype) ANOVA. Interactions were 
probed using a single cost measure, with a Bonferonni-adjusted alpha.  
 
6.3.5.2. Motivational factors and perceived difficulty 
 
Group differences in overall Grit score were analysed using a 2 (Age) x 2 (Genotype) between-
subjects ANOVA. For each scale of the NASA, a mixed 2 x 2 x 2 ANOVA was completed, 
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with Load (no load, WM load) as the repeated-measures factor, and Age and Genotype as the 
between-subjects factor. Interactions were probed using Bonferroni-adjusted t-tests. 
 
 
 
Figure 6.1. Timeline of experimental procedure 
 
 6.4. Results 
6.4.1. Volunteer Characteristics 
 
In the young group, there were no significant genotype differences in age, gender or IQ (p>.05). 
Mid-age adults did not significantly differ by genotype in age or gender (p>.05) however, mid-
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age ε4 carriers had significantly lower estimated IQ scores than mid-age ε3 carriers, t(53)=2.98, 
p=.004.9 
 
6.4.2. Category decision PM task 
 
6.4.2.1. PM accuracy 
 
Retrieval accuracy for focal PM was significantly higher than for non-focal PM, F(1, 
83)=28.48, p<.001, η2 p=.244. The main effects of Age and Genotype, as well as all interaction 
terms, were non-significant (p>.05). The mean proportion of focal and non-focal PM cues 
correctly retrieved for each volunteer group can be seen in Table 6.4.  
 
6.4.2.2. Category decision performance  
 
Accuracy was consistently high across conditions, ranging from 81% to 100%. In addition, the 
inclusion of a PM intention (focal or non-focal) did not significantly impact category decision 
accuracy, either under no load and WM load (p>.05). Hence all further considerations of 
category decision performance will be restricted to RTs. Table 6.2 shows mean accuracy for 
each group for each condition.   
 
Young participants were significantly faster in the baseline category decision condition than the 
mid-age group, F(1, 83)=9.38, p=.003, η2 p=.102, but the main effect of genotype was non-
significant (p >.05). There was no significant Genotype x Age interaction (p >.05).  
 
Table 6.2. Mean accuracy on the category decision task shown by age and genotype group 
  
Young Mid-age  
    ε3 ε4 ε3 ε4 
Control No Load .93 (.03) .91 (.03) .96 (.03) .96 (.03) 
 
WM Load  .93 (.03) .94 (.03) .96 (.02) .96 (.03) 
Focal No Load .92 (.03) .92 (.03) .96 (.03)  .96 (.03)  
 
WM Load  .93 (.02) .93 (.03) .96 (.02)  .96 (.03) 
Non-focal No Load .92 (.03) .93 (.03) .96 (.03) .97 (.03)  
  WM Load  .94 (.03)  .93 (.03)  .96 (.03)  .95 (.03)  
Notes: Values represent mean (SD) 
 
 																																																								9	All main analyses were run including IQ estimate as a covariate. IQ did not significantly 
(p>.05) account for variance in category decision task performance and so is not commented on 
further. 	
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6.4.2.3. PM interference cost  
 
Mean RT on the category decision task across control, focal and non-focal conditions is 
summarised by group in Table 6.3. 
 
6.4.2.3.1. Focal condition. 
 
Category decision RTs were significantly longer in the focal PM condition (M=1166, SE=21) 
compared to the control condition (M=1097ms, SE=21ms)(standard error=SE), F(1,83)=30.91, 
p<.001, η2 p=.271. In addition, mid-age volunteers (M=1207, SE=26) were significantly slower 
than young volunteers (M=1097ms, SE=21ms), F(1,83)=13.73, p<.001, η2 p=.142. Importantly, 
there was a significant Condition x Age x Genotype interaction, F(1,83)=4.50, p=.039, η2 
p=.051, shown in Figure 6.2. 
 
Only mid-age ε4 carriers showed a significant cost of carrying a focal PM intention on category 
decision RTs (p=.001); the cost in all other groups was non-significant (p>.006). Moreover, the 
Age x Genotype interaction indicated that mid-age ε4 carriers demonstrated greater cost than 
both young ε4 carriers (p=.016) and mid-age ε3 carriers (p=.029), however, following 
adjustment for multiple comparisons (SME, Bonferroni-adjusted α = .006) these differences did 
not reach significance. There was no significant genotype difference in young volunteers 
(p=.361), and focal PM cost was equivalent between age-groups for ε3 carriers (p=.680). 
 
 
Figure 6.2. Mean category decision RT shown for the control and focal condition.  
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6.4.2.3.2. Non-focal condition 
 
Category decision RTs were significantly longer in the non-focal PM condition (M=1486ms, 
SE=43ms) than the control condition (M=1097ms, SE=21ms), F(1,83)=142.99, p<.001, η2 
p=.633. In addition, across conditions mid-age volunteers (M=1394ms, SE=38ms) were 
significantly slower than young volunteers (M=1189ms, SE=46ms), F(1,83)=13.73, p<.001, η2 
p=.142. There was a significant Condition x Age x Genotype interaction, F(1,83)=5.27, p=.024, 
η2 p=.060, shown in Figure 6.3. 
 
SME analysis (Bonferroni adjusted α of .006) of the Age x Genotype interaction for non-focal 
RT cost (entered as a single variable) revealed mid-age ε4 carriers demonstrated significantly 
greater cost than young ε4 carriers (p=.003), while there was a non-significant age-difference in 
the ε3 group (p=.984). In young volunteers, the genotype difference was non-significant 
(p=.177). At mid-age, there was a trend for ε4 carriers demonstrating greater cost than their ε3 
counterparts (p=.054).  
 
 
 
Figure 6.3. Mean category decision RT shown for the control and non-focal condition.  
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Table 6.3. Mean RT and PM cost shown for category decision performance under no load and 
WM load  
      Young Mid 
      ε3 ε4 ε3 ε4 
Control No Load RT 1055 (129) 1008(142) 1134 (206) 1191 (223) 
 WM Load  1048 (104) 1008 (147) 1117 (184) 1181 (202) 
Focal No Load RT 1122 (163) 1039 (109) 1187 (219) 1314 (199) 
  
Cost 67 (77) 32 (72) 53 (120) 123 (136) 
 
WM Load RT 1139 (117) 1078 (158) 1224 (203) 1306 (295) 
  
Cost 91 (73) 70 (79) 106 (77) 125 (152) 
Non-Focal No Load RT 1439 (269) 1254 (218) 1516 (381) 1735 (556) 
  
Cost 383 (255) 247 (209) 382 (263) 544 (404) 
 
WM Load RT 1327 (119) 1245 (212) 1458 (350) 1550 (418) 
    Cost 279 (120) 237 (140) 340 (223) 369 (249) 
Notes: Values represent Mean (SD) 
 
6.4.2.4. The addition of a WM load 
 
Group differences in WM retrieval accuracy are included in the Appendix.  
 
6.4.2.4.1. PM retrieval 
 
Across both focal and non-focal PM, WM did not significantly impact PM retrieval accuracy (p 
>.05), however, there was a significant Load x Age interaction, F(1, 83)=4.33, p=.040, η2 
p=.050. In the mid-age volunteers, PM retrieval was marginally less accurate under the WM 
load condition than in the no load condition (p=.028). Young volunteers did not show a 
significant difference in PM accuracy between no load and WM load (p>.05) (Bonferroni-
corrected α=.025). There were no genotype differences in PM accuracy under WM load, and no 
significant genotype interactions (p>.05). Accuracy of PM retrieval under WM load is shown in 
Table 6.4. 
 
Table 6.4. The mean proportion of correct PM responses across conditions (Focal/Non-focal; 
No Load, WM Load) 
  
No Load WM load 
  
Focal Non-focal Focal Non-focal 
Young ε3 .98 (.08) .67 (.35) .92 (.26) .71 (.30) 
 
ε4 .82 (.34) .65 (.36) .96 (.16) .67 (.37) 
		
129	
Mid ε3 .94 (.21) .70 (.35) .89 (.26) .68 (.34) 
 ε4 .98 (.08) .74 (.35) .86 (.32) .67 (.35) 
 
6.4.2.4.2 Prospective interference under WM load 
 
Mean RT on the category decision task under WM load is shown for control, focal and non-
focal conditions in Table 6.3, summarised by group. Under WM load, category decision RTs 
were significantly longer in the focal PM condition (M=1186ms, SE=23ms) than the control 
condition (M=1089ms, SE=19ms), F(1,83)=79.49, p<.001, η2 p=.486; however, there were no 
significant effects of age or genotype (p>.05). All interaction terms were non-significant.  
 
Under WM load, category decision RTs were significantly longer in the non-focal PM condition 
(M=1395ms, SE=35ms) compared to the control condition (M=1089ms, SE=19ms), 
F(1,84)=79.49, p<.001, η2 p=.687. Across conditions, there was a main effect of Age, 
F(1,84)=10.50, p=.002, η2 p=.111, and a significant Age x Condition interaction, F(1,84)=4.57, 
p=.035, η2 p=.052. This was driven by the mid-age group (M=350ms, SD=231ms) 
demonstrating greater cost than the young group (M=258ms, SD=231ms), t(85.78)=-2.41, 
p=.018. The effect of genotype was non-significant, as were all other interactions (p>.05).    
 
6.4.3. Motivational factors and perceived difficulty 
 
6.4.3.1. Grit Trait Score 
 
There was a significant effect of age, F(1, 84)=7.90, p=.006, η2 p=.086, with mid-age adults 
(M=3.72, SD=.42) scoring higher on this questionnaire than young adults (M=3.42, SD=.45). 
There was a no main effect of Genotype, or Genotype x Age interaction (p>.05). 
 
6.4.3.2. The NASA task-load index 
 
Load ratings of the no load and WM load category decision task are shown in Table 6.5. 
 
The no load category decision task (M=44.76, se=2.52) was associated with higher mental 
demand than the WM load category decision task, M=33.26, se=2.31), F (1, 84)=23.85, p<.001, 
η2 p=.221. Mid-age volunteers (M=43.44, se=2.73) reported significantly greater mental 
demand than young adults (M=34.89, se=3.29), F(1, 84)=4.38, p=.039, η2 p=.050.  The main 
effect of genotype was non-significant (p>.05), but there was a significant Genotype x Load 
interaction, F(1, 84)=6.77, p=.039, η2 p=.075. SME (Bonferroni-adjusted α=.013) revealed ε4 
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carriers, but not ε3 carriers (p=.092), showed a significant drop in perceived demand under WM 
compared to the no load condition (p<.001). In the no load and in the WM load condition, 
genotype groups did not significantly differ in their mental demand ratings (p>.013).   
 
Subjective estimates of effort were greater for the no load condition (M=47.94, SD=24.62) than 
the WM load condition (M=36.00, SD=20.44), F(1, 83)=3.29, p=.073, η2 p=.038. The main 
effects of both age and genotype were non-significant (p>.05), however, there was a significant 
Load x Age x Genotype interaction, F(1, 83)=10.69, p=.002, η2 p=.114. SME analysis found no 
significant age-difference in ε4s in the perceived effort completing the no load condition 
(p=.513), however, mid-age ε4s reported greater effort than young ε4s under WM load 
(p=.019). In the young group, but not the mid-age group, effort decreased from no load to WM 
load (p<.001) (Bonferroni corrected α=.013). The Load x Age interaction was non-significant in 
the ε3 group (p>.05).  
 
Table 6.5. NASA scores of mental demand and effort for the no load and WM load version of 
the category decision task 
    Young Mid 
    ε3 ε4 ε3 ε4 
No Load Demand 37 (17) 46 (21) 43 (26) 54 (22) 
 
Effort 43 (28) 54 (27) 46 (27) 49 (23) 
WM load Demand 31 (18) 26 (19) 38 (24) 40 (18) 
  Effort 36 (18) 29 (16) 34 (22) 45 (22) 
 
 
6.5. Discussion 
 
The present study addressed two research questions: 1) Do carriers of an APOE ε4 allele, a 
genetic risk factor for poor cognitive ageing, show a distinct profile of age-related change in 
focal versus non-focal PM retrieval accuracy or cost of carrying an intention? 2) Does adding a 
WM load to the ongoing task differentially impact PM performance according to age or 
genotype? In addition, the research included subjective indices of mental demand and effort to 
explore group differences in how the task was performed.  
 
Irrespective of cue focality, the current findings do not support early life APOE-genotype 
differences in PM retrieval accuracy. PM interference, or the cost of carrying a PM intention on 
ongoing task performance, however, was sensitive to the detrimental effects of APOE ε4 by 
mid-adulthood. Carrying a focal PM intention selectively disadvantaged ongoing task 
performance in mid-age ε4 volunteers. For both focal and non-focal PM intentions, evidence for 
an age-associated increase in PM interference was limited to carriers of the disadvantageous ε4 
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allele. Furthermore, there was a trend of the mid-age ε4 group demonstrating greater non-focal 
cost than their age-equivalent ε3 counterparts. Including a concurrent WM load alongside 
ongoing category demands negatively impacted PM retrieval in the mid-age group only; 
however, inclusion of a WM load did exaggerate genotype differences in PM by mid-age.  
 
Based on previous research (Lancaster et al., 2016), we anticipated that genotype differences 
would selectively be observed in non-focal PM retrieval, consistent with the enhanced 
vulnerability of frontal-based executive systems to APOE genotype effects from mid-adulthood. 
In this study, ε4 carriers, demonstrated equivalent PM retrieval accuracy for both focal and non-
focal cues, but registered a cost in maintaining the PM intention. Past research measuring 
BOLD activity during non-focal PM retrieval suggested the employment of early compensatory 
strategies in mid-age ε4 carriers (Evans et al., 2014). Hence, it may be that ε4 carriers are 
employing attentional resources differently to support PM retrieval.  
 
Genotype differences were reported in the cost of maintaining a PM intention on ongoing task 
performance, with mid-age ε4 carriers demonstrating increased cost of carrying both a focal and 
non-focal PM intention. The presence of both focal and non-focal disadvantages by mid-
adulthood in this ‘at-risk’ group, importantly, is consistent with the profile of impairment 
observed in the very early stages of pathological memory decline (Duchek et al., 2006; 
McDaniel et al.2011). Focal PM retrieval is hypothesised to rely on spontaneous, associative 
memory processes, supported by the medial temporal lobe (MTL) (Atienza et al., 2011; 
McDaniel et al., 2013). Structural differences in MTL volume are associated with focal PM 
accuracy in both healthy older adults and adults in the early stages of dementia (Gordon, 
Shelton, Bugg, McDaniel, & Head, 2011). Hence, the presence of focal costs in ε4 carriers by 
mid-adulthood indicates compromised associative memory processes in this group. In support, 
other research has indicated MTL regions are sensitive to ε4 differences by mid-adulthood (Den 
Heijer et al., 2002; Shaw et al., 2007; Wishart et al., 2006), and these differences have been 
interpreted as early vulnerability in neural systems sensitive to the pathological change 
associated with AD. 
 
 In addition, ε4 carriers demonstrated increased interference of carrying a non-focal PM 
intention by mid-adulthood. One account of non-focal prospective interference costs is that 
individuals adjust the distribution of executive resources to the ongoing task based on their 
ability to cope with the demands of the PM (Boywitt & Rummel, 2012; Marsh et al., 2005). In 
support, increased variability of ongoing task RTs following the introduction of a non-focal PM 
correlated with successful PM retrieval (Loft et al., 2014), reflecting the necessary monitoring 
processes implemented to support retrieval. Our results suggest that by mid-adulthood, ε4 
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carriers may be committing a greater proportion of cognitive resources to support equivalent 
levels of PM retrieval compared to the ε3 group, and reduced ability to maintain and co-ordinate 
multiple goals at the forefront of attention (Lancaster et al, 2016), consistent with the speed-
accuracy trade-off reported by Evans et al (2014). Sustained processing during non-focal PM is 
associated with BOLD activation in dorsal frontal-parietal regions and the precuneus (Cona et 
al., 2016). Sensitivity to APOE differences has previously been reported in these regions (Chen 
et al., 2016; Evans et al., 2014). 
 
Mid-age ε4 carriers showed a greater age-related increase in ongoing task cost (relative to 
young ε4 carriers) than did mid-age ε3 carriers (relative to young ε3 carriers) for both focal and 
non-focal PM intentions. More broadly, this implies the APOE ε4 genotype represents a 
trajectory of accelerated ageing, with subtle impairments present from mid-adulthood. However, 
a recent investigation into the APOE differences in age-related cognitive change prior to age 50 
reported smaller declines in a composite of executive functioning in ε4 carriers (Taylor et al., 
2016). This composite consisted of a different set of executive processes (fluency, switching 
and inhibition) than those targeted in the present study, perhaps indicating non-uniform effects 
of APOE genotype across executive functions. Of interest, our data were in the direction of a 
smaller PM cost in young ε4 carriers compared to their ε3 counterparts. This aligns with 
previous reports of an ε4 advantage in executive attention in youth ((Marchant et al., 2010; 
Rusted et al., 2013).  
 
An alternative account of the age-related increase in PM interference costs observed in ε4 
carriers is that greater costs are associated with increased ongoing response hesitancy, resulting 
from the need to make a more complicated decision (i.e. both a category-decision and a PM 
decision) (Heathcote et al., 2015; Horn et al., 2013; Strickland et al., 2017). It may be that mid-
age ε4 carriers are adopting a more conservative task strategy to support PM retrieval, driving 
the observed performance differences.   
 
To increase the tax placed on executive resources, a concurrent WM load task was included 
alongside ongoing category decision-making. Independent of focality, the additional of a WM 
load negatively impacted PM retrieval in the mid-age group. This supports previous reports of 
an age-related difference in sensitivity to the effects of a secondary WM demand, with older 
adults demonstrating greater PM failings than young adults under load (Bisiacchi et al., 2013; 
Logie et al., 2004). In addition, the mid-age group recalled a smaller proportion of WM targets 
(see appendix), suggesting increased difficulty maintaining multiple task goals by mid-
adulthood, or the ability to flexibly apply attention to these goals (Kane & Engle, 2003).  
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While we anticipated that adding a WM load to ongoing processing would further expose early 
PM decline in ε4 carriers, there was in fact, no APOE-genotype difference in PM retrieval 
accuracy, and counter intuitively, the Age x Genotype interaction for ongoing task cost 
disappeared under WM load, with mid-age ε4 carriers showing similar cost to their ε3 
counterparts. Following the inclusion of a WM load, a cost of carrying a focal PM intention was 
observed irrespective of age or genotype, hence, increasing the cognitive load of ongoing 
activities may promote a shift in the strategy necessary to maintain multiple demands. The 
reduction in non-focal prospective interference cost observed in mid-age ε4 carriers under WM 
load did not negatively impact PM retrieval in this group. The WM load condition, however, 
was always completed second to the no load condition, hence, the absence of mid-age ε4 effects 
may represent a practice effect.  
 
Subjective measures of task load were included in an attempt to interrogate group differences in 
perceived demand and motivation. Consistent with an age-related decline in executive attention, 
mid-age adults reported greater mental demand than young adults. In both age groups, however, 
ε4 carriers reported greater mental demand selectively for the no load condition. This may 
reflect greater focus on maintaining the PM intention, which may disappear when resources are 
stretched across two concurrent ongoing demands. Given the WM load task was always 
completed in the second half of the session, however, reduced ratings of mental demand may be 
a product of having plenty of experience completing the ongoing task. Mid-age ε4 carriers did 
not demonstrate the same reduction in task effort under WM load as the other groups, perhaps 
indicating they are working harder to maintain performance.  
 
Finally, the absence of age-effects on PM retrieval accuracy is consistent with a previous study 
reporting comparable levels of PM accuracy in older (M=66.3 years), and mid-age (M=42.5 
years) adults compared to young adults on an event-based PM task (Einstein et al., 1995, 
Experiment 3). The current study builds on these findings by including ongoing task 
interference as an additional metric, suggesting that early age-related change in PM 
performance manifests as cost. A second conclusion of the earlier paper (Einstein et al., 1995) is 
that age-associated change in PM retrieval accuracy depends on the degree of self-initiation 
required. Increasing the level of self-initiation required could be an interesting manipulation for 
future research exploring APOE genotype effects on PM.  
 
One limitation of the current study is that the WM load embedded in the ongoing task may not 
have placed great enough demand on the central executive component of WM (see e.g., WM 
load effects on PM in young adults with a demanding central executive task; McDaniel & 
Scullin, 2010). Bisiacchi and colleagues (2013) included an additional WM load or an 
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additional monitoring load in the ongoing component of a PM task and found age-related 
declines in PM were selectively increased by the WM load (1-back, listening span), not the 
monitoring component. It is possible the load task included here did not place enough demand 
on manipulating information within attention. Finally, the sample size in each genotype group 
was relatively small.  
 
6.6. Conclusions 
 
Mid-age individuals carrying at least one copy of the APOE ε4 genetic variant, and hence at 
heightened risk of poor cognitive ageing, showed greater costs of maintaining a concurrent PM 
intention relative to their young adult counterparts. They did not, however, show select 
impairment in PM retrieval accuracy by mid-adulthood. This mid-age deficit in cost of carrying 
a PM intention was observed for both focal and non-focal PM cues, and selectively 
disadvantaged ongoing performance of ε4 carriers. This profile of impairment is consistent with 
the pattern of performance observed in individuals diagnosed with mild AD, and hence may 
represent early compromise to both MTL and frontal-based neural systems in carriers of this ‘at-
risk’ allele. In conclusion, this research confirms subtle differences in the early ageing trajectory 
of ε4 carriers, perhaps indicative of a vulnerability consistent with the preclinical stages of AD. 
Further research is needed to interrogate the mechanisms of early change in ε4 carriers, focusing 
on the vulnerability of neural systems to change across the lifespan, and the effect of strategies 
on PM task performance.  
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7. Article 6- 
 
 
Non-Focal Prospective Memory and Everyday 
Cognition in the Early Stages of Cognitive Decline 
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7.1. Abstract 
 
Background: Non-focal prospective memory (PM) provides a proxy measure of attentional 
control in everyday life. Support for non-focal PM deficits in the early stages of cognitive 
impairment is mixed; in part this may stem from the heterogeneity of PM paradigms used. This 
study will explore if a card-sort measure of non-focal PM is sensitive to behavioural differences 
in individuals self-referring to a memory assessment service (MAS), and if performance 
correlates with cognitive errors in everyday life. Furthermore, the moderation of performance 
differences by genetic risk for late-life dementia is considered.  
Methods: Forty-eight volunteers, recruited within nine months of their initial MAS 
appointment (35 mild cognitive impairment (MCI), 13 subjective cognitive dysfunction (SCD): 
hereafter referred to collectively as the ‘MAS’ group), and 52 healthy older adults completed 
the card-sort PM task. In addition, subjective ratings of cognitive errors in daily life and APOE 
genotype were considered as potential factors in performance differences.  
Results: The MAS group showed poorer baseline card-sorting performance, as indexed by RT 
and accuracy; however, PM retrieval and PM cost did not distinguish individuals in the early 
stages of decline from their cognitively healthy peers. PM accuracy marginally correlated with 
ratings of attentional control in daily life, however, there was no association between PM cost 
and cognitive errors in everyday life. APOE ε4 genotype did not significantly impact PM 
performance or subjective complaints. 
Discussion: Individuals in the early stages of cognitive decline showed comparable non-focal 
PM to a healthy older group, with no additional impairment shown beyond the typical profile of 
age-related decline. PM accuracy correlated with attentional control problems in everyday life, 
and hence this ability may be a good target for everyday interventions.  
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7.2. Introduction 
 
With the proportion of adults aged 65 years and older in the population increasing, cases of 
Alzheimer’s disease (AD) are expected to rise 35% by 2025 (Office for National Statistics, 
2012; Prince, 2015). Age-associated cognitive decline significantly impacts everyday 
independence in older adulthood (Salthouse, 2012). Despite episodic memory loss being the 
hallmark of cognitive ageing (e.g. Caselli et al., 2014; Chen et al., 2001; for a review see 
Mortamais et al., 2016), reported errors in ‘self-initiated’ prospective memory (PM) are 
prevalent both in healthy older adults and individuals with AD (Smith, Del Sala, Logie, & 
Maylor, 2000). Defined as the retrieval of an earlier formed intention at the appropriate time 
whilst engaged in ongoing cognitive activity, there are numerous examples of PM in the context 
of everyday life. Examples include medication adherence and remembering to attend 
appointments, hence this ability is suggested to be particularly relevant for maintaining 
independence in later life (Kliegel et al., 2016; McDaniel et al., 2008).  
 
This study considers if PM is a sensitive marker of individuals at heightened risk of converting 
to AD, including individuals with mild cognitive impairment (MCI) or subjective cognitive 
dysfunction (SCD) (Buckley et al., 2016; Hu et al., 2017; Mendonça, Alves, & Bugalho, 2016). 
MCI is characterised by marked impairment in one or more cognitive domains, however, the 
profile of cognitive deficits varies between individuals (Chertkow et al., 2007; Mariani, 
Monastero, & Mecocci, 2007a). The behavioural phenotype of SCD is less well characterised, 
and here refers to individuals who self-referred for a memory assessment and were not 
classified by the clinician to have MCI. Understanding the profile of cognition in these 
‘preclinical’ stages is an important target for furthering both the timely identification of 
individuals at greater risk and early intervention strategies (Sperling et al., 2011).  
 
7.2.1. Prospective memory in MCI and SCD 
 
Existing reviews indicate PM performance is impaired in individuals with MCI compared to 
healthy age-matched peers (Costa et al., 2011; van den Berg, Kant, & Postma, 2012), however 
there are inconsistencies in reported effects, in part stemming from variation between PM 
paradigms. The presence of PM impairment in MCI is suggested to depend on the cognitive 
demand of the task. In existent literature, typically a distinction is made between two types of 
PM retrieval, with the attentional requirements varying according to the focality of the PM 
retrieval cue (McDaniel et al., 2015; Scullin, McDaniel, & Shelton, 2013).  Focality is defined 
by the relationship of the PM cue to the ongoing task.  Non-focal cues are not processed as part 
of the ongoing task and hence attentional control is required for the active maintenance and 
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monitoring of the PM intention (Einstein et al., 2005; McDaniel et al., 2015; Scullin, McDaniel, 
Shelton, et al., 2010). Focal cues, in contrast, are salient to the processing of the ongoing task, 
and hence facilitate PM retrieval through relatively automatic, associative memory processes 
(McDaniel et al., 2015). 
 
Individuals with MCI demonstrate worse accuracy of non-focal PM retrieval compared to age-
matched healthy peers, despite equivalent ratings of subjective effort (Tam & Schmitter-
Edgecombe, 2013). In the context of a verbal working memory (WM) ongoing task, participants 
were instructed to carry out the PM intention when a stimulus was presented on the target 
background, requiring a large monitoring component. PM retrieval accuracy correlated with 
subjective reports of everyday memory failings in healthy older adults but not in individuals 
diagnosed with MCI. A further study directly manipulated the attentional demand of PM 
retrieval by varying the salience and specificity of cues on a ‘Silly sentences’ paradigm, 
requiring participants to make speeded judgements on the coherence of sentences (Blanco-
Campal et al., 2009). Retrieval of non-specific, non-salient (i.e. non-focal) cues was a better 
discriminator of MCI than both retrospective memory measures and focal PM retrieval.  
 
Several studies, however, report intact non-focal PM retrieval in MCI and in the very earliest 
stages of AD (McDaniel, Shelton, Breneiser, Moynan, & Balota, 2011; Niedźwieńska, 
Kvavilshvili, Ashaye, & Neckar, 2017). Alongside the same ongoing tasks (a category decision, 
and face-profession matching task respectively), focal PM retrieval was impaired in clinical 
groups compared to healthy older peers. This led to the suggestion that whilst non-focal PM is 
sensitive to typical age-related decline (e.g. Henry, MacLeod, Phillips, & Crawford, 2004; 
Kliegel, Jäger, & Phillips, 2008; Uttl, 2008), additional impairment in focal PM is a sensitive 
marker of early pathological cognitive decline. Further supporting this, Chi et al., (2014) found 
significant impairment in focal PM in an MCI group, but not in individuals experiencing SCD 
using the same paradigm as McDaniel et al., (2011). Non-focal PM impairment was found in 
individuals with MCI without marked memory impairment (naMCI), but not in individuals with 
amnestic MCI (aMCI) or SCD. On a ‘Supermarket shop’ experimental paradigm, individuals 
with SCD have also been reported to show intact focal and non-focal PM (Lee, Ong, Pike, & 
Kinsella, 2017). This supports the use of PM as a discriminator of the profile of early cognitive 
decline.  
 
Methodological discrepancies may underpin inconsistent reports of differential non-focal PM 
performance in the early stages of cognitive decline. Firstly, several studies consider PM 
retrieval accuracy in isolation as a measure of how well individuals are able to maintain a 
prospective intention (e.g. Lee et al, 2017; Tam & Schmitter-Edgecombe, 2013). Prospective 
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interference or cost to ongoing performance is suggested to index the allocation of attention 
control for the active maintenance and monitoring of non-focal PM intentions (Marsh et al., 
2003). Limited studies have considered this as a marker of PM performance in preclinical 
populations (McDaniel et al., 2011; Chi et al, 2014); however, less efficient attentional control 
may manifest in increased cost in preclinical groups. Furthermore, as PM targets are rare, there 
may be reduced sensitivity to detect performance differences (Costa et al., 2011; Uttl, 2008). A 
further issue concerns the suitability of computerised experimental paradigms for use in elderly 
populations. Many paradigms employ ongoing tasks removed from everyday life, for example 
lexical decision tasks. On more naturalistic measures of PM (i.e. when given a PM instruction to 
pass on a message at the appropriate moment), deficits in MCI and SCD individuals have been 
reported (Lee et al., 2017; Rabin et al., 2014).  
 
7.2.2. Current aims and hypothesis 
 
The current study explores if non-focal PM, a proxy measure for the everday application of 
attentional control, is sensitive to performance deficits in the earliest stages of cognitive 
impairment using a simple computerised card-sort measure of PM (Rusted, Sawyer, Jones, 
Trawley, & Marchant, 2009). In this paradigm, individuals are first asked to complete a baseline 
measure of the ongoing task: a speeded measure of card sorting according to suit. Following this 
they are provided with a non-focal PM instruction, asking them to make an additional response 
when they see a specific target card.  
 
The decision to focus on non-focal PM in the present study is supported by reports that 
executive attention is consistently affected in the earliest preclinical stages of AD (Elias et al., 
2000; Rajan, Wilson, Weuve, Barnes, & Evans, 2015; Twamley et al., 2006). Furthermore, this 
paradigm has been developed and used previously with older adults with memory impairment 
(Farina, Young, Tabet, & Rusted, 2013) and addresses some of the existing methodological 
concerns that may contribute to inconsistency in the literature. As participants complete a 
baseline sort task, the task provides a measure of both PM retrieval accuracy (of which there are 
12 possible targets) and PM cost, maximising sensitivity. Furthermore, the use of playing card 
stimuli provides a computerized version of a real-life scenario, maximising the ease in which 
participants can process the rules of both the ongoing and PM instructions. This further supports 
the suitability of using this task with an older population.  
 
The study recruits volunteers within nine months of their initial referral visit to a memory 
assessment clinic (MAS), including individuals experiencing the early stages of cognitive 
decline (MCI or SCD), in addition to a healthy control group. The MAS group are expected to 
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show marked impairment on the card-sort task, which may manifest as either reduced PM 
retrieval accuracy or increased cost of carrying a PM intention on ongoing sort performance. 
This aligns with previous reports of disadvantages in this group (Blanco-Campal et al., 2009; 
Costa et al., 2011; Tam & Schmitter-Edgecombe, 2013).  
 
An additional aim of the current study is to explore whether Apolipoprotein E (APOE) genotype 
moderates non-focal PM performance on the card-sort task in this preclinical population. The 
APOE ε4 allele is the greatest risk factor for late-onset AD, as well as being associated with 
poorer cognition in healthy older adults (Corder et al., 1993; Farrer et al., 1997; Wisdom, 
Callahan, & Hawkins, 2011). Furthermore, carrying a copy of this allele is associated with 
greater impairment in MCI and increased risk of progression to AD (Albert et al., 2014; 
Whitehair et al., 2010). The card-sort paradigm demonstrates sensitivity to genetic risk from 
mid-adulthood (Evans et al., 2014; Lancaster, Tabet, & Rusted, 2016). Whilst disadvantages on 
the card-sort task have been seen as reduced PM retrieval accuracy (Lancaster et al., 2016), on a 
category decision PM task ε4 disadvantages manifest as increased PM cost (Lancaster, 
McDaniel, Tabet & Rusted, in prep). Given the pattern of performance in ε4 carriers on the 
card-sort task in mid-adulthood, the presence of the ε4 allele in the MAS group is expected to 
exaggerate performance disadvantages on the card-sort paradigm, indexed by either PM 
retrieval or cost.  
 
Attentional control is necessary for activities of daily living, both in healthy and pathological 
ageing (Marshall et al., 2011); hence this research explores how performance in non-focal PM 
relates to reports of everyday cognition. Previous research reports PM is directly associated with 
everyday cognition in MCI (Schmitter-Edgecombe, Woo, & Greeley, 2009; Woods, Weinborn, 
Velnoweth, Rooney, & Bucks, 2012). As part of a preliminary phase, the current study collects 
subjective ratings of general cognitive functioning (the Cognitive Failures Questionnaire (CFq) 
(Broadbent et al., 1982)), and attentional control more specifically (the Attentional Control scale 
(ACs) (Derryberry & Reed, 2002)). Intuitively, individuals visiting the MAS are expected to 
report greater subjective problems with cognition in everyday life. As non-focal PM is 
supported by frontally-based executive resources (Cona et al., 2016; McDaniel et al., 2013), 
attentional control is expected to correlate with card-sort performance. In addition, due to the 
relevance of PM to everyday contexts, PM may correlate with errors more generally. 
 
7.3. Methods 
 
 
7.3.1. Participants 
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7.3.1.1. Preliminary questionnaire phase 
 
87 MAS-users (59 MCI, 28 SCD) completed subjective ratings of cognition in everyday life. 
This ‘preclinical group’ was recruited following appointments with a memory clinician at the 
Sussex Partnership NHS Foundation Trust, or via advertisement on the Join Dementia Research 
database (restricted to Sussex-based volunteers). In addition, the partners or spouses of the 
MAS-users were asked to participate as healthy controls (n=55), given they reported no prior 
history of cognitive complaints.   
 
7.3.1.2. Behavioural phase 
 
All volunteers completing the questionnaire were invited to participate in the behavioural 
session. 48 MAS-users (35 MCI, 13 SCD) participated alongside 52 controls. Due to the smaller 
number of healthy older controls in the initial questionnaire sample, an additional subset of 
healthy older adults were recruited to participate via advertisement at local University of the 
Third Age groups (n=25), alongside 27 of the healthy partners/spouses from the questionnaire 
phase. 
 
7.3.1.3. Inclusion criteria 
 
All volunteers were required to be aged 55 years or older, and speaking English as their daily 
language. In addition, volunteers were asked to report if they had any history of head injury or 
trauma, treatment for depression or treatment for hypertension within the past 5 years, however, 
these were not used as criteria for exclusion. 
 
In addition, the preclinical group was required to complete the study within 9 months of their 
initial MAS appointment, in which they received a diagnosis of MCI or no diagnosis but 
reported SCD. The criteria for a diagnosis of MCI was based on recommendations from the 
National Institute on Ageing and Alzheimer’s Association (Albert et al., 2011) including: 
subjective concerns regarding change in cognition, impairment in one or more cognitive 
domains, preservation of independence, and not meeting the criteria for a dementia diagnosis. 
There was no threshold for those classed as SCD, however neuropsychological test results were 
available for 23/28 SCD volunteers. 10  
 																																																								10	The mini-mental state examination was the most common neuropsychological test 
administered, with scores in the range of 25-30. 	
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7.3.1.4. APOE genotyping  
 
Volunteers completing the behavioural phase were genotyped for APOE status following 
Human Tissue Authority guidelines, with all procedures approved by Health Research 
Authority NHS ethics and the Research Ethics Committee of the School of Psychology and Life 
Sciences, University of Sussex. Volunteers first provided written informed consent, including 
acknowledgement that the results of the genotype analysis would not be made available to them. 
DNA was collected with a buccal swab, using an Isohelix SK1 kit. A triangulated 
anonymisation procedure was used for each sample, with the researcher remaining blind to 
genotype throughout. Samples were analysed by LGC Genomics (Hertfordshire, 
www.lgcgroup.com/genomics). APOE genotype was determined using fluorescence-based 
competitive allele-specific polymerase chain reactions to determine the presence of ε2, ε3, and 
ε4 alleles based on two single nucleotide polymorphisms (rs429358, rs7412).  The distribution 
of genotypes for the MAS patient group was as follows: 4 ε2 carriers (ε2/ε3), 24 homozygote ε3 
carriers, 20 ε4 carriers (1 ε2/ε4, 15 ε3/ε4, 4 ε4/ε4).  In the control group there were 6 ε2 carriers 
(1 ε2/ε2, 5 ε2/ε3), 33 homozygotes ε3 carriers and 13 ε4’s (1 ε2/ε3, 11 ε3/ε4, 1 ε4/ε4). Ε2 
carriers were excluded prior to analysis.  
 
 7.3.2. Materials 
 
Demographic information, including age and years of education was collected using a short 
questionnaire. For individuals completing the behavioural session, the National Adult Level 
Reading test (NART) (Nelson & Willison, 1991) was used to provide an estimate of premorbid 
IQ. In addition, the Cognitive Reserve Index quotient (CRIq) (Nucci, Mapelli & Mondini, 
2011), a 20-item questionnaire assessing education, occupational background and adult leisure 
activities, was administered orally as an index of cognitive engagement across adulthood.   
 
7.3.2.1. Questionnaires: Everyday cognition 
 
The CFq (Broadbent et al., 1982) asks volunteers to rate how often they make 25 common 
‘cognitive failures’, on a scale from ‘Never’ (0) to ‘Very often’ (5). Cognitive failures are 
premised to represent 4 subscales: memory, distractibility, naming and blunders (Wallace, Kass, 
& Stanny, 2002). The ACs (Derryberry & Reed, 2002) consists of 20 items targeting 3 
processes; mind wandering, susceptibility to boredom and distractibility. Previous exploratory 
factor analysis suggests questions cluster into two components; attentional focusing and shifting 
(Judah, Grant, Mills, & Lechner, 2014). Scores for each question were based on a 4-point Likert 
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Scale from ‘Almost never’ (1) to ‘Always’ (4). For both the CFq and ACs responses were 
scored so that higher values represent worse subjective cognition.  
 
7.3.2.2. Card-sort PM task 
 
The card-sort task (Rusted et al., 2009) presents participants with a sequence of playing card 
stimuli, displayed in a pseudorandom order. Each trial consists of a card back, presented for a 
variable duration (100-150ms), followed by a card face displayed for 1000ms. The ongoing task 
requires participants to respond to each card according to suit, making a ‘1’ keyboard response 
for a ‘spade’ and a ‘3’ keyboard response for a ‘heart’, as quickly and as accurately as possible. 
For cards belonging to ‘spades’ or ‘diamonds’, participants are required to provide no response.  
 
Participants initially complete one deck (52 cards: 26 sort trials; 26 non-sort trials) of the 
ongoing task (the control deck) to provide a baseline measure of decision-making performance. 
Participants are then provided with an additional PM instruction to make an alternative 
keyboard response (‘space’) each time they see the target card, which is any card with the 
number ‘7’. To ensure the PM instruction has been correctly interpreted, volunteers are required 
to repeat the instructions back to the experimenter in their own words. Following this there is a 
2-minute interval, before participants sort a further 3 decks of cards, containing 72 sort trials, 72 
non-sort trials and 12 PM trials. At the end of the task participants are requested to summarise 
the task instructions, ensuring that they remembered the additional PM instruction.  
 
Sort accuracy and RT are recorded for the control deck and the 3 decks following the 
introduction of the PM intention. For each participant, individual sort RTs were screened for 
outliers, defined as those more than 3 standard deviation (SD) away from the participant’s 
mean. In addition, accuracy of PM retrieval is also recorded. 
 
7.3.2.3. NASA task load index  
 
Perceived workload is measured for the control and PM decks of the card-sort PM task using a 
pen-and-paper version of the NASA task load index. This consists of 6 visual analogue scales 
measuring: mental demand, physical demand, temporal demand, performance, effort, and 
frustration. Participants are instructed to mark along the scale to rate how they experienced each 
section (baseline deck, PM decks of the card-sort task). Greater values represent increased 
ratings.  
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7.3.3. Procedure 
 
For the initial questionnaire phase, volunteers were asked to complete a demographic 
questionnaire and the two questionnaires of cognition in everyday life (the CFq, the ACs) in 
their own time and return them to the experimenter by post.  
 
For volunteers accepting the invitation to complete the behavioural session, individuals were 
first asked to complete the NART before beginning the card-sort PM task. Following 
completing the control sort-deck and receiving the PM instruction, there was a two-minute 
interval where volunteers were orally asked questions from the CRIq, prior to resuming the task. 
Any remaining questions from the CRIq were asked following completion of the card-sort PM 
task. Measures of task load were completed following the initial control card-sort deck (time 
point 1), and again following the three PM decks (time point 2). Finally participants were asked 
to provide a buccal swab for APOE genotype analysis. The session lasted a maximum of 60 
minutes.  	
7.3.4. Design 
 
Prior to analysis, data from nine individuals was excluded, as they were aged 54 years or 
younger (Questionnaire phase n=7; Behavioural phase n=2). Adults recruited from the MAS 
clinic, including both individuals diagnosed with MCI and experiencing SCD, were collectively 
analysed in comparison with a healthy older-adult group. For all genotype comparisons, ε4 
carriers (ε2/ε4, ε3/ε4, ε4/ε4) were compared to a homozygous ε3 group (the population norm). 
Group differences in demographic characteristics were screened prior to analysis using either a 
between-groups t-test for continuous variables, or a χ2 test for categorical variables.  
 
7.3.4.1. Card-sort PM task  
 
Prior to analysis, mean sort RTs and accuracy were screened for outliers based on the overall 
sample. Group differences in baseline card-sort performance (mean RT, accuracy) was analysed 
using a 2 (Group: MAS, healthy) x 2 (Genotype: ε3, ε4) ANOVA, with age and years of 
education included as covariates. 
 
For analysis of subsequent PM performance, data from individuals unable to recall the PM 
instruction were excluded (n=6). Accuracy of PM retrieval (/12) was analysed using a 2 (Group: 
MAS, healthy) x 2 (Genotype: ε3, ε4) ANOVA.  
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To establish if introducing a PM intention led to significant interference for ongoing sort 
performance, separate paired t-tests were used to compare card-sort RT and accuracy on the 
control deck and for each of the 3 subsequent PM decks (Bonferroni-corrected α=.017). 
Interference was probed further, where significant, using a single measure of cost for each deck 
(the difference between baseline sort performance and sort performance with the additional PM 
instruction). Separate ANOVAS with Deck as a within-subjects factor, Group and Genotype as 
between-subjects factors were completed for cost to sort RT and accuracy. Again, age and years 
of education were included as covariates.	11 
 
7.3.4.2. NASA task-load 
 
The impact of introducing a PM intention on the six indices of task load was analysed using 
repeated-measures t-tests comparing ratings of the baseline and PM condition (Bonferonni 
corrected α=.008). To screen for group differences in physical ability to complete the card-sort 
measure, 2 x 2 x 2 mixed ANOVA was completed with Group (MAS, healthy), Genotype (ε3, 
ε4) as the between-subjects factors and Condition (baseline, PM) as the repeated measures 
factor. In addition, group differences in perceived mental demand and effort were analysed 
(Group x Genotype x Condition mixed ANOVAs).  
 
7.3.4.3 Questionnaires: Cognitive errors in daily life 
 
Prior to analysis, responses to both the CFq and the ACs were screened for missing data. For 
participants with up to four blank responses per questionnaire, missing responses were 
estimated as the average score for that participant in order to ensure comparable scores. 
Questionnaire data for participants with over four missing responses were removed (CFq n=1; 
ACs n=1).   
 
																																																								11	To assess the profile of age-related change in performance on the card-sort paradigm, PM 
retrieval accuracy (/8) and PM cost was compared for the first 2 PM decks in the current study, 
with existing data from a mid-age sample (45-55 years) (Lancaster et al., 2016). Both measures 
of performance were compared in separate one-way ANOVAs comparing mid-age, healthy 
older-adults and MAS-users. PM retrieval accuracy was significantly higher in mid-age adults 
(M=7.03, SE=.27) compared to healthy older adults (p<.001) (M=5.20, SE=.32) and MAS users 
(p<.001)(M=4.75, SE=..31), F(2, 126)=18.21, p<.001, n2p=.224. Healthy older adults and MAS 
users did not significantly differ (p=.312). There was no significant difference in PM cost 
(p>.05).   	
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The total score on each questionnaire was compared between-groups (MAS, healthy) using a 
between-groups t-test. In addition, scores on the individual factors of each questionnaire were 
compared (CFq: Memory, Distractibility, Blunders, Naming (Wallace et al., 2002); ACs: 
Focusing, Shifting (Judah et al, 2013)), using Bonferonni-corrected t-tests (CFq α=.010, ACs 
α=.017).  Furthermore, for the preclinical group with known genotype, a 2 (Group: MAS, 
healthy) x 2 (Genotype: ε3, ε4) between-subjects ANOVA was run. Genotype differences in the 
control group were not analysed due to a small sample size (ε3 n=16, ε4 n=3).  
 
Pearson’s correlation coefficients were calculated between total scores on the CFq and ACs and 
measures of PM accuracy and interference.  
 
7.4. Results 
 
7.4.1. Demographics 
 
7.4.1.1. Preliminary questionnaire phase 
 
Demographic measures for the questionnaire phase are shown in Table 7.1. Between groups, the 
distribution of gender was not equivalent, with a higher proportion of males in the MAS group 
than the healthy group, χ2 (135)=7.21, p=.007. All other group differences were non-significant.  
 
Table 7.1. The demographic characteristics of volunteers completing the questionnaire phase 
shown according to group 
 
  Controls MAS 
  
  n 48 86 
Age 72.65 (7.67) 75.44 (8.89) 
Gender (% M) 33* 57* 
Education (years) 13.74 (3.30) 13.46 (3.60) 
Smokers (n) 0 4 
Hypertensive (%) 17 25 
* p <.05     
 
7.4.1.2. Behavioural phase 
 
Table 7.2 shows the demographic characteristics of volunteers completing the behavioural 
phase. The healthy group had significantly more years of education than the MAS group, F(1, 
85)=4.35, p=.040, n2p=.049, however, there was no significant difference in years of education 
between genotype groups (p>.05). No other group differences were significant (p>.05). 
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Table 7.2. Demographic characteristics of volunteers participating in the behavioural phase, 
shown according to group and APOE genotype 
 
Controls MAS 
  ε3 ε4 ε3 ε4 
n 33 12 24 20 
Age 71.49 (6.86) 71.15 (11.42) 73.88 (17.62) 71.25 (18.81) 
Gender (% M) 63 40 30 31 
IQ 117.97 (3.56) 117.37 (8.26) 118.96 (6.19) 118.84 (2.48) 
Education* 15.82 (4.60) 15.46 (5.19) 13.38 (4.30) 13.63 (4.37) 
CRq  135.30 (20.85) 129.39 (21.36) 130.58 (20.19) 129.40 (19.78) 
* p <.05 
 
7.4.2. Card-sort PM task 
 
For a summary of performance on this task by each group, see Table 7.3.  
 
7.4.2.1. Baseline decision-making 
 
MAS users (M=758.27ms, SD=177.20ms) were significantly slower to perform the card-sort in 
comparison to the healthy older adults, (M=625.63ms, SD=115.92ms), F(1, 82)=12.54, p=.001, 
n2p=.133. Age accounted for significant variance in sort RTs, F(1, 82)=5.92, p=.017, n2p=.067, 
with larger RTs recorded with increasing age (B=3.23).  The effects of genotype, year of 
education and all interaction terms were non-significant (p>.05).  
 
Across participants, accuracy on the baseline card-sort measure ranged from 56% to 100%.  
MAS users (M=90.83, SD=11.82) made significantly more errors than healthy older adults 
(M=96.51, SD=4.69), F(1, 79)=5.95, p=.017, n2p=.070. The effect of genotype, age, years of 
education and all interaction terms were non-significant (p>.05).  
 
7.4.2.2. PM retrieval accuracy 
 
There was no difference in PM retrieval accuracy (/12) between MAS users and healthy older 
adults (p>.05). The effect of genotype was also non-significant, as was the Group x Genotype 
interaction (p>.05). Age did not account for significant variation in PM retrieval accuracy, 
however, years of education was associated with increasing PM retrieval accuracy, F(1, 
78)=5.14, p=.026, n2p=.062, B=.181.  
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7.4.2.3. PM interference 	
Compared to the baseline deck, introducing the PM intention was associated with a significant 
slowing of card-sort RTs on all 3 subsequent decks (p<.001). Cost to sort RTs did not 
significantly change across decks (p>.05). There was no significant difference according to 
Group or Genotype (p>.05). In addition, age and years of education did not account for 
significant variation, and there were no significant interactions (p>.05).  
 
Carrying the PM intention was only associated with a significant cost in sort accuracy for the 
first deck following the introduction of the additional PM intention, t(81)=3.15, p=.002. The 
cost for the subsequent 2 decks was non-significant (p>.05). Cost to sort accuracy for this initial 
PM deck did not differ by Group or Genotype, and the Group x Genotype interaction term was 
also non-significant (p>.05). In addition, age and years of education did not account for 
significant variation (p>.05). 
 
7.4.2.5. Task-load ratings 
 
Subjective ratings of task load are shown in Table 7.4. Across participants, introducing the PM 
intention increased subjective ratings across 5 measures of task load (Mental demand: F(1, 
80)=66.67, p<.001, n2p=.455, Temporal demand: F(1, 80)=56.93, p<.001, n2p=.416, Physical 
demand: F(1, 80)=40.60, p<.001, n2p=.342, Effort: F(1, 80)=67.88, p<.001, n2p=.459, 
Frustration: F(1, 80)=21.28, p<.001, n2p=.210). In addition, perceived performance was lower 
in the PM condition, F(1, 80)=41.611, p<.001, n2p=.342.  
 
The group difference in perceived physical demand of the card-sort task was non-significant 
(p>.05), as were differences in subjective mental demand (p>.05). There was a marginal Group 
x Genotype interaction for perceived effort, F(1, 80)=3.70, p=.058, n2p=.044. In the healthy 
older group, ε4s reported significantly greater effort than the ε3 group (p=.012), but there was 
no genotype difference in MAS-users (p=.815). Split by genotype, there was no difference 
between groups (MAS, healthy older adults in perceived effort (p>.013) (Bonferonni corrected 
α=.013).  
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Table 7.3. Group differences on the card-sort task shown for the baseline condition, and as an 
average across the 3 PM decks.  
Group 
 
Baseline Deck PM decks  
RT (ms)  Accuracy (%) RT (ms)  Accuracy (%) 
PM 
retrieval/
12 
RT cost 
(ms) 
Controls 
ε3 636 (115) 96.84 (5.04) 721 (112) 95.81 (4.40) 8.97 129 (58) 
ε4 600 (119) 95.69 (3.72)  670 (115) 94.33 (3.73) 7.69 109 (84) 
MAS 
ε3 784 (178) 93.77 (8.98) 859 (179) 90.27 (11.61) 7.14 113 (97) 
ε4 727 (175) 89.10 (12.52) 791 (167) 85.44 (14.96)  8.18 126 (65) 
 
 
Table 7.4. Subjective ratings of task-load following the control card-sort deck (Time point 1) 
and the PM decks (Time point 2), shown as mean (SD) 
  
Controls MAS 
  Time point  ε3 ε4 ε3 ε4 
Mental demand 1 3.12 (2.44) 4.96 (2.49) 4.84 (2.36) 4.14 (3.42) 
 
2 6.43 (2.64) 6.51 (2.54) 6.62 (2.77) 5.88 (2.65) 
Physical demand 1 1.78 (2.38) 3.62 (2.41) 2.83 (2.20) 2.36 (2.85) 
 
2 3.76 (3.03) 6.32 (2.10) 4.20 (2.76) 3.77 (2.66) 
Temporal demand 1 4.48 (2.82) 5.66 (2.20) 5.01 (2.86) 4.97 (3.06) 
 
2 5.99 (2.79) 7.26 (2.24) 7.01 (2.12) 6.47 (2.22) 
Effort 1 3.82 (2.54) 5.74 (2.45) 5.28 (2.59) 4.79 (2.64) 
 
2 6.04 (2.70) 7.69 (1.89) 6.94 (2.07) 7.09 (2.03) 
Performance  1 7.44 (2.36) 6.52 (2.46) 6.16 (2.81) 3.93 (3.61) 
 
2 4.86 (2.33) 4.94 (2.45) 3.66 (2.93) 3.55 (2.63) 
Frustration 1 2.86 (2.86) 4.57 (2.98) 3.10 (2.41) 4.01 (3.47) 
  2 4.65 (3.03) 6.08 (2.11) 5.04 (2.50) 5.94 (3.09) 
 
 
7.4.3. Questionnaires: Cognitive errors in daily life 
 
Average scores on both questionnaires of cognition in everyday life (the CFq, the ACs) are 
summarised by group in Table 7.5. The MAS group (M=50.27, SD=14.13) reported a 
significantly higher numbers of cognitive failures in daily life than healthy older adults 
(M=34.33, SD=11.85), F(1, 124)=36.55, p<.001, η2ρ =.233.	Age and years of education did not 
account for significant variance in scores (p>.05). This difference was consistent across each of 
the four factors (memory, distractibility, blunders, naming) (p<.001). In the MAS group, ε4 
carriers (M=48.93, SD=15.88) did not significantly differ in total CFq compared to homozygous 
ε3 carriers (M=49.10, SD=12.50) (p>.010). In addition, the genotype difference was non-
significant across all four individual factors (p>.010).  
 
In addition, the MAS group reported significantly worse attentional control in daily life than the 
control group, F(1, 119)=29.26, p<.001, η2ρ =.197, indexed using the ACs. Age did not account 
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for significant variance in scores (p>.05), however, there was a marginal effect of education 
(β=-.40, p=.055). The effect of group was consistent across questions targeting attentional focus 
(p<.001) and shifting (p=.006). Education did not account for significant variance when 
considering these individual factors (p>.05). In the MAS group, ε3 carriers (M=49.07, 
SD=5.75) reported significantly worse attentional control than ε4 carriers (M=42.93, SD=9.24), 
t(41)=7.04, p=.011, η2ρ =.153. Following correction for multiple comparisons, when 
interrogating this difference for individual factors, the genotype difference in MAS users was 
marginal for both attentional focusing, t(41)=4.85, p=.034, η2ρ =.111, and shifting, t(41)=3.32, 
p=.076, η2ρ =.078. 
 
The correlation between ACs score and PM retrieval accuracy approached significance, r(73)=-
.211, p=.074, however, the relationship between CFq and PM retrieval was non-significant 
(p=.215). In addition, PM interference on ongoing task performance did not significantly 
correlate with subjective scores on either questionnaire (p>.05).  
 
Table 7.5. Subjective ratings of cognition in everyday life shown by group (control, preclinical) 
and genotype (ε3, ε4) 
 
Control MAS 
  
 
  ε3 ε4 
CFq 34.96 (11.96) 50.27 (14.13) 49.10 (12.50) 48.93 (15.88) 
Acs 39.79 (6.85) 47.87 (8.24) 49.07 (5.75) 42.93 (9.24) 
 
 
7.5. Discussion 
 
The present study addressed the following research questions: 1) is performance on a card-sort 
measure of non-focal PM impaired in individuals self-referring to memory assessment clinics 
with mild cognitive complaints? 2) Does non-focal PM correlate with subjective reports of 
everyday cognitive impairment? 3) Does carrying the APOE ε4 allele further moderate 
differences in executive control?  
 
The current findings suggest non-focal PM performance is intact in individuals in the early 
stages of cognitive decline; both PM retrieval and PM interference costs were equivalent 
compared to cognitively healthy older adults. The MAS group, however, demonstrated poorer 
performance (both accuracy and RTs) in the baseline card-sort condition, suggestive of some 
reduction of attentional resource in this group. As expected, reports of cognitive errors in daily 
life were greater in the MAS group, with PM retrieval accuracy correlating with reports of 
poorer attentional control, but not with cognitive failures more broadly. APOE ε4 genotype did 
not moderate PM performance in either the clinical group, or healthy older controls.  
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The card-sort paradigm indexes both the accuracy of PM retrieval and the cost of carrying a PM 
intention on ongoing performance, providing a sensitive measure of attentional control in 
prospective remembering. Equivalent performance on this paradigm in individuals experiencing 
the early stages of preclinical cognitive decline is inconsistent with reports of impaired non-
focal PM in MCI (Blanco-Campal et al., 2009; Tam & Schmitter-Edgecombe, 2013), and 
deficits in executive attention more broadly (Rajan et al., 2015; Twamley et al., 2006). As the 
behavioural profile of SCD is less defined (Stewart et al, 2012), an additional analysis 
confirmed intact non-focal PM performance in individuals diagnosed with MCI as an 
independent group. The current findings align with the theory that non-focal PM is generally 
sensitive to age-related decline (for reviews see Henry et al., 2004; Kliegel et al., 2008; Uttl, 
2008), but additional impairment in focal PM differentiates individuals in the preclinical stages 
of cognitive impairment (Chi et al., 2014; McDaniel et al., 2011; Niedźwieńska et al, 2017). 
Consistent with a profile of age-related decline, an informal comparison of performance levels 
in the current sample compared to existing mid-age data (Lancaster et al., 2016), suggested PM 
retrieval accuracy was poorer in both healthy older adults and the MAS group. This is in line 
with frontal regions being impacted early in the ageing trajectory (Bartzokis et al., 2003; Raz et 
al., 2005). AD-related pathology initially impacts medial temporal regions (Braak & Braak, 
1991). Hence focal PM, reliant on associative memory processes, may be a more sensitive 
marker of a divergent trajectory of cognitive ageing.  
 
Intact non-focal PM in the early stages of cognitive decline, as indicated in this study, 
contradicts reports of impaired attentional control in both MCI and SCD on neuropsychological 
assessment measures (Amariglio et al., 2012; Crowell, Luis, Vanderploeg, Schinka, & Mullan, 
2002; Traykov et al., 2007). Executive attention comprises multiple separable processes (e.g. 
Engle & Kane, 2002; Friedman & Miyake, 2015), which likely differ in their sensitivity to 
cognitive decline. The current results suggest that goal maintenance and monitoring abilities are 
preserved in the preclinical stages of AD. Differences may emerge in PM tasks placing greater 
demand on the active manipulation of information within WM, predictive of decline in MCI 
(Belleville, Chertkow, & Gauthier, 2007). In healthy older adults, increasing the monitoring 
load of a PM task did not impact performance, however, including a WM task requiring active 
updating significantly increased age-related PM deficits (Bisiacchi et al., 2013a). Hence, non-
focal PM deficits in the early stages of cognitive impairment may emerge in tasks with more 
attentionally demanding ongoing components.  
 
Non-focal PM may be sustained in the early stages of cognitive decline through compensatory 
mechanisms. In individuals reporting SCD, equivalent episodic memory performance is 
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associated with compensation-like increases in frontal activations (Erk, 2011). Although 
compensatory recruitment has not been demonstrated during non-focal PM performance, 
individuals in the early stages of cognitive decline may be recruiting additional neural resources 
to support performance. Cognitive strategies, both external (e.g. reminders in the physical 
environment) and internal (e.g. checking behaviours), can be used to support PM performance 
in naturalistic environments (Aronov et al., 2015). The use of internal cognitive strategies is 
linked to both executive function and general intelligence (Bouazzaoui et al., 2010); as the 
current study population is relatively well-educated, perhaps individuals in the MAS group are 
able to effectively employ strategies to sustain equivalent performance. Furthermore, 
individuals were recruited within nine months of their initial referral appointment; a slightly 
more progressed group may experience a breakdown of compensatory ability.  
 
PM was expected to correlate with reports of cognitive decline in everyday functioning; 
specifically due to the demand placed on executive attention by non-focal PM, a stronger 
relationship was predicted for indices of attentional control. The correlation between PM 
retrieval and attentional control in daily life was marginal, aligning with both measures being 
supported by frontal, executive abilities. Cognitive failures more generally did not correlate 
with measures of PM retrieval or cost, contradicting previous reports that PM is central to 
everyday functioning (Schmitter-Edgecombe et al., 2009; Woods et al., 2012). Recent research 
in individuals reporting SCD found that although there was a non-significant negative 
correlation between PM retrieval and functioning in daily life, the relationship between Stroop 
and memory for temporal order, and everyday cognition was significant (McAlister & 
Schmitter-Edgecombe, 2016). Everyday cognition is likely supported by a wider constellation 
of abilities, of which attentional control is an important factor. 
 
As a secondary aim of the study, the impact of APOE genotype on non-focal PM was explored. 
Despite evidence for differential performance on the card-sort task in APOE ε4 carriers by mid-
adulthood (Evans et al., 2014; Lancaster et al., 2016), carrying an ε4 allele did not negatively 
impact PM performance in the current study. In mild AD, APOE ε4 is associated with 
disadvantages on focal PM (Duchek et al., 2006), but not non-focal PM impairment (McDaniel 
et al., 2011). In MCI, APOE ε4 has been linked to impaired declarative memory performance 
but intact executive functions (van der Vlies et al., 2007; Wolk & Dickerson, 2010). 
Corresponding to these changes, ε4 carriers demonstrate greater atrophy of MTL regions, whilst 
frontal regions are more sensitive to deterioration in ε4 non-carriers (Wolk & Dickerson, 2010). 
Hence, in preclinical populations, ε4 may primarily impact on memory processes supported by 
MTL regions. Further research is needed to establish how, or whether, APOE ε4 effects 
differentiate between healthy and pathological ageing.  Subjective indices of task effort 
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indicated healthy ε4 carriers were working harder to maintain performance. Although based on 
a small sample, it may be that ε4 carriers are showing increased compensation to maintain 
performance (Filbey, Chen, Sunderland, & Cohen, 2010; Scheller et al., 2017; Wishart et al., 
2006).  
 
 
The initial cognitive complaints reported in the MAS group were not well defined. Due to the 
heterogeneity of cognitive deficits associated with MCI, two subtypes are proposed (amnestic 
MCI (aMCI), non-amnestic MCI (naMCI))(Petersen & Morris, 2005), and these have 
previously been linked to differential profiles of PM impairment. While individuals with both 
aMCI and naMCI demonstrate focal impairment, disadvantaged interference of carrying a non-
focal PM intention has previously been reported selectively in individuals with naMCI (Costa et 
al., 2010). This could be further explored in future studies. One limitation of the current study is 
the sample size of each APOE genotype group (ε3, ε4). The study employed an opportunistic 
sample, and while group sizes for ε4 carriers and ε3 homozygotes was relatively equal for the 
preclinical group, the healthy older adults group was biased towards homozygous ε3 carriers (as 
expected) 
 
7.6 Conclusions 
 
Performance was equivalent in adults experiencing the early stages of cognitive impairment on 
a card-sort measure of non-focal PM, selected for its sensitivity and suitability for 
administration in older populations, suggesting attentional control in an everyday context is not 
impacted in the preclinical stages of AD. These results indicate non-focal PM is not impaired 
beyond the trajectory of change expected in healthy ageing; however, there are inconsistencies 
across the literature and perhaps subtle effects emerge under more taxing executive conditions. 
Focal PM may be a more sensitive marker of preclinical change, and could be a useful addition 
to clinical assessments (Lee et al., 2016). Future research should interrogate the distinction 
between focal and non-focal PM using more ecologically relevant paradigms. PM is associated 
with attentional control in daily life, supporting the development of interventions to strategically 
improve this ability as a route to maintain functional independence in older adulthood.  
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8. General Discussion 
 
Carrying a copy of the APOE ε4 variant is associated with poorer cognitive ageing, however, 
the presence of behavioural differences in early adulthood highlights the importance of 
understanding the expression of APOE effects across the lifespan. The current thesis considered 
the following research questions: 1) Does APOE genotype impact cognition in mid-adulthood? 
2) Are individual attentional control processes differentially impacted by APOE variants? Focus 
was placed on the ε4 risk variant; however, effects of the protective ε2 variant were also 
considered to understand how allelic versions of APOE differentially contribute to cognitive 
ageing. Furthermore, the thesis began to explore if additional factors in age-related decline 
influence the presence of APOE effects in early cognitive ageing.   
 
This general discussion will collectively consider the empirical results included in this thesis 
and how the provided evidence speaks to those questions. In addition, as Articles 2 and 3 
investigated the independent effects of APOE ε2 on attentional control, the effects of this allele 
are considered as they relate to the reported late-life protective effects of this allele. Following 
this, theoretical accounts of APOE ε4 and individual differences in cognitive ageing will be 
discussed in relation to attentional control. Finally, the relevance of this research to clinical 
practice and our understanding of cognitive impairment in everyday life will be considered, 
followed by a short discussion of the present work’s limitations and future directions.  
 
8.1 APOE in mid-adulthood 
 
Article 1 systematically reviewed existing reports of APOE ε4 genotype differences in healthy 
middle-aged adults, and concluded that support for a differential profile of cognition in ε4 
carriers was limited before the end of the 5th decade. Closer interrogation of individual studies, 
however, suggested ε4 differences are present by mid-adulthood when administering 
behavioural paradigms sensitive to small effects. This highlighted a key methodological concern 
with the APOE literature to-date, motivating the careful selection of sensitive cognitive 
paradigms in subsequent experiments.  
 
Results from Articles 2, 3 and 5 are consistent with the conclusions of the mid-age review 
(Article 1): ε4 differences are not consistently present in adults aged 45-55 years, however, 
subtle disadvantages are detectable on select behavioural indices. Collectively, these results 
imply that performance of ε4 carriers is relatively intact until the end of the 5th decade within 
the domain of executive attention, with some evidence for deficits apparent on individual 
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cognitive processes. Whilst existing meta-analyses of ε4 effects in young and healthy older 
adulthood support a heterogeneous profile of effects across cognitive domains (Ihle et al., 2012; 
Wisdom et al., 2011), this research suggests effects may be nuanced at the level of individual 
cognitive processes.  
 
8.1.1 APOE ε4 and attentional control 
 
This thesis considered APOE genotype effects in ‘attentional control’ or ‘executive attention’ as 
this constellation of cognitive processes, in addition to showing marked age-related decline (e.g. 
Hasher & Zacks, 1988; Milham et al., 2002; Wasylyshyn & Sliwinski, 2011), is associated with 
ε4 differences in youth (e.g. Marchant, King, Tabet, & Rusted, 2010; Rusted et al., 2013; Taylor 
et al., 2016). Furthermore, behavioural paradigms targeting attentional control report ε4 
genotype effects in mid-adulthood, but not consistently so (e.g. Evans et al., 2014; Evans et al., 
2013; Greenwood, Lambert, Sunderland, Parasuraman, 2005; Greenwood, Sunderland, Friz, & 
Parasuraman, 2000; Velichkovsky, Roschina, & Selezneva, 2015) (see Article 1).   
 
The experiments completed in this thesis report equivalent visual search performance in mid-
age ε4 carriers on both the dynamic scaling task and the perceptual load task (Article 2). These 
tasks measure selective visual attention on trials requiring the heightened processing of a target 
location whilst preventing interference from distractor items. Selective attention, or simple WM 
capacity (Awh et al., 2006; Chun, 2011a), therefore, does not appear sensitive to the 
disadvantageous effects of ε4 until later in the lifespan, when carriers are suggested to show a 
profile of accelerated ageing (Espeseth et al., 2012; Greenwood et al., 2000; Greenwood, 
Espeseth, Lin, Reinvang, & Parasuraman, 2014).  
 
Higher-order, executive attention shows a differential profile of ε4 effects in mid-adulthood 
(Article 3). The rapid visual information processing (RVIP) task (Wesnes & Warburton, 1983) 
provides a measure of sustained attentional focus and the ability to continuously update ‘online’ 
information. Previous research reports mid-age ε4 carriers are slower, but more accurate in 
detecting target strings on this task (Evans et al., 2014), however, Article 3 suggested 
performance was comparable between mid-age ε4 carriers and ε3 homozygotes. On a Stroop-
switch task, however, mid-age ε4 carriers demonstrated a greater congruency effect for errors. 
In addition, ε4 disadvantages in non-focal PM manifested as either decreased PM retrieval 
accuracy on the card-sort paradigm (Article 3) or increased interference to ongoing task 
performance on the category decision task (Article 5). Previous studies of non-focal PM in mid-
age ε4 carriers, again, reported a speed-accuracy trade off on PM trials in association with 
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heightened frontal fMRI BOLD activations (Evans et al., 2014). This study, however, did not 
include an index of PM interference to provide a complete consideration of genotype effects.  
 
The profile of attentional control differences in mid-age ε4 carriers (Articles 2, 3 and 5) is 
suggestive of an early vulnerability in carriers of this variant in the ability to process multiple 
attentional sets, a central component of existing theoretical models of attentional control (Faust 
& Balota, 2007; Friedman & Miyake, 2015; Kane & Engle, 2003; Tiego et al., 2017). During 
non-focal PM individuals must process the ongoing task whilst maintaining and monitoring for 
the PM intention. Likewise, on the Stroop-switch paradigm, individuals must maintain multiple 
task rules (word naming, colour naming). Models of attentional control, importantly, indicate 
this complex goal maintenance ability is the overarching construct of executive attention, 
supporting additional processing such as inhibition and set shifting, and hence it may be this 
central ability that is most vulnerable to early ε4 deficits (Friedman & Miyake, 2015; Tiego et 
al., 2017). Article 5 explored how increasing the complexity of executive demand differentially 
impacted ε4 carriers in mid-adulthood by including a third WM component within a PM 
paradigm. The results were equivocal, however, and further interrogation of genotype 
differences in the ability to multi-task between several attentionally demanding tasks is needed. 
Furthermore, although the current study included a Stroop-switch paradigm, as the switches 
were regular and bi-trial (as opposed to random and unpredictable), the cost of attentional 
switching did not emerge as a sensitive index. To gain a more complete understanding of APOE 
genotype across individual processes of executive attention a more challenging switch task 
could be included in future research, with ε4 disadvantages predicted based on existing research 
(Velichkovsky et al., 2015). 
 
The presence of specific cognitive deficits in ε4 carriers by mid-adulthood can be used to infer 
which neural regions are vulnerable to early ε4 effects. Non-focal PM is supported by dorsal 
frontal-parietal regions, cingulate regions and the precuneus (Cona et al., 2016, 2015; McDaniel 
et al., 2013), aligning with reports of genotype differences within these regions prior to the 6th 
decade (e.g. Chen et al., 2016; Evans et al., 2014). As change in frontal regions are reported in 
the initial stages of cognitive ageing (Bartzokis et al., 2003; Raz, 2000; Villemagne et al., 
2011), perhaps ε4 are showing a premature decline in these regions. 
 
Aside from attentional control, Article 5 also reports ε4 differences in focal PM by mid-
adulthood, which were absent in youth. This suggests associative memory processes show early 
vulnerability to ε4 effects, reliant on medial temporal lobe function (Cona et al., 2016; Gordon 
et al., 2011; McDaniel et al., 2013). Ε4 differences in medial temporal lobe regions have 
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previously been reported in mid-adulthood (Den Heijer et al., 2002; Shaw et al., 2007; Wishart 
et al., 2006).  
 
8.1.2 APOE ε2 and attentional control 
 
The APOE ε2 variant is purported to have protective effects against LOAD (Corder, Saunders, 
Risch, Strittmatterl & Schmechel, 1994; Chiang et al, 2010) and the associated neuropathology 
(Grothe, Villeneuve, Dyrba, & Bartrés-faz, 2017; Nagy et al., 1995; Serrano-Pozo, Qian, 
Monsell, Betensky, & Hyman, 2015; Tiraboschi et al., 2004; for review see: Suri, Heise, 
Trachtenberg, & Mackay, 2013). Although infrequently studied, carrying an ε2 allele is linked 
to cognitive advantages in older adulthood (Bonner-Jackson et al., 2012; Deary et al., 2004; 
Helkala et al., 1996), as well as youth (Alexander et al., 2007; Alexopoulos et al., 2011; Konishi 
et al., 2016; Mondadori et al., 2007), although the data are less than consistent (Yasen, Raber, 
Miller, & Piper, 2015). Despite this, existing literature predominantly considers ε2 carriers 
collectively with homozygous ε3 carriers as a ‘non-ε4’ group, potentially biasing results, or 
excludes ε2 carriers from the sample altogether. This thesis independently considered the effects 
of this variant, as understanding the effects of all three alleles is essential for a complete 
understanding of how APOE genotype effects develop across the lifespan.  
 
Given the purported protective role of APOE ε2, carriers of this genotype were expected to 
show cognitive advantages in mid-adulthood. Articles 2 & 3, however, report ε2 disadvantages, 
relative to their ε3 peers, on measures of selective attention and sustained attentional updating 
(Articles 2 & 3). The presence of both ε4 and ε2 disadvantages in this thesis aligns with reports 
of comparable fMRI BOLD activations in task-unrelated regions in mid-age ε2 and ε4 carriers 
(Trachtenberg, Filippini, Cheeseman, et al., 2012), potentially representing similar levels of 
neural network dedifferentiation between these variants. Furthermore, mid-age ε4 and ε2 
carriers demonstrate similar profiles of resting-state BOLD activity (Trachtenberg, Filippini, 
Ebmeier, et al., 2012b). The presence of ε2 disadvantages earlier in the lifespan raises the 
question of how the opposing effects of ε4 and ε2 alleles develop in older adulthood. More 
recent research suggests that whilst ε2 and ε4 carriers both show diminished functional 
connectivity within the default mode network in older adulthood (aged 54-80 years), cross-
sectional comparisons indicate a differential trajectory of age-related change between these 
variants (Shu et al., 2016). Understanding the mechanisms for why the effects of these alleles 
diverge in cognitive ageing is an important future step.   
 
8.2 Theoretical accounts for the role of APOE ε4 in cognitive ageing  
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8.2.1 Mid-adulthood as a transitional stage in ε4 effects 
 
Overall, the results from the studies reported here suggest carriers of an ε4 genotype show 
relatively preserved attentional control until the end of the 5th decade, with subtle deficits 
detectable on individual behavioural parameters. Although only one cognitive domain was 
considered in the current thesis, broadly intact performance is not inconsistent with the 
antagonistic pleiotropy hypothesis (Han & Bondi, 2008). It may be that mid-adulthood 
represents a transitional stage, with the expression of ε4 effects shifting from being cognitively 
advantageous (e.g. Marchant et al., 2010; Mondadori et al., 2007; Rusted et al., 2013; Stening et 
al., 2016) to detrimental in later life (Wisdom et al., 2011). To allow for a cross-sectional 
comparison between young and mid-age ε4 carriers, adults aged 18-30 years were included in 
Article 5. Considering this age group independently, evidence for ε4 advantages on measures of 
focal and non-focal PM was non-significant in youth, out of line with the predictions of 
antagonistic pleiotropy. Longitudinal research, however, is needed to establish lifespan 
developmental effects of the ε4 allele. 
 
ε4 cognitive advantages in youth have been attributed to early compensatory strategies, 
supported by reports of increased fMRI BOLD activations, comparable to those seen in healthy 
ageing (e.g. Evans et al., 2014; Rusted et al., 2013). Continuation of compensatory strategies 
may in part be responsible for executive attention being largely intact in mid-age ε4 carriers; 
however, processes may be breaking down in line with small disadvantages appearing. In 
support, one study has reported that mid-age ε4 carriers show heightened fMRI BOLD 
activation at low levels of WM load, with no further increase in activation recorded under more 
challenging conditions as reported in their non-ε4 peers (Chen et al., 2013). This was interpreted 
as ε4 carriers utilising compensatory strategies to sustain performance under low demand, and 
hence being unable to further recruit additional support under more taxing conditions. Evidence 
for compensation is limited, however, in the absence of an association between neural 
activations and behaviour (Cabeza & Dennis, 2012).  
 
Developing the idea that ε4 carriers may be approaching cognitive tasks differently, this thesis 
explored subjective cognitive effort and task load. Across Articles 5 and 6, healthy ε4 carriers 
across a range of age groups (young, mid, older) report greater perceived effort in completion of 
a PM task. Furthermore, in Article 5, the presumed practice-related decrease in effort on the 
second session of the category-decision PM task (under WM load) was absent in mid-age ε4 
carriers only, suggestive of persistently high workload in this group. Hence ε4 carriers may 
consciously be exerting greater cognitive resource to maintain comparable levels of 
performance. These results are not inconsistent with the speed-accuracy trade-off reported in 
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Evans et al. (2014). Whilst using subjective reports to probe task load may not be the most 
accurate gauge of cognitive demand, further research exploring ε4 differences on physiological 
indices of response to task could be worthwhile. 
 
8.2.2 Premature Ageing in Mid-age APOE ε4 Carriers  
 
The presence of ε4 disadvantages on select processes implicated in attentional control supports 
early vulnerability in this group by mid-adulthood, with the uneven profile of impairment 
mirroring the non-uniform decline typical of healthy cognitive ageing. The pattern of 
impairment reported in ε4 carriers aged 45-55 years (Articles 3 and 5) is comparable with the 
profile of decline reported in older adulthood (Bélanger, Belleville, & Gauthier, 2010; Henry, 
MacLeod, Phillips, & Crawford, 2004; Kliegel, Jäger, & Phillips, 2008), suggestive that APOE 
ε4 is associated with an early loss of frontal-based cognitive resource. In addition, Article 5 
included a cross-sectional comparison between young (18-30 years) and mid-age ε4 carriers.  
Compared to the young group, ε4 carriers demonstrated a greater age-related increase in 
prospective interference compared to their ε3 counterparts, consistent with enhanced cognitive 
ageing in this group.  
 
Mid-age participants in this thesis were recruited from the age-range 45-55 years to minimise 
bias from individuals in the ‘preclinical’ stage of LOAD and the associated pathology 
(Sliwinski & Buschke, 1999; Sperling et al., 2011). Hence, the behavioural results consistent 
with premature ageing in mid-age ε4 carriers can be considered to result from a non-
pathological physiological mechanism, consistent with APOE ε4 representing a cognitive 
phenotype (Greenwood, Lambert, Sunderland, Parasuraman, 2005; Negash et al., 2009). 
Considering existing literature, one potential mechanism for differential ε4 impairment in mid-
adulthood may be altered cortical connectivity, linked to APOE ε4’s role in the synthesis and 
transport of cholesterol, and as a result, myelination and the efficiency of neuronal 
communication (Liu et al., 2013). In late mid-adulthood, APOE ε4 is associated with disrupted 
functional connectivity within the default mode, executive control and salience networks 
(Goveas et al., 2013b), including in individuals demonstrating no significant amyloid 
accumulation (Sheline et al., 2010). Importantly, demyelination accelerates in ε4 carriers from 
the 5th decade (Bartzokis, 2007) supporting this as a potential mechanism for decline from mid-
adulthood.  Higher-order cognitive processes requiring the integration of processing across 
multiple neural regions may be more significantly impacted by disrupted connectivity.  
 
Of interest, the attentional disadvantages reported in mid-age ε4 carriers overlap with the profile 
of cognitive impairment distinguishing individuals in the preclinical or early stages of LOAD 
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from age-matched healthy controls. Specifically, an effect of congruency on errors on the 
Stroop-switch task in mid-age ε4 carriers is comparable with behavioural deficits predictive of 
future LOAD onset in a group of healthy older adults (Balota et al., 2010)(Article 3). Whilst 
healthy cognitive ageing is associated with selective decline in non-focal PM, pathological 
ageing is distinguished by an additional impairment in focal PM (Chi et al., 2014; McDaniel, 
Shelton, Breneiser, Moynan, & Balota, 2011; Niedźwieńska, Kvailashvili, Ashaye, & Neckar, 
2017). By mid-adulthood ε4 carriers show significant impairment in both focal and non-focal 
PM, consistent with the profile characteristic of LOAD. Hence, a second possibility is that ε4 
carriers show early vulnerability to LOAD-related processes, driving increased age-related 
decline. 
 
Early vulnerability to pathological ageing may result from a differential trajectory of amyloid 
deposition in ε4 carriers. One influential model argues that the accumulation of β amyloid acts 
as the initial insult within the cascade of neurodegenerative processes (Selkoe & Hardy, 2016), 
and hence may be expected to influence individual differences in early cognitive ageing. Further 
supporting amyloid as a probable mechanism of LOAD-type vulnerability, carrying a copy of 
the ε4 variant directly impacts the accumulation and clearance of amyloid in the brain (Mahley 
et al., 2006). Although this thesis included adults aged 45-55 years, APOE ε4 is seen to 
accelerate the accumulation of amyloid earlier in the lifespan. For example, a higher proportion 
of ε4 carriers are reported to show build up of Aβ42 by their 40s (Morishima-Kawashima et al., 
2000). In addition, 10% of ε4 carriers show clinically significant levels of amyloid by the 5th 
decade (Jack et al., 2015). Below the threshold for clinically significant amyloid accumulation, 
the initial build up of this protein may impact early APOE genotype differences in cognitive 
ageing. Increased neural activation is hypothesised to accelerate amyloid deposition (Jagust & 
Mormino, 2011); hence increased frontal and medial temporal lobe BOLD activations in young 
ε4 carriers (e.g. Filippini et al., 2009; Rusted et al., 2013; Trachtenberg, Filippini, Cheeseman, 
et al., 2012) may indicate early vulnerability, stressing the need to consider the cumulative 
impact.  
 
In line with frontal regions being preferentially impacted by the neural deposition of amyloid 
(Rowe et al., 2007; Villemagne et al., 2011), several studies have investigated the relationship 
between APOE, executive attention, and amyloid in late-mid adulthood. The presence of 
amyloid is reported to accelerate decline in mid-age ε4 carriers (mean age 53.6 years) on 
neuropsychological assessment measures of inhibition, switching and processing speed (Clark 
et al., 2016). In further support, although no independent effect of ε4 was reported on cognition 
in adults aged 50-69 years, the presence of amyloid was associated with poorer executive 
attention in ε4 carriers (Mielke et al., 2015). On a behavioural paradigm of attentional control, a 
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speeded category-decision task, ε4 differences were mediated by the presence of Aβ42, 
specifically in regions including the prefrontal cortex, precuneus and temporal regions 
(Aschenbrenner et al., 2015). Therefore, there is support for both non-pathological and LOAD-
related mechanisms of premature ageing in ε4 carriers, supporting the need to take a 
dimensional approach to understanding cognitive ageing (Herrup, 2010; Sheline et al., 2010; 
Verghese, Castellano, & Holtzman, 2011). 
 
8.2.3 APOE ε4: a genetic vulnerability factor? 
 
Herrup (2010) suggested age-related processes are central to cognitive decline; however, the 
presence of neural insult is necessary to trigger an enhanced profile of deterioration. In addition 
to allowing for the role of APOE in the pathological accumulation of amyloid, this model 
suggests carrying an ε4 allele creates a general propensity for decline. Although APOE ε4 may 
reduce the reserve of the brain to cope with insult via multiple LOAD independent mechanisms, 
including neuroinflammation and mitochondrial dysfunction (Liu et al., 2013), a susceptibility 
to vascular damage is identified as the key factor in this model. In line with the methodological 
comments outlined in Article 1, this motivated an exploratory examination of the moderation of 
APOE effects by additional factors influencing cognitive ageing, including vascular health 
(Article 4).  
 
In line with previous research (Bender & Raz, 2012; Oberlin et al., 2015; McFall et al., 2015), 
APOE ε4 status was predicted to interact with poor vascular health to exaggerate cognitive 
deficits from mid-adulthood. Specifically, systolic blood pressure and ε4 in combination 
associate with decreased white matter volume and executive decline (Bender & Raz, 2012), 
supporting disruption in neural connectivity as a general mechanism for ε4 effects. This thesis 
did not find an association between vascular health and APOE genotype on measures of 
executive attention, however, this may stem from methodological limitations (detailed in the 
discussion of Article 4). The current studies report attentional disadvantages in both ε4 and ε2 
carriers in mid-adulthood (Articles 2, 3, 5), yet one possibility is that the opposing influence of 
these variants in later life stem from differential vulnerability to cognitive insult (McFall et al., 
2015). In youth, cerebrovascular reactivity and thus resistance to vascular insult increases in a 
stepwise manner across genotypes ε4, ε3, ε2 (Suri et al., 2015a). This fits with the suggestion 
that whilst the trajectory of ε4 carriers is more flexible, the ε2 allele may be more resistant to 
modification by external factors. Furthermore, beneficial effects of cognitive reserve were 
enhanced in ε4 carriers (Article 4), supporting the hypothesis that ε4 represents a plasticity gene 
(Belsky et al., 2015). 
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8.3 Limitations  
 
Each Article includes an independent discussion of potential shortcomings; here, common 
limitations across the studies are considered. A principle concern is the relatively small sample 
size of each genotype group across experimental studies. In particular, the study reported in 
Article 6 recruited participants opportunistically, either from the MAS clinics or local 
community groups, leading to an unequal distribution of APOE genotype groups. Small group 
sizes may result in underpowered statistical analysis, leading to under- or overestimated effect 
sizes (Button et al., 2013). In support, smaller effect sizes of APOE ε4 genotype are reported in 
studies with larger group sizes (e.g. Jorm et al., 2007; Marioni et al., 2015; Shin et al., 2014), as 
evidenced in the meta-analytic review of APOE ε4 effects in mid-adulthood (Article 1), and the 
meta-analysis of ε4 effects in youth (Ihle et al., 2012). Although effects of APOE ε4 on 
attentional control in mid-adulthood were consistent across studies in this thesis, research 
should focus on the reproducibility of APOE ε4 behavioural effects with larger sample sizes, to 
strengthen conclusions.  
 
The field of cognitive ageing is rapidly moving towards a reliance on large cohort studies, such 
as ‘Generation Scotland’ (Marioni et al., 2015a), the Arizona APOE cohort (Richard J Caselli et 
al., 2009) and the ‘Atherosclerosis Risk in Communities Study’ (Blair et al., 2005). Whilst these 
are invaluable for gathering cognitive data representative of the general population, cohort 
studies typically rely on quick-to-administer generic neuropsychological test batteries. The use 
of sensitive and process-specific cognitive paradigms is generally more time consuming, hence 
limiting study sample size. Future research could consider using remote computerised tasks to 
sensitively measure cognition in larger groups.  
 
Sample size further limited our consideration of APOE gene dose, with a small number of 
homozygotes in each study. The impact of ε4 reportedly increases with 0, 1 and 2 copies of the 
gene (Farrer et al., 1997; Raber et al., 2004; Wisdom et al., 2011).  The effects of APOE ε4 are 
reported to differ on measures of attention and general processing speed in mid-life according to 
zygosity (Blair et al., 2005; Greenwood, Lambert, Sunderland, Parasuraman, 2005), but not 
consistently (Trachtenberg, Filippini, Cheeseman, et al., 2012). The additive effects of carrying 
two copies of the ε4 allele could be explored in future research, with a necessity for large 
sample sizes due to the low frequency of homozygous ε4 carriers in the population (~2% (Raber 
et al., 2004)).   
 
A further limitation of the thesis is that the participating mid-age volunteers were generally high 
functioning, with many of them recruited from a university background and mean premorbid IQ 
		
163	
between 117- 119 for Articles 2, 3, 4 and 5. This makes it difficult to draw strong conclusions 
about how APOE ε4 effects generalise to a broader general population. Article 4 investigated 
the moderation of APOE genotype effects under varying environmental conditions, including 
past cognitive engagement, vascular and metabolic health, and physical activity. Again, low 
variability in participants along these variables limit exploration of APOE x Environment 
interactions.  
 
Finally one of the reasons for considering APOE genotype effects in mid-adulthood is that the 
presence of genotype effects at this stage of the lifespan will further understanding of how gene 
expression changes across the lifespan. It is difficult to draw conclusions of genetic differences 
in the trajectory of cognitive ageing, however, from taking snapshots of ε4 effects at any one 
window of the lifespan. Future longitudinal research is needed to validate lifespan models of 
APOE ε4 effects.  
 
8.4 Applications and Future Directions 
 
Clear evidence for subtle behavioural impairment in ε4 carriers by mid-adulthood has important 
applications for future research. The results of Articles 2-5 suggest individual processes within 
the framework of attentional control are differentially sensitive to the effects of the ε4 variant, 
however, this thesis did not administer paradigms sensitive to attentional set-shifting. 
Furthermore, although the profile of impairment reported in mid-age ε4 is consistent with 
deficits in the maintenance of multiple goals within attention, it may be differences emerge 
under conditions more taxing to the integration of multiple attentional processes. To explore 
APOE differences in a more ecologically valid context of attentional control, paradigms 
assessing multi-tasking may be explored in future research. This will allow more careful 
interrogation of APOE differences in frontally based processing. In addition, the focus of this 
thesis was investigating ε4 differences within the domain of attentional control. In line with the 
conclusions of Article 1, sensitive behavioural paradigms should be used to explore early 
genotype differences across a range of cognitive domains.   
 
An important next step for future research is to explore the biological basis of premature ageing 
in ε4 carriers, focusing on directly correlating changes in the behavioural phenotype with 
genotype differences in the brain. In addition to focusing on region-of-interest BOLD 
activations, studies considering the integration of cortical activity across brain regions are 
important. Further understanding the neural basis of ε4 effects has important applications for 
timely interventions against cognitive decline.   
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Reports of ε4 effects on attentional control by mid-adulthood (Articles 2-5) has wider relevance 
for understanding cognitive impairment in older adulthood. Whilst changes in episodic memory 
are considered the hallmark of cognitive ageing (e.g. Caselli et al., 2014; Chen et al., 2001; for 
review see Mortamais et al., 2016), changes in attentional control may be responsible for lapses 
in everyday function. The current thesis consistently demonstrated effects of APOE ε4 on PM in 
mid-adulthood (Articles 3 and 5), considered the archetypical form of ‘everyday’ memory. In 
light of this, the relationship between non-focal PM and cognitive errors in everyday life was 
explored in individuals self-referring to the MAS (Article 6). Although PM was not 
differentially impacted in this ‘at-risk’ group, the correlation between performance and 
subjective reports of lapses in attentional control encourages interventions targeting PM for the 
maintenance of independence in everyday life. 
 
The crucial conclusion of this thesis is that mid-adulthood represents a critical window when 
individual differences in the trajectory of cognitive decline may first be apparent. The 
demonstration of ε4 disadvantages at the end of the 5th decade presents the opportunity for early 
risk assessment and more timely intervention strategies. To build on the presence of existing ε4 
differences on measures of attentional control, future research should explore if the combination 
of APOE genotype with inter-individual differences in these parameters is predictive of a more 
detrimental trajectory of cognitive ageing. Furthermore, mid-adulthood is a key stage of the 
lifespan when additional factors in age-related decline, including vascular health and cognitive 
reserve may become more prominent in their effects (Ritchie, Ritchie, Yaffe, Skoog, & 
Scarmeas, 2015), and hence APOE ε4 should not be considered in isolation. Future research 
should explore environmental factors in depth to see if interventions can reverse early genotype 
differences in mid-adulthood. There is the potential to use APOE genotype in personalized 
medicine (Villeneuve, Brisson, Marchant, & Gaudet, 2014), referring to the tailoring of medical 
advice based on individual characteristics including genotype, family history and additional risk 
factors (Offit, 2011). If ε4 carriers show greater plasticity in their trajectory of cognitive decline, 
and increased vulnerability to cardiovascular risk mechanisms, APOE status could directly be 
used to implicate the most effective preventative steps. There are considerable ethical 
implications, however, for both the collection and disclosure of genotype information at the 
level of the individual.  
 
8.6 Conclusions 
 
Carrying a copy of the APOE ε4 risk variant is associated with disadvantages in executive 
attention by mid-adulthood. Importantly, an uneven profile of impairment was reported across 
attentional processes, with tasks requiring the maintenance of multiple goals within attention 
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most consistently affected. This suggests rather than ε4 being uniformly disadvantageous, 
distinct elements of attentional control are vulnerable to the negative effects of this allele. 
Overlap in the cognitive profile of ε4 carriers and the distinguishing behavioural impairments of 
LOAD is suggestive of APOE ε4 acting via both general ageing mechanisms and LOAD-related 
pathology, emphasising the need to adopt a dimensional approach to cognitive ageing. 
Cognitive reserve moderated ε4 effects in mid-adulthood, with differential sensitivity of this 
group positioning ε4 as a vulnerability gene. Furthermore, the mitigation of ε4 affects effects in 
mid-adulthood highlights the importance of focusing preventative steps earlier in the lifespan. 
Future research should focus on linking these early cognitive differences to their biological 
basis, and importantly on whether the influence of ε4 can be minimised at this formative stage 
through the interplay of this allele with additional factors.   
  
		
166	
References 
Acevedo, S. F., Piper, B. J., Craytor, M. J., Benice, T. S., & Raber, J. (2010). Apolipoprotein Ε4 
and sex affect neurobehavioural performance in primary school children. Pediatric 
Research, 67(3), 293–299. doi:10.1203/PDR.0b013ε3181cb8e68 
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., … Phelps, 
C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: 
Recommendations from the National Institute on Ageing-Alzheimer’s Association 
workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s and Dementia, 
7(3), 270–279. doi:10.1016/j.jalz.2011.03.008 
Albert, M., Soldan, A., Gottesman, R., McKhann, G., Sacktor, N., Farrington, L., … Selnes, O. 
(2014). Cognitive changes preceding clinical symptom onset of mild cognitive impairment 
and relationship to ApoE genotype. Current Alzheimer Research, 11(8), 773–784.  
Alexander, D. M., Williams, L. M., Gatt, J. M., Dobson-Stone, C., Kuan, S. a, Todd, E. G., … 
Gordon, E. (2007). The contribution of apolipoprotein E alleles on cognitive performance 
and dynamic neural activity over six decades. Biological Psychology, 75(3), 229–38. 
http://doi.org/10.1016/j.biopsycho.2007.03.001 
Alexopoulos, P., Richter-Schmidinger, T., Horn, M., Maus, S., Reichel, M., Sidiropoulos, C., … 
Kornhuber, J. (2011). Hippocampal volume differences between healthy young 
apolipoprotein E ε2 and ε4 carriers. Journal of Alzheimer’s Disease, 26(2), 207–210. 
Alzheimer's Society. (2016). Alzheimersorguk. Retrieved 5 April, 2016, from 
http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=341. 
Amariglio, R. E., Becker, J. A., Carmasin, J., Wadsworth, L. P., Lorius, N., Sullivan, C., … 
Rentz, D. M. (2012). Subjective cognitive complaints and amyloid burden in cognitively 
normal older individuals. Neuropsychologia, 50(12), 2880–2886. 
http://doi.org/10.1016/j.neuropsychologia.2012.08.011 
American Psychological Association (2013). Diagnostic and statistical manual of mental 
disorders (DSM-5®). American Psychiatric Pub. 
Anstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011). Body mass index in midlife and 
late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obesity 
Reviews, 12(501), 426–437. http://doi.org/10.1111/j.1467-789X.2010.00825.x 
Arenaza-Urquijo, E. M., Wirth, M., & Chételat, G. (2015). Cognitive reserve and lifestyle: 
moving towards preclinical Alzheimer’s disease. Frontiers in Ageing Neuroscience, 
7(AUGUST), 134. http://doi.org/10.3389/fnagi.2015.00134 
Aronov, A., Rabin, L. A., Fogel, J., Chi, S. Y., Kann, S. J., Abdelhak, N., & Zimmerman, M. E. 
(2015). Relationship of cognitive strategy use to prospective memory performance in a 
diverse sample of nondemented older adults with varying degrees of cognitive complaints 
and impairment. Ageing, Neuropsychology, and Cognition, 22(4), 486–501. 
		
167	
http://doi.org/10.1080/13825585.2014.984653 
Aschenbrenner, A. J., Balota, D. A., Tse, C.-S., Fagan, A. M., Holtzman, D. M., Benzinger, T. 
L. S., & Morris, J. C. (2015). Alzheimer disease biomarkers, attentional control, and 
semantic memory retrieval: Synergistic and mediational effects of biomarkers on a 
sensitive cognitive measure in non-demented older adults. Neuropsychology, 29(3), 368–
381. doi:10.1037/neu0000133 
Aschenbrenner, A. J., Balota, D. A., Tse, C., Fagan, A. M., David, M., Benzinger, T. L. S., … 
Morris, J. C. (2014). Neuropsychology Alzheimer Disease Biomarkers , Attentional 
Control , and Semantic Memory Retrieval : Synergistic and Mediational Effects of 
Biomarkers on a Sensitive Cognitive Measure in Non-Demented Older Adults. 
Neuropscyhology, 29, 368-381. 
Atienza, M., Atalaia-Silva, K. C., Gonzalez-Escamilla, G., Gil-Neciga, E., Suarez-Gonzalez, A., 
& Cantero, J. L. (2011). Associative memory deficits in mild cognitive impairment: the 
role of hippocampal formation. Neuroimage, 57(4), 1331–1342. 
Atzmon, G., Gabriely, I., Greiner, W., Davidson, D., Schechter, C., & Barzilai, N. (2002). 
Plasma HDL Levels Highly Correlate With Cognitive Function in Exceptional Longevity. 
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 57(11), 
712–715. http://doi.org/10.1093/gerona/57.11.M712 
Awh, E., Vogel, E. K., & Oh, S. H. (2006). Interactions between attention and working 
memory. Neuroscience, 139(1), 201–208. doi:10.1016/j.neuroscience.2005.08.023 
Baddeley, A. (2012). Working Memory: Theories, Models, and Controversies. Annual Review 
of Psychology, 63(1), 1–29. doi:10.1146/annurev-psych-120710-100422 
Baddeley, A., Baddeley, H., Bucks, R., & Wilcock, G. (2001). Attentional control in 
Alzheimer’s disease. Brain, 124, 1492–1508. doi:10.1093/brain/124.8.1492 
Balota, D. a, Tse, C.-S., Hutchison, K. a, Spieler, D. H., Duchek, J. M., & Morris, J. C. (2010). 
Predicting conversion to dementia of the Alzheimer’s type in a healthy control sample: the 
power of errors in Stroop color naming. Psychology and Ageing, 25(1), 208–18. 
doi:10.1037/a0017474 
Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer’s 
disease prevalence. The Lancet Neurology, 10(9), 819–828. doi:10.1016/S1474-
4422(11)70072-2 
Bartzokis, G. (2004). Age-related myelin breakdown: A developmental model of cognitive 
decline and Alzheimer’s disease. Neurobiology of Ageing, 25(1), 5–18. 
doi:/10.1016/j.neurobiolageing.2003.03.001 
Bartzokis, G., Cummings, J. L., Sultzer, D., Henderson, V. W., Nuechterlein, K. H., & Mintz, J. 
(2003). White Matter Structural Integrity in Healthy Ageing Adults and Patients With 
Alzheimer Disease. Archives of Neurology, 60(3), 393-398. doi:10.1001/archneur.60.3.393 
		
168	
Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., … Mintz, J. 
(2007). Apolipoprotein E affects both myelin breakdown and cognition: implications for 
age-related trajectories of decline into dementia. Biological Psychiatry, 62(12), 1380–
1387. 
Barulli, D., & Stern, Y. (2013). Efficiency, capacity, compensation, maintenance, plasticity: 
emerging concepts in cognitive reserve. Trends in Cognitive Sciences, 17(10), 502–509. 
Basso, D., Ferrari, M., & Palladino, P. (2010). Prospective memory and working memory: 
Asymmetrical effects during frontal lobe TMS stimulation. Neuropsychologia, 48(11), 
3282–3290. 
Bélanger, S., Belleville, S., & Gauthier, S. (2010). Inhibition impairments in Alzheimer’s 
disease, mild cognitive impairment and healthy ageing: Effect of congruency proportion in 
a Stroop task. Neuropsychologia, 48(2), 581–590.doi: 
10.1016/j.neuropsychologia.2009.10.021 
Belleville, S., Chertkow, H., & Gauthier, S. (2007). Working memory and control of attention 
in persons with Alzheimer’s disease and mild cognitive impairment. Neuropsychology, 
21(4), 458–469. doi:10.1037/0894-4105.21.4.458 
Belsky, D. W., Caspi, A., Houts, R., Cohen, H. J., Corcoran, D. L., Danese, A., … Moffitt, T. E. 
(2015). Quantification of biological ageing in young adults. Proc.Natl.Acad.Sci.U.S.A, 
112(30), Ε4104–Ε4110. doi:10.1073/pnas.1506264112 
Bender, A. R., & Raz, N. (2012). Age-related differences in memory and executive functions in 
healthy APOE ɛ4 carriers: The contribution of individual differences in prefrontal volumes 
and systolic blood pressure. Neuropsychologia, 50(5), 704–714. doi: 
10.1016/j.neuropsychologia.2011.12.025 
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., … de Faire, 
U. (2007). Association of apolipoprotein E genotypes with lipid levels and coronary risk. 
JAMA, 298(11), 1300–1311. 
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & 
Wilson, R. S. (2006). Neuropathology of older persons without cognitive impairment from 
two community-based studies. Neurology, 66(12), 1837–1844. 
doi:10.1212/01.wnl.0000219668.47116.e6 
Benoni, H., & Tsal, Y. (2013). Conceptual and methodological concerns in the theory of 
perceptual load. Frontiers in Psychology, 4(August), 522. doi:10.3389/fpsyg.2013.00522 
Berlau, D. J., Ph, D., Corrada, M. M., Sc, D., Head, E., & Kawas, H. (2010). APOE ε2 is 
associated with intact cognition but increased Alzheimer pathology in the oldest old, 
Neurology, 72(9), 829–834. doi:10.1212/01.wnl.0000343853.00346.a4.APOE 
Berteau-Pavy, F., Park, B., & Raber, J. (2007). Effects of sex and APOE ε4 on object 
recognition and spatial navigation in the elderly. Neuroscience, 147(1), 6–17. 
		
169	
http://doi.org/10.1016/j.neuroscience.2007.03.005 
Bisiacchi, P. S., Tarantino, V., & Ciccola, A. (2013). Ageing and prospective memory: the role 
of working memory and monitoring processes. Ageing Clinical and Experimental 
Research, 20(6), 569–577. doi:/10.1007/bf03324886 
Blair, C. K., Folsom,  A R., Knopman, D. S., Bray, M. S., Mosley, T. H., & Boerwinkle, E. 
(2005). APOE genotype and cognitive decline in a middle-aged cohort. Neurology, 64(2), 
268–76. http://doi.org/10.1212/01.WNL.0000149643.91367.8A 
Blanché, H., Cabanne, L., Sahbatou, M., & Thomas, G. (2001). A study of French centenarians: 
are ACE and APOE associated with longevity? Comptes Rendus de l’Académie Des 
Sciences-Series III-Sciences de La Vie, 324(2), 129–135. 
Blanco-Campal, A., Coen, R. F., Lawlor, B. A., Walsh, J. B., & Burke, T. E. (2009). Detection 
of prospective memory deficits in mild cognitive impairment of suspected Alzheimer’s 
disease etiology using a novel even. Journal of the International Neuropsychological 
Society : JINS, 15(1), 154–159. doi:10.1017/S1355617708090127 
Bloss, C. S., Delis, D. C., Salmon, D. P., & Bondi, M. W. (2008). Decreased Cognition in 
Children with Risk Factors for Alzheimer’s Disease. Biological Psychiatry, 64(10), 904–
906. doi:10.1016/j.biopsych.2008.07.004 
Bloss, C. S., Delis, D. C., Salmon, D. P., & Bondi, M. W. (2010). APOE genotype is associated 
with left-handedness and visuospatial skills in children. Neurobiology of Ageing, 31(5), 
787–795. 
Bonner-Jackson, A., Okonkwo, O., & Tremont, G. (2012). Apolipoprotein E ε2 and functional 
decline in amnestic mild cognitive impairment and Alzheimer disease. The American 
Journal of Geriatric Psychiatry, 20(7), 584–593. doi:10.1097/JGP.0b013ε3182203c32 
Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2009). Complex Data Structures. 
Introduction to Meta-Analysis (pp. 215-245). John Wiley & Sons Ltd., West Sussex, UK. 
Bouazzaoui, B., Isingrini, M., Fay, S., Angel, L., Vanneste, S., Clarys, D., & Taconnat, L. 
(2010). Ageing and self-reported internal and external memory strategy uses: The role of 
executive functioning. Acta Psychologica, 135(1), 59–66. 
Boywitt, C. D., & Rummel, J. (2012). A diffusion model analysis of task interference effects in 
prospective memory. Memory & Cognition, 40(1), 70–82. doi: 10.3758/s13421-011-0128-
6 
Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta 
Neuropathologica, 82(4), 239–259. 
Brewster, P. W. H., Melrose, R. J., Marquine, M. J., Johnson, J. K., Napoles, A., MacKay-
Brandt, A., … Mungas, D. (2014). Life experience and demographic influences on 
cognitive function in older adults. Neuropsychology, 28(6), 846–58. 
doi:10.1037/neu0000098 
		
170	
Broadbent, D. E., Cooper, P. F., FitzGerald, P., & Parkes, K. R. (1982). The cognitive failures 
questionnaire (CFQ) and its correlates. British Journal of Clinical Psychology, 21(1), 1–
16. 
Bruyer, R., & Brysbaert, M. (2011). Combining speed and accuracy in cognitive psychology: is 
the inverse efficiency score (IES) a better dependent variable than the mean reaction time 
(RT) and the percentage of errors (PE)? Psychologica Belgica, 51(1), 5–13. 
Bu, G. (2009). Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, 
pathogenesis and therapy. Nature Reviews. Neuroscience, 10(5), 333–44. 
doi:10.1038/nrn2620 
Buckley, R. F., Maruff, P., Ames, D., Bourgeat, P., Martins, R. N., Masters, C. L., … Ellis, K. 
A. (2016). Subjective memory decline predicts greater rates of clinical progression in 
preclinical Alzheimer’s disease. Alzheimer’s and Dementia, 12(7), 796–804. 
doi:10.1016/j.jalz.2015.12.013 
Bunce, D., Anstey, K. J., Burns, R., Christensen, H., & Easteal, S. (2011). Does possession of 
apolipoprotein E ɛ4 benefit cognitive function in healthy young adults? Neuropsychologia, 
49(7), 1693–1697. doi:10.1016/j.neuropsychologia.2011.02.042 
Bunce, D., Bielak, A. A M., Anstey, K. J., Cherbuin, N., Batterham, P. J., & Easteal, S. (2014). 
APOE genotype and cognitive change in young, middle-aged, and older adults living in 
the community. The Journals of Gerontology. Series A, Biological Sciences and Medical 
Sciences, 69(4), 379–386. doi:10.1093/gerona/glt103 
Bunce, D., Fratiglioni, L., Small, B. J., Winblad, B., & Bäckman, L. (2004). APOE and 
cognitive decline in preclinical Alzheimer disease and non-demented ageing. Neurology, 
63(5), 816–821. 
Bunce, D., Kivipelto, M., & Wahlin, A. (2004). Utilization of cognitive support in episodic free 
recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 
years and older. Neuropsychology, 18(2), 362–370. doi:10.1037/0894-4105.18.2.362 
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & 
Munafò, M. R. (2013). Power failure: why small sample size undermines the reliability of 
neuroscience. Nature Reviews Neuroscience, 14(5), 365–376. 
Cabeza, R., & Dennis, N. A. (2012). Frontal lobes and ageing. Principles of Frontal Lobe 
Function. 2d Ed. New York: Oxford University Press. 628–652. 
Cansino, S., Guzzon, D., Martinelli, M., Barollo, M., & Casco, C. (2011). Effects of ageing on 
interference control in selective attention and working memory. Memory & Cognition, 
39(8), 1409–1422. doi:10.3758/s13421-011-0109-9 
Carlson, M. C., Xue, Q. L., Zhou, J., & Fried, L. P. (2009). Executive decline and dysfunction 
precedes declines in memory: The Women’s Health and Ageing Study II. Journals of 
Gerontology - Series A Biological Sciences and Medical Sciences, 64(1), 110–117. 
		
171	
doi:10.1093/gerona/gln008 
Carlsson, C. M., Gleason, C. E., Hess, T. M., & Moreland, K. A. (2008). Effects of Simvastatin 
on Cerebrospinal Fluid Biomarkers and Cognition in Middle-Aged Adults at Risk for 
Alzheimer ’ s Disease, 13, 187–197. 
Caselli, R. J., Chen, K., Lee, W., Alexander, G. E., & Reiman, E. M. (2008). Correlating 
cerebral hypometabolism with future memory decline in subsequent converters to 
amnestic pre–mild cognitive impairment. Archives of Neurology, 65(9), 1231–1236. 
Caselli, R. J., Chen, K., Locke, D. E. C., Lee, W., Roontiva, A., Bandy, D., … Reiman, E. M. 
(2014). Subjective cognitive decline: self and informant comparisons. Alzheimer’s & 
Dementia, 10(1), 93–98. 
Caselli, R. J., Dueck, A. C., Locke, D. E. C., Baxter, L. C., Woodruff, B. K., & Geda, Y. E. 
(2015). Sex-Based Memory Advantages and Cognitive Ageing: A Challenge to the 
Cognitive Reserve Construct? Journal of the International Neuropsychological Society, 
21(2), 95–104. doi:10.1017/S1355617715000016 
Caselli, R. J., Dueck, A. C., Locke, D. E. C., Hoffman-Snyder, C. R., Woodruff, B. K., 
Rapcsak, S. Z., & Reiman, E. M. (2011). Longitudinal modeling of frontal cognition in 
APOE epsilon-4 homozygotes, heterozygotes, and noncarriers. Neurology, 76(16), 1383–
1388. doi:10.1212/WNL.0b013ε3182167147 
Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., … 
Reiman, E. M. (2009). Longitudinal modeling of age-related memory decline and the 
APOE epsilon4 effect. The New England Journal of Medicine, 361, 255–263. 
doi:10.1016/S0084-3954(09)79603-4 
Caselli, R. J., Graff–Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J., … 
Thibodeau, S. N. (1999). Preclinical memory decline in cognitively normal apolipoprotein 
E–ε4 homozygotes. Neurology, 53(1), 201. 
Caselli, R. J., Locke, D. E. C., Dueck, A. C., Knopman, D. S., Woodruff, B. K., Hoffman-
Snyder, C., … Reiman, E. M. (2014). The neuropsychology of normal ageing and 
preclinical Alzheimer’s disease. Alzheimer’s & Dementia, 10(1), 84–92. 
Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., & 
Alexander, G. G. (2004). Longitudinal changes in cognition and behaviour in 
asymptomatic carriers of the APOE ε4 allele. Neurology, 62(11), 1990–1995. 
doi:10.1212/01.WNL.0000129533.26544.BF 
Chang, L., Douet, V., Bloss, C., Lee, K., Pritchett, A., Jernigan, T. L., … Gruen, J. (2016). Gray 
matter maturation and cognition in children with different APOE ε genotypes. Neurology, 
87(6), 1-10. doi:10.1212/WNL.0000000000002939 
Chen, C.-J., Chen, C.-C., Wu, D., Chi, N.-F., Chen, P.-C., Liao, Y.-P., … Hu, C.-J. (2013). 
Effects of the apolipoprotein E ε4 allele on functional MRI during n-back working 
		
172	
memory tasks in healthy middle-aged adults. AJNR. American Journal of Neuroradiology, 
34(6), 1197–1202. doi:10.3174/ajnr.A3369 
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2001). 
Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective 
community study. Archives of General Psychiatry, 58(9), 853–858. 
Chen, Y., Liu, Z., Zhang, J., Chen, K., Yao, L., Li, X., … Zhang, Z. (2016). Precuneus 
degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural 
and functional MRI analyses. Human Brain Mapping, 0(April), 271–282. 
doi:10.1002/hbm.23359 
Cheng, S. T. (2016). Cognitive Reserve and the Prevention of Dementia: the Role of Physical 
and Cognitive Activities. Current Psychiatry Reports, 18(9). doi:10.1007/s11920-016-
0721-2 
Chertkow, H., Nasreddine, Z., Joanette, Y., Drolet, V., Kirk, J., Massoud, F., … Bergman, H. 
(2007). Mild cognitive impairment and cognitive impairment, no dementia: Part A, 
concept and diagnosis. Alzheimer’s & Dementia, 3(4), 266–282. 
doi:10.1016/j.jalz.2007.07.013 
Chi, S. Y., Rabin, L. A., Aronov, A., Fogel, J., Kapoor, A., & Wang, C. (2014). Differential 
Focal and Nonfocal Prospective Memory Accuracy in a Demographically Diverse Group 
of Nondemented Community-Dwelling Older Adults. Journal of the International 
Neuropsychological Society, 20(10), 1015–1027. doi:10.1017/S1355617714000964 
Chiang, G. C., Insel, P. S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S. T., … 
Weiner, M. W. (2010). Hippocampal atrophy rates and CSF biomarkers in elderly APOΕ2 
normal subjects. Neurology, 75(22), 1976–1981. 
Chun, M. M. (2011). Visual working memory as visual attention sustained internally over time. 
Neuropsychologia, 49(6), 1407–1409. doi:10.1016/j.neuropsychologia.2011.01.029 
Clark, L. R., Racine, A. M., Koscik, R. L., Okonkwo, O. C., Engelmen, C. D., Carlsson, C. M., 
… Johnson, S. C. (2016). Beta-amyloid and cognitive decline in late middle age: Findings 
from the Wisconsin Registry for Alzheimer’s Prevention study. Alzheimer’s and 
Dementia, 12(7), 805–814. doi:10.1016/j.jalz.2015.12.009 
Cohen, R. M., Small, C., Lalonde, F., Friz, J., & Sunderland, T. (2001). Effect of apolipoprotein 
E genotype on hippocampal volume loss in ageing healthy women. Neurology, 57(12), 
2223–2228. 
Colangeli, S., Boccia, M., Verde, P., Guariglia, P., Bianchini, F., & Piccardi, L. (2016). 
Cognitive Reserve in Healthy Ageing and Alzheimers Disease: A Meta-Analysis of fMRI 
Studies. American Journal of Alzheimer’s Disease and Other Dementias, 31(5), 1–7. 
doi:10.1177/1533317516653826 
Colditz, G. A., & Hankinson, S. E. (2005). The Nurses’ Health Study: lifestyle and health 
		
173	
among women. Nature Reviews Cancer, 5(5), 388–396. 
Colditz, G. A., Manson, J. E., & Hankinson, S. E. (1997). The Nurses’ Health Study: 20-year 
contribution to the understanding of health among women. Journal of Women’s Health, 
6(1), 49–62. 
Cona, G., Bisiacchi, P. S., Sartori, G., & Scarpazza, C. (2016). Effects of cue focality on the 
neural mechanisms of prospective memory: A meta-analysis of neuroimageing studies. 
Scientific Reports, 6(April), 1–13. doi:10.1038/srep25983 
Cona, G., Scarpazza, C., Sartori, G., Moscovitch, M., & Bisiacchi, P. S. (2015). Neural bases of 
prospective memory: A meta-analysis and the “Attention to Delayed Intention” (AtoDI) 
model. Neuroscience and Biobehavioural Reviews, 52, 21–37. 
http://doi.org/10.1016/j.neubiorev.2015.02.007 
Conway, A. R. A., & Kane, M. J. (2001). Capacity, control and conflict: An individual 
differences perspective on attentional capture. Attraction, Distraction and Action: Multiple 
Perspectives on Attention Capture, 133, 349–372. 
Corder, E.H., Saunders, A.M., Strittmatter, W. J., Schmechel, D.E., Gaskell, P.C., Small, 
G...&Pericak-Vance, M. . (1993). Gene does of apolipoprotein E type 4 allele and the risk 
of Alzheimer’s disease in late onset families. Science, 261(5123), 921–923. 
Corder, E. H., Saunders, A. M., Risch, N. I., Strittmatterl, W. I., & Schmechel, D. E. (1994). 
Protective effect of apolipoprotein E type 2 allele for late onset. Nature Genetics, 7, 180–
184. 
Corley, J., Gow, A. J., Starr, J. M., & Deary, I. J. (2010). Is body mass index in old age related 
to cognitive abilities? The Lothian Birth Cohort 1936 Study. Psychology and Ageing, 
25(4), 867. 
Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., … Stern, Y. 
(2008). APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease. 
Neurology, 70(19 Part 2), 1842–1849. 
Costa, A., Caltagirone, C., & Carlesimo, G. A. (2011). Prospective memory impairment in mild 
cognitive impairment: An analytical review. Neuropsychology Review, 21(4), 390–404. 
http://doi.org/10.1007/s11065-011-9172-z 
Costa, A., Perri, R., Serra, L., Barban, F., Gatto, I., Zabberoni, S., … Carlesimo, G. A. (2010). 
Prospective memory functioning in mild cognitive impairment. Neuropsychology, 24(3), 
327. 
Coull, J. T., Frith, C. D., Frackowiak, R. S., & Grasby, P. M. (1996). A fronto-parietal network 
for rapid visual information processing: a PET study of sustained attention and working 
memory. Neuropsychologia, 34(11), 1085–1095. 
Cowan, N. (1999). An embedded-processes model of working memory. Models of Working 
Memory: Mechanisms of Active Maintenance and Executive Control, 20, 506. 
		
174	
Craft, S., Teri, L., Edland, S. D., Kukull, W. A., Schellenberg, G., McCormick, W. C., … 
Larson, E. B. (1998). Accelerated decline in apolipoprotein E-ϵ4 homozygotes with 
Alzheimer’s disease. Neurology, 51(1), 149–153. 
Crowell, T. A., Luis, C. A., Vanderploeg, R. D., Schinka, J. A., & Mullan, M. (2002). Memory 
Patterns and Executive Functioning in Mild Cognitive Impairment and Alzheimer’s 
Disease. Ageing, Neuropsychology, and Cognition, 9(4), 288–297. 
doi:10.1076/anec.9.4.288.8772 
Dahl, A. K., Hassing, L. B., Fransson, E. I., Gatz, M., Reynolds, C. A., & Pedersen, N. L. 
(2013). BMI across midlife and cognitive change in late life, 37(2), 296–302. 
doi:10.1038/ijo.2012.37.Body 
Dahl, A. K., Hassing, L. B., Fransson, E. I., & Pedersen, N. L. (2010). Agreement between self-
reported and measured height, weight and body mass index in old age—a longitudinal 
study with 20 years of follow-up. Age and Ageing, 39(4), 445–451. 
Davis, S. W., Dennis, N. A., Daselaar, S. M., Fleck, M. S., & Cabeza, R. (2007). Que PASA? 
The posterior–anterior shift in ageing. Cerebral Cortex, 18(5), 1201–1209. 
DeCoster, J. (2009). Meta-analysis notes. Retrieved 07/28/2016 from http://www.stat-
help.com/notes.html. 
de Frias, C. M., Bunce, D., Wahlin, A., Adolfsson, R., Sleegers, K., Cruts, M., … Nilsson, L.-G. 
(2007). Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory 
functioning in older adults. The Journals of Gerontology. Series B, Psychological Sciences 
and Social Sciences, 62(2), 112–118. doi: 10.1037/a0036828 
Deary, I. J., Whiteman, M. C., Pattie, A., Starr, J. M., Hayward, C., Wright, A. F., … Whalley, 
L. J. (2004). Apolipoprotein E Gene Variability and Cognitive Functions at Age 79: A 
Follow-Up of the Scottish Mental Survey of 1932. Psychology and Ageing, 19(2), 367–
371. doi:10.1037/0882-7974.19.2.367 
Deeny, S. P., Poeppel, D., Zimmerman, J. B., Roth, S. M., Brandauer, J., Witkowski, S., … 
Brandt, J. (2008). Exercise, APOE, and working memory: MEG and behavioural evidence 
for benefit of exercise in epsilon4 carriers. Biological Psychology, 78(2), 179–187. 
Den Heijer, T., Oudkerk, M., Launer, L. J., Van Duijn, C. M., Hofman, A., & Breteler, M. M. 
B. (2002). Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E 
genotypes. Neurology, 59(5), 746–748. 
Dennis, N. A., Browndyke, J. N., Stokes, J., Need, A., Burke, J. R., Welsh-Bohmer, K. A., & 
Cabeza, R. (2010). Temporal lobe functional activity and connectivity in young adult 
APOE ɛ4 carriers. Alzheimer’s & Dementia, 6(4), 303–311. 
Derryberry, D., & Reed, M. a. (2002). Anxiety-related attentional biases and their regulation by 
attentional control. Journal of Abnormal Psychology, 111(2), 225–236. doi:10.1037//0021-
843X.111.2.225 
		
175	
Dienes, Z. (2014). Using Bayes to get the most out of non-significant results. Frontiers in 
Psychology, 5, 781. 
Donix, M., Burggren, A. C., Suthana, N. A., Siddarth, P., Ekstrom, A. D., Krupa, A. K., … 
Bookheimer, S. Y. (2010). Family history of Alzheimer’s disease and hippocampal 
structure in healthy people. American Journal of Psychiatry, 167(11), 1399–1406. 
http://doi.org/10.1176/appi.ajp.2010.09111575 
Duchek, J. M., Balota, D. A, & Cortese, M. (2006). Prospective memory and apolipoprotein E 
in healthy ageing and early stage Alzheimer’s disease. Neuropsychology, 20(6), 633–44. 
doi:10.1037/0894-4105.20.6.633 
Duckworth, A. L., Peterson, C., Matthews, M. D., & Kelly, D. R. (2007). Grit: perseverance and 
passion for long-term goals. Journal of Personality and Social Psychology, 92(6), 1087. 
Einstein, G. O., McDaniel, M. A., Richardson, S. L., Guynn, M. J., & Cunfer, A. (1995). 
Ageing and prospective memory: examining the influences of self-initiated retrieval 
processes. Journal of Experimental Psychology. Learning, Memory, and Cognition, 21(4), 
996–1007. doi:10.1037/0278-7393.21.4.996 
Einstein, G. O., McDaniel, M. A., Thomas, R., Mayfield, S., Shank, H., Morrisette, N., & 
Breneiser, J. (2005). Multiple processes in prospective memory retrieval: factors 
determining monitoring versus spontaneous retrieval. Journal of Experimental 
Psychology: General, 134(3), 327-342. 
El Haj, M., Antoine, P., Amouyel, P., Lambert, J.-C., Pasquier, F., & Kapogiannis, D. (2016). 
Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer’s disease: A 
review. Ageing Research Reviews, 27, 15–22. 
Elias, M. F., Beiser, A., Wolf, P. A., Au, R., White, R. F., & D’agostino, R. B. (2000). The 
preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham 
Cohort. Archives of Neurology, 57(6), 808–813. 
Engle, R. W., & Kane, M. J. (2002). Executive attention, working memory capacity, and a two-
factor theory of cognitive control. Psychology of Learning and Motivation, 44, 145–199. 
doi:10.1016/S0079-7421(03)44005-X 
Erk, S. (2011). Evidence of Neuronal Compensation During Episodic Memory in Subjective 
Memory Impairment. Archives of General Psychiatry, 68(8), 845. 
doi:10.1001/archgenpsychiatry.2011.80 
Espeseth, T., Greenwood, P. M., Reinvang, I., Fjell, A. M., Walhovd, K. B., Westlye, L. T., … 
Parasuraman, R. (2006). Interactive effects of APOE and CHRNA4 on attention and white 
matter volume in healthy middle-aged and older adults. Cognitive, Affective, & 
Behavioural Neuroscience, 6(1), 31–43. doi:10.3758/CABN.6.1.31 
Espeseth, T., Westlye, L. T., Fjell, A. M., Walhovd, K. B., Rootwelt, H., & Reinvang, I. (2008). 
Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. 
		
176	
Neurobiology of Ageing, 29(3), 329–40. doi:10.1016/j.neurobiolageing.2006.10.030 
Espeseth, T., Westlye, L. T., Walhovd, K. B., Fjell, A. M., Endestad, T., Rootwelt, H., & 
Reinvang, I. (2012). Apolipoprotein E ε4-related thickening of the cerebral cortex 
modulates selective attention. Neurobiology of Ageing, 33(2), 304–322.e1. 
doi:10.1016/j.neurobiolageing.2009.12.027 
Etnier, J. L., Caselli, R. J., Reiman, E. M., Alexander, G. E., Sibley, B. A., Tessier, D., & 
Mclemore, E. C. (2007). Cognitive performance in older women relative to ApoE-ε4 
genotype and aerobic fitness. Med. Sci. Sports Exerc, 39(1), 199–207. 
Evans, S., Dowell, N. G., Tabet, N., Tofts, P. S., King, S. L., Gray, M., & Rusted, J. M. (2013). 
Nicotine effects on attentional reorienting in mid-age adults, and interactions with 
apolipoprotein E status. Journal of Psychopharmacology, 27(11), 1007–14. 
doi:10.1177/0269881113499828 
Evans, S., Dowell, N. G., Tabet, N., Tofts, P. S., King, S. L., & Rusted, J. M. (2014). Cognitive 
and neural signatures of the APOE Ε4 allele in mid-aged adults. Neurobiology of Ageing, 
35(7), 1615–1623. doi:10.1016/j.neurobiolageing.2014.01.145 
Evans, S., Gray, M. A., Dowell, N. G., Tabet, N., Tofts, P. S., King, S. L., & Rusted, J. M. 
(2013). APOE Ε4 Carriers Show Prospective Memory Enhancement Under Nicotine, and 
Evidence for Specialisation Within Medial BA10. Neuropsychopharmacology, 38(4), 
655–663. doi:10.1038/Npp.2012.230 
Fan, J., McCandliss, B. D., Fossella, J., Flombaum, J. I., & Posner, M. I. (2005). The activation 
of attentional networks. NeuroImage, 26(2), 471–479. 
doi:10.1016/j.neuroimage.2005.02.004 
Farina, N., Young, J., Tabet, N., & Rusted, J. (2013). Prospective memory in Alzheimer-type 
dementia: Exploring prospective memory performance in an age-stratified sample. Journal 
of Clinical and Experimental Neuropsychology, 35(9), 983–992. 
doi:10.1080/13803395.2013.844772 
Farlow, M. R., He, Y., Tekin, S., Xu, J., Lane, R., & Charles, H. C. (2004). Impact of APOE in 
mild cognitive impairment. Neurology, 63(10), 1898–1901. 
Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. a, Mayeux, R., … van Duijn, 
C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein 
E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta 
Analysis Consortium. JAMA : The Journal of the American Medical Association, 278(16), 
1349–1356. doi:10.1001/jama.1997.03550160069041 
Faust, M. E., & Balota, D. A. (2007). Attentional Control in Dementia of the Alzheimer’s Type: 
The Role of Unifying Principles in Cognitive Theory Development. Inhibition in 
Cognition, 213–238. doi:10.1037/11587-011 
Filbey, F. M., Chen, G., Sunderland, T., & Cohen, R. M. (2010). Failing compensatory 
		
177	
mechanisms during working memory in older apolipoprotein Ε4 healthy adults. Brain 
Imageing and Behaviour, 4(2), 177–188. doi:10.1007/s11682-010-9097-9 
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., … 
Mackay, C. E. (2009). Distinct patterns of brain activity in young carriers of the APOE-
epsilon4 allele. Proceedings of the National Academy of Sciences of the United States of 
America, 106(17), 7209–7214. doi:/10.1073/pnas.0811879106 
Finch, C. E. (2009). The neurobiology of middle-age has arrived. Neurobiology of Ageing, 
30(4), 515–520. 
Fjell, A. M., McEvoy, L., Holland, D., Dale, A. M., & Walhovd, K. B. (2014). What is normal 
in normal ageing? Effects of ageing, amyloid and Alzheimer’s disease on the cerebral 
cortex and the hippocampus. Progress in Neurobiology, 117, 20–40. 
doi:10.1016/j.pneurobio.2014.02.004 
Flory, J. D., Manuck, S. B., Ferrell, R. E., Ryan, C. M., & Muldoon, M. F. (2000). Memory 
Performance and the Apolipoprotein E Polymorphism in a Community Sample of Middle-
Aged Adults. American Journal of Medical Genetics, 96(6), 707–711. 
http://doi.org/10.1002/1096-8628(20001204)96:6<707::AID-AJMG1>3.0.CO;2-V 
Fornicola, W., Pelcovits, A., Li, B.-X., Heath, J., Perry, G., & Castellani, R. J. (2014). 
Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect 
Between Amyloid-β and Phosphorylated Tau. The Open Neurology Journal, 8, 22–26. 
doi:10.2174/1874205X01408010022 
Forster, S., & Lavie, N. (2007). High perceptual load makes everybody equal: eliminating 
individual differences in distractibility with load. Psychological Science, 18(5), 377–81. 
doi:10.1111/j.1467-9280.2007.01908.x 
Forster, S., & Lavie, N. (2008). Failures to ignore entirely irrelevant distractors: the role of load. 
Journal of Experimental Psychology. Applied, 14(1), 73–83. doi:10.1037/1076-
898X.14.1.73 
Forstmeier, S., Maercker, A., Maier, W., van den Bussche, H., Riedel-Heller, S., 
Kaduszkiewicz, H., … Wagner, M. (2012). Motivational reserve: motivation-related 
occupational abilities and risk of mild cognitive impairment and Alzheimer disease. 
Psychology and Ageing, 27(2), 353–363. doi:10.1037/a0025117 
Freeman, T., Roca, V., Guggenheim, F., Kimbrell, T., & Griffin, W. (2005). Neuropsychiatric 
associations of apolipoprotein E alleles in subjects with combat-related posttraumatic 
stress disorder. The Journal of Neuropsychiatry and Clinical Neurosciences, 17(4), 541–
543. doi:/10.1176/appi.neuropsych.17.4.541 
Frias, C. M. De, Schaie, K. W., & Willis, S. L. (2014). Hypertension Moderates the Effect of 
APOE on 21-Year Cognitive Trajectories. Psychology and Ageing, 29(2), 431–439. 
doi:10.1037/a0036828 
		
178	
Friedman, N. P., & Miyake, A. (2015). Unity and diversity of executive functions: Individual 
differences as a window on cognitive structure. Cortex, 86, 186–204. 
doi:10.1016/j.cortex.2016.04.023 
Frisoni, G. B., Louhija, J., Geroldi, C., & Trabucchi, M. (2001). Longevity and the ε2 Allele of 
Apolipoprotein E The Finnish Centenarians Study. The Journals of Gerontology Series A: 
Biological Sciences and Medical Sciences, 56(2), 75–78. 
Gazzaley, A., Cooney, J. W., Rissman, J., & D’Esposito, M. (2005). Top-down suppression 
deficit underlies working memory impairment in normal ageing. Nature Neuroscience, 
8(10), 1298–1300. doi:10.1038/nn1543 
Gazzaley, A., & Nobre, A. C. (2012). Top-down modulation: Bridging selective attention and 
working memory. Trends in Cognitive Sciences, 16(2), 129–135. 
doi:10.1016/j.tics.2011.11.014 
Geroldi, C., Pihlajamäki, M., Laakso, M. P., DeCarli, C., Beltramello, A., Bianchetti, A., … 
Frisoni, G. B. (1999). APOE-ε4 is associated with less frontal and more medial temporal 
lobe atrophy in AD. Neurology, 53(8), 1825. 
Gordon, B. A., Shelton, J. T., Bugg, J. M., McDaniel, M. A., & Head, D. (2011). Structural 
correlates of prospective memory. Neuropsychologia, 49(14), 3795–3800. 
doi:10.1016/j.neuropsychologia.2011.09.035 
Goveas, J. S., Xie, C., Chen, G., Li, W., Ward, B. D., Franczak, M. B., … Li, S.-J. (2013). 
Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in 
middle-aged adults. PloS One, 8(2), e55902. doi:10.1371/journal.pone.0055902 
Grady, C. L., Springer, M. V, Hongwanishkul, D., McIntosh, A. R., & Winocur, G. (2006). 
Age-related changes in brain activity across the adult lifespan. Journal of Cognitive 
Neuroscience, 18(2), 227–241. 
Greenwood, P. M, Lambert, C Sunderland, T, Paraduraman, R. (2005). Effects of 
Apolipoprotein E Genotype on Spatial Attention, Working Memory, and their interaction 
in Healthy, Middle-Aged Adults: Results from the National Institute of Mental Health’s 
BIOCARD study. Neuropsychology, 19(2), 199–211. 
Greenwood, P. M., Espeseth, T., Lin, M.-K., Reinvang, I., & Parasuraman, R. (2014). 
Longitudinal change in working memory as a function of APOE genotype in midlife and 
old age. Scandinavian Journal of Psychology, 55(3), 268–77. doi: 10.1111/sjop.12123 
Greenwood, P. M., & Parasuraman, R. (1999). Scale of attentional focus in visual search. 
Perception & Psychophysics, 61(5), 837–59. doi:10.3758/BF03206901 
Greenwood, P. M., & Parasuraman, R. (2004). The scaling of spatial attention in visual search 
and its modification in healthy ageing. Perception & Psychophysics, 66(1), 3–22. 
doi:10.3758/BF03194857 
Greenwood, P. M., Sunderland, T., Friz, J. L., & Parasuraman, R. (2000). Genetics and visual 
		
179	
attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the 
apolipoprotein E gene. Proceedings of the National Academy of Sciences of the United 
States of America, 97(21), 11661–11666. doi:10.1073/pnas.97.21.11661 
Greenwood, P. M., Sunderland, T., Putnam, K., Levy, J., & Parasuraman, R. (2005). Scaling of 
visuospatial attention undergoes differential longitudinal change as a function of APOE 
genotype prior to old age: Results from the NIMH BIOCARD Study. Neuropsychology, 
19(6), 830–40. doi:10.1037/0894-4105.19.6.830 
Grothe, M. J., Villeneuve, S., Dyrba, M., & Bartrés-faz, D. (2017). Multimodal characterization 
of older APOΕ2 carriers reveals selective reduction of amyloid load. Neurology, 88, 1-8. 
doi:10.1212/WNL.0000000000003585 
Haan, M. N., & Mayeda, E. R. (2010). Apolipoprotein E Genotype and Cardiovascular Diseases 
in the Elderly. Current Cardiovascular Risk Reports, 4(5), 361–368. doi:10.1007/s12170-
010-0118-4 
Hampshire, A., Chamberlain, S. R., Monti, M. M., Duncan, J., & Owen, A. M. (2010). The role 
of the right inferior frontal gyrus: inhibition and attentional control. NeuroImage, 50(3), 
1313–1319. doi:10.1016/j.neuroimage.2009.12.109 
Hampshire, A., & Owen, A. M. (2006). Fractionating attentional control using event-related 
fMRI. Cerebral Cortex, 16(12), 1679–1689. 
Han, S. D., & Bondi, M. W. (2008). Revision of the apolipoprotein E compensatory mechanism 
recruitment hypothesis. Alzheimer’s & Dementia : The Journal of the Alzheimer’s 
Association, 4(4), 251–254. doi:10.1016/j.jalz.2008.02.006 
Han, S. D., Drake, A. I., Cessante, L. M., Jak, A. J., Houston, W. S., Delis, D. C., … Bondi, M. 
W. (2007). Apolipoprotein E and traumatic brain injury in a military population: evidence 
of a neuropsychological compensatory mechanism? Journal of Neurology, Neurosurgery, 
and Psychiatry, 78(10), 1103–1108. doi:10.1136/jnnp.2006.108183 
Harrington, M. G., Chiang, J., Pogoda, J. M., Gomez, M., Thomas, K., Marion, S. D., … 
Fonteh, A. N. (2013). Executive function changes before memory in preclinical 
Alzheimer’s pathology: A prospective, cross-sectional, case control study. PLoS ONE, 
8(11). doi:10.1371/journal.pone.0079378 
Harrison, T. L., & Einstein, G. O. (2010). Prospective memory: Are preparatory attentional 
processes necessary for a single focal cue? Memory & Cognition, 38(7), 860–867. 
Hasher, L., & Zacks, R. T. (1988). Working memory, comprehension, and ageing: A review and 
a new view. Psychology of Learning and Motivation, 22, 193–225. 
Hawkins, K. M., Goyal, A. I., & Sergio, L. E. (2015). Diffusion tensor imageing correlates of 
cognitive-motor decline in normal ageing and increased Alzheimer’s disease risk. Journal 
of Alzheimer’s Disease, 44(3), 867–878. doi:10.3233/JAD-142079 
Head, D., Bugg, J. M., Goate, A. M., Fagan, A. M., Mintun, M. A., Benzinger, T., … Morris, J. 
		
180	
C. (2012). Exercise Engagement as a Moderator of the Effects of APOE Genotype on 
Amyloid Deposition. Archives of Neurology, 69(5), 636–43. 
doi:10.1001/archneurol.2011.845 
Heathcote, A., Loft, S., & Remington, R. W. (2015). Slow down and remember to remember! A 
delay theory of prospective memory costs. Psychological Review, 122(2), 376-410. 
Helkala, E.-L., Koivisto, K., Hänninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., … 
Riekkinen, P. (1996). Memory functions in human subjects with different apolipoprotein E 
phenotypes during a 3-year population-based follow-up study. Neuroscience Letters, 
204(3), 177–180. doi:10.1016/0304-3940(96)12348-X 
Henry, J. D., MacLeod, M. S., Phillips, L. H., & Crawford, J. R. (2004). A meta-analytic review 
of prospective memory and ageing. Psychology and Aging, 19(1), 27-39.  
Herrup, K. (2010). Reimagining Alzheimer’s Disease--An Age-Based Hypothesis. Journal of 
Neuroscience, 30(50), 16755–16762. doi:10.1523/JNEUROSCI.4521-10.2010 
Hirono, N., Hashimoto, M., Yasuda, M., Kazui, H., & Mori, E. (2003). Accelerated memory 
decline in Alzheimer’s disease with apolipoprotein ε4 allele. The Journal of 
Neuropsychiatry and Clinical Neurosciences, 15(3), 354–358. 
Hopfinger, J. B., Buonocore, M. H., & Mangun, G. R. (2000). The neural mechanisms of top-
down attentional control. Nature Neuroscience, 3(3), 284. 
Horn, S. S., Bayen, U. J., & Smith, R. E. (2013). Adult age differences in interference from a 
prospective-memory task: a diffusion model analysis. Psychonomic Bulletin & Review, 
20(6), 1266–1273. doi:10.3758/s13423-013-0451-y 
Hu, C., Yu, D., Sun, X., Zhang, M., Wang, L., & Qin, H. (2017). The prevalence and 
progression of mild cognitive impairment among clinic and community populations: a 
systematic review and meta-analysis. International Psychogeriatrics, 1–14. 
doi:10.1017/S1041610217000473 
Hubacek, J. A., Pitha, J., Škodová, Z., Adámková, V., Lánská, V., & Poledne, R. (2001). A 
Possible Role of Apolipoprotein E Polymorphism in Predisposition to Higher Education. 
Neuropsychobiology, 43(3), 200–203. doi:10.1159/000054890 
Hutchison, K. A., Balota, D. A., & Ducheck, J. M. (2010). The utility of Stroop task switching 
as a marker for early-stage Alzheimer’s disease. Psychology and Ageing, 25(3), 545. 
Ihle, A., Bunce, D., & Kliegel, M. (2012). APOE ε4 and cognitive function in early life: a meta-
analysis. Neuropsychology, 26(3), 267-277. doi:10.1037/a0026769 
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., … 
Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer’s 
pathological cascade. The Lancet Neurology, 9(1), 119–128. 
Jack, C. R., Wiste, H. J., Weigand, S. D., Knopman, D. S., Vemuri, P., Mielke, M. M., … 
Petersen, R. C. (2015). Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and 
		
181	
β-Amyloid Across the Adult Life Span. JAMA Neurology, 72(5), 511. 
doi:10.1001/jamaneurol.2014.4821 
Jagust, W. J., & Mormino, E. C. (2011). Lifespan brain activity, β-amyloid, and Alzheimer’s 
disease. Trends in Cognitive Sciences, 15(11), 520–526. doi:10.1016/j.tics.2011.09.004 
Jochemsen, H. M., Muller, M., van der Graaf, Y., & Geerlings, M. I. (2012). APOE ε4 
differentially influences change in memory performance depending on age. The SMART-
MR study. Neurobiology of Ageing, 33(4), 832.e15-22. doi: 
10.1016/j.neurobiolageing.2011.07.016 
Johnson, L. A, Zuloaga, D. G., Bidiman, E., Marzulla, T., Weber, S., Wahbeh, H., & Raber, J. 
(2015). ApoΕ2 Exaggerates PTSD-Related Behavioural, Cognitive, and Neuroendocrine 
Alterations. Neuropsychopharmacology, 40(10), 1–11. doi:10.1038/npp.2015.95 
Jorm, A. F., Mather, K. A, Butterworth, P., Anstey, K. J., Christensen, H., & Easteal, S. (2007). 
APOE genotype and cognitive functioning in a large age-stratified population sample. 
Neuropsychology, 21(1), 1–8. doi:10.1037/0894-4105.21.1.1 
Judah, M. R., Grant, D. M., Mills, A. C., & Lechner, W. V. (2014). Factor structure and 
validation of the attentional control scale. Cognition and Emotion, 28(3), 433–451. 
doi:10.1080/02699931.2013.835254 
Juva, K., Verkkoniemi, A., Viramo, P., Polvikoski, T., Kainulainen, K., Kontula, K., & Sulkava, 
R. (2000). APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest 
old. Neurology, 54(2), 412. 
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., … Potocnik, 
F. (2008). Alzheimer’s disease and vascular dementia in developing countries: prevalence, 
management, and risk factors. The Lancet Neurology, 7(9), 812–826. 
Kane, M. J. (2002). The role of the prefrontal cortex in working-memory capacity, executive 
attention, and general fluid intelligence: An individual-differences perspective, 
Psychonomic Bulletin & Review, 9(4), 637–671. 
Kane, M. J., & Engle, R. W. (2003). Working-memory capacity and the control of attention: 
The contributions of goal neglect, response competition, and task set to Stroop 
interference. Journal of Experimental Psychology: General, 132(1), 47–70. 
doi:10.1017/CBO9781107415324.004 
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000). Age-specific 
incidence rates of Alzheimer’s disease The Baltimore Longitudinal Study of Ageing. 
Neurology, 54(11), 2072–2077. 
Kievit, R. A., Davis, S. W., Mitchell, D. J., Taylor, J. R., Duncan, J., & Henson, R. N. A. 
(2014). Distinct aspects of frontal lobe structure mediate age-related differences in fluid 
intelligence and multitasking. Nature Communications, 5, 5658. doi: 
10.1038/ncomms6658 
		
182	
Kim, K. W., Youn, J. C., Jhoo, J. H., Lee, D. Y., Lee, K. U., Lee, J. H., & Woo, J. I. (2002). 
Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in 
community-dwelling normal elderly individuals. Int J Geriatr Psychiatry, 17(7), 635–640.  
Kim, S., Hasher, L., & Zacks, R. T. (2007). Ageing and a benefit of distractibility. Psychonomic 
Bulletin & Review, 14(2), 301–305. 
Kim, T. Y., Chung, H. G., Shin, H., Kim, S. J., Choi, J. H., Chung, M. Y., … Cho, H. (2013). 
Apolipoprotein E gene polymorphism, alcohol use, and their interactions in combat-related 
posttraumatic stress disorder. Depression and Anxiety, 30(12), 1194–1201. 
Kivipelto, M., & Solomon, A. (2008). Alzheimer's disease- the ways of prevention, The Journal 
of Nutrition, Health and Aging, 12(1), 89–94. 
Kliegel, M., Ballhausen, N., Hering, A., Ihle, A., Schnitzspahn, K. M., & Zuber, S. (2016). 
Prospective memory in older adults: Where we are now and what is next. Gerontology, 
62(4), 459–466. 
Kliegel, M., Jäger, T., & Phillips, L. H. (2008). Adult age differences in event-based 
prospective memory: a meta-analysis on the role of focal versus nonfocal cues. 
Psychology and Ageing, 23(1), 203–208. doi:10.1037/0882-7974.23.1.203 
Köhler, S., Baars, M. A. E., Spauwen, P., Schievink, S., Verhey, F. R. J., & van Boxtel, M. J. P. 
(2014). Temporal evolution of cognitive changes in incident hypertension: prospective 
cohort study across the adult age span. Hypertension, 63(2), 245–51. doi: 
10.1161/HYPERTENSIONAHA.113.02096 
Konishi, K., Bhat, V., Banner, H., Poirier, J., Joober, R., & Bohbot, V. D. (2016). APOE ε2 is 
associated with spatial navigation strategies and increased grey matter in the hippocampus. 
Front. Hum. Neurosci., 10, 349 doi:10.3389/fnhum.2016.00349 
Kozauer, N. A., Mielke, M. M., Chan, G. K. C., Rebok, G. W., & Lyketsos, C. G. (2008). 
Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics, 
20(1), 109–123. doi:10.1017/S104161020700587X 
Kunz, L., Schroder, T. N., Lee, H., Montag, C., Lachmann, B., Sariyska, R., … Axmacher, N. 
(2015). Reduced grid-cell-like representations in adults at genetic risk for Alzheimer’s 
disease. Science, 350(6259), 430–433. 
Lancaster, C., Tabet, N., & Rusted, J. (2016). The APOE paradox : do attentional control 
differences in mid-adulthood reflect risk of late-life cognitive decline. Neurobiology of 
Ageing, 48, 114–121. doi:10.1016/j.neurobiolageing.2016.08.015 
Lancaster, C., Tabet, N., & Rusted, J. (2017). The Elusive Nature of APOE ε4 in Mid-
adulthood: Understanding the Cognitive Profile. Journal of the International 
Neuropsychological Society, (2016), 1–15. doi:10.1017/S1355617716000990 
Landau, S. M., Marks, S. M., Mormino, E. C., Rabinovici, G. D., Oh, H., O’Neil, J. P., … 
Jagust, W. J. (2012). Association of Lifetime Cognitive Engagement and Low β-Amyloid 
		
183	
Deposition. Archives of Neurology, 69(5), 623. doi:10.1001/archneurol.2011.2748 
Langbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., … Reeder, S. A. 
(2010). Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino 
individuals carrying the apolipoprotein E ε4 allele. Archives of Neurology, 67(4), 462–468. 
Laukka, E. J., Lövdén, M., Herlitz, A., Karlsson, S., Ferencz, B., Pantzar, A., … Bäckman, L. 
(2013). Genetic effects on old-age cognitive functioning: A population-based study. 
Psychology and Ageing, 28(1), 262–274. doi:10.1037/a0030829 
Lavie, N. (1995). Perceptual load as a necessary condition for selective attention. Journal of 
Experimental Psychology: Human Perception and Performance, 21(3), 451. 
Lavie, N. (2005). Distracted and confused?: selective attention under load. Trends in Cognitive 
Sciences, 9(2), 75–82. doi: 10.1016/j.tics.2004.12.004 
Lavie, N. (2010). Attention, Distraction, and Cognitive Control Under Load. Current Directions 
in Psychological Science, 19(3), 143–148. doi:10.1177/0963721410370295 
Lavie, N., Hirst, A., de Fockert, J. W., & Viding, E. (2004). Load theory of selective attention 
and cognitive control. Journal of Experimental Psychology: General, 133(3), 339–354. 
doi:10.1037/0096-3445.133.3.339 
Lee, S. D., Ong, B., Pike, K. E., & Kinsella, G. J. (2017). Prospective memory and subjective 
memory decline: A neuropsychological indicator of memory difficulties in community-
dwelling older people. Journal of Clinical and Experimental Neuropsychology, 0(0), 1–15. 
doi:10.1080/13803395.2017.1326465 
Lee, S., Ong, B., Pike, K. E., Mullaly, E., Rand, E., Storey, E., … Kinsella, G. J. (2016). The 
Contribution of Prospective Memory Performance to the Neuropsychological Assessment 
of Mild Cognitive Impairment. The Clinical Neuropsychologist, 30(1), 131–149. 
doi:10.1080/13854046.2015.1135983 
Levy, J. A., Bergeson, J., Putnam, K., Rosen, V., Cohen, R., Lalonde, F., … Sunderland, T. 
(2004). Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive 
evidence from the NIMH prospective study of risk for Alzheimer’s disease. Journal of the 
International Neuropsychological Society : JINS, 10(3), 362–370. 
doi:10.1017/S1355617704103044 
Li, W., Antuono, P. G., Xie, C., Chen, G., Jones, J. L., Ward, B. D., … Li, S.-J. (2014). 
Aberrant functional connectivity in Papez circuit correlates with memory performance in 
cognitively intact middle-aged APOΕ4 carriers. Cortex, 57, 167–76. doi: 
10.1016/j.cortex.2014.04.006 
Lindenberger, U. (2008). Age-related decline in brain resources magnifies genetic effects on 
cognitive functioning. Frontiers in Neuroscience, 2(2), 234–244. 
doi:10.3389/neuro.01.039.2008 
Lippa, C. F., Smith, T. W., Saunders, A. M., Hulette, C., Pulaski-Salo, D., & Roses, A. D. 
		
184	
(1997). Apolipoprotein E-epsilon 2 and Alzheimer’s disease Genotype influences 
pathologic phenotype. Neurology, 48(2), 515–519. 
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013). Apolipoprotein E and Alzheimer disease: 
risk, mechanisms and therapy. Nature Reviews Neurology, 9(2), 106–118. 
Lockhart, S. N., & DeCarli, C. (2014). Structural Imageing Measures of Brain Ageing. 
Neuropsychology Review, 24(3), 271–289. doi:10.1007/s11065-014-9268-3.  
Loft, S., Bowden, V. K., Ball, B. H., & Brewer, G. A. (2014). Fitting an ex-Gaussian function to 
examine costs in event-based prospective memory: evidence for a continuous monitoring 
profile. Acta Psychologica, 152, 177–182. doi:10.1016/j.actpsy.2014.08.010 
Logie, R. H., Maylor, E. A, & Della Sala, S. (2004). Working memory in event- and time-based 
prospective memory tasks : effects of secondary demand and age. European Journal of 
Cognitive Psychology, 16(3), 441–456. doi:10.1080/09541440340000114 
Mahley, R. W. (1988). Apolipoprotein E : cholesterol transport protein with expanding role in 
cell biology. Science, 240(4852), 622–630. 
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006). Apolipoprotein Ε4: a causative factor 
and therapeutic target in neuropathology, including Alzheimer’s disease. Proceedings of 
the National Academy of Sciences of the United States of America, 103(15), 5644–51. 
doi:10.1073/pnas.0600549103 
Marchant, N. L., King, S. L., Tabet, N., & Rusted, J. M. (2010). Positive effects of cholinergic 
stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacology, 35(5), 
1090–1096. doi:10.1038/npp.2009.214 
Mariani, E., Monastero, R., & Mecocci, P. (2007). Mild Cognitive Impairment : A Systematic 
Review, Journal of Alzheimer's Disease,12, 23–35. 
Marioni, R. E., Campbell, A., Scotland, G., Hayward, C., Porteous, D. J., & Deary, I. J. (2015). 
Differential effects of the APOE ε4 allele on different domains of cognitive ability across 
the life-course. European Journal of Human Genetics, 24, 1–5. doi:10.1038/ejhg.2015.210 
Marsh, R. L., Hancock, T. W., & Hicks, J. L. (2002). The demands of an ongoing activity 
influence the success of event-based prospective memory. Psychonomic Bulletin & 
Review, 9(3), 604–610. doi:10.3758/BF03196319 
Marsh, R. L., Hicks, J. L., & Cook, G. I. (2005). On the relationship between effort toward an 
ongoing task and cue detection in event-based prospective memory. Journal of 
Experimental Psychology. Learning, Memory, and Cognition, 31(1), 68–75. 
doi:10.1037/0278-7393.31.1.68 
Marsh, R. L., Hicks, J. L., Cook, G. I., Hansen, J. S., & Pallos, A. L. (2003). Interference to 
ongoing activities covaries with the characteristics of an event-based intention. Journal of 
Experimental Psychology: Learning, Memory, and Cognition, 29(5), 861. 
Marshall, G. A., Rentz, D. M., Frey, M. T., Locascio, J. J., Johnson, K. A., & Sperling, R. A. 
		
185	
(2011). Executive function and instrumental activities of daily living in mild cognitive 
impairment and Alzheimer’s disease. Alzheimer’s and Dementia, 7(3), 300–308. 
doi:10.1016/j.jalz.2010.04.005 
Maylor, E. A., & Lavie, N. (1998). The influence of perceptual load on age differences in 
selective attention. Psychology and Ageing, 13(4), 563–573. doi:10.1037//0882-
7974.13.4.563 
McAlister, C., & Schmitter-Edgecombe, M. (2016). Everyday functioning and cognitive 
correlates in healthy older adults with subjective cognitive concerns. The Clinical 
Neuropsychologist, 30(7), 1087–1103. doi:10.1080/13854046.2016.1190404 
McDaniel, M. A., Einstein, G. O., & Jacoby, L. L. (2008). New considerations in ageing and 
memory. The Handbook of Ageing and Cognition, 4, 251–310. 
McDaniel, M. A., LaMontagne, P., Beck, S. M., Scullin, M. K., & Braver, T. S. (2013). 
Dissociable neural routes to successful prospective memory. Psychological Science, 24(9), 
1791–1800. 
Mcdaniel, M. A., Shelton, J. T., & Breneiser, J. E. (2012). Focal and Non-focal Prospective 
Memory Performance in Very Mild Dementia: A Signature Decline, 25(3), 387–396. 
doi:10.1037/a0021682.Focal 
McDaniel, M. A., Shelton, J. T., Breneiser, J. E., Moynan, S., & Balota, D. A. (2011). Focal and 
nonfocal prospective memory performance in very mild dementia: A signature decline. 
Neuropsychology, 25(3), 387. 
McDaniel, M. A., Umanath, S., Einstein, G. O., & Waldum, E. R. (2015). Dual pathways to 
prospective remembering. Frontiers in Human Neuroscience, 9. 
doi:10.3389/fnhum.2015.00392 
McFall, P. G., Wiebe, S. A., Vergote, D., Westaway, D., Jhamandas, J., Backman, L., & Dixon, 
R. A. (2015). ApoE and pulse pressure interactively influence level and change in the 
ageing of episodic memory: Protective effects among epsilon2 carriers. Neuropsychology, 
29(3), 388–401. doi:10.1037/neu0000150 
Mendonça, M. D., Alves, L., & Bugalho, P. (2016). From Subjective Cognitive Complaints to 
Dementia. American Journal of Alzheimer’s Disease & Other Dementias, 31(2), 105–114. 
doi:10.1177/1533317515592331 
Mielke, M. M., Machulda, M. M., Hagen, C. E., Christianson, T. J., Roberts, R. O., Knopman, 
D. S., … Petersen, R. C. (2015). Influence of amyloid and apolipoprotein E on cognitive 
performance in a late middle-aged cohort. Alzheimer’s & Dementia, (November), 1–11. 
doi:10.1016/j.jalz.2015.09.010 
Milham, M. P., Erickson, K. I., Banich, M. T., Kramer, A. F., Webb, A., Wszalek, T., & Cohen, 
N. J. (2002). Attentional Control in the Ageing Brain: Insights from an fMRI Study of the 
Stroop Task. Brain and Cognition, 49(3), 277–296. doi:10.1006/brcg.2001.1501 
		
186	
Miyake, A., & Friedman, N. P. (2012). The Nature and Organisation of Individual Differences 
in Executive Functions : Four General Conclusions. Current Directions in Psychological 
Science, 21(1), 8–14. doi:/10.1177/0963721411429458. 
Miyake, A., Friedman, N. P., Emerson, M. J., Witzki,  A H., Howerter, A., & Wager, T. D. 
(2000). The unity and diversity of executive functions and their contributions to complex 
“Frontal Lobe” tasks: a latent variable analysis. Cognitive Psychology, 41(1), 49–100. 
doi:10.1006/cogp.1999.0734 
Moffat, S. D., Szekely, C. A., Zonderman, A. B., Kabani, N. J., & Resnick, S. M. (2000). 
Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. 
Neurology, 55(1), 134–136. 
Mondadori, C. R. A, de Quervain, D. J.-F., Buchmann, A., Mustovic, H., Wollmer, M. A., 
Schmidt, C. F., … Henke, K. (2007). Better memory and neural efficiency in young 
apolipoprotein E epsilon4 carriers. Cerebral Cortex, 17(8), 1934–47. 
doi:10.1093/cercor/bhl103 
Morishima-Kawashima, M., Oshima, N., Ogata, H., Yamaguchi, H., Yoshimura, M., Sugihara, 
S., & Ihara, Y. (2000). Effect of apolipoprotein E allele ε 4 on the initial phase of amyloid 
β-protein accumulation in the human brain. American Journal of Pathology, 157(6), 2093–
2099. doi:10.1016/S0002-9440(10)64847-X 
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, 
M. A. (2010). APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively 
normal ageing. Annals of Neurology, 67(1), 122–131. doi:10.1002/ana.21843 
Mortamais, M., Ash, J. a, Harrison, J., Kaye, J., Kramer, J., Randolph, C., … Ritchie, K. (2016). 
Detecting cognitive changes in preclinical Alzheimer’s disease: A review of its feasibility. 
Alzheimer’s & Dementia, 13(October), 1–25. doi:10.1016/j.jalz.2016.06.2365 
Motes, M. A., Biswal, B. B., & Rypma, B. (2011). Age-Dependent Relationships between 
Prefrontal Cortex Activation and Processing Efficiency. Cognitive Neuroscience, 2(1), 1–
17. doi:10.1080/17588928.2010.512974. 
Nagy, Z. S., Esiri, M. M., Jobst, K. A., Johnston, C., Litchfield, S., Sim, E., & Smith, A. D. 
(1995). Influence of the apolipoprotein E genotype on amyloid deposition and 
neurofibrillary tangle formation in Alzheimer’s disease. Neuroscience, 69(3), 757–761. 
Nao, J., Sun, H., Wang, Q., Ma, S., Zhang, S., Dong, X., … Zheng, D. (2017). Adverse Effects 
of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter 
Volume in Healthy Young Adults. Frontiers in Human Neuroscience, 11(June), 1–9. 
doi:10.3389/fnhum.2017.00346 
Neale, C., Johnston, P., Hughes, M., & Scholey, A. (2015). Functional activation during the 
rapid visual information processing task in a middle aged cohort: An fMRI study. PLoS 
ONE, 10(10), 1–20. doi:10.1371/journal.pone.0138994 
		
187	
Negash, S., Greenwood, P. M., Sunderland, T., Parasuraman, R., Geda, Y. E., Knopman, D. S., 
… Smith, G. E. (2009). The influence of apolipoprotein E genotype on visuospatial 
attention dissipates after age 80. Neuropsychology, 23(1), 81–89. doi:10.1037/a0014014 
Nelson, H. E., & Willison, J. (1991). National Adult Reading Test (NART). Nfer-Nelson. 
Newman, A. B., Lee, J. S., Visser, M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., 
… Harris, T. B. (2005). Weight change and the conservation of lean mass in old age: the 
Health, Ageing and Body Composition Study. The American Journal of Clinical Nutrition, 
82(4), 872–878. 
Nichols, L. M., Masdeu, J. C., Mattay, V. S., Kohn, P., Emery, M., Sambataro, F., … 
Weinberger, D. R. (2012). Interactive effect of apolipoprotein e genotype and age on 
hippocampal activation during memory processing in healthy adults. Archives of General 
Psychiatry, 69(8), 804–813. 
Niedźwieńska, A., Kvavilashvili, L., Ashaye, K., & Neckar, J. (2017). Spontaneous Retrieval 
Deficits in Amnestic Mild Cognitive Impairment: A Case of Focal Event-Based 
Prospective Memory. Neuropscyhology, in press, doi:10.1037/neu0000378 
Nilsson, L. G., & Nilsson, E. (2009). Overweight and cognition. Scandinavian Journal of 
Psychology, 50(6), 660–667. doi:10.1111/j.1467-9450.2009.00777.x 
Niti, M., Yap, K.-B., Kua, E.-H., Tan, C.-H., & Ng, T.-P. (2008). Physical, social and 
productive leisure activities, cognitive decline and interaction with APOE-ε4 genotype in 
Chinese older adults. International Psychogeriatrics, 20(2), 237–251. 
Nucci, M. & M. (2011). Cognitive Reserve Index questionnaire (CRIq): a new instrument for 
measuring cognitive reserve. Aging Clinical and Experimental Research, 24(3), 218-226. 
O’Hara, R., Yesavage, J. A., Kraemer, H. C., Mauricio, M., Friedman, L. F., & Murphy, G. M. 
(1998). The APOE epsilon4 allele is associated with decline on delayed recall 
performance in community-dwelling older adults. J Am Geriatr Soc, 46(12), 1493–1498. 
doi:10.1111/j.1532-5415.1998.tb01532.x 
Oberlin, L. E., Manuck, S. B., Gianaros, P. J., Ferrell, R. E., Muldoon, M. F., Jennings, J. R., … 
Erickson, K. I. (2015). Blood Pressure Interacts With APOE ε4 to Predict Memory 
Performance in a Midlife Sample. Neuropsychology, 29(5), 693–702. 
http://doi.org/neu0000177 
Office for National Statistics. (2012). Population Ageing in the United Kingdom, its Constituent 
Countries and the European Union. Office for National Statistics, (March), 1–12. 
http://doi.org/10.1057/pt.2010.7 
Offit, K. (2011). Personalized medicine: new genomics, old lessons. Human Genetics, 130(1), 
3–14. 
Okamura, N., Furumoto, S., Fodero-Tavoletti, M. T., Mulligan, R. S., Harada, R., Yates, P., … 
Yanai, K. (2014). Non-invasive assessment of Alzheimer’s disease neurofibrillary 
		
188	
pathology using 18F-THK5105 PET. Brain, 137(6), 1762–1771. 
Osaka, N., Osaka, M., Kondo, H., Morishita, M., Fukuyama, H., & Shibasaki, H. (2004). The 
neural basis of executive function in working memory: An fMRI study based on individual 
differences. NeuroImage, 21(2), 623–631. doi:10.1016/j.neuroimage.2003.09.069 
Packard, C. J., Westendorp, R. G. J., Stott, D. J., Caslake, M. J., Murray, H. M., Shepherd, J., … 
Twomey, C. (2007). Association between apolipoprotein Ε4 and cognitive decline in 
elderly adults. Journal of the American Geriatrics Society, 55(11), 1777–1785. 
doi:10.1111/j.1532-5415.2007.01415.x 
Panizzon, M. S., Hauger, R., Xian, H., Vuoksimaa, E., Spoon, K. M., Mendoza, S. P., … Franz, 
C. E. (2014). Interaction of APOE genotype and testosterone on episodic memory in 
middle-aged men. Neurobiology of Ageing, 35(7), 1778.e1-1778.e8. 
doi:10.1016/j.neurobiolageing.2013.12.025 
Parasuraman, R., Greenwood, P. M., & Alexander, G. E. (2000). Alzheimer disease constricts 
the dynamic range of spatial attention in visual search. Neuropsychologia, 38(8), 1126–
1135. doi:10.1016/S0028-3932(00)00024-5 
Parasuraman, R., Greenwood, P. M., Haxby, J. V, & Grady, C. L. (1992). Visuospatial attention 
in dementia of the Alzheimer type. Brain, 115(3), 711–733. 
Patel, K. T., Stevens, M. C., Pearlson, G. D., Winkler, A. M., Hawkins, K. A., Skudlarski, P., & 
Bauer, L. O. (2013). Default mode network activity and white matter integrity in healthy 
middle-aged ApoΕ4 carriers. Brain Imageing and Behaviour, 7(1), 60–67. 
doi:10.1007/s11682-012-9187-y 
Peila, R., White, L. R., Petrovich, H., Masaki, K., Ross, G. W., Havlik, R. J., & Launer, L. J. 
(2001). Joint effect of the APOE gene and midlife systolic blood pressure on late-life 
cognitive impairment: the Honolulu-Asia ageing study. Stroke, 32(12), 2882–2889. 
doi:10.1161/hs1201.100392 
Perry, R. J., & Hodges, J. R. (1999). Attention and executive deficits in Alzheimer’s disease A 
critical review, Brain, 122, 383–404. 
Pesce, C., & Bösel, R. (2001). Focusing of visuospatial attention: Electrophysiological evidence 
from subjects with and without attentional expertise. Journal of Psychophysiology, 15(4), 
256-274. 
Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal 
Medicine, 256(3), 183–194. 
Petersen, R. C., & Morris, J. C. (2005). Mild cognitive impairment as a clinical entity and 
treatment target. Archives of Neurology, 62(7), 1160–1163. 
Petersen, S. E., & Posner, M. I. (2012). The attention system of the human brain: 20 years after. 
Annual Review of Neuroscience, 35, 73–89. 
Poirier, J., Delisle, M.-C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., … Gilfix, B. M. 
		
189	
(1995). Apolipoprotein Ε4 allele as a predictor of cholinergic deficits and treatment 
outcome in Alzheimer disease. Proceedings of the National Academy of Sciences, 92(26), 
12260–12264. 
Posner, M. I. (1980). Orienting of attention. Quarterly Journal of Experimental Psychology, 
32(1), 3–25. 
Posner, M. I., & Petersen, S. E. (1989). The attention system of the human brain. DTIC 
Document. 
Prince, M. J. (2015). World Alzheimer Report 2015: the global impact of dementia: an analysis 
of prevalence, incidence, cost and trends. Alzheimer’s Disease International. 
Protas, H. D., Chen, K., Langbaum, J. B. S., Fleisher, A. S., Alexander, G. E., Lee, W., … 
Reiman, E. M. (2013). Posterior cingulate glucose metabolism, hippocampal glucose 
metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 
levels of genetic risk for Alzheimer disease. JAMA Neurology, 70(3), 320–5. 
doi:10.1001/2013.jamaneurol.286 
Puttonen, S., Elovainio, M., Kivimäki, M., Lehtimäki, T., & Keltikangas-Järvinen, L. (2003). 
The Combined Effects of Apolipoprotein E Polymorphism and Low-Density Lipoprotein 
Cholesterol on Cognitive Performance in Young Adults. Neuropsychobiology, 48(1), 35–
40. doi:10.1159/000071827 
Qiu, C., Kivipelto, M., & Von Strauss, E. (2009). Epidemiology of Alzheimer’s disease: 
Occurrence, determinants, and strategies toward intervention. Dialogues in Clinical 
Neuroscience, 11(2), 111–128. doi:10.1097/ALN.0b013ε318212ba87 
Raber, J., Huang, Y., & Ashford, J. W. (2004). ApoE genotype accounts for the vast majority of 
AD risk and AD pathology. Neurobiology of Ageing, 25(5), 641–650. 
doi:10.1016/j.neurobiolageing.2003.12.023 
Rabin, L. A., Chi, S. Y., Wang, C., Fogel, J., Kann, S. J., & Aronov, A. (2014). Prospective 
memory on a novel clinical task in older adults with mild cognitive impairment and 
subjective cognitive decline. Neuropsychological Rehabilitation, 24(6), 868–893. 
doi:10.1080/09602011.2014.915855 
Rajan, K. B., Skarupski, K. A., Rasmussen, H. E., & Evans, D. A. (2014). Gene-environment 
interaction of body mass index and apolipoprotein E ε4 allele on cognitive decline. 
Alzheimer Disease and Associated Disorders, 28(2), 134–40. 
doi:10.1097/WAD.0000000000000013 
Rajan, K. B., Wilson, R. S., Weuve, J., Barnes, L. L., & Evans, D. A. (2015). Cognitive 
impairment 18 years before clinical diagnosis of Alzheimer disease dementia. Neurology, 
85(10), 898–904. doi:10.1212/WNL.0000000000001774 
Raz, N. (2000). Ageing of the brain and its impact on cognitive performance: Integration of 
structural and functional findings. In Craik, F., Salthouse, T (Eds.), Handbook of Ageing 
		
190	
and Cognition, second ed. Erlbaum, Mahwah, NJ, pp 1-90. 
Raz, N., Lindenberger, U., Rodrigue, K. M., Kennedy, K. M., Head, D., Williamson, A., … 
Acker, J. D. (2005). Regional brain changes in ageing healthy adults: general trends, 
individual differences and modifiers. Cerebral Cortex, 15(11), 1676–1689. 
Raz, N., & Rodrigue, K. M. (2006). Differential ageing of the brain: Patterns, cognitive 
correlates and modifiers. Neuroscience and Biobehavioural Reviews, 30(6), 730–748. 
doi:10.1016/j.neubiorev.2006.07.001 
Ready, R. E., Baran, B., Chaudhry, M., Schatz, K., Gordon, J., & Spencer, R. M. C. (2011). 
Apolipoprotein E-ε4, processing speed, and white matter volume in a genetically enriched 
sample of midlife adults. American Journal of Alzheimer’s Disease and Other Dementias, 
26(6), 463–468. doi:10.1177/1533317511421921 
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., … Hardy, J. 
(2004). Functional brain abnormalities in young adults at genetic risk for late-onset 
Alzheimer’s dementia. Proceedings of the National Academy of Sciences of the United 
States of America, 101(1), 284–289. doi:10.1073/pnas.2635903100 
Reinvang, I., Winjevoll, I. L., Rootwelt, H., & Espeseth, T. (2010). Working memory deficits in 
healthy APOE epsilon 4 carriers. Neuropsychologia, 48(2), 566–73. 
doi:10.1016/j.neuropsychologia.2009.10.018 
Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., … Johnson, 
K. A. (2010). Cognition, reserve, and amyloid deposition in normal ageing. Annals of 
Neurology, 67(3), 353–364. doi:/10.1002/ana.21904 
Reynolds, J. R., West, R., & Braver, T. (2009). Distinct neural circuits support transient and 
sustained processes in prospective memory and working memory. Cerebral Cortex, 19(5), 
1208–1221. doi:10.1093/cercor/bhn164 
Risacher, S. L., Kim, S., Shen, L., Nho, K., Foroud, T., Green, R. C., … Saykin, A. J. (2013). 
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-
MCI). Frontiers in Ageing Neuroscience, 5(APR), 1–12. doi:10.3389/fnagi.2013.00011 
Ritchie, K., Ritchie, C. W., Yaffe, K., Skoog, I., & Scarmeas, N. (2015). Is late-onset 
Alzheimer’s disease really a disease of midlife? Alzheimer’s & Dementia: Translational 
Research & Clinical Interventions, 1(2), 122–130. 
Rizzi, L., Rosset, I., & Roriz-cruz, M. (2014). Global Epidemiology of Dementia : Alzheimer ’ s 
and Vascular Types. BioMed Research International, 2014 
Rodríguez-Aranda, C., & Sundet, K. (2006). The frontal hypothesis of cognitive ageing: factor 
structure and age effects on four frontal tests among healthy individuals. The Journal of 
Genetic Psychology, 167(3), 269–287. doi:10.3200/GNTP.167.3.269-287 
Rosen, V. M., Bergeson, J. L., Putnam, K., Harwell, A., & Sunderland, T. (2002). Working 
memory and apolipoprotein E : What’s the connection ? Neuropsychologia, 40, 2226–
		
191	
2233. 
Rovio, S., Kåreholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., … Kivipelto, 
M. (2005). Leisure-time physical activity at midlife and the risk of dementia and 
Alzheimer’s disease. The Lancet. Neurology, 4(11), 705–11. doi:10.1016/S1474-
4422(05)70198-8 
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., … Villemagne, V. L. 
(2007). Imageing B-amyloid burden in ageing and dementia. Neurology, 68(20), 1718–
1725. doi:10.1212/01.wnl.0000261919.22630.ea 
Ruiz, J. R., Castillo, R., Labayen, I., Moreno, L. A., Fuentes, M. G., Lamuno, D. G., … Group, 
A. S. (2010). Individual and combined effects of ApoE and MTHFR 677C/T 
polymorphisms on cognitive performance in Spanish adolescents: the AVENA study. The 
Journal of Pediatrics, 156(6), 978–984. 
Rusted, J., & Carare, R. O. (2015). Are the effects of APOE ε4 on cognitive function in 
nonclinical populations age-and gender-dependent? Neurodegenerative Disease 
Management, 5(1), 37–48. 
Rusted, J. M., Evans, S. L., King, S. L., Dowell, N., Tabet, N., & Tofts, P. S. (2013). APOE ε4 
polymorphism in young adults is associated with improved attention and indexed by 
distinct neural signatures. Neuroimage, 65, 364–373. 10.1016/j.neuroimage.2012.10.010 
Rusted, J. M., Sawyer, R., Jones, C., Trawley, S. L., & Marchant, N. L. (2009). Positive effects 
of nicotine on cognition: the deployment of attention for prospective memory. 
Psychopharmacology, 202(1–3), 93. 
Rusted, J., & Trawley, S. (2006). Comparable effects of nicotine in smokers and nonsmokers on 
a prospective memory task. Neuropsychopharmacology, 31(7), 1545–1549. 
Sachs-Ericsson, N. J., Sawyer, K. A., Corsentino, E. A., Collins, N. A., & Blazer, D. G. (2010). 
APOE epsilon 4 allele carriers: Biological, psychological, and social variables associated 
with cognitive impairment. Ageing & Mental Health, 14(6), 679–691. 
doi:10.1080/13607860903292594 
Sager, M., Hermann, B., & La Rue, A. (2005). Middle-aged children of persons with 
Alzheimer’s disease: APOE genotypes and cognitive function in the Wisconsin Registry 
for Alzheimer’s Prevention. Journal of Geriatric Psychiatry and Neurology, 18(4), 245–9. 
doi:10.1177/0891988705281882 
Salo, A., Ylikoski, R., Verkkoniemi, A., Polvikoski, T., Juva, K., Rastas, S., … Notkola, I.-L. 
(2001). Does apolipoprotein E influence learning and memory in the nondemented oldest 
old? International Psychogeriatrics, 13(4), 451–459. 
Salthouse, T. (2012). Consequences of age-related cognitive declines. Annual Review of 
Psychology, 63, 201–226. 
Salthouse, T. A. (1991). Mediation of adult age differences in cognition by reductions in 
		
192	
working memory and speed of processing. Psychological Science, 2(3), 179–183. 
Salthouse, T. A. (1996). The processing-speed theory of adult age differences in cognition. 
Psychological Review, 103(3), 403. 
Salthouse, T. A. (2009). Decomposing age correlations on neuropsychological and cognitive 
variables. Journal of the International Neuropsychological Society, 15(5), 650–661. 
Salthouse, T. A., Atkinson, T. M., & Berish, D. E. (2003). Executive functioning as a potential 
mediator of age-related cognitive decline in normal adults. Journal of Experimental 
Psychology: General, 132(4), 566. 
Salvato, G. (2015). Does apolipoprotein E genotype influence cognition in middle-aged 
individuals? Current Opinion in Neurology, 28(6), 612–617. 
Salvi, P. (2012). Pulse waves. How Vascular Hemodynamics Affects Blood Pressure. doi: 
10.1007/978-3-319-40501-8 
Scarmeas, N., & Stern, Y. (2003). Cognitive Reserve and Lifestyle. Journal of Clinical and 
Experimental Neuropsychology, 25, 625–633. doi:10.1076/jcen.25.5.625.14576 
Schaie, K. W. (2005). What can we learn from longitudinal studies of adult development? 
Research in Human Development, 2(3), 133–158. 
Scheller, E., Peter, J., Schumacher, L. V., Lahr, J., Mader, I., Kaller, C. P., & Klöppel, S. 
(2017). APOE moderates compensatory recruitment of neuronal resources during working 
memory processing in healthy older adults. Neurobiology of Ageing, 56, 127–137. 
http://doi.org/10.1016/j.neurobiolageing.2017.04.015 
Schiepers, O. J. G., Harris, S. E., Gow, A. J., Pattie, A., Brett, C. E., Starr, J. M., & Deary, I. J. 
(2012). APOE Ε4 status predicts age-related cognitive decline in the ninth decade: 
longitudinal follow-up of the Lothian Birth Cohort 1921. Molecular Psychiatry, 17(3), 
315–324. doi:10.1038/mp.2010.137 
Schmitter-Edgecombe, M., Woo, E., & Greeley, D. R. (2009). Characterizing multiple memory 
deficits and their relation to everyday functioning in individuals with mild cognitive 
impairment. Neuropsychology, 23(2), 168. 
Schnitzspahn, K. M., Stahl, C., Zeintl, M., Kaller, C. P., & Kliegel, M. (2013). The role of 
shifting, updating, and inhibition in prospective memory performance in young and older 
adults. Developmental Psychology, 49(8), 1544–1553. doi10.1037/a0030579 
Schreiber, S., Vogel, J., Schwimmer, H. D., Marks, S. M., Schreiber, F., & Jagust, W. (2016). 
Impact of lifestyle dimensions on brain pathology and cognition. Neurobiology of Ageing, 
40, 164–172. doi:10.1016/j.neurobiolageing.2016.01.012 
Schuit, A. J., Feskens, E. J., Launer, L. J., & Kromhout, D. (2001). Physical activity and 
cognitive decline, the role of the apolipoprotein ε4 allele. Medicine and Science in Sports 
and Exercise, 33(5), 772–777. 
Schultz, M. R., Lyons, M. J., Franz, C. E., Grant, M. D., Boake, C., Jacobson, K. C., … 
		
193	
Kremen, W. S. (2008). Apolipoprotein E genotype and memory in the sixth decade of life. 
Neurology, 70(19 Pt 2), 1771–1777. doi:10.1212/01.wnl.0000286941.74372.cc 
Scullin, M. K., McDaniel, M. A., & Einstein, G. O. (2010). Control of cost in prospective 
memory: Evidence for spontaneous retrieval processes. Journal of Experimental 
Psychology: Learning, Memory, and Cognition, 36(1), 190-203. doi:10.1037/a0018971 
Scullin, M. K., McDaniel, M. A., & Shelton, J. T. (2013). The Dynamic Multiprocess 
Framework: Evidence from prospective memory with contextual variability. Cognitive 
Psychology, 67(1–2), 55–71. doi:10.1016/j.cogpsych.2013.07.001 
Scullin, M. K., McDaniel, M. A., Shelton, J. T., & Lee, J. H. (2010). Focal/nonfocal cue effects 
in prospective memory: Monitoring difficulty or different retrieval processes? Journal of 
Experimental Psychology: Learning, Memory, and Cognition, 36(3), 736. 
Sebastian, M. V., Menor, J., & Elosua, M. R. (2006). Attentional dysfunction of the central 
executive in AD: Evidence from dual task and perseveration errors. Cortex, 42(7), 1015–
1020. 
Selkoe, D. J., & Hardy, J. (2016). The amyloid hypothesis of Alzheimer9s disease at 25 years. 
EMBO Molecular Medicine, 8(6), 595–608. 
Serrano-Pozo, A., Qian, J., Monsell, S. E., Betensky, R. A., & Hyman, B. T. (2015). APOEε2 is 
associated with milder clinical and pathological Alzheimer disease. Annals of Neurology, 
77(6), 917–729. doi:10.1002/ana.24369 
Sesso, H. D., Stampfer, M. J., Rosner, B., Hennekens, C. H., Gaziano, J. M., Manson, J. E., & 
Glynn, R. J. (2000). Systolic and diastolic blood pressure, pulse pressure, and mean 
arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension, 36(5), 
801–807. doi:10.1161/01.HYP.36.5.801 
Shaw, P., Lerch, J. P., Pruessner, J. C., Taylor, K. N., Rose, A. B., Greenstein, D., … Giedd, J. 
N. (2007). Cortical morphology in children and adolescents with different apolipoprotein 
E gene polymorphisms: an observational study. The Lancet Neurology, 6(6), 494–500. 
Sheline, Y. I., Morris, J. C., Snyder, A. Z., Price, J. L., Yan, Z., D’Angelo, G., … Mintun, M. a. 
(2010, December 15). APOΕ4 allele disrupts resting state fMRI connectivity in the 
absence of amyloid plaques or decreased CSF Aβ42. The Journal of Neuroscience, 30, 
17035-17040. doi:10.1523/JNEUROSCI.3987-10.2010 
Shin, M. H., Kweon, S. S., Choi, J. S., Lee, Y. H., Nam, H. S., Park, K. S., … Jeong, S. K. 
(2014). The effect of an APOE polymorphism on cognitive function depends on age. 
Journal of Neurology, 261, 66–72. doi:10.1007/s00415-013-7157-y 
Shu, H., Shi, Y., Chen, G., Wang, Z., Liu, D., Yue, C., … Zhang, Z. (2016). Opposite Neural 
Trajectories of Apolipoprotein e ??4 and ??2 Alleles with Ageing Associated with 
Different Risks of Alzheimer’s Disease. Cerebral Cortex, 26(4), 1421–1429. 
doi:10.1093/cercor/bhu237 
		
194	
Singh-Manoux, A., Kivimaki, M., Glymour, M. M., Elbaz, A., Berr, C., Ebmeier, K. P., … 
Dugravot, A. (2012). Timing of onset of cognitive decline: results from Whitehall II 
prospective cohort study. BMJ, 344. doi:10.1136/bmj.d7622 
Sliwinski, M., & Buschke, H. (1999). Cross-sectional and longitudinal relationships among age, 
cognition, and processing speed. Psychology and Ageing, 14(1), 18. 
Small, B. J., Rosnick, C. B., Fratiglioni, L., & Bäckman, L. (2004). Apolipoprotein E and 
cognitive performance: a meta-analysis. Psychology and Ageing, 19(4), 592–600. 
doi:10.1037/0882-7974.19.4.592 
Smith, G., Del Sala, S., Logie, R. H., & Maylor, E. A. (2000). Prospective and retrospective 
memory in normal ageing and dementia: A questionnaire study. Memory, 8(5), 311–321. 
doi:10.1080/09658210050117735 
Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J., & 
Petersen, R. C. (1998). Apolipoprotein E genotype influences cognitive “phenotype”in 
patients with Alzheimer’s disease but not in healthy control subjects. Neurology, 50(2), 
355–362. 
Smith, J. C., Nielson, K. A., Woodard, J. L., Seidenberg, M., Durgerian, S., Hazlett, K. E., … 
Rao, S. M. (2014). Physical activity reduces hippocampal atrophy in elders at genetic risk 
for Alzheimer’s disease. Frontiers in Ageing Neuroscience, 6(APR), 1–
doi:10.3389/fnagi.2014.00061 
Smith, P. J., Blumenthal, J. A., Hoffman, B. M., Strauman, T. A., Welsh-bohmer, K., Jeffrey, 
N., & Sherwood, A. (2011). Aerobic exercise and neurocognitive performance: a meta- 
analytic review of randomized controlled trials. Psychosomatic Medicine, 72(3), 239–252. 
doi:10.1097/PSY.0b013ε3181d14633.Aerobic 
Soldan, A., Pettigrew, C., Li, S., Wang, M.-C., Moghekar, A., Selnes, O. A., … O’Brien, R. 
(2013). Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the 
emergence of clinical symptoms in preclinical Alzheimer’s disease. Neurobiology of 
Ageing, 34(12), 2827–34. doi:10.1016/j.neurobiolageing.2013.06.017 
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., … 
Montine, T. J. (2011). Toward defining the preclinical stages of Alzheimer’s disease: 
Recommendations from the National Institute on Ageing-Alzheimer’s Association 
workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 
7(3), 280–292. 
Staehelin, H. B., Perrig-Chiello, P., Mitrache, C., Miserez, A. R., & Perrig, W. J. (1999). 
Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta 
Neurologica Scandinavica, 100(1), 53–60. 
Stening, E., Persson, J., Eriksson, E., Wahlund, L. O., Zetterberg, H., & Söderlund, H. (2016). 
Apolipoprotein E ε4 is positively related to spatial performance but unrelated to 
		
195	
hippocampal volume in healthy young adults. Behavioural Brain Research, 299, 11–18. 
doi:10.1016/j.bbr.2015.11.006 
Stern, Y. (2002). What is cognitive reserve? Theory and research application  of the reserve 
concept. Journal of the International Neuropsychological Society, 8(3), 448–460. 
Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological 
tests: Administration, norms, and commentary. American Chemical Society. 
Strickland, L., Heathcote, A., Remington, R. W., & Strickland, L. (2017). Accumulating 
evidence about what prospective memory costs actually reveal, Journal of Experimental 
Psychology: Learning, Memory and Cognition, 1–48. 
Sunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., … Cohen, R. M. 
(2004). Cerebrospinal fluid ??-amyloid 1-42 and tau in control subjects at risk for 
Alzheimer’s disease: The effect of APOE ??4 allele. Biological Psychiatry, 56(9), 670–
676. doi:10.1016/j.biopsych.2004.07.021 
Suri, S., Heise, V., Trachtenberg, A. J., & Mackay, C. E. (2013). The forgotten APOE allele: A 
review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2. 
Neuroscience & Biobehavioural Reviews, 37(10), 2878–2886. 
doi:10.1016/j.neubiorev.2013.10.010 
Suri, S., Mackay, C. E., Kelly, M. E., Germuska, M., Tunbridge, E. M., Frisoni, G. B., … 
Filippini, N. (2015). Reduced cerebrovascular reactivity in young adults carrying the 
APOE ε4 allele. Alzheimer’s and Dementia, 11(6), 648–657.e1. 
doi:10.1016/j.jalz.2014.05.1755 
Sweet, R. A., Seltman, H., Emanuel, J. E., Lopez, O. L., Becker, J. T., Bis, J. C., … Kuller, L. 
H. (2012). Effect of Alzheimer Disease Risk Genes on Trajectories of Cognitive Function 
in the Cardiovascular Health Study. The American Journal of Psychiatry, 169(9), 954–
962. doi:10.1176/appi.ajp.2012.11121815 
Tam, J. W., & Schmitter-Edgecombe, M. (2013). Event-based prospective memory and 
everyday forgetting in healthy older adults and individuals with mild cognitive 
impairment. Journal of Clinical and Experimental Neuropsychology, 35(3), 279–290. 
doi:10.1080/13803395.2013.770823 
Taylor, A. E., Guthrie, P. A. I., Smith, G. D., Golding, J., Sattar, N., Hingorani, A. D., … Day, 
I. N. M. (2011). IQ, educational attainment, memory and plasma lipids: associations with 
apolipoprotein E genotype in 5995 children. Biological Psychiatry, 70(2), 152–158. 
Taylor, W. D., Boyd, B., Turner, R., McQuoid, D. R., Ashley-Koch, A., MacFall, J. R., … 
Potter, G. G. (2016). APOE ε4 associated with preserved executive function performance 
and maintenance of temporal and cingulate brain volumes in younger adults. Brain 
Imageing and Behaviour. doi:10.1007/s11682-016-9522-9 
Thal, D. R., Attems, J., & Ewers, M. (2014). Spreading of amyloid, tau, and microvascular 
		
196	
pathology in Alzheimer’s disease: findings from neuropathological and neuroimageing 
studies. Journal of Alzheimer’s Disease, 42(s4), S421–S429. 
Tian, Y., Wang, Z., Jia, Y., Li, S., Wang, B., Wang, S., … Jiang, R. (2013). Intracranial 
pressure variability predicts short-term outcome after intracerebral hemorrhage: A 
retrospective study. Journal of the Neurological Sciences, 330(1–2), 38–44. 
doi:10.1016/j.jns.2013.04.001 
Tiego, J., Testa, R., Bellgrove, M. A., Pantelis, C., & Whittle, S. (2017). A three-component, 
hierarchical model of executive attention. in press 
Tiraboschi, P., Hansen, L. A., Masliah, E., Alford, M., Thal, L. J., & Corey-Bloom, J. (2004). 
Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer 
disease. Neurology, 62(11), 1977–1983. 
Tolppanen, A.-M., Solomon, A., Kulmala, J., Kåreholt, I., Ngandu, T., Rusanen, M., … 
Kivipelto, M. (2015). Leisure-time physical activity from mid- to late life, body mass 
index, and risk of dementia. Alzheimer’s & Dementia : The Journal of the Alzheimer’s 
Association, 11(4), 434–443. doi:10.1016/j.jalz.2014.01.008 
Townsend, J. T., & Ashby, F. G. (1978). Methods of modeling capacity in simple processing 
systems. Cognitive Theory, 3, 200–239. 
Trachtenberg, A. J., Filippini, N., Cheeseman, J., Duff, E. P., Neville, M. J., Ebmeier, K. P., … 
Mackay, C. E. (2012). The effects of APOE on brain activity do not simply reflect the risk 
of Alzheimer’s disease. Neurobiology of Ageing, 33(3), 618.e1-618.e13. 
doi:10.1016/j.neurobiolageing.2010.11.011 
Trachtenberg, A. J., Filippini, N., Ebmeier, K. P., Smith, S. M., Karpe, F., & Mackay, C. E. 
(2012). The effects of APOE on the functional architecture of the resting brain. 
NeuroImage, 59(1), 565–72. 10.1016/j.neuroimage.2011.07.059 
Traykov, L., Raoux, N., Latour, F., Gallo, L., Hanon, O., Baudic, S., … Rigaud, A.-S. (2007). 
Executive functions deficit in mild cognitive impairment. Cognitive and Behavioural 
Neurology, 20(4), 219–224. 
Treisman, A. M., & Gelade, G. (1980). A feature-integration theory of attention. Cognitive 
Psychology, 12(1), 97–136. 
Turic, D., Fisher, P. J., Plomin, R., & Owen, M. J. (2001). No association between 
apolipoprotein E polymorphisms and general cognitive ability in children. Neuroscience 
Letters, 299(1), 97–100. 
Turner, M. L., & Engle, R. W. (1989). Is working memory capacity task dependent? Journal of 
Memory and Language, 28(2), 127–154. 
Twamley, E. W., Ropacki, S. A L., & Bondi, M. W. (2006). Neuropsychological and 
neuroimageing changes in preclinical Alzheimer’s disease. Journal of the International 
Neuropsychological Society, 12(5), 707–735. doi:10.1017/S1355617706060863 
		
197	
Uttl, B. (2008). Transparent meta-analysis of prospective memory and ageing. PLoS ONE, 3(2). 
doi:/10.1371/journal.pone.0001568 
van den Berg, E., Kant, N., & Postma, A. (2012). Remember to buy milk on the way home! A 
meta-analytic review of prospective memory in mild cognitive impairment and dementia. 
Journal of the International Neuropsychological Society, 18(4), 706–716. 
van der Vlies, A. E., Pijnenburg, Y. A. L., Koene, T., Klein, M., Kok, A., Scheltens, P., & van 
der Flier, W. M. (2007). Cognitive impairment in Alzheimer’s disease is modified by 
APOE genotype. Dementia and Geriatric Cognitive Disorders, 24(2), 98–103. 
van Exel, E., de Craen, A. J. M., Gussekloo, J., Houx, P., Bootsma-van der Wiel, A., 
Macfarlane, P. W., … Westendorp, R. G. J. (2002). Association between high-density 
lipoprotein and cognitive impairment in the oldest old. Annals of Neurology, 51(6), 716–
721. doi:10.1002/ana.10220 
Velichkovsky, B. B., Roschina, I. F., & Selezneva, N. D. (2015). Cognitive control and memory 
in healthy ApoE-ε4 carriers with a family history of Alzheimer’s disease. Psychology in 
Russia: State of the Art, 8(1), 4–13. http://doi.org/10.11621/pir.2015.0101 
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Knopman, D. S., Machulda, M., Lowe, V. J., … 
Jack, C. R. (2016). Effect of intellectual enrichment on AD biomarker trajectories, 86(12), 
1128–1135. doi:10.1212/WNL.0000000000002490 
Vemuri, P., Lesnick, T. G., Przybelski, S. A., Machulda, M., Knopman, D. S., Mielke, M. M., 
… Jack, C. R. (2014). Association of Lifetime Intellectual Enrichment With Cognitive 
Decline in the Older Population. JAMA Neurology, 71(8), 1017. 
doi:10.1001/jamaneurol.2014.963 
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011). Apolipoprotein E in Alzheimer’s 
disease and other neurological disorders. The Lancet Neurology, 10(3), 241–252. 
Verhaeghen, P., & Cerella, J. (2002). Ageing, executive control, and attention: a review of 
meta-analyses. Neuroscience & Biobehavioural Reviews, 26(7), 849–857. 
doi:10.1016/S0149-7634(02)00071-4 
Villemagne, V., Pike, K., Chételat, G., Ellis, K., Mulligan, R., Bourgeat, P., … Rowe, C. 
(2011). Longitudinal assessment of Aβ and cognition in ageing and Alzheimer disease. 
Ann Neurol., 69(1), 181–192. doi:10.1002/ana.22248.Longitudinal 
Villeneuve, S., Brisson, D., Marchant, N. L., & Gaudet, D. (2014). The potential applications of 
Apolipoprotein E in personalized medicine. Frontiers in Ageing Neuroscience, 6(July), 1–
11. doi:10.3389/fnagi.2014.00154 
Walhovd, K. B., Fjell, A. M., & Espeseth, T. (2014). Cognitive decline and brain pathology in 
ageing--need for a dimensional, lifespan and systems vulnerability view. Scandinavian 
Journal of Psychology, 55(3), 244–254. doi: 10.1111/sjop.12120 
Wallace, J. C., Kass, S. J., & Stanny, C. J. (2002). The cognitive failures questionnaire 
		
198	
revisited: dimensions and correlates. The Journal of General Psychology, 129(3), 238–
256. doi:10.1080/00221300209602098 
Wasylyshyn, C., & Sliwinski, M. J. (2011). Ageing and Task Switching: A Meta-Analysis. 
Psychology and Ageing, 26(1), 15–20. doi:10.1037/a0020912.Ageing 
Wesnes, K., & Warburton, D. M. (1983). Effects of smoking on rapid information processing 
performance. Neuropsychobiology, 9(4), 223–229. 
West, R., Bowry, R., & Krompinger, J. (2006). The effects of working memory demands on the 
neural correlates of prospective memory. Neuropsychologia, 44(2), 197–207. 
Wetter, S. R., Delis, D. C., Houston, W. S., Jacobson, M. W., Lansing, A., Cobell, K., … Bondi, 
M. W. (2005). Deficits in inhibition and flexibility are associated with the APOE-Ε4 allele 
in nondemented older adults. Journal of Clinical and Experimental Neuropsychology, 
27(8), 943–952. doi:10.1080/13803390490919001 
Whitehair, D. C., Sherzai, A., Emond, J., Raman, R., Aisen, P. S., Petersen, R. C., & Fleisher, 
A. S. (2010). Influence of apolipoprotein E varepsilon4 on rates of cognitive and 
functional decline in mild cognitive impairment. Alzheimer’s & Dementia : The Journal of 
the Alzheimer’s Association, 6(5), 412–9. doi:10.1016/j.jalz.2009.12.003 
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005). Midlife 
cardiovascular risk factors and risk of dementia in late life. Neurology, 64(2), 277–281. 
doi:10.1212/01.WNL.0000149519.47454.F2 
Wilson, R. S., Bienias, J. L., Berry-Kravis, E., Evans, D. A., & Bennett, D. A. (2002). The 
apolipoprotein E ε2 allele and decline in episodic memory. Journal of Neurology, 
Neurosurgery & Psychiatry, 73(6), 672–677. 
Wilson, R.S., Leurgans, S. E., Boyle, P.A., & Bennett, D. A. (2011). Cognitive decline in 
prodromal alzheimer disease and mild cognitive impairment. Archives of Neurology, 
68(3), 351–356. doi:10.1001/archneurol.2011.31 
Wirth, M., Villeneuve, S., La Joie, R., Marks, S. M., & Jagust, W. J. (2014). Gene-environment 
interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden. The 
Journal of Neuroscience, 34(25), 8612–7. doi:10.1523/JNEUROSCI.4612-13.2014 
Wisdom, N. M., Callahan, J. L., & Hawkins, K. A. (2011). The effects of apolipoprotein E on 
non-impaired cognitive functioning: a meta-analysis. Neurobiology of Ageing, 32(1), 63–
74. doi:10.1016/j.neurobiolageing.2009.02.003 
Wishart, H. A., Saykin, A. J., Rabin, L. A., Santulli, R. B., Flashman, L. A., Guerin, S. J., … 
McAllister, T. W. (2006). Increased brain activation during working memory in 
cognitively intact adults with the APOE 34 allele. American Journal of Psychiatry, 163(9), 
1603–1610. doi:10.1176/appi.ajp.163.9.1603 
Wolk, D. a, & Dickerson, B. C. (2010). Apolipoprotein E (APOE) genotype has dissociable 
effects on memory and attentional-executive network function in Alzheimer’s disease. 
		
199	
Proceedings of the National Academy of Sciences of the United States of America, 
107(22), 10256–10261. doi:10.1073/pnas.1001412107 
Woodard, J., A. Sugarman, M., A. Nielson, K., Carson Smith, J., Seidenberg, M., Durgerian, S., 
… A. Matthews, M. (2012). Lifestyle and Genetic Contributions to Cognitive Decline and 
Hippocampal Structure and Function in Healthy Ageing. Current Alzheimer Research, 
9(4), 436–446. http://doi.org/10.2174/156720512800492477 
Woods, S. P., Weinborn, M., Velnoweth, A., Rooney, A., & Bucks, R. S. (2012). Memory for 
Intentions is Uniquely Associated with Instrumental Activities of Daily Living in Healthy 
Older Adults. Journal of the International Neuropsychological Society, 18(1), 134–138. 
Doi: 10.1017/S1355617711001263 
Xu, G., McLaren, D. G., Ries, M. L., Fitzgerald, M. E., Bendlin, B. B., Rowley, H. A, … 
Johnson, S. C. (2009). The influence of parental history of Alzheimer’s disease and 
apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain, 132(2), 
383–391. doi:10.1093/brain/awn254 
Yan, F.-X., Wu, C. W., Chao, Y.-P., Chen, C.-J., & Tseng, Y.-C. (2015). APOE-ε4 Allele 
Altered the Rest-Stimulus Interactions in Healthy Middle-Aged Adults. PloS One, 10(6), 
e0128442. doi:10.1371/journal.pone.0128442 
Yasen, A. L., Raber, J., Miller, J. K., & Piper, B. J. (2015). Sex, but not Apolipoprotein E 
Polymorphism, Differences in Spatial Performance in Young Adults. Archives of Sexual 
Behaviour, 44(8), 2219–2226. doi:10.1007/s10508-015-0497-1 
Yu, Y. W., Lin, C. H., Chen, S. P., Hong, C. J., & Tsai, S. J. (2000). Intelligence and event-
related potentials for young female human volunteer apolipoprotein E epsilon4 and non-
epsilon4 carriers. Neuroscience Letters, 294, 179–181.  
Yuan, P., & Raz, N. (2014). Prefrontal cortex and executive functions in healthy adults: A meta-
analysis of structural neuroimageing studies. Neuroscience and Biobehavioural Reviews, 
42, 180–192. doi:10.1016/j.neubiorev.2014.02.005 
Zade, D., Beiser, A., McGlinchey, R., Au, R., Seshadri, S., Palumbo, C., … Milberg, W. (2010). 
Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on 
Neuropsychological Performance and Structural Brain Changes. Journal of Stroke and 
Cerebrovascular Diseases, 19(4), 261–268. 
doi:10.1016/j.jstrokecerebrovasdis.2009.05.001 
Zhao, J. H., Brunner, E. J., Kumari, M., Singh-Manoux,  a., Hawe, E., Talmud, P. J., … 
Humphries, S. E. (2005). APOE polymorphism, socioeconomic status and cognitive 
function in mid-life. The Whitehall II longitudinal study. Social Psychiatry and 
Psychiatric Epidemiology, 40, 557–563. doi; 10.1007/s00127-005-0925-y 
Zheng, L., Sun, Z., Li, J., Zhang, R., Zhang, X., Liu, S., … Sun, Y. (2008). Pulse pressure and 
mean arterial pressure in relation to ischemic stroke among patients with uncontrolled 
		
200	
hypertension in rural areas of China. Stroke, 39(7), 1932–1937. 
doi:10.1161/STROKEAHA.107.510677 
Zimprich, D., & Mascherek, A. (2010). Five views of a secret: Does cognition change during 
middle adulthood? European Journal of Ageing, 7(3), 135–146. doi:10.1007/s10433-010-
0161-5 
Zuber, S., Kliegel, M., & Ihle, A. (2016). An individual difference perspective on focal versus 
nonfocal prospective memory. Memory & Cognition, 1192–1203. doi:10.3758/s13421-
016-0628-5 
Zuelsdorff, M. L., Engelman, C. D., Friedman, E. M., Koscik, R. L., Jonaitis, E. M., La Rue, A., 
& Sager, M. A. (2013). Stressful events, social support, and cognitive function in middle-
aged adults with a family history of Alzheimer’s disease. Journal of Ageing and Health, 
898264313498416. 
 
 	
 
 
  
		
201	
Appendix: 
 
In addition, group differences (Age, Genotype) in the proportion of WM targets identified in 
each condition (control, focal, non-focal) was probed using a 3 (Condition) x 2 (Age) x 2 
(Genotype) mixed ANOVA.  
 
The proportion of WM targets recalled in each PM condition is shown in Table 5. At trend 
level, young adults (M=.91, SD=.18) recalled a higher proportion of WM targets than mid-age 
adults (M=.84, SD=.19), F(1, 84)=3.16, p=.079, n2p=.036. The main effect of focality was non-
significant (p>.05), however there was a significant Focality x Age x Genotype interaction, 
F(1.79, 150.13)=3.18, p=.050, n2p=.036. In ε3 carriers, there was a significant Age x Focality 
interaction, F(2, 100)=3.17, p=.046, n2p=.060. SME analysis identified a trend of mid-age 
volunteers retrieving a smaller proportion of WM targets than young volunteers selectively in 
the non-focal condition (p=.039) (Bonferroni-corrected α=.013). In ε4s the Age x Focality 
interaction was non-significant (p>.05). 
 
Table A. The proportion of WM targets reported in each focality condition. 
    Control Focal Non-focal 
Young ε3 .81 (.27) .87 (.30) .95 (.17) 
 
ε4 1.01 (.16) .94 (.23) .88 (.28) 
Mid ε3 .87 (.24) .87 (.25) .78 (.30) 
  ε4 .85 (.19) .80 (.31) .86 (.38) 	
 
